data_2juf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2juf _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 79.8 t80 . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 120.858 0.361 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.48 -32.76 84.22 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.034 -0.984 . . . . 0.0 112.931 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 41.2 tt0 -62.86 -48.94 76.84 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.098 0.559 . . . . 0.0 110.274 173.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -57.51 -50.42 73.14 Favored 'General case' 0 C--N 1.358 0.971 0 O-C-N 124.017 0.823 . . . . 0.0 110.838 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.448 ' HB ' HD22 ' A' ' 22' ' ' LEU . 29.5 m -67.74 -39.01 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 O-C-N 123.535 0.522 . . . . 0.0 110.645 -177.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -56.91 -31.25 64.72 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.153 0.581 . . . . 0.0 111.723 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 26.4 mm-40 -81.94 -40.57 22.07 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.191 -177.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.5 t -100.46 -6.06 26.13 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -168.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.493 HD12 ' SD ' ' A' ' 26' ' ' MET . 1.1 mm? -69.7 107.79 3.61 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 118.164 0.438 . . . . 0.0 110.612 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -87.46 142.45 33.1 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.08 0.952 . . . . 0.0 110.498 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.489 ' HA ' ' CD1' ' A' ' 45' ' ' PHE . 34.7 Cg_exo -59.59 79.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.531 2.821 . . . . 0.0 114.061 176.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.33 19.32 1.22 Allowed Glycine 0 C--N 1.353 1.525 0 CA-C-O 119.534 -0.592 . . . . 0.0 113.015 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.493 ' SD ' HD12 ' A' ' 22' ' ' LEU . 4.7 ptp -93.91 174.68 7.04 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 117.704 0.752 . . . . 0.0 110.876 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -97.02 126.97 42.54 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.747 1.219 . . . . 0.0 109.055 -171.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.426 HG13 HD11 ' A' ' 22' ' ' LEU . 5.7 m -116.03 172.34 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.676 0.791 . . . . 0.0 109.999 -174.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -144.58 140.95 29.1 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.173 1.389 . . . . 0.0 108.329 -172.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.484 ' HE2' ' HA ' ' A' ' 30' ' ' MET . 1.4 tpt -98.95 112.15 24.34 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 74' ' ' GLU . 4.7 pp -89.48 -3.7 58.26 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -140.7 154.01 46.18 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.63 127.04 32.2 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.221 0.534 . . . . 0.0 110.144 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.435 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -107.06 172.68 6.69 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.734 0.813 . . . . 0.0 110.989 -178.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -50.11 -35.78 26.99 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.818 1.647 . . . . 0.0 113.237 -172.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -138.58 3.6 2.31 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.859 0.864 . . . . 0.0 111.182 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.435 ' HB ' ' HB2' ' A' ' 34' ' ' TYR . 7.2 mt -118.78 144.19 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.438 1.095 . . . . 0.0 108.503 -172.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 m -91.77 153.69 19.44 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.85 0.46 . . . . 0.0 110.909 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.11 116.14 12.18 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 166.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.7 -5.71 29.48 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.346 -172.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -79.17 156.23 28.31 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.748 0.419 . . . . 0.0 110.108 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -129.88 158.21 40.12 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.252 0.621 . . . . 0.0 111.136 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -149.26 -166.88 13.5 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.501 -172.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -135.47 139.26 43.93 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 24' ' ' PRO . 38.7 t80 -69.13 119.52 13.55 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.496 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 14.5 mmm180 -103.65 -46.96 4.38 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.618 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -172.21 156.92 4.05 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.734 1.214 . . . . 0.0 108.885 176.421 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.7 p -127.39 178.2 6.22 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.473 0.709 . . . . 0.0 110.335 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 . . . . . 0 C--O 1.238 0.499 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 170.013 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo . . . . . 0 CA--C 1.577 2.656 0 N-CA-C 118.361 2.408 . . . . 0.0 118.361 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 28.9 Cg_endo -61.68 107.75 0.55 Allowed 'Trans proline' 0 C--N 1.384 2.415 0 CA-C-N 123.101 2.143 . . . . 0.0 112.51 175.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.04 136.46 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.28 1.032 . . . . 0.0 109.502 169.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.618 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 1.8 mp0 -90.4 123.35 34.05 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.452 HG11 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -137.03 136.75 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.0 1.32 . . . . 0.0 108.546 -174.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -82.53 105.58 13.69 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -175.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.468 ' HB2' HG22 ' A' ' 62' ' ' THR . 95.6 m95 -90.14 130.61 36.27 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.064 0.946 . . . . 0.0 110.432 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -70.31 -31.33 68.61 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 123.863 0.727 . . . . 0.0 112.727 -174.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.6 t -70.08 -46.08 65.68 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 117.951 0.341 . . . . 0.0 111.536 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.468 HG22 ' HB2' ' A' ' 59' ' ' TRP . 9.8 t -86.45 -18.13 32.5 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 122.736 0.414 . . . . 0.0 110.676 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.8 19.71 78.69 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-O 119.727 -0.485 . . . . 0.0 114.277 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -153.04 165.0 36.95 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.317 0.579 . . . . 0.0 112.244 -173.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.507 HG22 ' HB3' ' A' ' 56' ' ' GLN . 2.1 m -87.05 121.63 29.78 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.933 -177.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -130.64 157.15 43.53 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.964 0.411 . . . . 0.0 111.283 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 12.3 m-90 -79.02 114.34 17.88 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.714 1.205 . . . . 0.0 110.191 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.431 HG21 HD23 ' A' ' 73' ' ' LEU . 11.6 m -129.05 155.34 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 122.838 0.455 . . . . 0.0 110.652 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -89.47 147.06 24.21 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.736 0.814 . . . . 0.0 110.169 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -59.82 -42.36 93.33 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.428 0.691 . . . . 0.0 112.59 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -66.99 -24.94 66.09 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 117.661 0.21 . . . . 0.0 111.336 -176.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 71.4 mtm -99.88 -1.82 36.43 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.732 0.413 . . . . 0.0 111.62 175.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.431 HD23 HG21 ' A' ' 68' ' ' VAL . 2.5 tm? -92.66 121.23 33.87 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 172.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.516 ' HB2' HD23 ' A' ' 31' ' ' LEU . 39.6 tt0 -115.69 151.59 34.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.882 1.273 . . . . 0.0 108.458 176.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.451 HG21 ' SD ' ' A' ' 26' ' ' MET . 10.7 pt . . . . . 0 N--CA 1.483 1.177 0 CA-C-N 118.433 0.56 . . . . 0.0 110.723 169.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.4 t80 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.02 -31.77 81.99 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.893 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 12.1 tp10 -69.14 -48.05 63.42 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -59.06 -49.92 76.05 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 114.986 -1.007 . . . . 0.0 111.396 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.8 -40.67 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 123.677 0.611 . . . . 0.0 110.721 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -57.64 -36.31 71.67 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.507 0.723 . . . . 0.0 111.932 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 23.5 mm-40 -80.21 -35.79 35.77 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.009 0.524 . . . . 0.0 111.171 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 t -101.04 7.82 43.24 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.806 0.443 . . . . 0.0 112.117 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.97 113.98 11.76 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.495 ' HB3' ' HB3' ' A' ' 26' ' ' MET . 34.3 tt0 -87.44 134.71 35.57 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.06 0.944 . . . . 0.0 109.673 -176.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.499 ' HA ' ' CD1' ' A' ' 45' ' ' PHE . 52.7 Cg_endo -64.81 80.3 0.18 Allowed 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 123.151 2.567 . . . . 0.0 113.457 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.99 26.44 1.54 Allowed Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.057 175.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.495 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 24.6 ptm -96.53 168.97 10.22 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.608 0.718 . . . . 0.0 110.54 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.424 ' HD2' ' HB3' ' A' ' 42' ' ' GLU . 18.6 tpp180 -90.01 126.31 35.71 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.851 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.459 HG13 HG21 ' A' ' 75' ' ' ILE . 8.0 m -116.44 171.02 5.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 C-N-CA 124.209 1.003 . . . . 0.0 108.833 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.46 ' HD2' ' N ' ' A' ' 30' ' ' MET . 2.6 tmm_? -137.29 143.93 42.41 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.529 ' HE3' ' HA ' ' A' ' 30' ' ' MET . 1.9 tpt -92.77 112.68 24.72 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.642 0.777 . . . . 0.0 109.133 -177.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.485 HD23 ' HB2' ' A' ' 74' ' ' GLU . 4.4 pp -89.19 -9.58 50.29 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.571 0.348 . . . . 0.0 111.547 -178.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -127.02 162.62 25.6 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.944 0.898 . . . . 0.0 109.344 -174.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.43 146.19 25.96 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.526 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 13.8 m-85 -133.53 173.07 11.9 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.645 0.778 . . . . 0.0 111.117 -176.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -50.93 -47.4 61.03 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.15 1.38 . . . . 0.0 112.043 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -131.09 -1.35 4.08 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.696 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.526 ' HB ' ' HB2' ' A' ' 34' ' ' TYR . 3.9 mp -112.64 143.02 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.2 t -103.32 154.5 19.31 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.263 0.625 . . . . 0.0 109.751 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.83 114.18 6.93 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.402 ' HA2' HH11 ' A' ' 29' ' ' ARG . . . 124.58 -17.54 7.33 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.314 -176.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.62 154.71 41.59 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.209 0.603 . . . . 0.0 111.259 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.424 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 45.0 mt-10 -112.79 138.61 49.37 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.601 0.761 . . . . 0.0 110.813 -175.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.56 -176.74 14.59 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.99 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -135.36 137.18 42.1 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 24' ' ' PRO . 60.4 t80 -69.65 120.35 15.29 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.485 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 9.9 mmm-85 -107.42 -47.52 3.63 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.604 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -169.06 166.38 10.99 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.252 1.021 . . . . 0.0 109.398 178.624 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 92.3 p -152.93 -179.18 7.43 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.689 0.757 . . . . 0.0 111.509 -176.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 . . . . . 0 CA--C 1.545 0.766 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 168.509 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 CA--C 1.584 2.982 0 N-CA-C 119.221 2.739 . . . . 0.0 119.221 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.95 106.24 0.63 Allowed 'Trans proline' 0 C--N 1.389 2.692 0 CA-C-N 123.558 2.306 . . . . 0.0 113.054 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 p -95.44 132.3 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.318 167.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.604 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.1 mp0 -92.12 124.62 36.34 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.487 HG13 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -134.71 139.05 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.09 1.356 . . . . 0.0 108.636 -174.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -81.52 107.13 14.03 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.562 0.745 . . . . 0.0 109.731 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.402 ' NE1' HG23 ' A' ' 57' ' ' VAL . 93.0 m95 -93.83 130.1 39.99 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.944 0.898 . . . . 0.0 110.618 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -71.17 -26.25 62.89 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 123.965 0.791 . . . . 0.0 112.508 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.3 t -62.62 -45.85 90.96 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.047 0.451 . . . . 0.0 111.401 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.9 t -99.16 -12.19 20.69 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.913 0.885 . . . . 0.0 110.36 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.18 22.31 74.34 Favored Glycine 0 C--N 1.352 1.458 0 CA-C-N 115.966 -0.561 . . . . 0.0 114.17 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -151.35 172.45 15.89 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 117.324 0.562 . . . . 0.0 111.202 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.11 139.64 31.57 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.268 1.027 . . . . 0.0 109.102 -175.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -144.71 155.41 43.55 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.056 0.455 . . . . 0.0 111.139 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -79.75 120.73 24.44 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.033 1.333 . . . . 0.0 109.351 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.438 HG21 HD12 ' A' ' 73' ' ' LEU . 6.7 m -131.44 160.91 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.206 0.602 . . . . 0.0 109.665 176.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 72' ' ' MET . 46.7 t60 -93.86 145.83 24.33 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.734 0.813 . . . . 0.0 108.826 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -60.15 -46.88 88.18 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.396 0.678 . . . . 0.0 112.501 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -73.15 -19.4 61.13 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.16 0.584 . . . . 0.0 111.003 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.449 ' HE3' ' OH ' ' A' ' 34' ' ' TYR . 46.5 mtp -98.32 2.64 48.3 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.252 1.021 . . . . 0.0 110.668 176.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.438 HD12 HG21 ' A' ' 68' ' ' VAL . 58.5 tp -111.03 133.78 53.15 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.518 1.127 . . . . 0.0 109.142 176.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.485 ' HB2' HD23 ' A' ' 31' ' ' LEU . 35.5 tt0 -107.25 152.56 23.94 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 172.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.459 HG21 HG13 ' A' ' 28' ' ' VAL . 21.7 pt . . . . . 0 N--CA 1.476 0.868 0 C-N-CA 122.905 0.482 . . . . 0.0 109.801 166.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 55.4 t80 . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 110.907 -0.034 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.91 -40.71 95.54 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.363 0.414 . . . . 0.0 113.247 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 25.7 tt0 -71.36 -36.09 71.35 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.925 0.49 . . . . 0.0 110.348 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -64.47 -49.49 71.22 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.096 0.958 . . . . 0.0 111.255 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.423 ' HA ' HG23 ' A' ' 21' ' ' THR . 28.8 m -63.45 -39.63 86.03 Favored 'Isoleucine or valine' 0 C--N 1.354 0.77 0 O-C-N 123.65 0.593 . . . . 0.0 110.316 -176.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -55.81 -38.77 70.43 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.196 0.599 . . . . 0.0 111.202 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 23.9 mm-40 -78.66 -38.94 38.27 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.408 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.423 HG23 ' HA ' ' A' ' 18' ' ' VAL . 12.6 t -94.11 2.06 56.04 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -173.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.488 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.2 OUTLIER -71.11 127.99 34.42 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 118.114 0.415 . . . . 0.0 109.944 176.448 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -116.41 133.67 22.95 Favored Pre-proline 0 N--CA 1.488 1.443 0 C-N-CA 124.26 1.024 . . . . 0.0 109.775 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.03 90.55 0.13 Allowed 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 123.227 2.618 . . . . 0.0 112.805 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.61 8.06 3.26 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 116.147 -0.478 . . . . 0.0 112.782 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.488 ' SD ' HD13 ' A' ' 22' ' ' LEU . 9.8 ptp -87.33 157.48 19.27 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 173.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -87.27 157.19 19.36 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.748 0.785 . . . . 0.0 109.342 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.491 HG12 HG23 ' A' ' 75' ' ' ILE . 9.5 m -133.88 173.63 14.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.415 ' NE ' ' HA2' ' A' ' 40' ' ' GLY . 3.6 tmt_? -151.21 145.84 25.67 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.438 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 31.9 tpp -98.43 126.95 44.15 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.009 0.924 . . . . 0.0 110.297 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.597 HD22 ' HB2' ' A' ' 74' ' ' GLU . 3.9 pp -95.47 -7.63 37.62 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.221 0.608 . . . . 0.0 111.857 -176.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 30' ' ' MET . 21.7 t70 -132.64 168.47 18.22 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.449 0.7 . . . . 0.0 110.411 -174.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -80.19 130.69 35.4 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 122.137 -0.352 . . . . 0.0 110.248 175.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.438 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 1.2 m-85 -120.07 171.79 8.21 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.045 0.938 . . . . 0.0 110.433 176.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -50.44 -49.51 54.77 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.497 1.519 . . . . 0.0 113.009 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -126.17 0.38 7.13 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.645 0.778 . . . . 0.0 111.318 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.47 HD13 ' HB3' ' A' ' 66' ' ' TYR . 4.9 mt -116.56 126.37 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.1 m -89.43 155.17 19.49 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.26 113.36 3.54 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.415 ' HA2' ' NE ' ' A' ' 29' ' ' ARG . . . 124.37 -21.92 6.72 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.22 -177.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.411 ' OD2' ' HB3' ' A' ' 59' ' ' TRP . 28.4 t0 -62.19 142.45 57.65 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.301 0.64 . . . . 0.0 112.07 -176.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -104.1 148.29 26.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.256 1.022 . . . . 0.0 110.761 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.63 -173.85 13.09 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.434 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -134.91 140.69 45.96 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.478 ' HA ' HG11 ' A' ' 57' ' ' VAL . 59.3 t80 -71.63 119.75 16.24 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 123.864 0.727 . . . . 0.0 110.08 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.494 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 11.4 mmm180 -107.58 -47.68 3.57 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -174.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.531 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -164.42 157.18 17.1 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.338 1.055 . . . . 0.0 109.412 177.179 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.439 ' HA ' HG21 ' A' ' 55' ' ' VAL . 29.8 p -117.4 178.31 4.42 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.914 0.886 . . . . 0.0 111.169 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 . . . . . 0 C--O 1.236 0.375 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.61 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo . . . . . 0 CA--C 1.581 2.832 0 N-CA-C 118.074 2.298 . . . . 0.0 118.074 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.504 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 43.1 Cg_endo -68.51 109.09 1.97 Allowed 'Trans proline' 0 C--N 1.384 2.401 0 CA-C-N 123.325 2.223 . . . . 0.0 111.827 169.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.439 HG21 ' HA ' ' A' ' 48' ' ' SER . 3.2 p -90.34 141.62 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.621 1.168 . . . . 0.0 110.478 171.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.531 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.0 mp0 -93.33 125.17 37.8 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.549 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.478 HG11 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -138.89 138.45 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.167 1.387 . . . . 0.0 108.538 -176.581 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -81.96 106.67 14.06 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.429 ' HB2' HG21 ' A' ' 62' ' ' THR . 97.6 m95 -91.73 130.49 37.51 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.579 1.152 . . . . 0.0 110.647 -176.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.23 -26.93 60.53 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -174.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.3 t -72.6 -41.49 65.56 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.025 0.375 . . . . 0.0 111.378 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.429 HG21 ' HB2' ' A' ' 59' ' ' TRP . 10.5 t -87.76 -30.78 20.03 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 122.783 0.433 . . . . 0.0 109.843 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.58 16.76 58.07 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.911 -0.586 . . . . 0.0 114.096 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.75 175.37 12.47 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.593 0.757 . . . . 0.0 112.032 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.47 132.96 33.8 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.882 1.273 . . . . 0.0 109.716 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.47 ' HB3' HD13 ' A' ' 37' ' ' ILE . 12.7 t80 -138.82 156.99 46.88 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.09 0.472 . . . . 0.0 111.028 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.504 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 12.9 m-90 -83.51 113.74 21.0 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.128 1.371 . . . . 0.0 109.744 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.42 HG23 HD11 ' A' ' 73' ' ' LEU . 17.0 m -130.15 154.55 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.326 0.651 . . . . 0.0 110.546 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -80.62 145.5 31.66 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.994 0.518 . . . . 0.0 110.352 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -59.51 -45.59 91.29 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.526 0.731 . . . . 0.0 112.042 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -70.56 -25.36 63.05 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.528 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 74.7 mtm -93.2 1.27 57.17 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.745 0.418 . . . . 0.0 111.13 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.42 HD11 HG23 ' A' ' 68' ' ' VAL . 26.5 tp -97.11 118.82 34.39 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 174.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.597 ' HB2' HD22 ' A' ' 31' ' ' LEU . 42.9 tt0 -108.2 108.4 19.42 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.975 0.91 . . . . 0.0 108.924 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.491 HG23 HG12 ' A' ' 28' ' ' VAL . 17.9 pt . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 121.737 0.779 . . . . 0.0 111.415 -174.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.1 t80 . . . . . 0 N--CA 1.481 1.118 0 CA-C-O 120.823 0.344 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.62 -42.99 87.01 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.147 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -71.05 -22.49 62.12 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.769 0.827 . . . . 0.0 111.735 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -70.95 -50.99 28.54 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.27 0.228 . . . . 0.0 110.792 170.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.8 m -66.63 -41.55 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -169.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -55.78 -30.29 61.05 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.336 0.654 . . . . 0.0 112.706 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -78.32 -36.93 45.7 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.056 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.2 t -94.36 -0.36 54.96 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.452 HD12 ' SD ' ' A' ' 26' ' ' MET . 0.6 OUTLIER -72.1 117.61 13.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 122.039 -0.413 . . . . 0.0 110.738 177.074 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -96.86 135.66 22.01 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 124.112 0.965 . . . . 0.0 110.253 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.427 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 27.9 Cg_exo -62.97 82.19 0.11 Allowed 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.657 2.905 . . . . 0.0 113.188 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.03 15.92 1.64 Allowed Glycine 0 C--N 1.345 1.056 0 CA-C-N 116.4 -0.363 . . . . 0.0 112.467 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.452 ' SD ' HD12 ' A' ' 22' ' ' LEU . 5.3 ptp -90.7 163.75 14.39 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.539 0.685 . . . . 0.0 110.298 176.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.433 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 25.2 tpt180 -83.73 129.02 34.95 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.192 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 m -115.62 172.03 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -141.63 141.94 33.42 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.228 1.411 . . . . 0.0 108.272 -172.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.504 ' HA ' ' HE2' ' A' ' 30' ' ' MET . 2.3 tpt -86.43 110.53 19.79 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.3 tp -81.13 -29.44 34.77 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.061 0.544 . . . . 0.0 110.599 -175.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -143.1 151.75 41.08 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -66.33 151.0 48.01 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.062 0.545 . . . . 0.0 111.51 -168.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -133.15 172.16 13.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.636 0.774 . . . . 0.0 111.436 -174.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -49.23 -47.8 46.08 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.037 1.735 . . . . 0.0 112.483 -175.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -129.99 2.88 4.82 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.995 0.918 . . . . 0.0 111.32 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -118.56 143.87 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.4 m -98.98 148.76 23.67 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.907 0.483 . . . . 0.0 110.208 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.1 117.48 5.59 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.998 0.519 . . . . 0.0 110.076 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.28 -15.93 20.17 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.487 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.98 151.06 43.51 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 117.265 0.533 . . . . 0.0 109.856 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -118.34 146.37 44.42 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.403 0.62 . . . . 0.0 110.939 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . -127.9 -165.36 11.83 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.252 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -136.27 142.64 43.97 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.435 ' HA ' HG11 ' A' ' 57' ' ' VAL . 75.4 t80 -75.57 119.58 19.81 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.416 0.686 . . . . 0.0 110.276 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.54 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 11.9 mmm180 -108.06 -49.6 3.18 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -175.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.54 ' NE2' ' HB2' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -164.82 163.67 21.17 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.44 1.096 . . . . 0.0 109.271 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 87.8 p -161.95 179.74 7.79 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 122.088 0.947 . . . . 0.0 112.517 -176.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 . . . . . 0 C--O 1.239 0.536 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 167.309 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 CA--C 1.578 2.678 0 N-CA-C 118.848 2.595 . . . . 0.0 118.848 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.66 101.75 0.27 Allowed 'Trans proline' 0 C--N 1.389 2.662 0 CA-C-N 123.256 2.199 . . . . 0.0 112.199 171.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.11 135.3 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.722 168.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.521 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.0 mp0 -91.01 121.89 33.21 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.435 HG11 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -135.27 136.6 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.91 1.284 . . . . 0.0 108.411 -176.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -82.38 106.18 14.04 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.849 0.46 . . . . 0.0 109.917 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -94.11 131.0 40.08 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.053 0.941 . . . . 0.0 110.535 -177.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -71.04 -24.8 62.42 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.5 p -62.03 -45.75 92.22 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.414 0.626 . . . . 0.0 111.53 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.8 t -99.51 -17.87 17.69 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.367 -176.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.59 19.21 74.12 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-O 119.789 -0.45 . . . . 0.0 113.961 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -152.27 170.12 20.83 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.499 0.666 . . . . 0.0 111.216 -175.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.443 HG22 ' HB3' ' A' ' 56' ' ' GLN . 1.3 m -86.52 129.14 34.97 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.773 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -131.99 154.71 49.05 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.268 0.556 . . . . 0.0 111.612 -174.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -85.18 100.48 11.78 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.396 1.478 . . . . 0.0 109.427 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.8 m -116.94 162.02 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 122.744 0.418 . . . . 0.0 110.348 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.536 ' HD2' ' H ' ' A' ' 71' ' ' HIS . 8.8 t60 -91.59 147.79 22.75 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.301 0.641 . . . . 0.0 109.846 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -58.84 -45.66 89.54 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.363 1.065 . . . . 0.0 113.291 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.536 ' H ' ' HD2' ' A' ' 69' ' ' HIS . 57.5 t-80 -66.44 -21.59 66.2 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.431 0.693 . . . . 0.0 111.797 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 76.3 mtm -101.94 9.66 40.37 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.2 0.6 . . . . 0.0 111.248 174.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.7 tt -109.64 120.62 43.05 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 172.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -106.86 150.22 26.61 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.903 1.281 . . . . 0.0 107.774 171.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.2 pt . . . . . 0 N--CA 1.485 1.295 0 CA-C-N 119.123 0.874 . . . . 0.0 111.818 174.734 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.403 ' HH ' ' HA ' ' A' ' 74' ' ' GLU . 75.1 t80 . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.539 0.209 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.56 -28.81 71.95 Favored Glycine 0 C--N 1.354 1.563 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.6 176.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.27 -47.73 59.98 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.963 0.505 . . . . 0.0 110.406 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -58.08 -50.21 74.25 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.055 0.847 . . . . 0.0 110.925 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.5 m -66.23 -37.3 79.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.311 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -31.36 59.19 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.72 0.808 . . . . 0.0 110.687 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -91.96 -47.98 7.01 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.573 0.749 . . . . 0.0 111.2 -174.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.9 t -79.13 -11.99 59.99 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -173.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.71 112.17 5.28 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 117.917 0.326 . . . . 0.0 110.575 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -97.53 132.81 24.52 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 123.875 0.87 . . . . 0.0 109.771 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.01 84.45 0.25 Allowed 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 123.021 2.48 . . . . 0.0 112.666 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 143.68 -0.68 1.25 Allowed Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.826 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.8 ptp -88.73 154.56 20.19 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -85.28 157.91 20.45 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 m -128.69 173.3 13.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.728 -1.123 . . . . 0.0 108.316 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.534 ' HD3' ' HA2' ' A' ' 40' ' ' GLY . 3.6 tmm_? -141.54 136.6 31.29 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.529 ' HA ' ' HE2' ' A' ' 30' ' ' MET . 3.2 tpt -76.82 111.45 12.36 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.511 1.124 . . . . 0.0 109.279 -178.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 41.2 tp -69.88 -36.53 75.52 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.137 0.575 . . . . 0.0 111.0 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -141.34 150.92 43.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.668 0.787 . . . . 0.0 109.18 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -65.58 129.88 41.33 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.831 0.707 . . . . 0.0 111.234 -170.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -106.97 173.58 6.26 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.128 0.971 . . . . 0.0 110.749 -177.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -47.41 -44.95 24.98 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.813 1.645 . . . . 0.0 113.386 -175.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -131.36 7.33 4.55 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.885 0.874 . . . . 0.0 111.058 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.23 144.79 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.825 0.85 . . . . 0.0 109.391 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.4 m -93.44 147.33 23.05 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.076 0.55 . . . . 0.0 110.543 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.48 117.86 8.6 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.534 ' HA2' ' HD3' ' A' ' 29' ' ' ARG . . . 115.16 -18.95 15.56 Favored Glycine 0 N--CA 1.469 0.862 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -66.64 144.45 56.39 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.606 0.762 . . . . 0.0 110.648 178.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -109.1 144.14 37.52 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.407 0.623 . . . . 0.0 110.659 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.65 -168.43 12.32 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.639 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -137.18 142.49 42.15 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 169.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 48' ' ' SER . 85.4 t80 -88.31 118.23 27.78 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.924 0.889 . . . . 0.0 109.451 177.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.417 ' HG2' ' NE2' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -115.94 -47.17 2.79 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.317 0.247 . . . . 0.0 111.286 175.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.417 ' NE2' ' HG2' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -136.86 150.66 48.4 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.606 0.362 . . . . 0.0 110.407 -177.095 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.442 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 64.4 p -145.12 165.28 28.74 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.638 0.775 . . . . 0.0 111.745 -177.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 . . . . . 0 CA--C 1.541 0.626 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 173.776 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 CA--C 1.579 2.747 0 N-CA-C 118.292 2.382 . . . . 0.0 118.292 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.635 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 57.4 Cg_endo -71.36 109.09 2.52 Favored 'Trans proline' 0 C--N 1.383 2.393 0 CA-C-N 123.523 2.294 . . . . 0.0 112.241 169.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.404 HG21 ' HA ' ' A' ' 48' ' ' SER . 6.4 p -86.93 144.45 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.061 0.944 . . . . 0.0 110.774 173.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -89.64 122.63 32.95 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.14 136.16 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -80.93 104.12 11.22 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -176.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.49 ' HB2' HG21 ' A' ' 62' ' ' THR . 88.6 m95 -92.01 130.03 37.84 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.434 1.094 . . . . 0.0 109.745 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -70.01 -34.87 73.86 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 123.61 0.569 . . . . 0.0 111.775 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.1 t -60.65 -45.18 95.07 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.666 0.386 . . . . 0.0 111.371 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.49 HG21 ' HB2' ' A' ' 59' ' ' TRP . 8.9 t -90.88 -16.68 27.76 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.762 0.425 . . . . 0.0 110.984 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.78 14.56 80.82 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 119.612 -0.549 . . . . 0.0 114.206 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -152.77 176.83 11.36 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 117.439 0.619 . . . . 0.0 110.9 -172.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 p -84.91 136.84 33.46 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.006 0.522 . . . . 0.0 109.727 173.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -134.89 156.02 49.68 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 123.886 0.742 . . . . 0.0 110.041 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.635 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 14.9 m-90 -87.6 101.37 13.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.34 1.456 . . . . 0.0 109.498 -173.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.3 m -117.09 153.27 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.147 0.579 . . . . 0.0 109.7 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -85.19 146.71 26.96 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -58.91 -40.13 83.61 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.886 0.875 . . . . 0.0 112.764 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -69.69 -20.76 63.55 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 123.316 0.646 . . . . 0.0 112.164 -176.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 69.4 mtm -106.1 14.29 27.94 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 122.973 0.509 . . . . 0.0 111.424 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.3 tt -104.53 121.69 44.01 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 172.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.403 ' HA ' ' HH ' ' A' ' 14' ' ' TYR . 37.2 tt0 -106.6 152.7 23.38 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 171.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.7 pt . . . . . 0 N--CA 1.475 0.824 0 C-N-CA 122.864 0.465 . . . . 0.0 111.71 174.405 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.2 t80 . . . . . 0 N--CA 1.486 1.361 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.89 -30.4 77.9 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 114.443 -1.253 . . . . 0.0 113.71 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 26.5 tt0 -70.34 -41.79 72.73 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 175.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -60.37 -49.57 77.07 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.243 0.617 . . . . 0.0 111.148 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.444 ' HA ' HG22 ' A' ' 21' ' ' THR . 34.2 m -64.94 -36.45 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 O-C-N 123.397 0.435 . . . . 0.0 110.493 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.1 -30.97 60.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.676 0.79 . . . . 0.0 111.27 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 43.8 mm-40 -80.32 -52.8 7.27 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.774 0.429 . . . . 0.0 110.771 177.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 18' ' ' VAL . 10.8 t -82.8 -7.42 59.66 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -167.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -69.43 107.13 3.21 Favored 'General case' 0 CA--C 1.558 1.251 0 CA-C-N 118.519 0.599 . . . . 0.0 110.801 176.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -88.37 134.26 34.88 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 124.143 0.977 . . . . 0.0 110.226 176.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.91 90.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.117 2.545 . . . . 0.0 112.227 171.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.14 -2.38 3.92 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.996 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.1 ptp -87.79 164.81 15.74 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 117.353 0.577 . . . . 0.0 110.57 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.62 140.01 31.06 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.699 1.199 . . . . 0.0 109.821 -173.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.427 HG12 HD13 ' A' ' 22' ' ' LEU . 4.4 m -117.19 172.83 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.816 0.846 . . . . 0.0 109.187 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -145.07 143.92 30.69 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.558 1.143 . . . . 0.0 108.651 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.1 tpp -97.62 139.1 34.03 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 122.779 0.431 . . . . 0.0 110.696 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.513 HD22 ' HB2' ' A' ' 74' ' ' GLU . 3.3 pp -112.87 -7.42 13.76 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.235 1.014 . . . . 0.0 111.676 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -127.13 172.2 10.74 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.244 1.018 . . . . 0.0 109.58 -174.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -91.11 143.09 27.05 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.797 -0.565 . . . . 0.0 110.629 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -133.28 171.77 13.59 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.984 1.313 . . . . 0.0 110.231 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -45.93 -46.98 16.4 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.367 1.467 . . . . 0.0 112.266 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -139.08 1.84 2.06 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.85 0.86 . . . . 0.0 111.398 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mp -115.1 146.45 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 174.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.0 m -130.74 164.25 25.51 Favored 'General case' 0 C--O 1.245 0.819 0 O-C-N 121.988 -0.445 . . . . 0.0 110.051 172.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.29 114.63 2.5 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 123.788 0.68 . . . . 0.0 110.286 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.28 -34.35 2.95 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.399 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -65.09 145.84 55.77 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.033 0.533 . . . . 0.0 110.192 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -120.4 146.29 46.34 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.998 0.919 . . . . 0.0 110.357 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.7 -167.52 12.4 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.126 -178.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -136.89 141.38 42.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 171.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.532 ' HA ' HG12 ' A' ' 57' ' ' VAL . 76.8 t80 -74.97 119.66 19.45 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.877 0.471 . . . . 0.0 109.988 178.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.5 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 19.5 mmm180 -108.99 -49.22 3.16 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.679 0.791 . . . . 0.0 109.592 -173.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.509 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -161.7 164.04 29.35 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.48 1.112 . . . . 0.0 109.056 177.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 16.3 p -132.07 168.56 17.75 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.622 0.769 . . . . 0.0 112.01 -175.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 . . . . . 0 C--O 1.238 0.495 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 164.768 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo . . . . . 0 CA--C 1.576 2.605 0 N-CA-C 117.775 2.183 . . . . 0.0 117.775 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.535 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 66.5 Cg_endo -76.35 111.42 3.26 Favored 'Trans proline' 0 C--N 1.377 2.062 0 CA-C-N 122.851 2.054 . . . . 0.0 112.295 165.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 p -84.38 142.95 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.598 1.159 . . . . 0.0 110.076 169.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.509 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.0 mp0 -92.32 122.69 35.02 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -136.3 138.11 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.892 1.277 . . . . 0.0 108.566 -178.222 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -82.88 104.68 13.29 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.485 ' HB2' HG23 ' A' ' 62' ' ' THR . 89.2 m95 -86.29 128.17 34.88 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.977 0.911 . . . . 0.0 109.684 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -71.71 -23.62 61.67 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -173.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.0 t -78.08 -44.68 25.56 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.48 0.582 . . . . 0.0 111.326 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.485 HG23 ' HB2' ' A' ' 59' ' ' TRP . 11.0 t -85.3 -18.94 32.39 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-O 121.006 0.432 . . . . 0.0 110.453 176.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.38 22.07 73.97 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-N 115.867 -0.606 . . . . 0.0 114.465 174.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -153.18 168.41 26.03 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 117.459 0.63 . . . . 0.0 111.999 -174.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.421 HG23 ' HB3' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -86.8 126.18 34.45 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.554 1.142 . . . . 0.0 109.215 -176.243 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -135.56 157.43 46.9 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.286 0.565 . . . . 0.0 111.42 -173.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.535 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 12.4 m-90 -86.28 111.22 20.23 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.389 1.476 . . . . 0.0 109.58 -174.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 m -131.67 150.67 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.126 0.57 . . . . 0.0 110.013 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -78.51 146.6 34.25 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 122.677 0.391 . . . . 0.0 110.964 -175.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -59.54 -48.77 80.36 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.332 1.053 . . . . 0.0 112.013 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -68.04 -27.91 66.94 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.283 0.563 . . . . 0.0 110.438 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.472 ' HA ' HD11 ' A' ' 31' ' ' LEU . 38.8 mtp -93.69 9.09 38.39 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.068 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.7 tp -112.22 120.05 40.45 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 123.728 0.811 . . . . 0.0 108.842 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.513 ' HB2' HD22 ' A' ' 31' ' ' LEU . 39.0 tt0 -107.56 135.89 48.26 Favored 'General case' 0 C--O 1.207 -1.14 0 C-N-CA 124.733 1.213 . . . . 0.0 107.789 175.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.4 pt . . . . . 0 N--CA 1.482 1.165 0 CA-C-N 119.73 1.15 . . . . 0.0 111.914 -179.278 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.405 ' HB3' ' CD2' ' A' ' 71' ' ' HIS . 41.1 t80 . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.904 0.383 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.15 -29.86 75.74 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.83 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 44.0 tt0 -72.92 -38.48 66.84 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -62.38 -48.32 80.25 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.165 0.586 . . . . 0.0 111.222 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.439 ' HB ' HD22 ' A' ' 22' ' ' LEU . 33.0 m -62.1 -37.25 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -29.99 62.97 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.984 0.914 . . . . 0.0 110.454 178.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 54.5 mm-40 -78.88 -47.33 16.73 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.988 0.515 . . . . 0.0 110.101 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 t -96.96 4.52 51.51 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -166.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.491 HD12 ' SD ' ' A' ' 26' ' ' MET . 2.0 mm? -87.59 115.28 24.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.818 -0.551 . . . . 0.0 111.574 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.418 ' O ' ' HG2' ' A' ' 26' ' ' MET . 1.4 mp0 -92.94 137.24 23.94 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 124.003 0.921 . . . . 0.0 109.688 171.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.56 86.68 0.21 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.472 2.115 . . . . 0.0 111.371 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 144.71 4.55 0.62 Allowed Glycine 0 C--N 1.347 1.171 0 CA-C-N 115.737 -0.665 . . . . 0.0 113.065 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.665 ' SD ' HG21 ' A' ' 75' ' ' ILE . 6.2 ptp -95.01 175.52 6.6 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 117.345 0.573 . . . . 0.0 110.827 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -99.52 128.4 45.63 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.058 1.343 . . . . 0.0 109.815 -170.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -115.58 171.36 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.589 0.756 . . . . 0.0 109.655 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.493 ' HA ' ' HG2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -144.0 126.95 16.37 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -174.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -78.89 121.91 25.45 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 74' ' ' GLU . 4.2 pp -105.6 14.09 28.98 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 117.945 0.339 . . . . 0.0 111.34 176.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -137.04 172.37 13.11 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.144 0.978 . . . . 0.0 111.327 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -97.35 140.53 31.67 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.889 0.876 . . . . 0.0 110.107 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -134.41 173.66 11.39 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.677 1.191 . . . . 0.0 111.421 -176.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -46.34 -45.03 17.35 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.585 1.554 . . . . 0.0 111.955 175.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -140.84 -1.95 1.37 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.183 -171.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -116.22 147.58 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 124.251 1.021 . . . . 0.0 108.344 175.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.1 m -127.49 160.96 29.89 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.958 0.503 . . . . 0.0 109.674 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.1 113.89 4.83 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.17 -61.04 0.56 Allowed Glycine 0 C--N 1.343 0.947 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -172.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -77.33 148.72 35.48 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.4 0.619 . . . . 0.0 110.632 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.493 ' HG2' ' HA ' ' A' ' 29' ' ' ARG . 42.4 mt-10 -125.62 161.34 27.45 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.014 -161.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.75 -171.97 12.64 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.887 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -133.07 135.87 45.58 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.493 ' HA ' HG13 ' A' ' 57' ' ' VAL . 16.3 t80 -72.66 121.37 19.68 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.531 0.732 . . . . 0.0 109.258 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.516 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 7.9 mmm180 -107.32 -46.37 3.89 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -175.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.516 ' NE2' ' HB2' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -152.86 159.56 43.03 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.851 0.861 . . . . 0.0 110.071 -179.127 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 64.7 p -119.58 173.39 7.03 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.72 0.808 . . . . 0.0 111.205 -176.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 . . . . . 0 N--CA 1.471 0.615 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.429 -178.884 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo . . . . . 0 CA--C 1.576 2.61 0 N-CA-C 116.71 1.773 . . . . 0.0 116.71 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.674 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 96.1 Cg_endo -75.68 97.5 1.11 Allowed 'Trans proline' 0 C--N 1.384 2.444 0 CA-C-N 122.411 1.897 . . . . 0.0 112.397 169.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.8 p -90.64 153.27 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.004 0.922 . . . . 0.0 111.297 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -96.76 129.9 44.1 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.237 0.615 . . . . 0.0 111.665 -172.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.493 HG13 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -139.85 141.79 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 125.743 1.617 . . . . 0.0 108.788 178.313 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -81.2 107.25 13.84 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.913 0.885 . . . . 0.0 109.143 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.509 ' HB2' HG23 ' A' ' 62' ' ' THR . 99.0 m95 -90.9 133.82 34.95 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.147 0.979 . . . . 0.0 111.097 -177.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -59.57 -35.19 73.78 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 124.04 0.837 . . . . 0.0 111.535 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.9 p -66.8 -45.31 78.81 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.653 0.781 . . . . 0.0 112.221 -173.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.509 HG23 ' HB2' ' A' ' 59' ' ' TRP . 10.6 t -104.84 -9.4 18.06 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.175 0.59 . . . . 0.0 111.695 -174.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.52 21.6 72.69 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 114.291 0.476 . . . . 0.0 114.291 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -151.8 176.08 11.78 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.277 0.631 . . . . 0.0 110.665 -176.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 2.1 p -85.23 129.62 34.77 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.066 0.547 . . . . 0.0 109.969 175.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -130.13 158.54 39.41 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.314 0.578 . . . . 0.0 110.196 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.674 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 18.7 m-90 -81.59 104.82 12.28 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.796 1.239 . . . . 0.0 110.782 -176.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.5 m -126.21 156.84 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.063 0.545 . . . . 0.0 110.33 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.477 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 9.1 t-160 -84.44 147.51 27.06 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 122.939 0.496 . . . . 0.0 110.944 -174.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -59.94 -47.01 87.55 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.898 0.879 . . . . 0.0 111.253 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.405 ' CD2' ' HB3' ' A' ' 14' ' ' TYR . 58.1 t-80 -66.32 -25.85 67.03 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.56 0.744 . . . . 0.0 111.471 -178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.477 ' SD ' ' HB3' ' A' ' 69' ' ' HIS . 59.5 mtp -95.14 -2.42 49.91 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.954 0.902 . . . . 0.0 111.676 -171.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 pp -110.07 157.73 19.03 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 167.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.47 ' HB2' HD21 ' A' ' 31' ' ' LEU . 30.7 tt0 -138.13 137.13 37.38 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 125.074 1.35 . . . . 0.0 108.231 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.665 HG21 ' SD ' ' A' ' 26' ' ' MET . 7.2 pt . . . . . 0 CA--C 1.537 0.45 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 169.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 40.8 t80 . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.61 -26.63 71.05 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 114.59 -1.186 . . . . 0.0 113.401 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 15.1 tp10 -71.45 -47.34 56.4 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -58.38 -50.01 75.18 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.955 0.784 . . . . 0.0 111.052 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.2 m -67.59 -36.35 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.833 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -54.96 -34.59 63.42 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.405 0.682 . . . . 0.0 111.333 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 48.5 mm-40 -85.06 -48.69 8.95 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.074 -176.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 t -85.98 -9.98 55.9 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -168.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.478 HD12 ' SD ' ' A' ' 26' ' ' MET . 0.2 OUTLIER -66.89 107.21 2.13 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 118.589 0.631 . . . . 0.0 110.176 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -94.75 132.72 27.9 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 124.016 0.926 . . . . 0.0 110.424 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.2 84.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.388 2.725 . . . . 0.0 113.868 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 141.05 4.8 1.07 Allowed Glycine 0 C--N 1.343 0.944 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.759 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.478 ' SD ' HD12 ' A' ' 22' ' ' LEU . 5.4 ptp -91.89 166.82 12.53 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 117.479 0.64 . . . . 0.0 110.717 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -88.76 134.84 33.79 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.595 1.158 . . . . 0.0 109.375 -174.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.0 m -117.15 172.31 5.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -151.01 140.01 21.03 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.7 tpp -85.94 128.94 34.95 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.142 0.496 . . . . 0.0 110.863 -175.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 23.2 tp -106.03 -5.79 19.24 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.868 0.867 . . . . 0.0 111.365 -173.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -138.27 160.66 38.9 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.537 0.735 . . . . 0.0 111.136 -174.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -82.74 127.39 33.38 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -122.49 171.36 9.15 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.07 0.948 . . . . 0.0 111.409 -174.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -49.66 -45.4 48.58 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.542 1.537 . . . . 0.0 111.847 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -132.16 -5.4 3.45 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.684 -170.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mt -118.74 140.74 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.7 t -100.85 153.53 19.4 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 172.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.4 115.26 4.93 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.78 -36.1 2.22 Favored Glycine 0 C--N 1.338 0.694 0 O-C-N 123.665 0.603 . . . . 0.0 112.089 -175.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -63.24 141.62 58.7 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.23 0.612 . . . . 0.0 111.608 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -102.45 161.62 13.57 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.672 0.789 . . . . 0.0 111.13 -175.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.83 -170.2 19.59 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.466 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -135.3 137.81 42.84 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 48' ' ' SER . 57.4 t80 -85.23 119.6 25.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.927 173.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.407 ' HG2' ' NE2' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -115.79 -45.95 2.86 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 122.236 0.214 . . . . 0.0 111.198 172.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.408 ' NE2' ' H ' ' A' ' 47' ' ' GLN . 0.5 OUTLIER -126.85 163.54 23.39 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.917 0.487 . . . . 0.0 110.056 -177.394 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 37.8 t -148.86 168.52 22.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.596 0.758 . . . . 0.0 112.265 -167.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 . . . . . 0 CA--C 1.542 0.662 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 164.191 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 CA--C 1.581 2.828 0 N-CA-C 118.111 2.312 . . . . 0.0 118.111 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.446 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 58.6 Cg_endo -72.57 106.5 2.11 Favored 'Trans proline' 0 C--N 1.383 2.354 0 CA-C-N 123.084 2.137 . . . . 0.0 112.521 170.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.547 HG22 ' HA ' ' A' ' 48' ' ' SER . 8.9 p -86.49 146.12 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.642 168.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -91.94 128.14 37.67 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.91 136.47 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.269 1.028 . . . . 0.0 108.485 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -81.88 108.68 15.6 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.496 ' HB2' HG23 ' A' ' 62' ' ' THR . 95.3 m95 -93.15 131.0 38.61 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.941 0.896 . . . . 0.0 110.864 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -63.81 -27.28 69.07 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 124.133 0.896 . . . . 0.0 110.66 172.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.8 t -65.49 -47.04 77.41 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 124.369 1.068 . . . . 0.0 112.055 -173.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.496 HG23 ' HB2' ' A' ' 59' ' ' TRP . 6.6 t -103.28 -14.48 16.3 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.002 0.921 . . . . 0.0 110.458 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.84 14.14 82.35 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.86 -0.609 . . . . 0.0 113.688 178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -150.26 172.01 16.05 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.266 0.555 . . . . 0.0 110.979 -174.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.43 124.52 33.51 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.629 1.172 . . . . 0.0 108.917 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -128.27 154.51 45.81 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.184 0.516 . . . . 0.0 110.763 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 14.4 m-90 -81.04 111.27 17.36 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.358 -1.292 . . . . 0.0 109.736 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.9 m -126.81 159.15 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.026 0.53 . . . . 0.0 109.838 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -86.81 147.11 25.96 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.386 0.674 . . . . 0.0 110.124 -174.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -61.41 -48.5 80.9 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.084 0.554 . . . . 0.0 111.691 -178.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -69.3 -11.43 60.8 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.447 0.699 . . . . 0.0 111.734 -177.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 34.8 mtp -113.62 10.03 17.97 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.233 1.013 . . . . 0.0 110.787 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.9 tp -113.82 121.42 43.97 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 124.211 1.004 . . . . 0.0 108.708 176.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -107.84 132.44 53.42 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.911 0.885 . . . . 0.0 110.028 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.413 HD12 HD21 ' A' ' 22' ' ' LEU . 28.8 pt . . . . . 0 N--CA 1.478 0.96 0 O-C-N 121.824 -0.548 . . . . 0.0 111.012 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.1 t80 . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.49 -36.83 84.58 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-O 121.409 0.449 . . . . 0.0 112.963 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 8.3 mp0 -71.26 -42.56 68.63 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.805 0.842 . . . . 0.0 109.132 176.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -60.28 -48.91 79.73 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 124.183 0.927 . . . . 0.0 111.798 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.8 m -64.06 -38.31 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 123.264 0.353 . . . . 0.0 110.572 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -56.13 -32.44 64.23 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.266 0.626 . . . . 0.0 111.103 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 41.8 mm-40 -77.16 -51.78 10.4 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.575 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.2 t -87.69 5.54 39.26 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.618 0.767 . . . . 0.0 112.383 -170.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.17 108.83 5.55 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 26' ' ' MET . 35.1 tt0 -87.31 131.86 43.0 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 123.686 0.794 . . . . 0.0 110.179 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.424 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 72.4 Cg_exo -53.12 88.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.682 2.921 . . . . 0.0 113.031 170.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.73 22.86 5.23 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.155 170.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.462 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 3.8 ptp -89.39 168.73 11.99 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.256 0.551 . . . . 0.0 110.387 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -86.95 147.08 25.91 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.838 1.255 . . . . 0.0 108.967 -176.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.509 HG21 HG22 ' A' ' 75' ' ' ILE . 55.9 t -130.71 164.08 34.73 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 C-N-CA 124.444 1.098 . . . . 0.0 109.469 -172.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.417 ' HD2' ' N ' ' A' ' 30' ' ' MET . 3.5 tmm_? -142.7 145.65 33.59 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.376 1.47 . . . . 0.0 107.607 172.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.511 ' HA ' ' HE2' ' A' ' 30' ' ' MET . 4.4 tpt -85.18 112.26 20.55 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.137 0.575 . . . . 0.0 109.734 -175.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 39.0 tp -86.46 -20.02 28.74 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.339 0.656 . . . . 0.0 111.682 -174.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -136.67 155.12 50.31 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.741 0.416 . . . . 0.0 110.29 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -76.51 138.98 40.58 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.933 0.493 . . . . 0.0 110.339 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -131.21 171.42 13.32 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.306 1.042 . . . . 0.0 110.822 -172.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -48.58 -58.76 4.22 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.126 1.37 . . . . 0.0 112.032 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -117.96 -1.0 11.55 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.11 0.964 . . . . 0.0 111.402 -175.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mp -118.18 139.86 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.6 m -104.79 152.48 22.52 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.72 114.24 3.88 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.99 -36.12 2.1 Favored Glycine 0 C--N 1.346 1.131 0 O-C-N 123.488 0.493 . . . . 0.0 112.36 -173.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -61.61 147.82 44.44 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.198 0.599 . . . . 0.0 111.753 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -102.23 155.46 18.2 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.337 0.655 . . . . 0.0 111.009 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -140.32 -175.73 14.67 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.835 -175.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -139.33 138.54 36.74 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.522 ' HA ' HG11 ' A' ' 57' ' ' VAL . 87.1 t80 -71.07 122.4 20.01 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 122.685 0.394 . . . . 0.0 110.015 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.521 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 22.8 mmm180 -108.75 -48.57 3.28 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -176.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.521 ' NE2' ' HB2' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -167.19 155.46 9.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.364 179.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.8 p -123.11 179.4 4.7 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.135 0.974 . . . . 0.0 109.955 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 172.343 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.445 ' HA ' ' CD1' ' A' ' 70' ' ' TRP . 13.6 Cg_endo . . . . . 0 CA--C 1.584 2.982 0 N-CA-C 118.172 2.335 . . . . 0.0 118.172 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.84 101.45 0.79 Allowed 'Trans proline' 0 C--N 1.394 2.941 0 CA-C-N 122.736 2.013 . . . . 0.0 112.558 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 p -94.43 140.52 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.944 0.898 . . . . 0.0 109.918 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.476 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.1 mp0 -93.65 122.81 36.49 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.381 0.672 . . . . 0.0 109.72 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.522 HG11 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -132.78 140.63 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 125.262 1.425 . . . . 0.0 108.825 -178.522 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -79.38 108.1 12.64 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.494 ' HB2' HG22 ' A' ' 62' ' ' THR . 93.8 m95 -91.65 131.36 37.1 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.943 0.897 . . . . 0.0 110.066 177.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -59.41 -31.85 69.64 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.223 1.009 . . . . 0.0 111.688 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.7 t -67.55 -45.63 75.09 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.695 0.798 . . . . 0.0 112.07 -172.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.494 HG22 ' HB2' ' A' ' 59' ' ' TRP . 6.1 t -97.68 -21.24 17.12 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.32 0.648 . . . . 0.0 110.988 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.8 18.66 69.7 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.783 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -151.95 -176.93 5.85 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.138 0.575 . . . . 0.0 110.579 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 56' ' ' GLN . 5.2 p -86.03 144.38 27.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.503 0.721 . . . . 0.0 110.753 173.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -140.0 154.47 47.15 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.198 0.599 . . . . 0.0 109.942 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -81.4 111.99 18.26 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.555 1.142 . . . . 0.0 109.959 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.65 HG21 HD11 ' A' ' 73' ' ' LEU . 19.1 m -126.03 159.98 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.185 0.594 . . . . 0.0 110.772 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.518 ' HB3' ' HB2' ' A' ' 72' ' ' MET . 14.9 t-80 -91.14 147.04 23.34 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.283 1.033 . . . . 0.0 109.475 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.445 ' CD1' ' HA ' ' A' ' 53' ' ' PRO . 97.2 m95 -64.99 -45.99 83.3 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.013 0.525 . . . . 0.0 111.917 -175.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -70.47 -17.26 62.97 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.077 0.465 . . . . 0.0 111.678 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.518 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 21.3 mtp -104.16 14.19 30.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.526 1.13 . . . . 0.0 110.502 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.65 HD11 HG21 ' A' ' 68' ' ' VAL . 29.1 tp -119.19 121.26 39.33 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.298 1.039 . . . . 0.0 108.578 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -112.68 119.81 39.37 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.509 HG22 HG21 ' A' ' 28' ' ' VAL . 14.0 pt . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 121.488 0.661 . . . . 0.0 110.533 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.8 t80 . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.77 -36.43 91.18 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.497 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 33.6 tt0 -63.24 -47.45 82.42 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 171.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -57.83 -51.97 67.41 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.376 1.048 . . . . 0.0 111.854 -173.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.7 m -67.13 -37.88 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 O-C-N 123.789 0.681 . . . . 0.0 110.764 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.78 -34.17 67.37 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.575 0.75 . . . . 0.0 110.225 177.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 25.4 mm-40 -79.29 -50.01 11.57 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.815 0.446 . . . . 0.0 111.068 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.1 t -90.84 3.97 53.04 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -169.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.83 125.09 25.87 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 26' ' ' MET . 21.3 tt0 -90.96 139.63 25.95 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 124.145 0.978 . . . . 0.0 109.384 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.519 ' HA ' ' CD1' ' A' ' 45' ' ' PHE . 25.9 Cg_exo -63.63 84.62 0.13 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.742 2.294 . . . . 0.0 112.922 172.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.59 31.51 1.79 Allowed Glycine 0 C--N 1.353 1.49 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 171.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.5 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 25.9 ptm -100.59 174.61 6.0 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.268 0.556 . . . . 0.0 109.857 177.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 19.1 tpt180 -91.05 130.6 36.94 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 124.349 1.059 . . . . 0.0 108.995 -173.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.5 m -116.45 173.23 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.439 0.696 . . . . 0.0 109.33 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.07 137.15 25.79 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -171.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.533 ' HE3' ' HA ' ' A' ' 30' ' ' MET . 3.6 tpt -82.62 111.61 18.74 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 55.2 tp -80.39 -38.59 30.01 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.176 0.591 . . . . 0.0 110.698 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -126.86 154.04 44.91 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.212 0.605 . . . . 0.0 110.553 -175.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.99 119.47 17.27 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.337 0.655 . . . . 0.0 110.605 -174.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -102.6 173.46 6.33 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.386 1.074 . . . . 0.0 111.502 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -45.61 -52.1 11.11 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 126.174 1.79 . . . . 0.0 112.2 -175.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -124.9 -11.41 7.15 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.462 -177.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.2 mp -102.21 132.19 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.7 m -94.48 148.66 22.02 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.496 0.318 . . . . 0.0 110.39 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.8 115.73 4.61 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.94 -18.93 8.43 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 123.479 0.487 . . . . 0.0 112.452 -172.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -75.24 155.21 37.02 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.156 0.582 . . . . 0.0 109.57 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -126.7 154.29 44.31 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.582 0.706 . . . . 0.0 111.165 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.404 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . -137.42 -169.5 11.65 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.815 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -137.22 144.34 42.76 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.519 ' CD1' ' HA ' ' A' ' 24' ' ' PRO . 51.1 t80 -69.62 121.86 17.96 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.443 0.697 . . . . 0.0 109.31 177.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.492 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 10.2 mmm180 -108.95 -43.75 4.14 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.617 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -170.78 172.68 5.59 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.354 1.461 . . . . 0.0 107.895 177.237 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -157.18 179.8 8.93 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.748 0.785 . . . . 0.0 112.317 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 . . . . . 0 CA--C 1.544 0.742 0 CA-C-N 114.076 -1.42 . . . . 0.0 107.633 171.984 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo . . . . . 0 CA--C 1.579 2.731 0 N-CA-C 118.961 2.639 . . . . 0.0 118.961 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.1 110.15 2.55 Favored 'Trans proline' 0 C--N 1.372 1.772 0 CA-C-N 122.925 2.08 . . . . 0.0 113.316 173.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.94 139.46 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.303 1.041 . . . . 0.0 109.82 167.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.617 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 1.7 mp0 -91.94 122.05 34.1 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.82 136.24 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.571 1.149 . . . . 0.0 108.819 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 59.9 t80 -82.01 106.42 13.9 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.435 ' HB2' HG21 ' A' ' 62' ' ' THR . 89.0 m95 -90.29 130.71 36.37 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.426 1.09 . . . . 0.0 110.125 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -69.51 -37.93 77.36 Favored 'General case' 0 CA--C 1.554 1.099 0 O-C-N 123.842 0.714 . . . . 0.0 112.679 -173.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.1 t -69.59 -43.19 73.31 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.436 0.294 . . . . 0.0 111.677 -174.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.435 HG21 ' HB2' ' A' ' 59' ' ' TRP . 11.4 t -86.18 -17.13 35.71 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.794 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.48 18.32 76.08 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 114.539 0.576 . . . . 0.0 114.539 172.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -152.8 166.55 31.91 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.229 0.538 . . . . 0.0 112.086 -172.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 1.4 m -85.67 130.79 34.47 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.841 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -137.16 148.91 46.92 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.885 0.374 . . . . 0.0 110.688 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.452 ' CD1' ' HG3' ' A' ' 56' ' ' GLN . 11.1 m0 -76.76 114.15 15.21 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.462 1.105 . . . . 0.0 109.323 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.441 HG22 HD13 ' A' ' 73' ' ' LEU . 18.6 m -126.46 156.47 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.112 0.565 . . . . 0.0 109.676 175.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -86.07 145.92 26.85 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -63.09 -42.7 99.67 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.219 0.608 . . . . 0.0 111.768 -175.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -68.11 -14.42 62.97 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.538 0.735 . . . . 0.0 111.995 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 72.3 mtm -113.03 16.95 19.19 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.406 0.682 . . . . 0.0 110.958 174.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.441 HD13 HG22 ' A' ' 68' ' ' VAL . 40.6 tp -114.83 122.14 45.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.305 0.642 . . . . 0.0 109.295 176.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -105.23 147.29 28.2 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.409 1.084 . . . . 0.0 108.367 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.0 pt . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 121.378 0.609 . . . . 0.0 110.222 173.159 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 64.5 t80 . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.469 0.176 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.0 -38.86 63.9 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.904 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.557 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 3.2 mp0 -70.91 -37.6 72.95 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -58.44 -49.12 78.45 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.913 0.758 . . . . 0.0 111.417 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 27.0 m -62.58 -38.96 82.82 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -58.84 -40.64 84.8 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.141 0.576 . . . . 0.0 109.846 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 25.1 mm-40 -66.76 -40.0 88.1 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.313 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.4 t -110.53 13.08 22.73 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -169.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.609 HD13 ' SD ' ' A' ' 26' ' ' MET . 18.1 tp -87.55 110.93 20.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.858 -0.527 . . . . 0.0 110.428 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.615 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 38.7 mt-30 -87.84 141.44 31.65 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 124.203 1.001 . . . . 0.0 109.892 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.89 85.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.972 2.448 . . . . 0.0 111.728 173.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.64 73.71 1.19 Allowed Glycine 0 C--N 1.342 0.905 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.797 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.615 ' HB3' ' HB2' ' A' ' 23' ' ' GLN . 21.8 ptm -118.78 -58.32 1.97 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 118.465 -0.779 . . . . 0.0 112.044 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.428 ' H ' ' HG3' ' A' ' 26' ' ' MET . 24.8 tpt180 146.08 122.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 128.088 2.555 . . . . 0.0 107.929 173.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 m -118.14 171.74 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-O 121.326 0.584 . . . . 0.0 110.206 177.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -148.81 150.34 32.89 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.719 1.608 . . . . 0.0 107.529 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.603 ' HE1' ' HA ' ' A' ' 30' ' ' MET . 3.1 tpt -90.33 111.89 23.26 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 34.4 tp -77.41 -33.16 55.06 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.421 0.689 . . . . 0.0 110.912 -174.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -145.29 153.99 41.87 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.627 0.771 . . . . 0.0 109.072 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.46 142.03 58.09 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.52 0.728 . . . . 0.0 111.573 -172.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -126.33 171.76 10.69 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.818 0.847 . . . . 0.0 110.921 -175.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -47.37 -37.81 11.93 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.728 1.611 . . . . 0.0 113.233 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -139.94 -0.01 1.73 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.494 -171.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 mt -119.83 141.01 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.224 1.01 . . . . 0.0 109.19 -175.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.4 p -91.41 142.35 27.77 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.059 0.544 . . . . 0.0 109.969 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.39 117.39 5.61 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.665 0.386 . . . . 0.0 110.069 171.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.92 -4.27 28.88 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 123.542 0.526 . . . . 0.0 112.537 -175.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -77.34 156.57 31.19 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.165 0.586 . . . . 0.0 109.658 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -113.15 157.26 21.88 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.752 0.787 . . . . 0.0 111.596 -178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -146.25 -172.53 16.66 Favored Glycine 0 C--O 1.244 0.756 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.046 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -138.2 141.34 40.01 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 170.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.454 ' HE1' ' HB3' ' A' ' 48' ' ' SER . 32.8 t80 -70.58 120.45 16.23 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.639 0.776 . . . . 0.0 110.207 176.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.515 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 15.0 mmm180 -108.85 -47.63 3.42 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.804 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.563 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -163.78 155.86 17.23 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.537 1.135 . . . . 0.0 109.316 -177.12 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.454 ' HB3' ' HE1' ' A' ' 45' ' ' PHE . 41.4 p -132.09 179.03 6.34 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.715 0.806 . . . . 0.0 110.772 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.089 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 CA--C 1.571 2.345 0 N-CA-C 117.933 2.244 . . . . 0.0 117.933 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.621 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 55.9 Cg_endo -67.36 111.99 2.45 Favored 'Trans proline' 0 C--N 1.378 2.124 0 CA-C-N 123.297 2.213 . . . . 0.0 111.649 171.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 p -81.54 141.44 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.467 1.107 . . . . 0.0 110.689 171.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.563 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 1.7 mp0 -90.17 126.85 35.95 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.418 HG21 ' NE1' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -138.26 137.34 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 125.16 1.384 . . . . 0.0 108.817 -177.548 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 75.3 t80 -82.03 105.78 13.41 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.24 0.616 . . . . 0.0 109.818 -175.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.473 ' HB2' HG23 ' A' ' 62' ' ' THR . 91.7 m95 -92.58 132.62 36.7 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.34 1.056 . . . . 0.0 111.2 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -69.2 -28.33 66.28 Favored 'General case' 0 CA--C 1.55 0.967 0 O-C-N 124.141 0.901 . . . . 0.0 112.078 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.0 t -64.37 -46.46 83.27 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.05 0.387 . . . . 0.0 112.01 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.473 HG23 ' HB2' ' A' ' 59' ' ' TRP . 10.2 t -98.17 -12.08 22.08 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.543 0.737 . . . . 0.0 110.756 -176.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.3 16.09 79.94 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-N 115.986 -0.552 . . . . 0.0 113.898 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -151.9 170.69 19.22 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.345 0.593 . . . . 0.0 111.682 -174.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.521 HG21 ' HB3' ' A' ' 56' ' ' GLN . 1.7 m -87.0 120.06 27.86 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.271 -177.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -127.95 157.13 41.43 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.75 0.42 . . . . 0.0 111.152 -175.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.621 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 4.3 m-90 -75.65 120.67 21.37 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.456 1.102 . . . . 0.0 110.649 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.46 HG22 HD13 ' A' ' 73' ' ' LEU . 6.3 m -135.41 147.89 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 173.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -78.95 148.21 32.72 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.928 0.491 . . . . 0.0 110.496 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -54.47 -49.66 69.56 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.282 1.033 . . . . 0.0 112.305 -178.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -74.83 -13.11 60.53 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.073 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 29.1 mtp -106.76 13.88 27.44 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.857 0.863 . . . . 0.0 110.356 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.46 HD13 HG22 ' A' ' 68' ' ' VAL . 53.6 tp -116.18 131.32 56.98 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.641 1.177 . . . . 0.0 108.799 176.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -106.12 140.89 38.38 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.753 1.221 . . . . 0.0 108.234 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 pt . . . . . 0 N--CA 1.489 1.477 0 CA-C-N 118.435 0.562 . . . . 0.0 111.52 175.558 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.1 t80 . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.49 -42.05 74.62 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 121.512 0.506 . . . . 0.0 112.601 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 8.4 mp0 -69.33 -34.33 74.48 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 176.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -65.22 -49.73 68.56 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 123.866 0.728 . . . . 0.0 111.891 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.4 m -59.62 -38.86 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 123.319 0.387 . . . . 0.0 110.435 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -54.71 -35.47 63.67 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.364 0.665 . . . . 0.0 111.493 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 43.4 mm-40 -82.36 -36.25 27.02 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.463 -172.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.8 t -109.24 4.22 22.55 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.853 0.461 . . . . 0.0 112.142 -172.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.423 HD13 HG21 ' A' ' 75' ' ' ILE . 16.7 tp -86.08 116.73 24.47 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 122.007 -0.433 . . . . 0.0 109.994 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -92.01 137.47 25.15 Favored Pre-proline 0 N--CA 1.481 1.095 0 C-N-CA 124.207 1.003 . . . . 0.0 111.136 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.2 92.41 0.39 Allowed 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.017 2.478 . . . . 0.0 112.105 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.0 -8.22 4.15 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.661 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 5.5 ptp -92.46 166.5 12.51 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -88.17 162.7 16.56 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-O 121.896 0.855 . . . . 0.0 110.305 -171.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.6 m -131.64 175.65 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.061 176.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.527 ' HB3' ' HB3' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -143.89 146.07 32.75 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -174.424 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.508 ' HE1' ' HA ' ' A' ' 30' ' ' MET . 1.5 tpt -98.05 118.17 34.05 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.777 0.831 . . . . 0.0 110.043 178.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.8 mt -74.94 -43.39 54.4 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.417 0.687 . . . . 0.0 112.066 -177.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -129.5 163.99 24.71 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -67.09 120.53 13.85 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.292 0.568 . . . . 0.0 110.889 -176.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.03 173.12 6.98 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.988 0.915 . . . . 0.0 110.384 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -47.79 -48.07 30.52 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.348 1.459 . . . . 0.0 113.542 -176.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -128.31 8.5 6.03 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.306 0.642 . . . . 0.0 111.571 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -120.07 143.56 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.3 m -99.46 154.02 18.55 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.561 0.619 . . . . 0.0 109.848 174.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.6 118.3 6.89 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.623 0.769 . . . . 0.0 110.068 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.53 -10.39 23.87 Favored Glycine 0 C--N 1.341 0.834 0 O-C-N 123.331 0.395 . . . . 0.0 113.237 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -79.95 157.26 26.9 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 120.948 0.404 . . . . 0.0 110.725 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 45.0 mt-10 -120.55 159.95 24.19 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.038 -174.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -141.7 -167.76 11.35 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.647 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -138.52 140.13 39.0 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 170.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.424 ' HA ' HG11 ' A' ' 57' ' ' VAL . 55.6 t80 -79.7 121.31 25.16 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.225 0.61 . . . . 0.0 110.102 176.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -108.26 -47.91 3.45 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.47 151.08 27.3 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.754 0.821 . . . . 0.0 110.109 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.468 ' HA ' HG23 ' A' ' 55' ' ' VAL . 48.6 p -117.49 162.63 17.66 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.091 0.956 . . . . 0.0 111.123 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 . . . . . 0 C--O 1.237 0.427 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 160.355 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo . . . . . 0 CA--C 1.583 2.949 0 N-CA-C 118.268 2.372 . . . . 0.0 118.268 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.508 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 39.4 Cg_endo -67.56 105.87 1.16 Allowed 'Trans proline' 0 C--N 1.389 2.67 0 CA-C-N 123.56 2.307 . . . . 0.0 111.793 169.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.468 HG23 ' HA ' ' A' ' 48' ' ' SER . 6.4 p -86.59 145.84 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.467 1.107 . . . . 0.0 110.709 176.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -92.22 122.08 34.36 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.424 HG11 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -133.89 136.68 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.857 1.263 . . . . 0.0 108.752 178.855 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -81.09 108.65 14.94 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.502 ' HB2' HG22 ' A' ' 62' ' ' THR . 94.5 m95 -93.52 131.14 39.04 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.849 0.86 . . . . 0.0 110.898 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 18.4 pt20 -61.72 -27.21 68.55 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 124.114 0.883 . . . . 0.0 110.977 169.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.3 t -60.46 -45.16 94.71 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.609 1.164 . . . . 0.0 112.307 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.502 HG22 ' HB2' ' A' ' 59' ' ' TRP . 8.6 t -113.09 -10.74 13.41 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.685 0.794 . . . . 0.0 111.265 -174.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.45 13.89 82.74 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 116.359 -0.382 . . . . 0.0 113.91 178.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -152.47 173.65 14.86 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.274 0.559 . . . . 0.0 111.387 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.05 126.78 34.98 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.557 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -128.67 155.35 45.17 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 120.984 0.421 . . . . 0.0 111.059 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 10.1 m-90 -82.09 108.66 15.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.991 1.316 . . . . 0.0 109.732 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 m -125.97 151.54 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.128 0.571 . . . . 0.0 109.73 177.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -80.32 146.42 31.59 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -54.89 -45.37 74.65 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.833 1.253 . . . . 0.0 113.293 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -72.54 -22.39 61.02 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -173.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 70.7 mtm -93.39 -6.28 47.53 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.205 0.602 . . . . 0.0 111.424 174.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 tt -90.93 123.56 34.53 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 171.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 29' ' ' ARG . 40.4 tt0 -104.04 143.58 32.7 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.423 HG21 HD13 ' A' ' 22' ' ' LEU . 37.5 pt . . . . . 0 CA--C 1.546 0.789 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.4 t80 . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.08 -30.18 75.49 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.802 -0.635 . . . . 0.0 113.028 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.5 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 8.3 tp10 -72.28 -47.47 49.81 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 171.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -57.45 -48.78 78.26 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.294 1.038 . . . . 0.0 111.256 -172.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 m -58.29 -43.31 85.82 Favored 'Isoleucine or valine' 0 C--N 1.35 0.612 0 O-C-N 123.729 0.643 . . . . 0.0 110.259 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -62.12 -31.51 71.98 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.458 0.703 . . . . 0.0 111.189 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 79.5 mm-40 -82.22 -32.32 29.84 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.188 0.595 . . . . 0.0 111.519 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.2 t -107.79 8.35 28.73 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.944 0.498 . . . . 0.0 111.966 -175.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.586 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.1 OUTLIER -67.66 117.83 10.12 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.062 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.711 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 9.8 mm100 -86.23 133.4 40.77 Favored Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.14 87.4 0.73 Allowed 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.875 2.383 . . . . 0.0 112.261 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.24 23.99 2.8 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.711 ' HB3' ' HB2' ' A' ' 23' ' ' GLN . 16.8 ptm -91.69 168.48 11.45 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.194 0.597 . . . . 0.0 110.118 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 ppp_? -90.3 147.14 23.69 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.797 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.4 t -129.28 164.88 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 124.937 1.295 . . . . 0.0 107.648 -169.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -149.53 133.13 16.76 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.511 ' HE1' ' HA ' ' A' ' 30' ' ' MET . 2.0 tpt -82.81 112.59 19.78 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.782 0.833 . . . . 0.0 109.869 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.637 HD22 ' HB2' ' A' ' 74' ' ' GLU . 4.0 pp -85.9 -2.88 58.7 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 122.862 0.465 . . . . 0.0 111.19 176.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -124.79 162.87 23.37 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.198 0.999 . . . . 0.0 109.427 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -98.76 117.3 32.92 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -106.17 173.26 6.39 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.527 1.131 . . . . 0.0 112.175 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -51.71 -44.95 63.37 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.818 1.647 . . . . 0.0 112.455 -175.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.63 3.95 3.59 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.969 0.908 . . . . 0.0 111.396 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 mp -118.41 137.39 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 175.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.3 m -99.32 155.07 17.71 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.24 0.473 . . . . 0.0 109.919 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.17 114.15 5.68 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.31 -26.54 3.91 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 123.572 0.545 . . . . 0.0 112.402 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -69.94 158.22 36.0 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.234 0.613 . . . . 0.0 112.494 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -116.94 157.31 25.94 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 123.832 0.853 . . . . 0.0 111.552 -177.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.15 -173.75 14.97 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.731 -176.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -136.04 142.52 44.41 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 171.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.423 ' CE1' ' HB3' ' A' ' 48' ' ' SER . 91.4 t80 -87.28 118.29 26.6 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.004 0.922 . . . . 0.0 110.059 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.32 -47.57 3.09 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 120.803 0.335 . . . . 0.0 110.653 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.77 161.93 38.81 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.61 0.764 . . . . 0.0 109.375 -175.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.423 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 53.4 p -158.64 169.28 24.76 Favored 'General case' 0 C--O 1.239 0.53 0 O-C-N 123.777 0.673 . . . . 0.0 111.988 -171.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 . . . . . 0 CA--C 1.541 0.6 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 171.888 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo . . . . . 0 CA--C 1.573 2.429 0 N-CA-C 117.767 2.18 . . . . 0.0 117.767 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.583 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 49.2 Cg_endo -70.37 107.82 2.06 Favored 'Trans proline' 0 C--N 1.383 2.393 0 CA-C-N 123.145 2.159 . . . . 0.0 111.702 168.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.3 p -85.68 141.43 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.326 1.05 . . . . 0.0 110.311 171.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -87.99 122.67 31.86 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.39 136.15 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.43 1.092 . . . . 0.0 108.544 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -81.53 108.03 14.78 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -176.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -92.87 131.05 38.24 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.699 0.799 . . . . 0.0 111.115 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -62.69 -31.3 72.17 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.928 0.891 . . . . 0.0 111.427 172.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.5 t -60.07 -43.74 95.26 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.82 1.248 . . . . 0.0 111.808 -172.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.1 t -113.07 -8.93 13.6 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.163 -174.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.02 15.39 81.19 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 116.351 -0.386 . . . . 0.0 114.028 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -151.65 169.6 21.75 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.528 0.68 . . . . 0.0 111.598 -172.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.21 123.42 32.2 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.267 -176.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -126.74 155.67 42.38 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.523 0.678 . . . . 0.0 110.809 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.583 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 9.3 m-90 -89.37 111.97 22.96 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.465 1.506 . . . . 0.0 109.288 -172.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.4 m -129.51 153.17 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.279 0.632 . . . . 0.0 110.51 -176.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -80.56 147.09 30.94 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.811 0.444 . . . . 0.0 110.734 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -59.42 -49.35 78.13 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.268 1.027 . . . . 0.0 112.929 -176.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -67.81 -23.18 65.16 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.164 0.585 . . . . 0.0 111.625 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.482 ' HA ' HD12 ' A' ' 31' ' ' LEU . 40.2 mtp -95.82 -4.13 44.36 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.573 1.149 . . . . 0.0 111.095 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.4 tt -93.95 141.07 28.94 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 172.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.637 ' HB2' HD22 ' A' ' 31' ' ' LEU . 39.4 tt0 -125.82 135.35 51.89 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.819 0.848 . . . . 0.0 108.902 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.1 pt . . . . . 0 N--CA 1.479 1.025 0 CA-C-O 121.235 0.54 . . . . 0.0 110.512 177.455 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.1 t80 . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.22 -34.65 86.47 Favored Glycine 0 C--N 1.344 1.007 0 O-C-N 123.279 0.362 . . . . 0.0 113.244 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 7.2 tp10 -73.74 -38.93 64.59 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.637 0.375 . . . . 0.0 110.411 174.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -57.99 -50.29 73.92 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.975 0.91 . . . . 0.0 111.417 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.515 ' HB ' HD21 ' A' ' 22' ' ' LEU . 28.1 m -62.52 -37.81 79.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 O-C-N 124.345 1.028 . . . . 0.0 110.657 -177.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -42.11 70.6 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.136 0.574 . . . . 0.0 109.678 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 50.2 mm-40 -82.95 -29.52 29.04 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.461 -170.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 t -102.33 -2.43 28.98 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.515 HD21 ' HB ' ' A' ' 18' ' ' VAL . 0.9 OUTLIER -81.04 117.13 21.37 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 118.33 0.514 . . . . 0.0 110.946 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -102.43 140.21 20.92 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 124.041 0.936 . . . . 0.0 109.508 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.48 87.85 0.34 Allowed 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.48 2.12 . . . . 0.0 111.232 174.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 148.2 2.19 0.44 Allowed Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.153 176.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.45 ' SD ' HD13 ' A' ' 22' ' ' LEU . 12.3 ptp -96.63 165.45 12.14 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.706 0.753 . . . . 0.0 111.296 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.481 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 20.6 tpt180 -91.51 128.46 37.34 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.828 1.251 . . . . 0.0 109.316 -171.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 m -116.28 170.96 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.631 0.773 . . . . 0.0 109.546 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.566 HH11 ' HA2' ' A' ' 40' ' ' GLY . 2.2 tmm_? -152.31 131.17 12.48 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.459 1.104 . . . . 0.0 108.083 -178.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.447 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 31.6 tpp -88.64 127.29 35.56 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.805 0.842 . . . . 0.0 111.195 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.459 HD22 ' HB2' ' A' ' 74' ' ' GLU . 3.3 pp -102.34 3.75 38.3 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.569 0.748 . . . . 0.0 112.153 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.423 ' O ' ' HG3' ' A' ' 30' ' ' MET . 29.6 t70 -126.76 164.13 22.01 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.779 0.832 . . . . 0.0 109.764 -178.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -95.96 117.09 29.96 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.886 -0.509 . . . . 0.0 110.015 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -111.16 170.52 8.05 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.0 1.32 . . . . 0.0 109.442 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -40.91 -55.33 2.52 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 125.919 1.688 . . . . 0.0 112.996 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -126.19 3.1 7.13 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.743 0.817 . . . . 0.0 111.47 -175.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -119.64 101.61 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.409 0.684 . . . . 0.0 109.167 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -78.82 150.58 32.28 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.89 115.55 3.78 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.347 0.659 . . . . 0.0 110.757 -175.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.566 ' HA2' HH11 ' A' ' 29' ' ' ARG . . . 127.78 -14.45 6.36 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.86 -176.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -73.42 154.24 40.08 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.645 0.378 . . . . 0.0 111.58 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -114.88 159.26 20.89 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.726 0.811 . . . . 0.0 110.702 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.481 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . -151.94 -171.65 19.89 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.391 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -134.98 142.67 46.51 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.439 ' CG ' HD11 ' A' ' 22' ' ' LEU . 20.9 t80 -80.01 122.58 26.92 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.499 0.719 . . . . 0.0 109.326 -176.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.558 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 12.2 mmm180 -108.4 -45.76 3.83 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.315 0.578 . . . . 0.0 109.726 -171.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.558 ' NE2' ' HB2' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -151.71 157.22 41.75 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.85 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.2 p -118.37 157.75 26.54 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 123.873 0.733 . . . . 0.0 110.642 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.608 HD22 ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER . . . . . 0 CA--C 1.529 0.138 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 175.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo . . . . . 0 CA--C 1.576 2.619 0 N-CA-C 116.195 1.575 . . . . 0.0 116.195 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.712 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 92.3 Cg_endo -79.53 98.25 1.14 Allowed 'Trans proline' 0 C--N 1.382 2.296 0 CA-C-N 122.371 1.883 . . . . 0.0 111.861 166.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.608 ' HA ' HD22 ' A' ' 49' ' ' ASN . 14.5 p -82.55 154.51 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.333 1.053 . . . . 0.0 111.829 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -94.86 128.81 41.89 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.151 0.58 . . . . 0.0 110.585 -172.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -140.66 140.45 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 125.298 1.439 . . . . 0.0 108.627 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -81.8 106.84 14.05 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.447 ' CH2' ' HB2' ' A' ' 30' ' ' MET . 96.2 m95 -88.77 130.97 35.25 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.314 1.046 . . . . 0.0 110.374 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -69.52 -26.66 64.63 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.705 0.802 . . . . 0.0 112.171 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.6 t -68.89 -44.22 73.67 Favored 'General case' 0 C--N 1.357 0.929 0 CA-C-O 120.69 0.281 . . . . 0.0 111.178 -177.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.2 t -94.88 -30.32 14.24 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.397 0.679 . . . . 0.0 111.681 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.68 23.54 30.52 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-O 119.733 -0.482 . . . . 0.0 114.271 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -154.19 176.87 11.75 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 117.439 0.62 . . . . 0.0 111.754 -175.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 2.0 p -83.59 142.35 30.9 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 172.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -144.98 154.76 42.89 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.35 0.595 . . . . 0.0 110.096 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.712 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 16.3 m-90 -81.98 115.68 21.25 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.01 -176.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.411 HG22 ' HZ2' ' A' ' 59' ' ' TRP . 19.9 m -137.68 145.11 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.365 0.666 . . . . 0.0 109.687 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.51 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 9.5 t-80 -69.44 147.06 51.46 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.607 0.363 . . . . 0.0 110.841 -177.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . 0.444 ' O ' HG21 ' A' ' 18' ' ' VAL . 90.4 m95 -59.45 -45.78 90.62 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.546 0.738 . . . . 0.0 111.634 -176.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -65.18 -23.26 67.05 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.502 0.721 . . . . 0.0 111.918 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.51 ' SD ' ' HB3' ' A' ' 69' ' ' HIS . 33.8 mtp -90.04 -14.2 34.36 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.223 1.009 . . . . 0.0 111.077 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.4 tt -90.78 122.01 33.15 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.459 ' HB2' HD22 ' A' ' 31' ' ' LEU . 35.3 tt0 -123.12 125.23 44.78 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.296 1.039 . . . . 0.0 109.212 -176.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.465 HD13 HD22 ' A' ' 22' ' ' LEU . 12.2 pt . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 121.314 0.578 . . . . 0.0 111.609 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 55.3 t80 . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.59 -36.91 88.92 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-O 122.029 0.794 . . . . 0.0 112.717 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 2.5 mp0 -73.78 -33.08 64.09 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.027 -1.086 . . . . 0.0 110.246 177.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -68.63 -49.41 59.39 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.825 0.85 . . . . 0.0 110.837 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.562 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 20.9 m -59.11 -39.14 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 O-C-N 123.779 0.675 . . . . 0.0 110.135 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -57.57 -38.7 75.28 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.141 0.976 . . . . 0.0 111.55 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 52.9 mm-40 -78.2 -43.03 29.64 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.412 0.285 . . . . 0.0 111.282 -176.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.1 t -88.66 2.0 54.03 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.109 0.563 . . . . 0.0 112.384 -174.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.562 ' HB2' ' O ' ' A' ' 18' ' ' VAL . 12.7 tp -76.72 124.99 28.49 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.455 0.702 . . . . 0.0 111.176 -173.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.428 ' H ' ' HE3' ' A' ' 26' ' ' MET . 50.1 mt-30 -113.6 124.89 30.38 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 123.736 0.815 . . . . 0.0 109.617 -175.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.47 85.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 124.24 3.293 . . . . 0.0 114.547 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.61 26.8 1.54 Allowed Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.837 174.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.503 ' SD ' HD12 ' A' ' 22' ' ' LEU . 4.5 ptp -91.73 175.63 6.83 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.436 0.636 . . . . 0.0 110.844 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.0 tpt85 -94.61 126.55 39.98 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.931 -170.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.425 HG22 HG22 ' A' ' 75' ' ' ILE . 41.6 t -119.01 160.07 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 C-N-CA 124.572 1.149 . . . . 0.0 111.26 -167.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.5 tpp85 -140.71 151.87 44.85 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 126.673 1.989 . . . . 0.0 108.567 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.512 ' HA ' ' HE2' ' A' ' 30' ' ' MET . 3.9 tpt -94.89 115.5 27.54 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.481 0.712 . . . . 0.0 109.524 177.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.8 tp -83.68 -29.03 27.93 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.192 0.597 . . . . 0.0 111.149 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -137.19 154.6 50.17 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.754 0.422 . . . . 0.0 110.777 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -65.29 144.44 57.14 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.677 0.791 . . . . 0.0 111.588 -176.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -133.12 175.34 9.47 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.964 1.306 . . . . 0.0 110.275 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.57 -51.85 67.82 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.01 1.324 . . . . 0.0 111.706 -173.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -119.23 0.1 11.12 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.836 0.855 . . . . 0.0 111.741 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mp -119.89 146.03 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.248 1.019 . . . . 0.0 108.487 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.7 m -112.01 160.2 17.71 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 119.242 0.928 . . . . 0.0 110.025 173.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.24 117.67 8.16 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.38 -30.67 4.89 Favored Glycine 0 C--N 1.343 0.926 0 O-C-N 123.551 0.532 . . . . 0.0 111.993 -174.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -67.73 153.4 43.79 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.482 0.713 . . . . 0.0 111.012 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -127.19 154.83 44.31 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.536 0.684 . . . . 0.0 112.178 -166.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.66 -169.77 12.92 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.458 -171.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -136.58 140.5 42.93 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 172.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.483 ' HA ' HG11 ' A' ' 57' ' ' VAL . 30.8 t80 -72.64 124.21 24.81 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 123.63 0.581 . . . . 0.0 110.579 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.484 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 11.1 mmm180 -109.14 -47.99 3.34 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.678 0.391 . . . . 0.0 111.216 -174.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.54 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -167.43 147.67 5.32 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.725 0.81 . . . . 0.0 110.03 -179.318 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.435 ' HA ' HG22 ' A' ' 55' ' ' VAL . 38.9 p -117.76 173.22 6.87 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.665 0.786 . . . . 0.0 111.429 -175.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 . . . . . 0 CA--C 1.537 0.447 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.768 175.157 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo . . . . . 0 CA--C 1.575 2.564 0 N-CA-C 117.648 2.134 . . . . 0.0 117.648 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.509 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 59.0 Cg_endo -70.79 111.04 2.92 Favored 'Trans proline' 0 C--N 1.386 2.501 0 CA-C-N 122.744 2.016 . . . . 0.0 112.351 171.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.526 HG13 HD23 ' A' ' 73' ' ' LEU . 3.0 p -91.33 137.22 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.281 1.032 . . . . 0.0 109.656 166.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.54 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 1.9 mp0 -90.14 126.79 35.92 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 122.983 0.513 . . . . 0.0 109.888 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.483 HG11 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -135.52 137.22 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 124.923 1.289 . . . . 0.0 108.773 -177.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -81.47 108.45 15.07 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.493 ' HB2' HG21 ' A' ' 62' ' ' THR . 85.4 m95 -93.08 128.06 38.85 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.87 0.868 . . . . 0.0 110.049 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -67.49 -23.47 65.49 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 123.671 0.607 . . . . 0.0 110.887 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.7 t -60.63 -44.98 95.72 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 124.659 1.184 . . . . 0.0 111.764 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.493 HG21 ' HB2' ' A' ' 59' ' ' TRP . 8.7 t -108.02 -6.36 16.6 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.975 0.91 . . . . 0.0 110.777 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.25 13.67 76.74 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 116.134 -0.485 . . . . 0.0 113.869 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -151.4 173.97 13.9 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.321 0.56 . . . . 0.0 111.032 -175.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.11 136.3 33.27 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.132 -175.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -137.76 157.41 46.5 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.657 0.741 . . . . 0.0 111.036 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.509 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 15.8 m-90 -83.73 108.75 16.99 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.816 1.646 . . . . 0.0 110.089 -176.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 m -123.82 157.75 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 122.796 0.438 . . . . 0.0 110.93 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -87.43 148.94 24.76 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.576 0.75 . . . . 0.0 110.495 -175.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -61.85 -43.8 98.11 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.671 0.788 . . . . 0.0 111.939 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -73.1 -11.66 60.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.689 0.396 . . . . 0.0 111.408 -176.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 70.5 mtm -114.33 6.35 16.05 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.058 0.943 . . . . 0.0 110.622 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.526 HD23 HG13 ' A' ' 55' ' ' VAL . 35.9 tp -92.01 119.49 31.77 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 170.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -121.48 128.02 51.66 Favored 'General case' 0 C--O 1.212 -0.92 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.425 HG22 HG22 ' A' ' 28' ' ' VAL . 15.3 pt . . . . . 0 N--CA 1.478 0.964 0 CA-C-O 121.417 0.627 . . . . 0.0 111.461 -176.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.3 t80 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.61 0.243 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.79 -40.26 58.43 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.523 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 2.2 mp0 -69.97 -26.09 63.93 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.647 0.779 . . . . 0.0 110.788 177.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -75.11 -50.11 17.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.736 0.814 . . . . 0.0 110.671 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.2 m -63.97 -34.61 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 123.516 0.51 . . . . 0.0 110.265 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.59 -31.28 56.63 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.442 1.097 . . . . 0.0 111.03 177.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 49.4 mm-40 -88.97 -44.67 10.25 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.982 0.513 . . . . 0.0 111.015 -176.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.8 t -83.8 -17.91 39.45 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -171.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.531 HD21 ' SD ' ' A' ' 26' ' ' MET . 10.9 mt -66.2 118.64 10.2 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.163 0.585 . . . . 0.0 111.341 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -110.99 140.84 23.14 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.726 1.21 . . . . 0.0 110.157 -176.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.22 85.01 0.34 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.32 2.68 . . . . 0.0 112.41 -177.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.8 2.6 1.41 Allowed Glycine 0 C--N 1.342 0.907 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.696 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.531 ' SD ' HD21 ' A' ' 22' ' ' LEU . 6.0 ptp -85.96 168.91 13.73 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 121.455 0.645 . . . . 0.0 111.224 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.41 ' NH1' ' HB3' ' A' ' 42' ' ' GLU . 15.7 tpt85 -99.84 123.21 43.85 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.772 1.229 . . . . 0.0 110.066 -168.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.7 m -118.77 174.21 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.696 0.798 . . . . 0.0 110.832 -174.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.527 ' HG2' ' HG2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -149.11 140.4 23.18 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.165 1.386 . . . . 0.0 107.836 -172.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.495 ' HA ' ' HE2' ' A' ' 30' ' ' MET . 1.4 tpt -94.81 113.69 25.47 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.931 0.892 . . . . 0.0 109.671 177.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.575 HD11 ' HA ' ' A' ' 72' ' ' MET . 3.6 pp -97.73 4.24 49.97 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.721 0.409 . . . . 0.0 111.678 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -133.07 162.43 31.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.156 0.583 . . . . 0.0 109.965 -170.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -89.04 122.6 32.54 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.259 0.624 . . . . 0.0 109.694 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -121.25 170.56 9.47 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.565 0.698 . . . . 0.0 112.292 -176.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -53.54 -49.03 68.51 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 113.781 -1.554 . . . . 0.0 112.178 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -128.67 1.45 5.5 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.404 0.682 . . . . 0.0 111.412 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.2 mp -118.92 144.85 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.5 m -112.0 156.59 21.9 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 122.871 0.468 . . . . 0.0 109.758 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.3 116.7 6.91 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.06 -25.37 5.52 Favored Glycine 0 N--CA 1.469 0.883 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -173.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -76.85 155.21 33.14 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.144 0.578 . . . . 0.0 110.693 175.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.527 ' HG2' ' HG2' ' A' ' 29' ' ' ARG . 51.3 mt-10 -135.13 155.26 51.02 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.848 0.859 . . . . 0.0 110.225 -169.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -147.58 -166.0 12.27 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.049 -170.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -136.52 137.4 40.26 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.584 0.754 . . . . 0.0 109.374 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.505 ' HE1' HG23 ' A' ' 55' ' ' VAL . 71.5 t80 -71.38 124.99 25.81 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.265 0.626 . . . . 0.0 109.799 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.525 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 21.4 mmm180 -109.3 -49.65 3.09 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.804 0.441 . . . . 0.0 110.499 -173.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.605 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -164.72 169.14 17.19 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.225 1.01 . . . . 0.0 109.237 -177.766 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.495 ' HA ' HG21 ' A' ' 55' ' ' VAL . 13.8 p -138.19 166.16 24.85 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.669 0.788 . . . . 0.0 112.04 -171.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 171.018 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo . . . . . 0 CA--C 1.583 2.972 0 N-CA-C 117.884 2.225 . . . . 0.0 117.884 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.619 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 60.9 Cg_endo -71.06 107.76 2.17 Favored 'Trans proline' 0 C--N 1.387 2.567 0 CA-C-N 122.94 2.086 . . . . 0.0 112.297 171.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.505 HG23 ' HE1' ' A' ' 45' ' ' PHE . 5.5 p -90.9 143.33 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 124.841 1.256 . . . . 0.0 111.0 171.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.605 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 1.9 mp0 -93.79 131.83 38.77 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-O 121.29 0.567 . . . . 0.0 110.225 -176.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.436 HG11 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -139.39 137.54 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 125.639 1.576 . . . . 0.0 108.106 -178.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 56.2 t80 -81.36 109.06 15.5 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -177.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.434 ' HB2' HG21 ' A' ' 62' ' ' THR . 85.8 m95 -93.51 117.81 30.56 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.72 0.808 . . . . 0.0 109.299 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -61.38 -25.88 67.47 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.05 0.94 . . . . 0.0 111.462 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.6 t -60.46 -45.13 94.82 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.436 1.094 . . . . 0.0 111.75 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.434 HG21 ' HB2' ' A' ' 59' ' ' TRP . 7.1 t -105.88 -9.81 16.97 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.912 0.885 . . . . 0.0 110.711 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.79 16.5 79.96 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 114.24 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -152.77 165.12 36.33 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.412 0.625 . . . . 0.0 111.844 -173.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.56 HG23 ' HB3' ' A' ' 56' ' ' GLN . 2.7 m -88.45 120.37 29.77 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.309 -177.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -127.1 157.68 39.04 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.455 0.645 . . . . 0.0 110.661 -173.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.619 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 12.1 m-90 -83.94 116.61 22.88 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.505 1.522 . . . . 0.0 109.816 -173.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.436 HG22 HD13 ' A' ' 73' ' ' LEU . 7.1 m -130.12 158.36 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.897 0.879 . . . . 0.0 109.738 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.457 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 11.4 t-80 -86.79 147.87 25.65 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.953 0.501 . . . . 0.0 110.287 -177.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -57.2 -50.41 72.96 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.002 0.921 . . . . 0.0 111.571 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -72.78 -1.45 16.6 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.607 0.763 . . . . 0.0 112.005 -176.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.575 ' HA ' HD11 ' A' ' 31' ' ' LEU . 43.0 mtp -120.58 14.39 11.84 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.173 0.989 . . . . 0.0 110.756 -178.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.436 HD13 HG22 ' A' ' 68' ' ' VAL . 33.8 tp -123.37 124.37 42.78 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.91 0.884 . . . . 0.0 109.415 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.538 ' HB2' HD23 ' A' ' 31' ' ' LEU . 10.8 tp10 -106.52 142.97 35.3 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.387 1.075 . . . . 0.0 109.56 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 26.8 pt . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 121.085 0.469 . . . . 0.0 112.009 178.653 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.0 t80 . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 120.652 0.263 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.44 -38.25 90.81 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.625 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 4.5 mp0 -72.32 -31.59 65.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.617 -0.791 . . . . 0.0 109.757 178.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -67.37 -50.43 59.79 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 123.542 0.737 . . . . 0.0 110.533 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 m -63.65 -36.83 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 123.555 0.535 . . . . 0.0 109.964 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.46 -34.41 61.44 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.12 0.968 . . . . 0.0 110.742 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 58.0 mm-40 -84.11 -37.41 22.05 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.042 0.537 . . . . 0.0 111.112 -175.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.423 HG23 HD12 ' A' ' 75' ' ' ILE . 11.7 t -102.48 3.74 37.93 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.539 0.736 . . . . 0.0 112.414 -172.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.435 ' HA ' ' SD ' ' A' ' 26' ' ' MET . 8.8 mt -75.15 108.16 7.72 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.948 0.499 . . . . 0.0 109.672 174.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 39.7 mt-30 -85.8 130.72 49.62 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 123.657 0.783 . . . . 0.0 108.914 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.83 82.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 123.333 2.689 . . . . 0.0 113.52 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.36 17.73 1.55 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.721 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.582 ' HB3' ' HB2' ' A' ' 23' ' ' GLN . 14.2 ptm -91.35 173.78 7.73 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.677 0.751 . . . . 0.0 111.267 -175.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.8 tpt85 -96.25 131.42 42.75 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.109 -169.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.54 154.36 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 124.375 1.07 . . . . 0.0 111.396 -167.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -129.7 147.05 51.45 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.71 1.604 . . . . 0.0 108.092 169.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.418 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 32.9 tpp -98.41 129.45 45.05 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.011 0.924 . . . . 0.0 108.724 170.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 74' ' ' GLU . 3.8 pp -106.88 2.38 25.34 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -176.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -140.6 172.37 12.81 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.543 0.337 . . . . 0.0 110.152 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -83.46 140.74 32.16 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 122.001 -0.437 . . . . 0.0 110.798 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.41 173.2 11.54 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.377 1.071 . . . . 0.0 110.427 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -50.57 -44.5 56.76 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.392 1.477 . . . . 0.0 112.674 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -138.23 4.19 2.44 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.455 0.702 . . . . 0.0 111.776 -175.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.2 mp -119.57 145.12 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.5 m -112.33 162.95 14.97 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 123.312 0.645 . . . . 0.0 109.887 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.3 118.69 9.03 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.193 0.597 . . . . 0.0 109.815 173.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.87 0.74 28.77 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 116.435 -0.348 . . . . 0.0 113.221 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -88.95 156.4 18.91 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.043 0.449 . . . . 0.0 110.647 173.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -123.97 148.56 46.84 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.392 -169.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -145.42 -170.06 14.08 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.091 -175.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -135.57 137.0 41.56 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.599 ' HZ ' ' HB3' ' A' ' 48' ' ' SER . 87.6 t80 -76.55 118.85 19.63 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.413 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 21.4 mmm-85 -105.3 -47.08 4.05 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -175.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 46' ' ' ARG . 0.4 OUTLIER -152.86 158.66 42.5 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.959 -176.175 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.599 ' HB3' ' HZ ' ' A' ' 45' ' ' PHE . 77.4 p -116.46 175.69 5.45 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.846 0.858 . . . . 0.0 110.699 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.4 HD22 HE22 ' A' ' 56' ' ' GLN . 83.0 m-20 . . . . . 0 C--O 1.237 0.42 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.859 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo . . . . . 0 CA--C 1.577 2.67 0 N-CA-C 116.565 1.717 . . . . 0.0 116.565 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.721 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 71.8 Cg_endo -73.84 98.68 1.09 Allowed 'Trans proline' 0 C--N 1.384 2.399 0 CA-C-N 122.598 1.963 . . . . 0.0 112.097 169.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.516 HG22 ' HA ' ' A' ' 48' ' ' SER . 7.6 p -83.37 150.46 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 125.126 1.37 . . . . 0.0 111.588 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.4 HE22 HD22 ' A' ' 49' ' ' ASN . 1.7 mp0 -90.86 127.79 36.5 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.197 0.599 . . . . 0.0 110.362 -175.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.19 134.2 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.315 1.446 . . . . 0.0 107.722 178.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 69.3 t80 -81.28 107.81 14.37 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.5 ' HB2' HG21 ' A' ' 62' ' ' THR . 83.5 m95 -92.76 123.4 36.01 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.888 0.875 . . . . 0.0 109.408 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -63.85 -29.04 70.27 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.777 0.673 . . . . 0.0 111.128 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.8 t -61.93 -46.71 88.12 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.166 0.986 . . . . 0.0 112.018 -175.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.5 HG21 ' HB2' ' A' ' 59' ' ' TRP . 9.8 t -98.6 -14.06 20.09 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.658 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.78 16.61 74.82 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 116.126 -0.488 . . . . 0.0 114.165 176.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -152.14 165.85 33.5 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.409 0.623 . . . . 0.0 111.547 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -87.01 114.44 23.63 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.368 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -124.83 153.82 41.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.671 0.748 . . . . 0.0 110.391 -173.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.721 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 7.8 m0 -83.87 116.82 22.94 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.102 -172.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.9 m -131.21 149.35 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -76.22 147.64 38.23 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -53.11 -38.93 63.04 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 124.118 0.967 . . . . 0.0 111.453 -178.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -67.59 -28.41 67.74 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -175.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.415 ' HA ' HD11 ' A' ' 31' ' ' LEU . 4.9 mpp? -96.15 -5.56 40.37 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.497 0.319 . . . . 0.0 111.494 176.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.3 tt -90.1 122.23 32.88 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 174.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.581 ' HB2' HD23 ' A' ' 31' ' ' LEU . 35.1 tt0 -110.73 149.14 30.93 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.507 1.123 . . . . 0.0 108.698 174.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.423 HD12 HG23 ' A' ' 21' ' ' THR . 34.7 pt . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.7 t80 . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.3 -37.86 80.84 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.059 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -70.38 -34.21 72.32 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.438 0.695 . . . . 0.0 110.068 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -69.92 -49.68 49.56 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.201 0.6 . . . . 0.0 111.511 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.0 m -59.11 -37.91 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 123.515 0.51 . . . . 0.0 110.772 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -54.48 -34.97 62.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.065 0.946 . . . . 0.0 111.835 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 42.1 mm-40 -81.63 -42.36 20.13 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.907 -175.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.6 t -92.14 3.34 55.51 Favored 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 123.416 0.687 . . . . 0.0 112.175 -174.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.67 122.18 22.81 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 122.99 0.516 . . . . 0.0 110.2 177.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -104.2 132.43 20.99 Favored Pre-proline 0 N--CA 1.488 1.456 0 C-N-CA 123.832 0.853 . . . . 0.0 110.573 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.78 89.97 0.29 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.98 2.453 . . . . 0.0 111.245 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.8 -6.03 4.8 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.939 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 6.8 ptp -80.67 153.04 28.14 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 173.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -85.66 163.1 18.49 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.1 m -133.99 171.14 18.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -136.58 138.35 41.15 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.528 ' HA ' ' HE2' ' A' ' 30' ' ' MET . 3.0 tpt -85.65 111.15 19.82 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.239 1.016 . . . . 0.0 108.974 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 72' ' ' MET . 4.5 pp -91.04 -15.67 29.18 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 117.778 0.263 . . . . 0.0 111.248 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 30' ' ' MET . 21.3 t70 -125.75 151.91 46.05 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.753 0.821 . . . . 0.0 109.363 -176.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -80.45 119.34 23.01 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.663 0.385 . . . . 0.0 110.048 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -106.66 173.28 6.39 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.725 1.21 . . . . 0.0 111.645 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -48.09 -58.79 4.0 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.364 1.466 . . . . 0.0 112.484 -175.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -121.67 5.54 10.03 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.077 0.951 . . . . 0.0 111.39 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mp -120.0 133.29 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 173.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.6 m -99.92 155.44 17.68 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.992 0.517 . . . . 0.0 109.854 177.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.89 115.86 6.44 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.55 -29.23 3.31 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -172.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -74.51 157.36 35.65 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.51 0.724 . . . . 0.0 111.756 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 41.5 mt-10 -115.73 153.68 30.94 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.782 0.833 . . . . 0.0 111.057 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.83 -170.26 11.88 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.866 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -139.0 140.93 38.32 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 170.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.45 ' HA ' HG13 ' A' ' 57' ' ' VAL . 84.5 t80 -76.71 121.78 23.78 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.037 0.535 . . . . 0.0 110.645 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.523 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 19.9 mmm180 -108.51 -48.39 3.34 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.324 0.65 . . . . 0.0 110.141 -174.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.523 ' NE2' ' HB2' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -158.91 161.13 36.74 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.154 0.982 . . . . 0.0 109.636 -177.764 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.495 ' HA ' HG21 ' A' ' 55' ' ' VAL . 14.5 p -130.96 171.63 12.99 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.877 0.846 . . . . 0.0 111.896 -176.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.543 0.688 0 CA-C-N 113.576 -1.647 . . . . 0.0 108.198 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo . . . . . 0 CA--C 1.581 2.859 0 N-CA-C 118.088 2.303 . . . . 0.0 118.088 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.577 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 93.3 Cg_endo -80.36 108.61 2.19 Favored 'Trans proline' 0 C--N 1.379 2.15 0 CA-C-N 123.376 2.242 . . . . 0.0 112.084 168.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.495 HG21 ' HA ' ' A' ' 48' ' ' SER . 7.7 p -81.08 146.69 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.031 0.933 . . . . 0.0 110.71 172.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.513 ' HB3' HG23 ' A' ' 65' ' ' THR . 1.9 mp0 -93.74 127.91 39.69 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-O 121.191 0.519 . . . . 0.0 109.604 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.45 HG13 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -138.26 135.19 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 125.448 1.499 . . . . 0.0 108.052 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 47.6 t80 -80.92 106.76 13.18 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -177.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.471 ' HB2' HG21 ' A' ' 62' ' ' THR . 86.5 m95 -89.9 123.06 33.51 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.796 0.838 . . . . 0.0 109.811 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 16.9 pt20 -62.17 -28.11 69.43 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.19 0.996 . . . . 0.0 111.663 175.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.9 t -63.86 -44.49 92.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.853 0.861 . . . . 0.0 111.766 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.471 HG21 ' HB2' ' A' ' 59' ' ' TRP . 8.9 t -105.24 -6.01 20.12 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.494 0.718 . . . . 0.0 111.246 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.32 15.93 80.03 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 114.438 0.535 . . . . 0.0 114.438 175.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -152.83 165.94 33.81 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.323 0.582 . . . . 0.0 112.053 -172.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.513 HG23 ' HB3' ' A' ' 56' ' ' GLN . 2.0 m -87.26 117.99 26.39 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.141 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -125.86 156.82 39.01 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.461 0.648 . . . . 0.0 110.651 -171.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.577 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 11.9 m-90 -84.37 111.53 19.52 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.62 1.568 . . . . 0.0 109.488 -173.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.25 149.65 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.492 0.717 . . . . 0.0 110.092 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -78.5 146.61 34.28 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.766 0.426 . . . . 0.0 110.491 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -61.07 -46.17 91.73 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.57 0.748 . . . . 0.0 112.071 -176.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -67.95 -22.22 65.05 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.17 0.588 . . . . 0.0 111.266 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.472 ' HA ' HD12 ' A' ' 31' ' ' LEU . 38.5 mtp -101.85 13.28 35.27 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.764 1.226 . . . . 0.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -117.84 125.71 51.05 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -105.44 150.99 24.8 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 173.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.4 pt . . . . . 0 CA--C 1.54 0.574 0 C-N-CA 123.717 0.807 . . . . 0.0 110.11 176.212 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 62.4 t80 . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.82 -34.89 83.95 Favored Glycine 0 C--N 1.341 0.812 0 O-C-N 123.623 0.577 . . . . 0.0 112.797 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 44.6 mp0 -71.3 -41.4 69.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 123.945 0.898 . . . . 0.0 109.445 177.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.424 ' O ' HG21 ' A' ' 21' ' ' THR . 18.8 t80 -59.36 -51.17 71.07 Favored 'General case' 0 C--N 1.358 0.958 0 O-C-N 123.85 0.719 . . . . 0.0 110.964 178.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.7 m -63.17 -40.1 87.77 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -58.49 -47.48 83.96 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 124.003 0.815 . . . . 0.0 110.873 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 22.6 mm-40 -64.52 -46.37 83.2 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.714 0.293 . . . . 0.0 110.868 -175.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 17' ' ' TYR . 14.7 t -93.15 13.07 22.15 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.457 0.703 . . . . 0.0 111.93 -175.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.731 HD11 ' SD ' ' A' ' 26' ' ' MET . 0.1 OUTLIER -70.94 114.96 9.53 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.91 0.484 . . . . 0.0 109.723 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.642 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 50.0 mt-30 -87.98 137.94 31.24 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.696 0.798 . . . . 0.0 110.777 -177.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.422 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 29.8 Cg_exo -62.74 88.16 0.12 Allowed 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.39 2.727 . . . . 0.0 113.118 177.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.72 40.96 1.79 Allowed Glycine 0 C--N 1.35 1.309 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.731 ' SD ' HD11 ' A' ' 22' ' ' LEU . 20.3 ptm -98.82 177.66 5.21 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.719 0.771 . . . . 0.0 110.814 -177.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -96.56 122.03 39.04 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.19 1.396 . . . . 0.0 108.942 -177.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.0 m -117.0 171.74 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.146 0.578 . . . . 0.0 109.607 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -143.01 143.26 31.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.103 1.361 . . . . 0.0 107.705 -176.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.497 ' HA ' ' HE2' ' A' ' 30' ' ' MET . 1.7 tpt -88.3 125.53 34.72 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 72' ' ' MET . 4.4 pp -105.38 -9.74 17.39 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.627 0.371 . . . . 0.0 111.085 178.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -125.16 156.14 38.86 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.336 0.655 . . . . 0.0 110.27 -175.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -87.23 121.01 29.1 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.217 0.607 . . . . 0.0 109.752 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.535 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 10.4 m-85 -110.68 173.39 6.35 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.512 1.125 . . . . 0.0 111.772 -175.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -50.41 -52.86 33.9 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.435 1.494 . . . . 0.0 111.401 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.533 ' HG3' HG13 ' A' ' 37' ' ' ILE . 10.0 pt-20 -117.3 -19.2 9.69 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.815 -174.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 34' ' ' TYR . 4.6 mt -104.89 145.75 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.45 1.1 . . . . 0.0 108.995 -176.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 m -110.72 152.29 26.74 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.48 113.66 4.88 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 138.17 -29.1 2.65 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 119.569 -0.573 . . . . 0.0 113.711 -178.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -90.42 160.68 15.93 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 118.06 0.93 . . . . 0.0 111.927 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -109.26 159.99 16.5 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.922 0.889 . . . . 0.0 111.641 -164.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -141.64 -176.14 15.69 Favored Glycine 0 C--O 1.241 0.58 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.481 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -133.97 140.52 46.79 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 174.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.519 ' HA ' HG12 ' A' ' 57' ' ' VAL . 78.1 t80 -72.37 121.96 20.38 Favored 'General case' 0 C--N 1.342 0.261 0 O-C-N 123.494 0.496 . . . . 0.0 110.244 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.509 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 7.5 mmm180 -108.35 -47.76 3.46 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -177.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.525 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -166.31 151.24 8.07 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.05 0.94 . . . . 0.0 109.561 179.061 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.417 ' HA ' HG23 ' A' ' 55' ' ' VAL . 30.8 p -118.02 178.23 4.5 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.234 1.014 . . . . 0.0 111.004 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 168.466 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo . . . . . 0 CA--C 1.577 2.664 0 N-CA-C 118.901 2.616 . . . . 0.0 118.901 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.32 105.3 1.39 Allowed 'Trans proline' 0 C--N 1.381 2.269 0 CA-C-N 123.112 2.147 . . . . 0.0 112.092 172.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 48' ' ' SER . 3.2 p -89.53 138.77 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.238 1.015 . . . . 0.0 109.923 169.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.525 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.1 mp0 -92.73 124.1 36.49 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -134.65 142.37 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.913 1.285 . . . . 0.0 108.631 -179.19 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -84.84 107.66 17.12 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.54 ' HB2' HG21 ' A' ' 62' ' ' THR . 83.2 m95 -91.06 127.46 36.49 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.751 0.821 . . . . 0.0 110.133 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -21.37 63.63 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.762 0.664 . . . . 0.0 112.01 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.9 t -65.99 -46.28 78.59 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.08 0.552 . . . . 0.0 112.132 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.54 HG21 ' HB2' ' A' ' 59' ' ' TRP . 9.9 t -97.41 -16.14 20.34 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.816 0.846 . . . . 0.0 110.351 -177.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.18 15.68 80.72 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.494 -0.615 . . . . 0.0 114.037 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -151.4 176.99 10.73 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 117.632 0.716 . . . . 0.0 111.252 -174.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.08 138.52 31.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.38 1.072 . . . . 0.0 109.268 178.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -141.8 156.48 45.56 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.06 0.457 . . . . 0.0 110.966 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 -83.07 106.72 15.12 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.777 1.231 . . . . 0.0 109.98 -177.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.6 m -121.19 156.77 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.226 0.61 . . . . 0.0 110.129 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -89.44 146.48 24.62 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.697 0.799 . . . . 0.0 109.675 -176.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -56.17 -49.3 74.41 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.866 0.866 . . . . 0.0 112.607 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -70.06 -19.97 63.26 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.428 0.691 . . . . 0.0 111.582 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.476 ' HE2' ' OH ' ' A' ' 34' ' ' TYR . 31.2 mtp -100.26 1.55 41.88 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.708 0.803 . . . . 0.0 111.23 176.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.0 tt -104.48 130.71 52.38 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.617 1.167 . . . . 0.0 108.235 170.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HB2' HD21 ' A' ' 31' ' ' LEU . 41.3 tt0 -107.45 146.89 31.16 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.103 0.961 . . . . 0.0 108.746 173.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.1 pt . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 120.831 0.348 . . . . 0.0 110.116 170.951 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.1 t80 . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.5 -44.93 39.28 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-O 121.785 0.658 . . . . 0.0 113.357 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -70.92 -26.19 63.09 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.191 0.596 . . . . 0.0 109.682 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -71.28 -49.22 45.15 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.456 1.102 . . . . 0.0 111.585 174.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 m -62.71 -33.99 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 122.563 0.345 . . . . 0.0 110.426 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.85 -33.35 49.18 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.22 1.008 . . . . 0.0 110.545 177.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -80.66 -53.42 6.54 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.208 0.603 . . . . 0.0 110.577 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.5 t -90.94 17.07 8.32 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.649 0.78 . . . . 0.0 112.463 -167.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.642 HD11 ' SD ' ' A' ' 26' ' ' MET . 0.2 OUTLIER -76.24 149.76 37.13 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 173.25 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.498 HE21 ' N ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -117.69 140.24 27.34 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.252 1.021 . . . . 0.0 109.612 177.045 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.447 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 72.8 Cg_endo -72.68 78.98 1.98 Allowed 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.34 2.693 . . . . 0.0 113.429 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.67 28.31 0.82 Allowed Glycine 0 C--N 1.352 1.422 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.642 ' SD ' HD11 ' A' ' 22' ' ' LEU . 27.8 ptm -98.95 170.84 8.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.241 0.616 . . . . 0.0 111.29 -176.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -82.76 124.3 30.13 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.179 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.0 m -116.45 170.47 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.475 ' HE ' ' HG2' ' A' ' 42' ' ' GLU . 21.4 tpp85 -138.41 153.57 48.89 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -175.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' MET . . . . . 0.433 ' HE1' ' HB2' ' A' ' 34' ' ' TYR . 11.4 tpt -97.26 124.57 41.41 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.2 tp -96.23 -9.69 29.8 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.456 0.702 . . . . 0.0 111.258 -173.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 30' ' ' MET . 12.2 t70 -151.22 157.03 42.1 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.282 0.633 . . . . 0.0 109.325 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -73.43 142.16 46.9 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.433 ' HB2' ' HE1' ' A' ' 30' ' ' MET . 0.6 OUTLIER -132.44 172.19 12.8 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.979 0.511 . . . . 0.0 110.434 -177.025 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -40.74 -55.53 2.39 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 126.178 1.791 . . . . 0.0 113.05 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -124.19 0.4 8.41 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.552 -172.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.6 mt -118.71 138.72 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 124.142 0.977 . . . . 0.0 108.508 -175.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.2 m -87.9 150.94 23.19 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 122.915 0.486 . . . . 0.0 110.426 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.17 119.71 11.94 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 171.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.71 11.91 54.31 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.969 -177.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -79.56 153.49 29.45 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.91 0.484 . . . . 0.0 110.079 175.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.475 ' HG2' ' HE ' ' A' ' 29' ' ' ARG . 48.5 mt-10 -112.62 120.44 41.57 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.929 0.492 . . . . 0.0 110.601 -176.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.94 -172.6 21.87 Favored Glycine 0 C--O 1.243 0.683 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.569 173.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -134.04 138.21 45.2 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 171.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.457 ' HA ' HG13 ' A' ' 57' ' ' VAL . 64.1 t80 -70.47 123.27 21.37 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.532 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 21.7 mmm180 -106.36 -49.41 3.35 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -177.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.549 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -167.71 167.29 13.34 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.929 -179.406 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 72.3 p -141.51 -179.93 6.44 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.825 0.85 . . . . 0.0 110.922 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 . . . . . 0 CA--C 1.539 0.543 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 168.988 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo . . . . . 0 CA--C 1.577 2.667 0 N-CA-C 118.831 2.589 . . . . 0.0 118.831 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.14 110.22 1.93 Allowed 'Trans proline' 0 C--N 1.385 2.492 0 CA-C-N 123.597 2.32 . . . . 0.0 111.594 169.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.78 141.67 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.134 0.974 . . . . 0.0 110.152 170.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . 0.549 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 1.6 mp0 -93.32 121.34 34.6 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.457 HG13 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -135.87 137.2 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.977 1.311 . . . . 0.0 108.403 -177.136 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -83.59 106.08 15.03 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.484 ' HB2' HG21 ' A' ' 62' ' ' THR . 87.5 m95 -95.6 131.62 41.62 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.367 1.067 . . . . 0.0 110.326 -176.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -69.36 -25.05 63.99 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 123.847 0.717 . . . . 0.0 112.268 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.8 t -59.65 -44.17 93.64 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.348 0.594 . . . . 0.0 110.881 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.484 HG21 ' HB2' ' A' ' 59' ' ' TRP . 10.1 t -105.16 -14.49 15.37 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.957 -1.019 . . . . 0.0 111.826 -174.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.13 15.83 81.13 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.111 -0.495 . . . . 0.0 114.097 178.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -152.94 173.46 15.36 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.317 0.579 . . . . 0.0 111.578 -172.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.1 132.67 34.22 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.14 1.376 . . . . 0.0 109.576 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -141.5 158.11 44.27 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.265 0.555 . . . . 0.0 111.695 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -88.2 115.75 25.92 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.497 1.519 . . . . 0.0 109.776 -174.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.81 147.53 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.861 0.865 . . . . 0.0 109.251 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.523 ' HD2' ' H ' ' A' ' 71' ' ' HIS . 15.5 t60 -73.3 146.88 45.0 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -54.1 -31.26 51.51 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.57 1.548 . . . . 0.0 113.863 -177.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . 0.523 ' H ' ' HD2' ' A' ' 69' ' ' HIS . 59.1 t-80 -79.39 -18.11 52.99 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.731 0.812 . . . . 0.0 111.191 -173.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.5 mtm -100.31 4.84 44.35 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.484 0.714 . . . . 0.0 110.655 171.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 tt -103.68 120.32 40.69 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 170.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -105.19 129.09 53.65 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.314 1.046 . . . . 0.0 108.235 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.9 pt . . . . . 0 CA--C 1.54 0.592 0 CA-C-O 121.543 0.687 . . . . 0.0 109.896 175.613 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 79.8 t80 . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 120.858 0.361 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.48 -32.76 84.22 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.034 -0.984 . . . . 0.0 112.931 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 41.2 tt0 -62.86 -48.94 76.84 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.098 0.559 . . . . 0.0 110.274 173.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 10.3 t80 -57.51 -50.42 73.14 Favored 'General case' 0 C--N 1.358 0.971 0 O-C-N 124.017 0.823 . . . . 0.0 110.838 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.448 ' HB ' HD22 ' A' ' 22' ' ' LEU . 29.5 m -67.74 -39.01 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 O-C-N 123.535 0.522 . . . . 0.0 110.645 -177.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -56.91 -31.25 64.72 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.153 0.581 . . . . 0.0 111.723 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 26.4 mm-40 -81.94 -40.57 22.07 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.191 -177.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.5 t -100.46 -6.06 26.13 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -168.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.493 HD12 ' SD ' ' A' ' 26' ' ' MET . 1.1 mm? -69.7 107.79 3.61 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 118.164 0.438 . . . . 0.0 110.612 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -87.46 142.45 33.1 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.08 0.952 . . . . 0.0 110.498 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.489 ' HA ' ' CD1' ' A' ' 45' ' ' PHE . 34.7 Cg_exo -59.59 79.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.531 2.821 . . . . 0.0 114.061 176.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.33 19.32 1.22 Allowed Glycine 0 C--N 1.353 1.525 0 CA-C-O 119.534 -0.592 . . . . 0.0 113.015 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.493 ' SD ' HD12 ' A' ' 22' ' ' LEU . 4.7 ptp -93.91 174.68 7.04 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 117.704 0.752 . . . . 0.0 110.876 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.588 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 21.4 tpt180 -97.02 126.97 42.54 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.747 1.219 . . . . 0.0 109.055 -171.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.426 HG13 HD11 ' A' ' 22' ' ' LEU . 5.7 m -116.03 172.34 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.676 0.791 . . . . 0.0 109.999 -174.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -144.58 140.95 29.1 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.173 1.389 . . . . 0.0 108.329 -172.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.484 ' HE2' ' HA ' ' A' ' 30' ' ' MET . 1.4 tpt -98.95 112.15 24.34 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 74' ' ' GLU . 4.7 pp -89.48 -3.7 58.26 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -140.7 154.01 46.18 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.63 127.04 32.2 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.221 0.534 . . . . 0.0 110.144 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.435 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -107.06 172.68 6.69 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.734 0.813 . . . . 0.0 110.989 -178.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -50.11 -35.78 26.99 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.818 1.647 . . . . 0.0 113.237 -172.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -138.58 3.6 2.31 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.859 0.864 . . . . 0.0 111.182 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.435 ' HB ' ' HB2' ' A' ' 34' ' ' TYR . 7.2 mt -118.78 144.19 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.438 1.095 . . . . 0.0 108.503 -172.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 m -91.77 153.69 19.44 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.85 0.46 . . . . 0.0 110.909 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.11 116.14 12.18 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 166.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.7 -5.71 29.48 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.346 -172.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -79.17 156.23 28.31 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.748 0.419 . . . . 0.0 110.108 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -129.88 158.21 40.12 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.252 0.621 . . . . 0.0 111.136 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -149.26 -166.88 13.5 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.501 -172.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -135.47 139.26 43.93 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.489 ' CD1' ' HA ' ' A' ' 24' ' ' PRO . 38.7 t80 -69.13 119.52 13.55 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.496 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 14.5 mmm180 -103.65 -46.96 4.38 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.618 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -172.21 156.92 4.05 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.734 1.214 . . . . 0.0 108.885 176.421 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.7 p -127.39 178.2 6.22 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.473 0.709 . . . . 0.0 110.335 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 31.6 m-80 -118.31 136.27 53.8 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 170.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -67.93 -52.71 32.98 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.226 0.61 . . . . 0.0 110.898 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.29 -23.31 32.18 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-N 115.18 -0.918 . . . . 0.0 113.282 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.538 HG22 ' HD2' ' A' ' 54' ' ' PRO . 5.9 mm -101.68 114.06 65.7 Favored Pre-proline 0 N--CA 1.479 0.988 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -177.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -59.51 -33.55 97.11 Favored 'Trans proline' 0 CA--C 1.577 2.656 0 N-CA-C 118.361 2.408 . . . . 0.0 118.361 -174.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.538 ' HD2' HG22 ' A' ' 52' ' ' ILE . 28.9 Cg_endo -61.68 107.75 0.55 Allowed 'Trans proline' 0 C--N 1.384 2.415 0 CA-C-N 123.101 2.143 . . . . 0.0 112.51 175.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.04 136.46 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.28 1.032 . . . . 0.0 109.502 169.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.618 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 1.8 mp0 -90.4 123.35 34.05 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.452 HG11 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -137.03 136.75 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.0 1.32 . . . . 0.0 108.546 -174.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -82.53 105.58 13.69 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -175.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.468 ' HB2' HG22 ' A' ' 62' ' ' THR . 95.6 m95 -90.14 130.61 36.27 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.064 0.946 . . . . 0.0 110.432 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -70.31 -31.33 68.61 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 123.863 0.727 . . . . 0.0 112.727 -174.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.6 t -70.08 -46.08 65.68 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 117.951 0.341 . . . . 0.0 111.536 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.468 HG22 ' HB2' ' A' ' 59' ' ' TRP . 9.8 t -86.45 -18.13 32.5 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 122.736 0.414 . . . . 0.0 110.676 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.8 19.71 78.69 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-O 119.727 -0.485 . . . . 0.0 114.277 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -153.04 165.0 36.95 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.317 0.579 . . . . 0.0 112.244 -173.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.507 HG22 ' HB3' ' A' ' 56' ' ' GLN . 2.1 m -87.05 121.63 29.78 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.933 -177.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -130.64 157.15 43.53 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.964 0.411 . . . . 0.0 111.283 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 12.3 m-90 -79.02 114.34 17.88 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.714 1.205 . . . . 0.0 110.191 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.431 HG21 HD23 ' A' ' 73' ' ' LEU . 11.6 m -129.05 155.34 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 122.838 0.455 . . . . 0.0 110.652 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -89.47 147.06 24.21 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.736 0.814 . . . . 0.0 110.169 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -59.82 -42.36 93.33 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.428 0.691 . . . . 0.0 112.59 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -66.99 -24.94 66.09 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 117.661 0.21 . . . . 0.0 111.336 -176.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 71.4 mtm -99.88 -1.82 36.43 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.732 0.413 . . . . 0.0 111.62 175.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.431 HD23 HG21 ' A' ' 68' ' ' VAL . 2.5 tm? -92.66 121.23 33.87 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 172.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.516 ' HB2' HD23 ' A' ' 31' ' ' LEU . 39.6 tt0 -115.69 151.59 34.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.882 1.273 . . . . 0.0 108.458 176.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.451 HG21 ' SD ' ' A' ' 26' ' ' MET . 10.7 pt -114.18 123.2 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 118.433 0.56 . . . . 0.0 110.723 169.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 84.0 mt -121.7 3.73 10.08 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.971 0.908 . . . . 0.0 109.838 173.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.588 ' HA3' ' HB3' ' A' ' 27' ' ' ARG . . . . . . . . 0 C--N 1.352 1.466 0 O-C-N 123.659 0.599 . . . . 0.0 113.197 176.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.4 t80 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.02 -31.77 81.99 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.893 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 12.1 tp10 -69.14 -48.05 63.42 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -59.06 -49.92 76.05 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 114.986 -1.007 . . . . 0.0 111.396 -177.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.8 -40.67 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 123.677 0.611 . . . . 0.0 110.721 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -57.64 -36.31 71.67 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.507 0.723 . . . . 0.0 111.932 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 23.5 mm-40 -80.21 -35.79 35.77 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.009 0.524 . . . . 0.0 111.171 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 t -101.04 7.82 43.24 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.806 0.443 . . . . 0.0 112.117 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.97 113.98 11.76 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.495 ' HB3' ' HB3' ' A' ' 26' ' ' MET . 34.3 tt0 -87.44 134.71 35.57 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.06 0.944 . . . . 0.0 109.673 -176.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.499 ' HA ' ' CD1' ' A' ' 45' ' ' PHE . 52.7 Cg_endo -64.81 80.3 0.18 Allowed 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 123.151 2.567 . . . . 0.0 113.457 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.99 26.44 1.54 Allowed Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.057 175.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.495 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 24.6 ptm -96.53 168.97 10.22 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.608 0.718 . . . . 0.0 110.54 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.542 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 18.6 tpp180 -90.01 126.31 35.71 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.851 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.459 HG13 HG21 ' A' ' 75' ' ' ILE . 8.0 m -116.44 171.02 5.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 C-N-CA 124.209 1.003 . . . . 0.0 108.833 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.46 ' HD2' ' N ' ' A' ' 30' ' ' MET . 2.6 tmm_? -137.29 143.93 42.41 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.529 ' HA ' ' HE3' ' A' ' 30' ' ' MET . 1.9 tpt -92.77 112.68 24.72 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.642 0.777 . . . . 0.0 109.133 -177.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.485 HD23 ' HB2' ' A' ' 74' ' ' GLU . 4.4 pp -89.19 -9.58 50.29 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.571 0.348 . . . . 0.0 111.547 -178.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -127.02 162.62 25.6 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.944 0.898 . . . . 0.0 109.344 -174.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.43 146.19 25.96 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.526 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 13.8 m-85 -133.53 173.07 11.9 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.645 0.778 . . . . 0.0 111.117 -176.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -50.93 -47.4 61.03 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.15 1.38 . . . . 0.0 112.043 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -131.09 -1.35 4.08 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.696 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.526 ' HB ' ' HB2' ' A' ' 34' ' ' TYR . 3.9 mp -112.64 143.02 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.2 t -103.32 154.5 19.31 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.263 0.625 . . . . 0.0 109.751 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.83 114.18 6.93 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.402 ' HA2' HH11 ' A' ' 29' ' ' ARG . . . 124.58 -17.54 7.33 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.314 -176.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.62 154.71 41.59 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.209 0.603 . . . . 0.0 111.259 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.424 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 45.0 mt-10 -112.79 138.61 49.37 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.601 0.761 . . . . 0.0 110.813 -175.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.56 -176.74 14.59 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.99 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -135.36 137.18 42.1 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 24' ' ' PRO . 60.4 t80 -69.65 120.35 15.29 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.485 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 9.9 mmm-85 -107.42 -47.52 3.63 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.604 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -169.06 166.38 10.99 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.252 1.021 . . . . 0.0 109.398 178.624 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 92.3 p -152.93 -179.18 7.43 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.689 0.757 . . . . 0.0 111.509 -176.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 18.8 m-80 -121.71 122.59 39.9 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 168.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -84.02 1.41 43.93 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.72 -29.56 1.15 Allowed Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 175.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.552 HG23 ' HD2' ' A' ' 54' ' ' PRO . 5.1 mm -105.22 127.0 29.51 Favored Pre-proline 0 N--CA 1.482 1.164 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.9 -29.04 75.81 Favored 'Trans proline' 0 CA--C 1.584 2.982 0 N-CA-C 119.221 2.739 . . . . 0.0 119.221 -171.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.552 ' HD2' HG23 ' A' ' 52' ' ' ILE . 37.6 Cg_endo -63.95 106.24 0.63 Allowed 'Trans proline' 0 C--N 1.389 2.692 0 CA-C-N 123.558 2.306 . . . . 0.0 113.054 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 p -95.44 132.3 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.318 167.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.604 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.1 mp0 -92.12 124.62 36.34 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.487 HG13 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -134.71 139.05 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.09 1.356 . . . . 0.0 108.636 -174.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -81.52 107.13 14.03 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.562 0.745 . . . . 0.0 109.731 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.402 ' NE1' HG23 ' A' ' 57' ' ' VAL . 93.0 m95 -93.83 130.1 39.99 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.944 0.898 . . . . 0.0 110.618 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -71.17 -26.25 62.89 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 123.965 0.791 . . . . 0.0 112.508 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.3 t -62.62 -45.85 90.96 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.047 0.451 . . . . 0.0 111.401 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.9 t -99.16 -12.19 20.69 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.913 0.885 . . . . 0.0 110.36 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.18 22.31 74.34 Favored Glycine 0 C--N 1.352 1.458 0 CA-C-N 115.966 -0.561 . . . . 0.0 114.17 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -151.35 172.45 15.89 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 117.324 0.562 . . . . 0.0 111.202 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.11 139.64 31.57 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.268 1.027 . . . . 0.0 109.102 -175.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -144.71 155.41 43.55 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.056 0.455 . . . . 0.0 111.139 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -79.75 120.73 24.44 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.033 1.333 . . . . 0.0 109.351 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.438 HG21 HD12 ' A' ' 73' ' ' LEU . 6.7 m -131.44 160.91 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.206 0.602 . . . . 0.0 109.665 176.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 72' ' ' MET . 46.7 t60 -93.86 145.83 24.33 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.734 0.813 . . . . 0.0 108.826 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -60.15 -46.88 88.18 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.396 0.678 . . . . 0.0 112.501 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -73.15 -19.4 61.13 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.16 0.584 . . . . 0.0 111.003 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.449 ' HE3' ' OH ' ' A' ' 34' ' ' TYR . 46.5 mtp -98.32 2.64 48.3 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.252 1.021 . . . . 0.0 110.668 176.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.438 HD12 HG21 ' A' ' 68' ' ' VAL . 58.5 tp -111.03 133.78 53.15 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.518 1.127 . . . . 0.0 109.142 176.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.485 ' HB2' HD23 ' A' ' 31' ' ' LEU . 35.5 tt0 -107.25 152.56 23.94 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 172.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.459 HG21 HG13 ' A' ' 28' ' ' VAL . 21.7 pt -111.99 137.64 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 122.905 0.482 . . . . 0.0 109.801 166.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 tt -159.98 96.71 1.24 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.542 ' HA3' ' HB3' ' A' ' 27' ' ' ARG . . . . . . . . 0 CA--C 1.528 0.849 0 CA-C-O 118.823 -0.987 . . . . 0.0 112.127 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 55.4 t80 . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 110.907 -0.034 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.91 -40.71 95.54 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.363 0.414 . . . . 0.0 113.247 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 25.7 tt0 -71.36 -36.09 71.35 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.925 0.49 . . . . 0.0 110.348 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -64.47 -49.49 71.22 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.096 0.958 . . . . 0.0 111.255 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.423 ' HA ' HG23 ' A' ' 21' ' ' THR . 28.8 m -63.45 -39.63 86.03 Favored 'Isoleucine or valine' 0 C--N 1.354 0.77 0 O-C-N 123.65 0.593 . . . . 0.0 110.316 -176.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -55.81 -38.77 70.43 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.196 0.599 . . . . 0.0 111.202 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.43 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 23.9 mm-40 -78.66 -38.94 38.27 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.408 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.423 HG23 ' HA ' ' A' ' 18' ' ' VAL . 12.6 t -94.11 2.06 56.04 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -173.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.488 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.2 OUTLIER -71.11 127.99 34.42 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 118.114 0.415 . . . . 0.0 109.944 176.448 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -116.41 133.67 22.95 Favored Pre-proline 0 N--CA 1.488 1.443 0 C-N-CA 124.26 1.024 . . . . 0.0 109.775 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.03 90.55 0.13 Allowed 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 123.227 2.618 . . . . 0.0 112.805 -175.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.61 8.06 3.26 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 116.147 -0.478 . . . . 0.0 112.782 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.488 ' SD ' HD13 ' A' ' 22' ' ' LEU . 9.8 ptp -87.33 157.48 19.27 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 173.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -87.27 157.19 19.36 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.748 0.785 . . . . 0.0 109.342 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.491 HG12 HG23 ' A' ' 75' ' ' ILE . 9.5 m -133.88 173.63 14.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.43 ' HB3' HD12 ' A' ' 76' ' ' LEU . 3.6 tmt_? -151.21 145.84 25.67 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.438 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 31.9 tpp -98.43 126.95 44.15 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.009 0.924 . . . . 0.0 110.297 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.597 HD22 ' HB2' ' A' ' 74' ' ' GLU . 3.9 pp -95.47 -7.63 37.62 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.221 0.608 . . . . 0.0 111.857 -176.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 30' ' ' MET . 21.7 t70 -132.64 168.47 18.22 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.449 0.7 . . . . 0.0 110.411 -174.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -80.19 130.69 35.4 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 122.137 -0.352 . . . . 0.0 110.248 175.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.438 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 1.2 m-85 -120.07 171.79 8.21 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.045 0.938 . . . . 0.0 110.433 176.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -50.44 -49.51 54.77 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.497 1.519 . . . . 0.0 113.009 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -126.17 0.38 7.13 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.645 0.778 . . . . 0.0 111.318 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.47 HD13 ' HB3' ' A' ' 66' ' ' TYR . 4.9 mt -116.56 126.37 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.1 m -89.43 155.17 19.49 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.26 113.36 3.54 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.415 ' HA2' ' NE ' ' A' ' 29' ' ' ARG . . . 124.37 -21.92 6.72 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.22 -177.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.411 ' OD2' ' HB3' ' A' ' 59' ' ' TRP . 28.4 t0 -62.19 142.45 57.65 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.301 0.64 . . . . 0.0 112.07 -176.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -104.1 148.29 26.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.256 1.022 . . . . 0.0 110.761 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.63 -173.85 13.09 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.434 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -134.91 140.69 45.96 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.478 ' HA ' HG11 ' A' ' 57' ' ' VAL . 59.3 t80 -71.63 119.75 16.24 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 123.864 0.727 . . . . 0.0 110.08 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.494 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 11.4 mmm180 -107.58 -47.68 3.57 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -174.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.531 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -164.42 157.18 17.1 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.338 1.055 . . . . 0.0 109.412 177.179 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.439 ' HA ' HG21 ' A' ' 55' ' ' VAL . 29.8 p -117.4 178.31 4.42 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.914 0.886 . . . . 0.0 111.169 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 27.9 m-80 -132.14 120.98 23.02 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -72.27 -33.38 67.43 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.212 0.605 . . . . 0.0 111.22 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -105.71 -8.28 35.05 Favored Glycine 0 C--N 1.346 1.124 0 O-C-N 123.773 0.67 . . . . 0.0 113.537 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.551 HG23 ' HD2' ' A' ' 54' ' ' PRO . 13.1 mm -118.94 112.57 36.38 Favored Pre-proline 0 N--CA 1.486 1.366 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.88 -29.89 89.0 Favored 'Trans proline' 0 CA--C 1.581 2.832 0 N-CA-C 118.074 2.298 . . . . 0.0 118.074 -175.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.551 ' HD2' HG23 ' A' ' 52' ' ' ILE . 43.1 Cg_endo -68.51 109.09 1.97 Allowed 'Trans proline' 0 C--N 1.384 2.401 0 CA-C-N 123.325 2.223 . . . . 0.0 111.827 169.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.439 HG21 ' HA ' ' A' ' 48' ' ' SER . 3.2 p -90.34 141.62 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.621 1.168 . . . . 0.0 110.478 171.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.531 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.0 mp0 -93.33 125.17 37.8 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.549 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.478 HG11 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -138.89 138.45 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.167 1.387 . . . . 0.0 108.538 -176.581 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -81.96 106.67 14.06 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.429 ' HB2' HG21 ' A' ' 62' ' ' THR . 97.6 m95 -91.73 130.49 37.51 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.579 1.152 . . . . 0.0 110.647 -176.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.23 -26.93 60.53 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -174.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.3 t -72.6 -41.49 65.56 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.025 0.375 . . . . 0.0 111.378 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.429 HG21 ' HB2' ' A' ' 59' ' ' TRP . 10.5 t -87.76 -30.78 20.03 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 122.783 0.433 . . . . 0.0 109.843 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.58 16.76 58.07 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.911 -0.586 . . . . 0.0 114.096 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.75 175.37 12.47 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.593 0.757 . . . . 0.0 112.032 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.47 132.96 33.8 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.882 1.273 . . . . 0.0 109.716 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.47 ' HB3' HD13 ' A' ' 37' ' ' ILE . 12.7 t80 -138.82 156.99 46.88 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.09 0.472 . . . . 0.0 111.028 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.504 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 12.9 m-90 -83.51 113.74 21.0 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.128 1.371 . . . . 0.0 109.744 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.42 HG23 HD11 ' A' ' 73' ' ' LEU . 17.0 m -130.15 154.55 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.326 0.651 . . . . 0.0 110.546 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -80.62 145.5 31.66 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.994 0.518 . . . . 0.0 110.352 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -59.51 -45.59 91.29 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.526 0.731 . . . . 0.0 112.042 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -70.56 -25.36 63.05 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.528 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 74.7 mtm -93.2 1.27 57.17 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.745 0.418 . . . . 0.0 111.13 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.42 HD11 HG23 ' A' ' 68' ' ' VAL . 26.5 tp -97.11 118.82 34.39 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 174.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.597 ' HB2' HD22 ' A' ' 31' ' ' LEU . 42.9 tt0 -108.2 108.4 19.42 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.975 0.91 . . . . 0.0 108.924 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.491 HG23 HG12 ' A' ' 28' ' ' VAL . 17.9 pt -89.62 115.59 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-O 121.737 0.779 . . . . 0.0 111.415 -174.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.43 HD12 ' HB3' ' A' ' 29' ' ' ARG . 10.9 mp -98.84 3.24 47.3 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.228 1.011 . . . . 0.0 110.247 173.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.532 0 C-N-CA 123.292 0.472 . . . . 0.0 112.785 174.613 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.1 t80 . . . . . 0 N--CA 1.481 1.118 0 CA-C-O 120.823 0.344 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.62 -42.99 87.01 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.147 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -71.05 -22.49 62.12 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.769 0.827 . . . . 0.0 111.735 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -70.95 -50.99 28.54 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.27 0.228 . . . . 0.0 110.792 170.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.8 m -66.63 -41.55 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -169.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -55.78 -30.29 61.05 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.336 0.654 . . . . 0.0 112.706 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 56.5 mm-40 -78.32 -36.93 45.7 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.056 -179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.2 t -94.36 -0.36 54.96 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.452 HD12 ' SD ' ' A' ' 26' ' ' MET . 0.6 OUTLIER -72.1 117.61 13.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 122.039 -0.413 . . . . 0.0 110.738 177.074 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -96.86 135.66 22.01 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 124.112 0.965 . . . . 0.0 110.253 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.427 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 27.9 Cg_exo -62.97 82.19 0.11 Allowed 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.657 2.905 . . . . 0.0 113.188 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.03 15.92 1.64 Allowed Glycine 0 C--N 1.345 1.056 0 CA-C-N 116.4 -0.363 . . . . 0.0 112.467 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.452 ' SD ' HD12 ' A' ' 22' ' ' LEU . 5.3 ptp -90.7 163.75 14.39 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.539 0.685 . . . . 0.0 110.298 176.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.546 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 25.2 tpt180 -83.73 129.02 34.95 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.192 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 m -115.62 172.03 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -141.63 141.94 33.42 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.228 1.411 . . . . 0.0 108.272 -172.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.504 ' HA ' ' HE2' ' A' ' 30' ' ' MET . 2.3 tpt -86.43 110.53 19.79 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.3 tp -81.13 -29.44 34.77 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.061 0.544 . . . . 0.0 110.599 -175.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -143.1 151.75 41.08 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -66.33 151.0 48.01 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.062 0.545 . . . . 0.0 111.51 -168.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -133.15 172.16 13.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.636 0.774 . . . . 0.0 111.436 -174.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -49.23 -47.8 46.08 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.037 1.735 . . . . 0.0 112.483 -175.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -129.99 2.88 4.82 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.995 0.918 . . . . 0.0 111.32 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -118.56 143.87 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.4 m -98.98 148.76 23.67 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.907 0.483 . . . . 0.0 110.208 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.1 117.48 5.59 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.998 0.519 . . . . 0.0 110.076 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.28 -15.93 20.17 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.487 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.98 151.06 43.51 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 117.265 0.533 . . . . 0.0 109.856 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -118.34 146.37 44.42 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.403 0.62 . . . . 0.0 110.939 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.433 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . -127.9 -165.36 11.83 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.252 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -136.27 142.64 43.97 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.435 ' HA ' HG11 ' A' ' 57' ' ' VAL . 75.4 t80 -75.57 119.58 19.81 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.416 0.686 . . . . 0.0 110.276 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.54 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 11.9 mmm180 -108.06 -49.6 3.18 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -175.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.54 ' NE2' ' HB2' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -164.82 163.67 21.17 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.44 1.096 . . . . 0.0 109.271 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 87.8 p -161.95 179.74 7.79 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 122.088 0.947 . . . . 0.0 112.517 -176.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.438 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 3.2 m-80 -133.49 128.95 36.47 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 167.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -78.3 -33.7 49.2 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.642 0.377 . . . . 0.0 110.798 -177.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.5 -32.7 15.3 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.721 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.438 ' HB ' ' HB2' ' A' ' 49' ' ' ASN . 35.3 mm -100.15 100.62 12.09 Favored Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 175.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -62.47 -22.14 73.66 Favored 'Trans proline' 0 CA--C 1.578 2.678 0 N-CA-C 118.848 2.595 . . . . 0.0 118.848 -165.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.66 101.75 0.27 Allowed 'Trans proline' 0 C--N 1.389 2.662 0 CA-C-N 123.256 2.199 . . . . 0.0 112.199 171.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.11 135.3 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.722 168.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.521 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.0 mp0 -91.01 121.89 33.21 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.435 HG11 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -135.27 136.6 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.91 1.284 . . . . 0.0 108.411 -176.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -82.38 106.18 14.04 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.849 0.46 . . . . 0.0 109.917 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -94.11 131.0 40.08 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.053 0.941 . . . . 0.0 110.535 -177.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -71.04 -24.8 62.42 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.5 p -62.03 -45.75 92.22 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.414 0.626 . . . . 0.0 111.53 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.8 t -99.51 -17.87 17.69 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.367 -176.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.59 19.21 74.12 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-O 119.789 -0.45 . . . . 0.0 113.961 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -152.27 170.12 20.83 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.499 0.666 . . . . 0.0 111.216 -175.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.443 HG22 ' HB3' ' A' ' 56' ' ' GLN . 1.3 m -86.52 129.14 34.97 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.773 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -131.99 154.71 49.05 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.268 0.556 . . . . 0.0 111.612 -174.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -85.18 100.48 11.78 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.396 1.478 . . . . 0.0 109.427 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.8 m -116.94 162.02 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 122.744 0.418 . . . . 0.0 110.348 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.536 ' HD2' ' H ' ' A' ' 71' ' ' HIS . 8.8 t60 -91.59 147.79 22.75 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.301 0.641 . . . . 0.0 109.846 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -58.84 -45.66 89.54 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.363 1.065 . . . . 0.0 113.291 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.536 ' H ' ' HD2' ' A' ' 69' ' ' HIS . 57.5 t-80 -66.44 -21.59 66.2 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.431 0.693 . . . . 0.0 111.797 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 76.3 mtm -101.94 9.66 40.37 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.2 0.6 . . . . 0.0 111.248 174.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.7 tt -109.64 120.62 43.05 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 172.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -106.86 150.22 26.61 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.903 1.281 . . . . 0.0 107.774 171.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.2 pt -113.96 116.65 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 CA-C-N 119.123 0.874 . . . . 0.0 111.818 174.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 66.0 mt -102.49 11.56 37.74 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.743 0.817 . . . . 0.0 110.182 170.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.546 ' HA2' ' HB3' ' A' ' 27' ' ' ARG . . . . . . . . 0 C--N 1.352 1.425 0 CA-C-O 119.147 -0.807 . . . . 0.0 113.308 174.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.403 ' HH ' ' HA ' ' A' ' 74' ' ' GLU . 75.1 t80 . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.539 0.209 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.56 -28.81 71.95 Favored Glycine 0 C--N 1.354 1.563 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.6 176.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.27 -47.73 59.98 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.963 0.505 . . . . 0.0 110.406 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -58.08 -50.21 74.25 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.055 0.847 . . . . 0.0 110.925 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.5 m -66.23 -37.3 79.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.311 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -31.36 59.19 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.72 0.808 . . . . 0.0 110.687 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -91.96 -47.98 7.01 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.573 0.749 . . . . 0.0 111.2 -174.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.9 t -79.13 -11.99 59.99 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -173.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.71 112.17 5.28 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 117.917 0.326 . . . . 0.0 110.575 177.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -97.53 132.81 24.52 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 123.875 0.87 . . . . 0.0 109.771 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.01 84.45 0.25 Allowed 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 123.021 2.48 . . . . 0.0 112.666 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 143.68 -0.68 1.25 Allowed Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.826 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.8 ptp -88.73 154.56 20.19 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -85.28 157.91 20.45 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 m -128.69 173.3 13.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.728 -1.123 . . . . 0.0 108.316 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.534 ' HD3' ' HA2' ' A' ' 40' ' ' GLY . 3.6 tmm_? -141.54 136.6 31.29 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.529 ' HA ' ' HE2' ' A' ' 30' ' ' MET . 3.2 tpt -76.82 111.45 12.36 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.511 1.124 . . . . 0.0 109.279 -178.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 41.2 tp -69.88 -36.53 75.52 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.137 0.575 . . . . 0.0 111.0 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -141.34 150.92 43.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.668 0.787 . . . . 0.0 109.18 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -65.58 129.88 41.33 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.831 0.707 . . . . 0.0 111.234 -170.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -106.97 173.58 6.26 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.128 0.971 . . . . 0.0 110.749 -177.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -47.41 -44.95 24.98 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.813 1.645 . . . . 0.0 113.386 -175.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -131.36 7.33 4.55 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.885 0.874 . . . . 0.0 111.058 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.23 144.79 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.825 0.85 . . . . 0.0 109.391 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.4 m -93.44 147.33 23.05 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.076 0.55 . . . . 0.0 110.543 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.48 117.86 8.6 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.534 ' HA2' ' HD3' ' A' ' 29' ' ' ARG . . . 115.16 -18.95 15.56 Favored Glycine 0 N--CA 1.469 0.862 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -66.64 144.45 56.39 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.606 0.762 . . . . 0.0 110.648 178.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -109.1 144.14 37.52 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.407 0.623 . . . . 0.0 110.659 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.65 -168.43 12.32 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.639 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -137.18 142.49 42.15 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 169.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.442 ' CE1' ' HB3' ' A' ' 48' ' ' SER . 85.4 t80 -88.31 118.23 27.78 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.924 0.889 . . . . 0.0 109.451 177.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.417 ' HG2' ' NE2' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -115.94 -47.17 2.79 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.317 0.247 . . . . 0.0 111.286 175.543 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.417 ' NE2' ' HG2' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -136.86 150.66 48.4 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.606 0.362 . . . . 0.0 110.407 -177.095 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.442 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 64.4 p -145.12 165.28 28.74 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.638 0.775 . . . . 0.0 111.745 -177.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 8.2 m-80 -124.42 121.47 35.0 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 173.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.02 -30.58 44.29 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.015 0.526 . . . . 0.0 110.382 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.27 -34.63 9.41 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.78 177.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.493 HG21 ' HD2' ' A' ' 54' ' ' PRO . 13.8 mm -100.64 106.58 44.16 Favored Pre-proline 0 N--CA 1.479 1.004 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.59 -25.34 79.17 Favored 'Trans proline' 0 CA--C 1.579 2.747 0 N-CA-C 118.292 2.382 . . . . 0.0 118.292 -171.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.635 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 57.4 Cg_endo -71.36 109.09 2.52 Favored 'Trans proline' 0 C--N 1.383 2.393 0 CA-C-N 123.523 2.294 . . . . 0.0 112.241 169.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.404 HG21 ' HA ' ' A' ' 48' ' ' SER . 6.4 p -86.93 144.45 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.061 0.944 . . . . 0.0 110.774 173.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -89.64 122.63 32.95 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.14 136.16 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -80.93 104.12 11.22 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -176.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.49 ' HB2' HG21 ' A' ' 62' ' ' THR . 88.6 m95 -92.01 130.03 37.84 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.434 1.094 . . . . 0.0 109.745 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -70.01 -34.87 73.86 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 123.61 0.569 . . . . 0.0 111.775 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.1 t -60.65 -45.18 95.07 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.666 0.386 . . . . 0.0 111.371 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.49 HG21 ' HB2' ' A' ' 59' ' ' TRP . 8.9 t -90.88 -16.68 27.76 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.762 0.425 . . . . 0.0 110.984 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.78 14.56 80.82 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 119.612 -0.549 . . . . 0.0 114.206 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -152.77 176.83 11.36 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 117.439 0.619 . . . . 0.0 110.9 -172.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 p -84.91 136.84 33.46 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.006 0.522 . . . . 0.0 109.727 173.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -134.89 156.02 49.68 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 123.886 0.742 . . . . 0.0 110.041 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.635 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 14.9 m-90 -87.6 101.37 13.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.34 1.456 . . . . 0.0 109.498 -173.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.3 m -117.09 153.27 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.147 0.579 . . . . 0.0 109.7 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -85.19 146.71 26.96 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -58.91 -40.13 83.61 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.886 0.875 . . . . 0.0 112.764 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -69.69 -20.76 63.55 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 123.316 0.646 . . . . 0.0 112.164 -176.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 69.4 mtm -106.1 14.29 27.94 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 122.973 0.509 . . . . 0.0 111.424 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.3 tt -104.53 121.69 44.01 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 172.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.403 ' HA ' ' HH ' ' A' ' 14' ' ' TYR . 37.2 tt0 -106.6 152.7 23.38 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 171.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.7 pt -113.71 126.17 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 122.864 0.465 . . . . 0.0 111.71 174.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.3 mt -104.44 6.74 35.17 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.457 0.703 . . . . 0.0 110.017 167.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.584 0 O-C-N 123.773 0.67 . . . . 0.0 112.448 174.626 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.2 t80 . . . . . 0 N--CA 1.486 1.361 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.89 -30.4 77.9 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 114.443 -1.253 . . . . 0.0 113.71 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.404 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 26.5 tt0 -70.34 -41.79 72.73 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 175.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -60.37 -49.57 77.07 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.243 0.617 . . . . 0.0 111.148 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.444 ' HA ' HG22 ' A' ' 21' ' ' THR . 34.2 m -64.94 -36.45 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 O-C-N 123.397 0.435 . . . . 0.0 110.493 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.1 -30.97 60.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.676 0.79 . . . . 0.0 111.27 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.404 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 43.8 mm-40 -80.32 -52.8 7.27 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.774 0.429 . . . . 0.0 110.771 177.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 18' ' ' VAL . 10.8 t -82.8 -7.42 59.66 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -167.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.503 HD12 ' HB2' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -69.43 107.13 3.21 Favored 'General case' 0 CA--C 1.558 1.251 0 CA-C-N 118.519 0.599 . . . . 0.0 110.801 176.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -88.37 134.26 34.88 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 124.143 0.977 . . . . 0.0 110.226 176.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.91 90.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.117 2.545 . . . . 0.0 112.227 171.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.14 -2.38 3.92 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.996 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.1 ptp -87.79 164.81 15.74 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 117.353 0.577 . . . . 0.0 110.57 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.62 140.01 31.06 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.699 1.199 . . . . 0.0 109.821 -173.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.427 HG12 HD13 ' A' ' 22' ' ' LEU . 4.4 m -117.19 172.83 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.816 0.846 . . . . 0.0 109.187 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -145.07 143.92 30.69 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.558 1.143 . . . . 0.0 108.651 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.1 tpp -97.62 139.1 34.03 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 122.779 0.431 . . . . 0.0 110.696 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.513 HD22 ' HB2' ' A' ' 74' ' ' GLU . 3.3 pp -112.87 -7.42 13.76 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.235 1.014 . . . . 0.0 111.676 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -127.13 172.2 10.74 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.244 1.018 . . . . 0.0 109.58 -174.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -91.11 143.09 27.05 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.797 -0.565 . . . . 0.0 110.629 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -133.28 171.77 13.59 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.984 1.313 . . . . 0.0 110.231 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -45.93 -46.98 16.4 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.367 1.467 . . . . 0.0 112.266 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -139.08 1.84 2.06 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.85 0.86 . . . . 0.0 111.398 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mp -115.1 146.45 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 174.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.0 m -130.74 164.25 25.51 Favored 'General case' 0 C--O 1.245 0.819 0 O-C-N 121.988 -0.445 . . . . 0.0 110.051 172.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.29 114.63 2.5 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 123.788 0.68 . . . . 0.0 110.286 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.28 -34.35 2.95 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.399 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 50.5 t0 -65.09 145.84 55.77 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.033 0.533 . . . . 0.0 110.192 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -120.4 146.29 46.34 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.998 0.919 . . . . 0.0 110.357 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.7 -167.52 12.4 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.126 -178.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -136.89 141.38 42.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 171.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.532 ' HA ' HG12 ' A' ' 57' ' ' VAL . 76.8 t80 -74.97 119.66 19.45 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.877 0.471 . . . . 0.0 109.988 178.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.5 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 19.5 mmm180 -108.99 -49.22 3.16 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.679 0.791 . . . . 0.0 109.592 -173.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.509 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -161.7 164.04 29.35 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.48 1.112 . . . . 0.0 109.056 177.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 16.3 p -132.07 168.56 17.75 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.622 0.769 . . . . 0.0 112.01 -175.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.422 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 14.6 m-80 -137.14 121.47 18.13 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 164.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -75.12 -38.75 60.99 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -177.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.52 -18.35 45.53 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.418 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.475 HG21 ' HD2' ' A' ' 54' ' ' PRO . 20.5 mm -104.27 102.49 33.24 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 173.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -60.55 -22.41 72.12 Favored 'Trans proline' 0 CA--C 1.576 2.605 0 N-CA-C 117.775 2.183 . . . . 0.0 117.775 -171.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.535 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 66.5 Cg_endo -76.35 111.42 3.26 Favored 'Trans proline' 0 C--N 1.377 2.062 0 CA-C-N 122.851 2.054 . . . . 0.0 112.295 165.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 p -84.38 142.95 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.598 1.159 . . . . 0.0 110.076 169.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.509 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.0 mp0 -92.32 122.69 35.02 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -136.3 138.11 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.892 1.277 . . . . 0.0 108.566 -178.222 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -82.88 104.68 13.29 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.485 ' HB2' HG23 ' A' ' 62' ' ' THR . 89.2 m95 -86.29 128.17 34.88 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.977 0.911 . . . . 0.0 109.684 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -71.71 -23.62 61.67 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -173.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.0 t -78.08 -44.68 25.56 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.48 0.582 . . . . 0.0 111.326 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.485 HG23 ' HB2' ' A' ' 59' ' ' TRP . 11.0 t -85.3 -18.94 32.39 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-O 121.006 0.432 . . . . 0.0 110.453 176.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.38 22.07 73.97 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-N 115.867 -0.606 . . . . 0.0 114.465 174.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -153.18 168.41 26.03 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 117.459 0.63 . . . . 0.0 111.999 -174.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.421 HG23 ' HB3' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -86.8 126.18 34.45 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.554 1.142 . . . . 0.0 109.215 -176.243 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -135.56 157.43 46.9 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.286 0.565 . . . . 0.0 111.42 -173.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.535 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 12.4 m-90 -86.28 111.22 20.23 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.389 1.476 . . . . 0.0 109.58 -174.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.4 m -131.67 150.67 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.126 0.57 . . . . 0.0 110.013 178.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -78.51 146.6 34.25 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 122.677 0.391 . . . . 0.0 110.964 -175.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -59.54 -48.77 80.36 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.332 1.053 . . . . 0.0 112.013 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -68.04 -27.91 66.94 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.283 0.563 . . . . 0.0 110.438 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.472 ' HA ' HD11 ' A' ' 31' ' ' LEU . 38.8 mtp -93.69 9.09 38.39 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.068 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.7 tp -112.22 120.05 40.45 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 123.728 0.811 . . . . 0.0 108.842 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.513 ' HB2' HD22 ' A' ' 31' ' ' LEU . 39.0 tt0 -107.56 135.89 48.26 Favored 'General case' 0 C--O 1.207 -1.14 0 C-N-CA 124.733 1.213 . . . . 0.0 107.789 175.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.4 pt -111.73 119.01 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 119.73 1.15 . . . . 0.0 111.914 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.3 mp -96.38 -0.94 48.64 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.469 1.108 . . . . 0.0 110.629 173.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.298 0 CA-C-O 119.726 -0.486 . . . . 0.0 112.732 174.641 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.405 ' HB3' ' CD2' ' A' ' 71' ' ' HIS . 41.1 t80 . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.904 0.383 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.15 -29.86 75.74 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.83 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 44.0 tt0 -72.92 -38.48 66.84 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -62.38 -48.32 80.25 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.165 0.586 . . . . 0.0 111.222 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.439 ' HB ' HD22 ' A' ' 22' ' ' LEU . 33.0 m -62.1 -37.25 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -29.99 62.97 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.984 0.914 . . . . 0.0 110.454 178.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.41 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 54.5 mm-40 -78.88 -47.33 16.73 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.988 0.515 . . . . 0.0 110.101 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 t -96.96 4.52 51.51 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -166.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.491 HD12 ' SD ' ' A' ' 26' ' ' MET . 2.0 mm? -87.59 115.28 24.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.818 -0.551 . . . . 0.0 111.574 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.418 ' O ' ' HG2' ' A' ' 26' ' ' MET . 1.4 mp0 -92.94 137.24 23.94 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 124.003 0.921 . . . . 0.0 109.688 171.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.56 86.68 0.21 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.472 2.115 . . . . 0.0 111.371 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 144.71 4.55 0.62 Allowed Glycine 0 C--N 1.347 1.171 0 CA-C-N 115.737 -0.665 . . . . 0.0 113.065 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.665 ' SD ' HG21 ' A' ' 75' ' ' ILE . 6.2 ptp -95.01 175.52 6.6 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 117.345 0.573 . . . . 0.0 110.827 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -99.52 128.4 45.63 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.058 1.343 . . . . 0.0 109.815 -170.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -115.58 171.36 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.589 0.756 . . . . 0.0 109.655 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.493 ' HA ' ' HG2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -144.0 126.95 16.37 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -174.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -78.89 121.91 25.45 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.47 HD21 ' HB2' ' A' ' 74' ' ' GLU . 4.2 pp -105.6 14.09 28.98 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 117.945 0.339 . . . . 0.0 111.34 176.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -137.04 172.37 13.11 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.144 0.978 . . . . 0.0 111.327 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -97.35 140.53 31.67 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.889 0.876 . . . . 0.0 110.107 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -134.41 173.66 11.39 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.677 1.191 . . . . 0.0 111.421 -176.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -46.34 -45.03 17.35 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.585 1.554 . . . . 0.0 111.955 175.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -140.84 -1.95 1.37 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.183 -171.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -116.22 147.58 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 124.251 1.021 . . . . 0.0 108.344 175.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.1 m -127.49 160.96 29.89 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.958 0.503 . . . . 0.0 109.674 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.1 113.89 4.83 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.17 -61.04 0.56 Allowed Glycine 0 C--N 1.343 0.947 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -172.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -77.33 148.72 35.48 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.4 0.619 . . . . 0.0 110.632 -177.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.493 ' HG2' ' HA ' ' A' ' 29' ' ' ARG . 42.4 mt-10 -125.62 161.34 27.45 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.014 -161.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.75 -171.97 12.64 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.887 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -133.07 135.87 45.58 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.493 ' HA ' HG13 ' A' ' 57' ' ' VAL . 16.3 t80 -72.66 121.37 19.68 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.531 0.732 . . . . 0.0 109.258 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.516 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 7.9 mmm180 -107.32 -46.37 3.89 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -175.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.516 ' NE2' ' HB2' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -152.86 159.56 43.03 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.851 0.861 . . . . 0.0 110.071 -179.127 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 64.7 p -119.58 173.39 7.03 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.72 0.808 . . . . 0.0 111.205 -176.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -126.88 138.88 53.38 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.429 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -62.11 -38.81 90.31 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.925 0.89 . . . . 0.0 112.223 -176.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.26 26.58 0.24 Allowed Glycine 0 C--N 1.345 1.044 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.711 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.7 mm -101.19 108.52 55.19 Favored Pre-proline 0 N--CA 1.477 0.886 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.16 -39.31 91.61 Favored 'Trans proline' 0 CA--C 1.576 2.61 0 C-N-CA 122.638 2.225 . . . . 0.0 116.71 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.674 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 96.1 Cg_endo -75.68 97.5 1.11 Allowed 'Trans proline' 0 C--N 1.384 2.444 0 CA-C-N 122.411 1.897 . . . . 0.0 112.397 169.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.8 p -90.64 153.27 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.004 0.922 . . . . 0.0 111.297 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -96.76 129.9 44.1 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.237 0.615 . . . . 0.0 111.665 -172.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.493 HG13 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -139.85 141.79 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 125.743 1.617 . . . . 0.0 108.788 178.313 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -81.2 107.25 13.84 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.913 0.885 . . . . 0.0 109.143 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.509 ' HB2' HG23 ' A' ' 62' ' ' THR . 99.0 m95 -90.9 133.82 34.95 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.147 0.979 . . . . 0.0 111.097 -177.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -59.57 -35.19 73.78 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 124.04 0.837 . . . . 0.0 111.535 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.9 p -66.8 -45.31 78.81 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.653 0.781 . . . . 0.0 112.221 -173.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.509 HG23 ' HB2' ' A' ' 59' ' ' TRP . 10.6 t -104.84 -9.4 18.06 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.175 0.59 . . . . 0.0 111.695 -174.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.52 21.6 72.69 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 114.291 0.476 . . . . 0.0 114.291 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -151.8 176.08 11.78 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.277 0.631 . . . . 0.0 110.665 -176.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 2.1 p -85.23 129.62 34.77 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.066 0.547 . . . . 0.0 109.969 175.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -130.13 158.54 39.41 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.314 0.578 . . . . 0.0 110.196 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.674 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 18.7 m-90 -81.59 104.82 12.28 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.796 1.239 . . . . 0.0 110.782 -176.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.5 m -126.21 156.84 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.063 0.545 . . . . 0.0 110.33 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.477 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 9.1 t-160 -84.44 147.51 27.06 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 122.939 0.496 . . . . 0.0 110.944 -174.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -59.94 -47.01 87.55 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.898 0.879 . . . . 0.0 111.253 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.405 ' CD2' ' HB3' ' A' ' 14' ' ' TYR . 58.1 t-80 -66.32 -25.85 67.03 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.56 0.744 . . . . 0.0 111.471 -178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.477 ' SD ' ' HB3' ' A' ' 69' ' ' HIS . 59.5 mtp -95.14 -2.42 49.91 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.954 0.902 . . . . 0.0 111.676 -171.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 pp -110.07 157.73 19.03 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 167.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.47 ' HB2' HD21 ' A' ' 31' ' ' LEU . 30.7 tt0 -138.13 137.13 37.38 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 125.074 1.35 . . . . 0.0 108.231 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.665 HG21 ' SD ' ' A' ' 26' ' ' MET . 7.2 pt -85.72 112.19 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 169.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 31.4 tp -119.09 6.71 11.29 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.416 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.458 0 CA-C-O 119.447 -0.64 . . . . 0.0 113.021 179.769 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 40.8 t80 . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.61 -26.63 71.05 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 114.59 -1.186 . . . . 0.0 113.401 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.499 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 15.1 tp10 -71.45 -47.34 56.4 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -58.38 -50.01 75.18 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.955 0.784 . . . . 0.0 111.052 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.2 m -67.59 -36.35 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.833 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -54.96 -34.59 63.42 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.405 0.682 . . . . 0.0 111.333 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 48.5 mm-40 -85.06 -48.69 8.95 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.074 -176.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 t -85.98 -9.98 55.9 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -168.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.478 HD12 ' SD ' ' A' ' 26' ' ' MET . 0.2 OUTLIER -66.89 107.21 2.13 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 118.589 0.631 . . . . 0.0 110.176 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -94.75 132.72 27.9 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 124.016 0.926 . . . . 0.0 110.424 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.2 84.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.388 2.725 . . . . 0.0 113.868 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 141.05 4.8 1.07 Allowed Glycine 0 C--N 1.343 0.944 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.759 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.478 ' SD ' HD12 ' A' ' 22' ' ' LEU . 5.4 ptp -91.89 166.82 12.53 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 117.479 0.64 . . . . 0.0 110.717 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -88.76 134.84 33.79 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.595 1.158 . . . . 0.0 109.375 -174.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.0 m -117.15 172.31 5.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -151.01 140.01 21.03 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.7 tpp -85.94 128.94 34.95 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.142 0.496 . . . . 0.0 110.863 -175.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 23.2 tp -106.03 -5.79 19.24 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.868 0.867 . . . . 0.0 111.365 -173.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -138.27 160.66 38.9 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.537 0.735 . . . . 0.0 111.136 -174.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -82.74 127.39 33.38 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -122.49 171.36 9.15 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.07 0.948 . . . . 0.0 111.409 -174.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -49.66 -45.4 48.58 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.542 1.537 . . . . 0.0 111.847 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -132.16 -5.4 3.45 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.684 -170.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mt -118.74 140.74 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.7 t -100.85 153.53 19.4 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 172.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.4 115.26 4.93 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.78 -36.1 2.22 Favored Glycine 0 C--N 1.338 0.694 0 O-C-N 123.665 0.603 . . . . 0.0 112.089 -175.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -63.24 141.62 58.7 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.23 0.612 . . . . 0.0 111.608 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -102.45 161.62 13.57 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.672 0.789 . . . . 0.0 111.13 -175.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.83 -170.2 19.59 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.466 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -135.3 137.81 42.84 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 48' ' ' SER . 57.4 t80 -85.23 119.6 25.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.927 173.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.407 ' HG2' ' NE2' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -115.79 -45.95 2.86 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 122.236 0.214 . . . . 0.0 111.198 172.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.408 ' NE2' ' H ' ' A' ' 47' ' ' GLN . 0.5 OUTLIER -126.85 163.54 23.39 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.917 0.487 . . . . 0.0 110.056 -177.394 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.567 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 37.8 t -148.86 168.52 22.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.596 0.758 . . . . 0.0 112.265 -167.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -137.36 118.52 14.48 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 164.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -89.91 -3.81 57.86 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.024 0.53 . . . . 0.0 111.761 -175.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -117.77 -25.4 3.1 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.023 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.626 HG22 ' HD2' ' A' ' 54' ' ' PRO . 7.2 mm -104.7 118.54 56.16 Favored Pre-proline 0 CA--C 1.557 1.212 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.39 -29.02 84.84 Favored 'Trans proline' 0 CA--C 1.581 2.828 0 N-CA-C 118.111 2.312 . . . . 0.0 118.111 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.626 ' HD2' HG22 ' A' ' 52' ' ' ILE . 58.6 Cg_endo -72.57 106.5 2.11 Favored 'Trans proline' 0 C--N 1.383 2.354 0 CA-C-N 123.084 2.137 . . . . 0.0 112.521 170.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.547 HG22 ' HA ' ' A' ' 48' ' ' SER . 8.9 p -86.49 146.12 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.642 168.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -91.94 128.14 37.67 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.91 136.47 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.269 1.028 . . . . 0.0 108.485 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -81.88 108.68 15.6 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.496 ' HB2' HG23 ' A' ' 62' ' ' THR . 95.3 m95 -93.15 131.0 38.61 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.941 0.896 . . . . 0.0 110.864 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -63.81 -27.28 69.07 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 124.133 0.896 . . . . 0.0 110.66 172.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.8 t -65.49 -47.04 77.41 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 124.369 1.068 . . . . 0.0 112.055 -173.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.496 HG23 ' HB2' ' A' ' 59' ' ' TRP . 6.6 t -103.28 -14.48 16.3 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.002 0.921 . . . . 0.0 110.458 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.84 14.14 82.35 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.86 -0.609 . . . . 0.0 113.688 178.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -150.26 172.01 16.05 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.266 0.555 . . . . 0.0 110.979 -174.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.43 124.52 33.51 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.629 1.172 . . . . 0.0 108.917 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -128.27 154.51 45.81 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.184 0.516 . . . . 0.0 110.763 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 14.4 m-90 -81.04 111.27 17.36 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.358 -1.292 . . . . 0.0 109.736 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.9 m -126.81 159.15 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.026 0.53 . . . . 0.0 109.838 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -86.81 147.11 25.96 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.386 0.674 . . . . 0.0 110.124 -174.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -61.41 -48.5 80.9 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.084 0.554 . . . . 0.0 111.691 -178.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -69.3 -11.43 60.8 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.447 0.699 . . . . 0.0 111.734 -177.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 34.8 mtp -113.62 10.03 17.97 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.233 1.013 . . . . 0.0 110.787 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.9 tp -113.82 121.42 43.97 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 124.211 1.004 . . . . 0.0 108.708 176.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -107.84 132.44 53.42 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.911 0.885 . . . . 0.0 110.028 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.413 HD12 HD21 ' A' ' 22' ' ' LEU . 28.8 pt -113.03 134.69 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.824 -0.548 . . . . 0.0 111.012 172.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -98.32 7.73 45.82 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.65 0.78 . . . . 0.0 109.514 168.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.935 0 C-N-CA 124.308 0.956 . . . . 0.0 113.764 179.675 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.1 t80 . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.49 -36.83 84.58 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-O 121.409 0.449 . . . . 0.0 112.963 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 8.3 mp0 -71.26 -42.56 68.63 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.805 0.842 . . . . 0.0 109.132 176.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -60.28 -48.91 79.73 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 124.183 0.927 . . . . 0.0 111.798 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.8 m -64.06 -38.31 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 123.264 0.353 . . . . 0.0 110.572 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -56.13 -32.44 64.23 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.266 0.626 . . . . 0.0 111.103 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 41.8 mm-40 -77.16 -51.78 10.4 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.575 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.2 t -87.69 5.54 39.26 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.618 0.767 . . . . 0.0 112.383 -170.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.17 108.83 5.55 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 26' ' ' MET . 35.1 tt0 -87.31 131.86 43.0 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 123.686 0.794 . . . . 0.0 110.179 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.424 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 72.4 Cg_exo -53.12 88.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.682 2.921 . . . . 0.0 113.031 170.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.73 22.86 5.23 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.155 170.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.462 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 3.8 ptp -89.39 168.73 11.99 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.256 0.551 . . . . 0.0 110.387 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.427 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 1.4 ttt180 -86.95 147.08 25.91 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.838 1.255 . . . . 0.0 108.967 -176.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.509 HG21 HG22 ' A' ' 75' ' ' ILE . 55.9 t -130.71 164.08 34.73 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 C-N-CA 124.444 1.098 . . . . 0.0 109.469 -172.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.417 ' HD2' ' N ' ' A' ' 30' ' ' MET . 3.5 tmm_? -142.7 145.65 33.59 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.376 1.47 . . . . 0.0 107.607 172.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.511 ' HA ' ' HE2' ' A' ' 30' ' ' MET . 4.4 tpt -85.18 112.26 20.55 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.137 0.575 . . . . 0.0 109.734 -175.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 39.0 tp -86.46 -20.02 28.74 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.339 0.656 . . . . 0.0 111.682 -174.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -136.67 155.12 50.31 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.741 0.416 . . . . 0.0 110.29 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -76.51 138.98 40.58 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.933 0.493 . . . . 0.0 110.339 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -131.21 171.42 13.32 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.306 1.042 . . . . 0.0 110.822 -172.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -48.58 -58.76 4.22 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.126 1.37 . . . . 0.0 112.032 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -117.96 -1.0 11.55 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.11 0.964 . . . . 0.0 111.402 -175.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mp -118.18 139.86 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.6 m -104.79 152.48 22.52 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.72 114.24 3.88 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.99 -36.12 2.1 Favored Glycine 0 C--N 1.346 1.131 0 O-C-N 123.488 0.493 . . . . 0.0 112.36 -173.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -61.61 147.82 44.44 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.198 0.599 . . . . 0.0 111.753 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -102.23 155.46 18.2 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.337 0.655 . . . . 0.0 111.009 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -140.32 -175.73 14.67 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.835 -175.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -139.33 138.54 36.74 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.522 ' HA ' HG11 ' A' ' 57' ' ' VAL . 87.1 t80 -71.07 122.4 20.01 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 122.685 0.394 . . . . 0.0 110.015 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.521 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 22.8 mmm180 -108.75 -48.57 3.28 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -176.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.521 ' NE2' ' HB2' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -167.19 155.46 9.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.364 179.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.8 p -123.11 179.4 4.7 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.135 0.974 . . . . 0.0 109.955 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -107.84 140.07 41.49 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 172.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.402 HD21 ' N ' ' A' ' 51' ' ' GLY . 0.3 OUTLIER -51.43 -22.43 3.03 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -168.06 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.402 ' N ' HD21 ' A' ' 50' ' ' ASN . . . -173.65 30.67 0.1 OUTLIER Glycine 0 N--CA 1.467 0.761 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 176.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.59 HG23 ' HD2' ' A' ' 54' ' ' PRO . 4.9 mm -117.09 130.02 24.91 Favored Pre-proline 0 N--CA 1.477 0.904 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.445 ' HA ' ' CD1' ' A' ' 70' ' ' TRP . 13.6 Cg_endo -55.43 -40.77 83.71 Favored 'Trans proline' 0 CA--C 1.584 2.982 0 C-N-CA 122.842 2.361 . . . . 0.0 118.172 -175.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.59 ' HD2' HG23 ' A' ' 52' ' ' ILE . 57.7 Cg_endo -68.84 101.45 0.79 Allowed 'Trans proline' 0 C--N 1.394 2.941 0 CA-C-N 122.736 2.013 . . . . 0.0 112.558 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 p -94.43 140.52 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.944 0.898 . . . . 0.0 109.918 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.476 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.1 mp0 -93.65 122.81 36.49 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.381 0.672 . . . . 0.0 109.72 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.522 HG11 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -132.78 140.63 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 125.262 1.425 . . . . 0.0 108.825 -178.522 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -79.38 108.1 12.64 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.494 ' HB2' HG22 ' A' ' 62' ' ' THR . 93.8 m95 -91.65 131.36 37.1 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.943 0.897 . . . . 0.0 110.066 177.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -59.41 -31.85 69.64 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.223 1.009 . . . . 0.0 111.688 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.7 t -67.55 -45.63 75.09 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.695 0.798 . . . . 0.0 112.07 -172.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.494 HG22 ' HB2' ' A' ' 59' ' ' TRP . 6.1 t -97.68 -21.24 17.12 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.32 0.648 . . . . 0.0 110.988 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.8 18.66 69.7 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.783 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -151.95 -176.93 5.85 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.138 0.575 . . . . 0.0 110.579 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.451 ' HB ' ' HB3' ' A' ' 56' ' ' GLN . 5.2 p -86.03 144.38 27.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.503 0.721 . . . . 0.0 110.753 173.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -140.0 154.47 47.15 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.198 0.599 . . . . 0.0 109.942 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -81.4 111.99 18.26 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.555 1.142 . . . . 0.0 109.959 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.65 HG21 HD11 ' A' ' 73' ' ' LEU . 19.1 m -126.03 159.98 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.185 0.594 . . . . 0.0 110.772 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.518 ' HB3' ' HB2' ' A' ' 72' ' ' MET . 14.9 t-80 -91.14 147.04 23.34 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.283 1.033 . . . . 0.0 109.475 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.445 ' CD1' ' HA ' ' A' ' 53' ' ' PRO . 97.2 m95 -64.99 -45.99 83.3 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.013 0.525 . . . . 0.0 111.917 -175.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -70.47 -17.26 62.97 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.077 0.465 . . . . 0.0 111.678 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.518 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 21.3 mtp -104.16 14.19 30.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.526 1.13 . . . . 0.0 110.502 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.65 HD11 HG21 ' A' ' 68' ' ' VAL . 29.1 tp -119.19 121.26 39.33 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.298 1.039 . . . . 0.0 108.578 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -112.68 119.81 39.37 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.509 HG22 HG21 ' A' ' 28' ' ' VAL . 14.0 pt -86.81 117.54 31.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.488 0.661 . . . . 0.0 110.533 175.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 16.8 tp -96.22 15.17 21.73 Favored 'General case' 0 CA--C 1.556 1.173 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.121 174.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.427 ' HA2' ' HB3' ' A' ' 27' ' ' ARG . . . . . . . . 0 C--N 1.36 1.892 0 C-N-CA 123.741 0.686 . . . . 0.0 112.681 170.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.8 t80 . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.77 -36.43 91.18 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.497 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 33.6 tt0 -63.24 -47.45 82.42 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 171.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -57.83 -51.97 67.41 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.376 1.048 . . . . 0.0 111.854 -173.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.7 m -67.13 -37.88 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 O-C-N 123.789 0.681 . . . . 0.0 110.764 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.78 -34.17 67.37 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.575 0.75 . . . . 0.0 110.225 177.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 25.4 mm-40 -79.29 -50.01 11.57 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.815 0.446 . . . . 0.0 111.068 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.1 t -90.84 3.97 53.04 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -169.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.83 125.09 25.87 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.5 ' HB3' ' HB3' ' A' ' 26' ' ' MET . 21.3 tt0 -90.96 139.63 25.95 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 124.145 0.978 . . . . 0.0 109.384 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.519 ' HA ' ' CD1' ' A' ' 45' ' ' PHE . 25.9 Cg_exo -63.63 84.62 0.13 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.742 2.294 . . . . 0.0 112.922 172.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.59 31.51 1.79 Allowed Glycine 0 C--N 1.353 1.49 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 171.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.5 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 25.9 ptm -100.59 174.61 6.0 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.268 0.556 . . . . 0.0 109.857 177.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.663 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 19.1 tpt180 -91.05 130.6 36.94 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 124.349 1.059 . . . . 0.0 108.995 -173.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.5 m -116.45 173.23 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.439 0.696 . . . . 0.0 109.33 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.07 137.15 25.79 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -171.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.533 ' HE3' ' HA ' ' A' ' 30' ' ' MET . 3.6 tpt -82.62 111.61 18.74 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 55.2 tp -80.39 -38.59 30.01 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.176 0.591 . . . . 0.0 110.698 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -126.86 154.04 44.91 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.212 0.605 . . . . 0.0 110.553 -175.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.99 119.47 17.27 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.337 0.655 . . . . 0.0 110.605 -174.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -102.6 173.46 6.33 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.386 1.074 . . . . 0.0 111.502 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -45.61 -52.1 11.11 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 126.174 1.79 . . . . 0.0 112.2 -175.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -124.9 -11.41 7.15 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.462 -177.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.2 mp -102.21 132.19 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.7 m -94.48 148.66 22.02 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.496 0.318 . . . . 0.0 110.39 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.8 115.73 4.61 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.94 -18.93 8.43 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 123.479 0.487 . . . . 0.0 112.452 -172.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -75.24 155.21 37.02 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.156 0.582 . . . . 0.0 109.57 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -126.7 154.29 44.31 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.582 0.706 . . . . 0.0 111.165 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.404 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . -137.42 -169.5 11.65 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.815 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -137.22 144.34 42.76 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.519 ' CD1' ' HA ' ' A' ' 24' ' ' PRO . 51.1 t80 -69.62 121.86 17.96 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.443 0.697 . . . . 0.0 109.31 177.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.492 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 10.2 mmm180 -108.95 -43.75 4.14 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.617 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -170.78 172.68 5.59 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.354 1.461 . . . . 0.0 107.895 177.237 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -157.18 179.8 8.93 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.748 0.785 . . . . 0.0 112.317 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -126.46 126.55 43.95 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.076 -1.42 . . . . 0.0 107.633 171.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -73.51 -44.55 57.46 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.195 0.598 . . . . 0.0 110.72 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.98 -27.51 25.96 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.189 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.599 HG22 ' HD2' ' A' ' 54' ' ' PRO . 9.0 mm -100.55 118.72 60.42 Favored Pre-proline 0 CA--C 1.554 1.111 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -176.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -60.4 -31.01 92.13 Favored 'Trans proline' 0 CA--C 1.579 2.731 0 N-CA-C 118.961 2.639 . . . . 0.0 118.961 -172.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.599 ' HD2' HG22 ' A' ' 52' ' ' ILE . 56.8 Cg_endo -70.1 110.15 2.55 Favored 'Trans proline' 0 C--N 1.372 1.772 0 CA-C-N 122.925 2.08 . . . . 0.0 113.316 173.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.94 139.46 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.303 1.041 . . . . 0.0 109.82 167.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.617 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 1.7 mp0 -91.94 122.05 34.1 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.82 136.24 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.571 1.149 . . . . 0.0 108.819 -177.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 59.9 t80 -82.01 106.42 13.9 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.435 ' HB2' HG21 ' A' ' 62' ' ' THR . 89.0 m95 -90.29 130.71 36.37 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.426 1.09 . . . . 0.0 110.125 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -69.51 -37.93 77.36 Favored 'General case' 0 CA--C 1.554 1.099 0 O-C-N 123.842 0.714 . . . . 0.0 112.679 -173.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.1 t -69.59 -43.19 73.31 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.436 0.294 . . . . 0.0 111.677 -174.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.435 HG21 ' HB2' ' A' ' 59' ' ' TRP . 11.4 t -86.18 -17.13 35.71 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.794 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.48 18.32 76.08 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 114.539 0.576 . . . . 0.0 114.539 172.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -152.8 166.55 31.91 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.229 0.538 . . . . 0.0 112.086 -172.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 1.4 m -85.67 130.79 34.47 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.841 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -137.16 148.91 46.92 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.885 0.374 . . . . 0.0 110.688 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.452 ' CD1' ' HG3' ' A' ' 56' ' ' GLN . 11.1 m0 -76.76 114.15 15.21 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.462 1.105 . . . . 0.0 109.323 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.441 HG22 HD13 ' A' ' 73' ' ' LEU . 18.6 m -126.46 156.47 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.112 0.565 . . . . 0.0 109.676 175.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -86.07 145.92 26.85 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -63.09 -42.7 99.67 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.219 0.608 . . . . 0.0 111.768 -175.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -68.11 -14.42 62.97 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.538 0.735 . . . . 0.0 111.995 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 72.3 mtm -113.03 16.95 19.19 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.406 0.682 . . . . 0.0 110.958 174.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.441 HD13 HG22 ' A' ' 68' ' ' VAL . 40.6 tp -114.83 122.14 45.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.305 0.642 . . . . 0.0 109.295 176.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -105.23 147.29 28.2 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.409 1.084 . . . . 0.0 108.367 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.0 pt -112.43 115.95 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 121.378 0.609 . . . . 0.0 110.222 173.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.6 tp -136.62 101.66 4.69 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.663 ' HA3' ' HB3' ' A' ' 27' ' ' ARG . . . . . . . . 0 C--N 1.341 0.858 0 CA-C-O 119.432 -0.649 . . . . 0.0 112.465 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 64.5 t80 . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.469 0.176 . . . . 0.0 111.167 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.0 -38.86 63.9 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.904 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.557 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 3.2 mp0 -70.91 -37.6 72.95 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -58.44 -49.12 78.45 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.913 0.758 . . . . 0.0 111.417 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 27.0 m -62.58 -38.96 82.82 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -58.84 -40.64 84.8 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.141 0.576 . . . . 0.0 109.846 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.557 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 25.1 mm-40 -66.76 -40.0 88.1 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.313 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.4 t -110.53 13.08 22.73 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -169.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.609 HD13 ' SD ' ' A' ' 26' ' ' MET . 18.1 tp -87.55 110.93 20.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.858 -0.527 . . . . 0.0 110.428 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.615 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 38.7 mt-30 -87.84 141.44 31.65 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 124.203 1.001 . . . . 0.0 109.892 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.89 85.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.972 2.448 . . . . 0.0 111.728 173.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.64 73.71 1.19 Allowed Glycine 0 C--N 1.342 0.905 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.797 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.615 ' HB3' ' HB2' ' A' ' 23' ' ' GLN . 21.8 ptm -118.78 -58.32 1.97 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 118.465 -0.779 . . . . 0.0 112.044 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.555 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 24.8 tpt180 146.08 122.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 128.088 2.555 . . . . 0.0 107.929 173.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 m -118.14 171.74 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-O 121.326 0.584 . . . . 0.0 110.206 177.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.668 ' HB2' HD22 ' A' ' 76' ' ' LEU . 7.1 tpt180 -148.81 150.34 32.89 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.719 1.608 . . . . 0.0 107.529 -169.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.603 ' HA ' ' HE1' ' A' ' 30' ' ' MET . 3.1 tpt -90.33 111.89 23.26 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 34.4 tp -77.41 -33.16 55.06 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.421 0.689 . . . . 0.0 110.912 -174.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -145.29 153.99 41.87 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.627 0.771 . . . . 0.0 109.072 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.46 142.03 58.09 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.52 0.728 . . . . 0.0 111.573 -172.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -126.33 171.76 10.69 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.818 0.847 . . . . 0.0 110.921 -175.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -47.37 -37.81 11.93 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.728 1.611 . . . . 0.0 113.233 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -139.94 -0.01 1.73 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.494 -171.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 mt -119.83 141.01 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.224 1.01 . . . . 0.0 109.19 -175.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.4 p -91.41 142.35 27.77 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.059 0.544 . . . . 0.0 109.969 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.39 117.39 5.61 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.665 0.386 . . . . 0.0 110.069 171.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.92 -4.27 28.88 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 123.542 0.526 . . . . 0.0 112.537 -175.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -77.34 156.57 31.19 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.165 0.586 . . . . 0.0 109.658 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -113.15 157.26 21.88 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.752 0.787 . . . . 0.0 111.596 -178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -146.25 -172.53 16.66 Favored Glycine 0 C--O 1.244 0.756 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.046 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -138.2 141.34 40.01 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 170.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.454 ' HE1' ' HB3' ' A' ' 48' ' ' SER . 32.8 t80 -70.58 120.45 16.23 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.639 0.776 . . . . 0.0 110.207 176.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.515 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 15.0 mmm180 -108.85 -47.63 3.42 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.804 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.563 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -163.78 155.86 17.23 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.537 1.135 . . . . 0.0 109.316 -177.12 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.454 ' HB3' ' HE1' ' A' ' 45' ' ' PHE . 41.4 p -132.09 179.03 6.34 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.715 0.806 . . . . 0.0 110.772 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 3.2 m-80 -139.51 132.7 29.78 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -86.49 -30.94 21.6 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.363 0.665 . . . . 0.0 110.054 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.62 -35.99 27.33 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.926 175.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 26.2 mm -106.74 100.97 34.13 Favored Pre-proline 0 N--CA 1.485 1.317 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -56.25 -30.65 81.13 Favored 'Trans proline' 0 CA--C 1.571 2.345 0 C-N-CA 122.746 2.297 . . . . 0.0 117.933 -173.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.621 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 55.9 Cg_endo -67.36 111.99 2.45 Favored 'Trans proline' 0 C--N 1.378 2.124 0 CA-C-N 123.297 2.213 . . . . 0.0 111.649 171.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 p -81.54 141.44 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.467 1.107 . . . . 0.0 110.689 171.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.563 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 1.7 mp0 -90.17 126.85 35.95 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.418 HG21 ' NE1' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -138.26 137.34 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 125.16 1.384 . . . . 0.0 108.817 -177.548 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 75.3 t80 -82.03 105.78 13.41 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.24 0.616 . . . . 0.0 109.818 -175.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.473 ' HB2' HG23 ' A' ' 62' ' ' THR . 91.7 m95 -92.58 132.62 36.7 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.34 1.056 . . . . 0.0 111.2 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -69.2 -28.33 66.28 Favored 'General case' 0 CA--C 1.55 0.967 0 O-C-N 124.141 0.901 . . . . 0.0 112.078 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.0 t -64.37 -46.46 83.27 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.05 0.387 . . . . 0.0 112.01 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.473 HG23 ' HB2' ' A' ' 59' ' ' TRP . 10.2 t -98.17 -12.08 22.08 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.543 0.737 . . . . 0.0 110.756 -176.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.3 16.09 79.94 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-N 115.986 -0.552 . . . . 0.0 113.898 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -151.9 170.69 19.22 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.345 0.593 . . . . 0.0 111.682 -174.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.521 HG21 ' HB3' ' A' ' 56' ' ' GLN . 1.7 m -87.0 120.06 27.86 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.271 -177.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -127.95 157.13 41.43 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.75 0.42 . . . . 0.0 111.152 -175.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.621 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 4.3 m-90 -75.65 120.67 21.37 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.456 1.102 . . . . 0.0 110.649 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.46 HG22 HD13 ' A' ' 73' ' ' LEU . 6.3 m -135.41 147.89 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 173.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -78.95 148.21 32.72 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.928 0.491 . . . . 0.0 110.496 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -54.47 -49.66 69.56 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.282 1.033 . . . . 0.0 112.305 -178.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -74.83 -13.11 60.53 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.073 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 29.1 mtp -106.76 13.88 27.44 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.857 0.863 . . . . 0.0 110.356 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.46 HD13 HG22 ' A' ' 68' ' ' VAL . 53.6 tp -116.18 131.32 56.98 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.641 1.177 . . . . 0.0 108.799 176.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -106.12 140.89 38.38 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.753 1.221 . . . . 0.0 108.234 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 pt -115.4 148.43 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-N 118.435 0.562 . . . . 0.0 111.52 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.668 HD22 ' HB2' ' A' ' 29' ' ' ARG . 2.1 pt? -152.08 35.94 0.54 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.839 0.856 . . . . 0.0 109.559 178.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.555 ' HA2' ' HB3' ' A' ' 27' ' ' ARG . . . . . . . . 0 CA--C 1.537 1.459 0 CA-C-O 118.666 -1.074 . . . . 0.0 115.534 -173.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.1 t80 . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.49 -42.05 74.62 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 121.512 0.506 . . . . 0.0 112.601 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 8.4 mp0 -69.33 -34.33 74.48 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 176.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -65.22 -49.73 68.56 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 123.866 0.728 . . . . 0.0 111.891 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.4 m -59.62 -38.86 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 123.319 0.387 . . . . 0.0 110.435 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -54.71 -35.47 63.67 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.364 0.665 . . . . 0.0 111.493 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.539 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 43.4 mm-40 -82.36 -36.25 27.02 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.463 -172.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.8 t -109.24 4.22 22.55 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.853 0.461 . . . . 0.0 112.142 -172.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.423 HD13 HG21 ' A' ' 75' ' ' ILE . 16.7 tp -86.08 116.73 24.47 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 122.007 -0.433 . . . . 0.0 109.994 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -92.01 137.47 25.15 Favored Pre-proline 0 N--CA 1.481 1.095 0 C-N-CA 124.207 1.003 . . . . 0.0 111.136 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.2 92.41 0.39 Allowed 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.017 2.478 . . . . 0.0 112.105 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.0 -8.22 4.15 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.661 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 5.5 ptp -92.46 166.5 12.51 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -88.17 162.7 16.56 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-O 121.896 0.855 . . . . 0.0 110.305 -171.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.6 m -131.64 175.65 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.061 176.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.527 ' HB3' ' HB3' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -143.89 146.07 32.75 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -174.424 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.508 ' HE1' ' HA ' ' A' ' 30' ' ' MET . 1.5 tpt -98.05 118.17 34.05 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.777 0.831 . . . . 0.0 110.043 178.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.8 mt -74.94 -43.39 54.4 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.417 0.687 . . . . 0.0 112.066 -177.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -129.5 163.99 24.71 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -67.09 120.53 13.85 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.292 0.568 . . . . 0.0 110.889 -176.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.03 173.12 6.98 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.988 0.915 . . . . 0.0 110.384 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -47.79 -48.07 30.52 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.348 1.459 . . . . 0.0 113.542 -176.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -128.31 8.5 6.03 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.306 0.642 . . . . 0.0 111.571 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -120.07 143.56 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.3 m -99.46 154.02 18.55 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.561 0.619 . . . . 0.0 109.848 174.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.6 118.3 6.89 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.623 0.769 . . . . 0.0 110.068 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.53 -10.39 23.87 Favored Glycine 0 C--N 1.341 0.834 0 O-C-N 123.331 0.395 . . . . 0.0 113.237 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -79.95 157.26 26.9 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 120.948 0.404 . . . . 0.0 110.725 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.419 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 45.0 mt-10 -120.55 159.95 24.19 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.038 -174.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -141.7 -167.76 11.35 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.647 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -138.52 140.13 39.0 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 170.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.424 ' HA ' HG11 ' A' ' 57' ' ' VAL . 55.6 t80 -79.7 121.31 25.16 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.225 0.61 . . . . 0.0 110.102 176.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -108.26 -47.91 3.45 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -155.47 151.08 27.3 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.754 0.821 . . . . 0.0 110.109 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.468 ' HA ' HG23 ' A' ' 55' ' ' VAL . 48.6 p -117.49 162.63 17.66 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.091 0.956 . . . . 0.0 111.123 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 8.6 m-80 -124.46 121.47 34.96 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 160.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -89.87 -27.12 20.11 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.538 0.735 . . . . 0.0 109.943 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.32 -28.08 34.48 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.125 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.446 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 3.1 mp -114.31 102.43 54.82 Favored Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -178.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.4 -26.12 81.98 Favored 'Trans proline' 0 CA--C 1.583 2.949 0 N-CA-C 118.268 2.372 . . . . 0.0 118.268 -170.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.508 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 39.4 Cg_endo -67.56 105.87 1.16 Allowed 'Trans proline' 0 C--N 1.389 2.67 0 CA-C-N 123.56 2.307 . . . . 0.0 111.793 169.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.468 HG23 ' HA ' ' A' ' 48' ' ' SER . 6.4 p -86.59 145.84 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.467 1.107 . . . . 0.0 110.709 176.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -92.22 122.08 34.36 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.424 HG11 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -133.89 136.68 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.857 1.263 . . . . 0.0 108.752 178.855 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -81.09 108.65 14.94 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.502 ' HB2' HG22 ' A' ' 62' ' ' THR . 94.5 m95 -93.52 131.14 39.04 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.849 0.86 . . . . 0.0 110.898 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.419 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 18.4 pt20 -61.72 -27.21 68.55 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 124.114 0.883 . . . . 0.0 110.977 169.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.3 t -60.46 -45.16 94.71 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.609 1.164 . . . . 0.0 112.307 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.502 HG22 ' HB2' ' A' ' 59' ' ' TRP . 8.6 t -113.09 -10.74 13.41 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.685 0.794 . . . . 0.0 111.265 -174.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.45 13.89 82.74 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 116.359 -0.382 . . . . 0.0 113.91 178.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -152.47 173.65 14.86 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.274 0.559 . . . . 0.0 111.387 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.05 126.78 34.98 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.557 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -128.67 155.35 45.17 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 120.984 0.421 . . . . 0.0 111.059 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 10.1 m-90 -82.09 108.66 15.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.991 1.316 . . . . 0.0 109.732 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 m -125.97 151.54 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.128 0.571 . . . . 0.0 109.73 177.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -80.32 146.42 31.59 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -54.89 -45.37 74.65 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.833 1.253 . . . . 0.0 113.293 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -72.54 -22.39 61.02 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -173.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 70.7 mtm -93.39 -6.28 47.53 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.205 0.602 . . . . 0.0 111.424 174.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 tt -90.93 123.56 34.53 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 171.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 29' ' ' ARG . 40.4 tt0 -104.04 143.58 32.7 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.423 HG21 HD13 ' A' ' 22' ' ' LEU . 37.5 pt -105.91 117.16 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.0 mt -112.97 5.28 17.19 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.214 0.605 . . . . 0.0 110.831 173.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.311 0 CA-C-O 118.922 -0.932 . . . . 0.0 112.132 -179.215 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.4 t80 . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.08 -30.18 75.49 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.802 -0.635 . . . . 0.0 113.028 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.5 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 8.3 tp10 -72.28 -47.47 49.81 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 171.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -57.45 -48.78 78.26 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.294 1.038 . . . . 0.0 111.256 -172.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 m -58.29 -43.31 85.82 Favored 'Isoleucine or valine' 0 C--N 1.35 0.612 0 O-C-N 123.729 0.643 . . . . 0.0 110.259 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -62.12 -31.51 71.98 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.458 0.703 . . . . 0.0 111.189 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 79.5 mm-40 -82.22 -32.32 29.84 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.188 0.595 . . . . 0.0 111.519 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.2 t -107.79 8.35 28.73 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.944 0.498 . . . . 0.0 111.966 -175.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.586 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.1 OUTLIER -67.66 117.83 10.12 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.062 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.711 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 9.8 mm100 -86.23 133.4 40.77 Favored Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.14 87.4 0.73 Allowed 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.875 2.383 . . . . 0.0 112.261 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.24 23.99 2.8 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.711 ' HB3' ' HB2' ' A' ' 23' ' ' GLN . 16.8 ptm -91.69 168.48 11.45 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.194 0.597 . . . . 0.0 110.118 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 ppp_? -90.3 147.14 23.69 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.797 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.4 t -129.28 164.88 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 124.937 1.295 . . . . 0.0 107.648 -169.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -149.53 133.13 16.76 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.511 ' HE1' ' HA ' ' A' ' 30' ' ' MET . 2.0 tpt -82.81 112.59 19.78 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.782 0.833 . . . . 0.0 109.869 -178.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.637 HD22 ' HB2' ' A' ' 74' ' ' GLU . 4.0 pp -85.9 -2.88 58.7 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 122.862 0.465 . . . . 0.0 111.19 176.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -124.79 162.87 23.37 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.198 0.999 . . . . 0.0 109.427 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -98.76 117.3 32.92 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -106.17 173.26 6.39 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.527 1.131 . . . . 0.0 112.175 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -51.71 -44.95 63.37 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.818 1.647 . . . . 0.0 112.455 -175.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.63 3.95 3.59 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.969 0.908 . . . . 0.0 111.396 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 mp -118.41 137.39 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 175.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.3 m -99.32 155.07 17.71 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.24 0.473 . . . . 0.0 109.919 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.17 114.15 5.68 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.31 -26.54 3.91 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 123.572 0.545 . . . . 0.0 112.402 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -69.94 158.22 36.0 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.234 0.613 . . . . 0.0 112.494 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -116.94 157.31 25.94 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 123.832 0.853 . . . . 0.0 111.552 -177.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.15 -173.75 14.97 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.731 -176.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -136.04 142.52 44.41 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 171.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.423 ' CE1' ' HB3' ' A' ' 48' ' ' SER . 91.4 t80 -87.28 118.29 26.6 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.004 0.922 . . . . 0.0 110.059 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.32 -47.57 3.09 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 120.803 0.335 . . . . 0.0 110.653 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.77 161.93 38.81 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.61 0.764 . . . . 0.0 109.375 -175.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.423 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 53.4 p -158.64 169.28 24.76 Favored 'General case' 0 C--O 1.239 0.53 0 O-C-N 123.777 0.673 . . . . 0.0 111.988 -171.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.417 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 7.5 m-80 -139.13 139.66 37.7 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 171.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -93.62 -33.33 13.74 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.945 0.498 . . . . 0.0 110.319 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.11 -31.01 40.07 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.943 174.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.417 ' HB ' ' HB2' ' A' ' 49' ' ' ASN . 3.6 mp -104.33 99.8 19.09 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.27 -24.68 72.04 Favored 'Trans proline' 0 CA--C 1.573 2.429 0 N-CA-C 117.767 2.18 . . . . 0.0 117.767 -171.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.583 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 49.2 Cg_endo -70.37 107.82 2.06 Favored 'Trans proline' 0 C--N 1.383 2.393 0 CA-C-N 123.145 2.159 . . . . 0.0 111.702 168.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.3 p -85.68 141.43 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.326 1.05 . . . . 0.0 110.311 171.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -87.99 122.67 31.86 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.39 136.15 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.43 1.092 . . . . 0.0 108.544 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -81.53 108.03 14.78 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -176.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -92.87 131.05 38.24 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.699 0.799 . . . . 0.0 111.115 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -62.69 -31.3 72.17 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.928 0.891 . . . . 0.0 111.427 172.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.5 t -60.07 -43.74 95.26 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.82 1.248 . . . . 0.0 111.808 -172.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.1 t -113.07 -8.93 13.6 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.163 -174.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.02 15.39 81.19 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 116.351 -0.386 . . . . 0.0 114.028 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -151.65 169.6 21.75 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.528 0.68 . . . . 0.0 111.598 -172.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.21 123.42 32.2 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.267 -176.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -126.74 155.67 42.38 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.523 0.678 . . . . 0.0 110.809 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.583 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 9.3 m-90 -89.37 111.97 22.96 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.465 1.506 . . . . 0.0 109.288 -172.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.4 m -129.51 153.17 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.279 0.632 . . . . 0.0 110.51 -176.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -80.56 147.09 30.94 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.811 0.444 . . . . 0.0 110.734 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -59.42 -49.35 78.13 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.268 1.027 . . . . 0.0 112.929 -176.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -67.81 -23.18 65.16 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.164 0.585 . . . . 0.0 111.625 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.482 ' HA ' HD12 ' A' ' 31' ' ' LEU . 40.2 mtp -95.82 -4.13 44.36 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.573 1.149 . . . . 0.0 111.095 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.4 tt -93.95 141.07 28.94 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 172.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.637 ' HB2' HD22 ' A' ' 31' ' ' LEU . 39.4 tt0 -125.82 135.35 51.89 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.819 0.848 . . . . 0.0 108.902 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.1 pt -110.69 117.18 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-O 121.235 0.54 . . . . 0.0 110.512 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.4 mp -92.14 -6.65 50.37 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.189 0.996 . . . . 0.0 110.309 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.249 0 CA-C-O 118.853 -0.971 . . . . 0.0 111.771 176.698 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.1 t80 . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.22 -34.65 86.47 Favored Glycine 0 C--N 1.344 1.007 0 O-C-N 123.279 0.362 . . . . 0.0 113.244 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 7.2 tp10 -73.74 -38.93 64.59 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.637 0.375 . . . . 0.0 110.411 174.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -57.99 -50.29 73.92 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.975 0.91 . . . . 0.0 111.417 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.515 ' HB ' HD21 ' A' ' 22' ' ' LEU . 28.1 m -62.52 -37.81 79.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 O-C-N 124.345 1.028 . . . . 0.0 110.657 -177.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -42.11 70.6 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.136 0.574 . . . . 0.0 109.678 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 50.2 mm-40 -82.95 -29.52 29.04 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.461 -170.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 t -102.33 -2.43 28.98 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.515 HD21 ' HB ' ' A' ' 18' ' ' VAL . 0.9 OUTLIER -81.04 117.13 21.37 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 118.33 0.514 . . . . 0.0 110.946 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -102.43 140.21 20.92 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 124.041 0.936 . . . . 0.0 109.508 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.48 87.85 0.34 Allowed 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.48 2.12 . . . . 0.0 111.232 174.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 148.2 2.19 0.44 Allowed Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.153 176.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.45 ' SD ' HD13 ' A' ' 22' ' ' LEU . 12.3 ptp -96.63 165.45 12.14 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.706 0.753 . . . . 0.0 111.296 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.481 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 20.6 tpt180 -91.51 128.46 37.34 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.828 1.251 . . . . 0.0 109.316 -171.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 m -116.28 170.96 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.631 0.773 . . . . 0.0 109.546 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.566 HH11 ' HA2' ' A' ' 40' ' ' GLY . 2.2 tmm_? -152.31 131.17 12.48 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.459 1.104 . . . . 0.0 108.083 -178.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.447 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 31.6 tpp -88.64 127.29 35.56 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.805 0.842 . . . . 0.0 111.195 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.459 HD22 ' HB2' ' A' ' 74' ' ' GLU . 3.3 pp -102.34 3.75 38.3 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.569 0.748 . . . . 0.0 112.153 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.423 ' O ' ' HG3' ' A' ' 30' ' ' MET . 29.6 t70 -126.76 164.13 22.01 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.779 0.832 . . . . 0.0 109.764 -178.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -95.96 117.09 29.96 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.886 -0.509 . . . . 0.0 110.015 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -111.16 170.52 8.05 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.0 1.32 . . . . 0.0 109.442 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -40.91 -55.33 2.52 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 125.919 1.688 . . . . 0.0 112.996 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -126.19 3.1 7.13 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.743 0.817 . . . . 0.0 111.47 -175.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -119.64 101.61 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.409 0.684 . . . . 0.0 109.167 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -78.82 150.58 32.28 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.89 115.55 3.78 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.347 0.659 . . . . 0.0 110.757 -175.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.566 ' HA2' HH11 ' A' ' 29' ' ' ARG . . . 127.78 -14.45 6.36 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.86 -176.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -73.42 154.24 40.08 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.645 0.378 . . . . 0.0 111.58 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -114.88 159.26 20.89 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.726 0.811 . . . . 0.0 110.702 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.481 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . -151.94 -171.65 19.89 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.391 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -134.98 142.67 46.51 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.439 ' CG ' HD11 ' A' ' 22' ' ' LEU . 20.9 t80 -80.01 122.58 26.92 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.499 0.719 . . . . 0.0 109.326 -176.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.558 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 12.2 mmm180 -108.4 -45.76 3.83 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.315 0.578 . . . . 0.0 109.726 -171.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.558 ' NE2' ' HB2' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -151.71 157.22 41.75 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.85 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.2 p -118.37 157.75 26.54 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 123.873 0.733 . . . . 0.0 110.642 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.608 HD22 ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -153.68 118.37 4.97 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 175.123 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -100.19 -15.6 18.07 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.277 1.031 . . . . 0.0 110.319 -170.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.16 -20.14 59.6 Favored Glycine 0 C--N 1.349 1.275 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 168.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.8 mp -114.73 98.94 50.96 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.23 -31.09 92.75 Favored 'Trans proline' 0 CA--C 1.576 2.619 0 C-N-CA 122.106 1.871 . . . . 0.0 116.195 -177.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.712 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 92.3 Cg_endo -79.53 98.25 1.14 Allowed 'Trans proline' 0 C--N 1.382 2.296 0 CA-C-N 122.371 1.883 . . . . 0.0 111.861 166.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.608 ' HA ' HD22 ' A' ' 49' ' ' ASN . 14.5 p -82.55 154.51 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.333 1.053 . . . . 0.0 111.829 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -94.86 128.81 41.89 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.151 0.58 . . . . 0.0 110.585 -172.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -140.66 140.45 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 125.298 1.439 . . . . 0.0 108.627 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -81.8 106.84 14.05 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.447 ' CH2' ' HB2' ' A' ' 30' ' ' MET . 96.2 m95 -88.77 130.97 35.25 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.314 1.046 . . . . 0.0 110.374 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -69.52 -26.66 64.63 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.705 0.802 . . . . 0.0 112.171 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.6 t -68.89 -44.22 73.67 Favored 'General case' 0 C--N 1.357 0.929 0 CA-C-O 120.69 0.281 . . . . 0.0 111.178 -177.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.2 t -94.88 -30.32 14.24 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.397 0.679 . . . . 0.0 111.681 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.68 23.54 30.52 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-O 119.733 -0.482 . . . . 0.0 114.271 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -154.19 176.87 11.75 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 117.439 0.62 . . . . 0.0 111.754 -175.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 2.0 p -83.59 142.35 30.9 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 172.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -144.98 154.76 42.89 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.35 0.595 . . . . 0.0 110.096 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.712 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 16.3 m-90 -81.98 115.68 21.25 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.01 -176.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.411 HG22 ' HZ2' ' A' ' 59' ' ' TRP . 19.9 m -137.68 145.11 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.365 0.666 . . . . 0.0 109.687 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.51 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 9.5 t-80 -69.44 147.06 51.46 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.607 0.363 . . . . 0.0 110.841 -177.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . 0.444 ' O ' HG21 ' A' ' 18' ' ' VAL . 90.4 m95 -59.45 -45.78 90.62 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.546 0.738 . . . . 0.0 111.634 -176.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -65.18 -23.26 67.05 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.502 0.721 . . . . 0.0 111.918 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.51 ' SD ' ' HB3' ' A' ' 69' ' ' HIS . 33.8 mtp -90.04 -14.2 34.36 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.223 1.009 . . . . 0.0 111.077 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.4 tt -90.78 122.01 33.15 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.459 ' HB2' HD22 ' A' ' 31' ' ' LEU . 35.3 tt0 -123.12 125.23 44.78 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.296 1.039 . . . . 0.0 109.212 -176.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.465 HD13 HD22 ' A' ' 22' ' ' LEU . 12.2 pt -100.28 118.75 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 121.314 0.578 . . . . 0.0 111.609 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 mp -106.56 9.23 31.51 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 165.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.434 0 CA-C-O 119.193 -0.782 . . . . 0.0 112.964 -175.201 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 55.3 t80 . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.59 -36.91 88.92 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-O 122.029 0.794 . . . . 0.0 112.717 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 2.5 mp0 -73.78 -33.08 64.09 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.027 -1.086 . . . . 0.0 110.246 177.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -68.63 -49.41 59.39 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.825 0.85 . . . . 0.0 110.837 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.562 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 20.9 m -59.11 -39.14 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 O-C-N 123.779 0.675 . . . . 0.0 110.135 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -57.57 -38.7 75.28 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.141 0.976 . . . . 0.0 111.55 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.502 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 52.9 mm-40 -78.2 -43.03 29.64 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.412 0.285 . . . . 0.0 111.282 -176.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.1 t -88.66 2.0 54.03 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.109 0.563 . . . . 0.0 112.384 -174.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.562 ' HB2' ' O ' ' A' ' 18' ' ' VAL . 12.7 tp -76.72 124.99 28.49 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.455 0.702 . . . . 0.0 111.176 -173.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.428 ' H ' ' HE3' ' A' ' 26' ' ' MET . 50.1 mt-30 -113.6 124.89 30.38 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 123.736 0.815 . . . . 0.0 109.617 -175.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.47 85.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 124.24 3.293 . . . . 0.0 114.547 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.61 26.8 1.54 Allowed Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.837 174.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.503 ' SD ' HD12 ' A' ' 22' ' ' LEU . 4.5 ptp -91.73 175.63 6.83 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.436 0.636 . . . . 0.0 110.844 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.0 tpt85 -94.61 126.55 39.98 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.931 -170.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.425 HG22 HG22 ' A' ' 75' ' ' ILE . 41.6 t -119.01 160.07 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 C-N-CA 124.572 1.149 . . . . 0.0 111.26 -167.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.5 tpp85 -140.71 151.87 44.85 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 126.673 1.989 . . . . 0.0 108.567 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.512 ' HA ' ' HE2' ' A' ' 30' ' ' MET . 3.9 tpt -94.89 115.5 27.54 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.481 0.712 . . . . 0.0 109.524 177.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.8 tp -83.68 -29.03 27.93 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.192 0.597 . . . . 0.0 111.149 -177.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -137.19 154.6 50.17 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.754 0.422 . . . . 0.0 110.777 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -65.29 144.44 57.14 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.677 0.791 . . . . 0.0 111.588 -176.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -133.12 175.34 9.47 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.964 1.306 . . . . 0.0 110.275 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.57 -51.85 67.82 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.01 1.324 . . . . 0.0 111.706 -173.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -119.23 0.1 11.12 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.836 0.855 . . . . 0.0 111.741 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mp -119.89 146.03 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.248 1.019 . . . . 0.0 108.487 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.7 m -112.01 160.2 17.71 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 119.242 0.928 . . . . 0.0 110.025 173.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.24 117.67 8.16 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.38 -30.67 4.89 Favored Glycine 0 C--N 1.343 0.926 0 O-C-N 123.551 0.532 . . . . 0.0 111.993 -174.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -67.73 153.4 43.79 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.482 0.713 . . . . 0.0 111.012 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -127.19 154.83 44.31 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.536 0.684 . . . . 0.0 112.178 -166.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.66 -169.77 12.92 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.458 -171.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -136.58 140.5 42.93 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 172.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.483 ' HA ' HG11 ' A' ' 57' ' ' VAL . 30.8 t80 -72.64 124.21 24.81 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 123.63 0.581 . . . . 0.0 110.579 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.484 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 11.1 mmm180 -109.14 -47.99 3.34 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.678 0.391 . . . . 0.0 111.216 -174.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.54 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -167.43 147.67 5.32 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.725 0.81 . . . . 0.0 110.03 -179.318 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.435 ' HA ' HG22 ' A' ' 55' ' ' VAL . 38.9 p -117.76 173.22 6.87 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.665 0.786 . . . . 0.0 111.429 -175.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -128.71 119.95 25.57 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.768 175.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -88.37 71.17 9.08 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.409 0.623 . . . . 0.0 109.631 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.42 -27.68 0.97 Allowed Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.918 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.578 HG21 ' HD2' ' A' ' 54' ' ' PRO . 6.7 mm -103.45 118.71 57.0 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.57 -34.1 85.71 Favored 'Trans proline' 0 CA--C 1.575 2.564 0 N-CA-C 117.648 2.134 . . . . 0.0 117.648 -174.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.578 ' HD2' HG21 ' A' ' 52' ' ' ILE . 59.0 Cg_endo -70.79 111.04 2.92 Favored 'Trans proline' 0 C--N 1.386 2.501 0 CA-C-N 122.744 2.016 . . . . 0.0 112.351 171.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.526 HG13 HD23 ' A' ' 73' ' ' LEU . 3.0 p -91.33 137.22 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.281 1.032 . . . . 0.0 109.656 166.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.54 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 1.9 mp0 -90.14 126.79 35.92 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 122.983 0.513 . . . . 0.0 109.888 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.483 HG11 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -135.52 137.22 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 124.923 1.289 . . . . 0.0 108.773 -177.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -81.47 108.45 15.07 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.493 ' HB2' HG21 ' A' ' 62' ' ' THR . 85.4 m95 -93.08 128.06 38.85 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.87 0.868 . . . . 0.0 110.049 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -67.49 -23.47 65.49 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 123.671 0.607 . . . . 0.0 110.887 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.7 t -60.63 -44.98 95.72 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 124.659 1.184 . . . . 0.0 111.764 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.493 HG21 ' HB2' ' A' ' 59' ' ' TRP . 8.7 t -108.02 -6.36 16.6 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.975 0.91 . . . . 0.0 110.777 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.25 13.67 76.74 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 116.134 -0.485 . . . . 0.0 113.869 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -151.4 173.97 13.9 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.321 0.56 . . . . 0.0 111.032 -175.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.11 136.3 33.27 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.132 -175.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -137.76 157.41 46.5 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.657 0.741 . . . . 0.0 111.036 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.509 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 15.8 m-90 -83.73 108.75 16.99 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.816 1.646 . . . . 0.0 110.089 -176.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 m -123.82 157.75 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 122.796 0.438 . . . . 0.0 110.93 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -87.43 148.94 24.76 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.576 0.75 . . . . 0.0 110.495 -175.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 75.3 m95 -61.85 -43.8 98.11 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.671 0.788 . . . . 0.0 111.939 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -73.1 -11.66 60.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.689 0.396 . . . . 0.0 111.408 -176.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 70.5 mtm -114.33 6.35 16.05 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.058 0.943 . . . . 0.0 110.622 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.526 HD23 HG13 ' A' ' 55' ' ' VAL . 35.9 tp -92.01 119.49 31.77 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 170.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -121.48 128.02 51.66 Favored 'General case' 0 C--O 1.212 -0.92 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.425 HG22 HG22 ' A' ' 28' ' ' VAL . 15.3 pt -110.96 115.02 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-O 121.417 0.627 . . . . 0.0 111.461 -176.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -106.81 80.69 1.47 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 170.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.723 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.827 -178.293 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.3 t80 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.61 0.243 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.79 -40.26 58.43 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.523 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 2.2 mp0 -69.97 -26.09 63.93 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.647 0.779 . . . . 0.0 110.788 177.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -75.11 -50.11 17.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.736 0.814 . . . . 0.0 110.671 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.2 m -63.97 -34.61 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 123.516 0.51 . . . . 0.0 110.265 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -54.59 -31.28 56.63 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.442 1.097 . . . . 0.0 111.03 177.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.453 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 49.4 mm-40 -88.97 -44.67 10.25 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.982 0.513 . . . . 0.0 111.015 -176.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.8 t -83.8 -17.91 39.45 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -171.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.531 HD21 ' SD ' ' A' ' 26' ' ' MET . 10.9 mt -66.2 118.64 10.2 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.163 0.585 . . . . 0.0 111.341 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -110.99 140.84 23.14 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.726 1.21 . . . . 0.0 110.157 -176.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.22 85.01 0.34 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.32 2.68 . . . . 0.0 112.41 -177.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.8 2.6 1.41 Allowed Glycine 0 C--N 1.342 0.907 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.696 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.531 ' SD ' HD21 ' A' ' 22' ' ' LEU . 6.0 ptp -85.96 168.91 13.73 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 121.455 0.645 . . . . 0.0 111.224 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.41 ' NH1' ' HB3' ' A' ' 42' ' ' GLU . 15.7 tpt85 -99.84 123.21 43.85 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.772 1.229 . . . . 0.0 110.066 -168.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.7 m -118.77 174.21 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.696 0.798 . . . . 0.0 110.832 -174.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.527 ' HG2' ' HG2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -149.11 140.4 23.18 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.165 1.386 . . . . 0.0 107.836 -172.726 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.495 ' HE2' ' HA ' ' A' ' 30' ' ' MET . 1.4 tpt -94.81 113.69 25.47 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.931 0.892 . . . . 0.0 109.671 177.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.575 HD11 ' HA ' ' A' ' 72' ' ' MET . 3.6 pp -97.73 4.24 49.97 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.721 0.409 . . . . 0.0 111.678 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -133.07 162.43 31.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.156 0.583 . . . . 0.0 109.965 -170.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -89.04 122.6 32.54 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.259 0.624 . . . . 0.0 109.694 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -121.25 170.56 9.47 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.565 0.698 . . . . 0.0 112.292 -176.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -53.54 -49.03 68.51 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 113.781 -1.554 . . . . 0.0 112.178 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -128.67 1.45 5.5 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.404 0.682 . . . . 0.0 111.412 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.2 mp -118.92 144.85 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.5 m -112.0 156.59 21.9 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 122.871 0.468 . . . . 0.0 109.758 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.3 116.7 6.91 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.06 -25.37 5.52 Favored Glycine 0 N--CA 1.469 0.883 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -173.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -76.85 155.21 33.14 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.144 0.578 . . . . 0.0 110.693 175.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.527 ' HG2' ' HG2' ' A' ' 29' ' ' ARG . 51.3 mt-10 -135.13 155.26 51.02 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.848 0.859 . . . . 0.0 110.225 -169.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -147.58 -166.0 12.27 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.049 -170.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -136.52 137.4 40.26 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.584 0.754 . . . . 0.0 109.374 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.505 ' HE1' HG23 ' A' ' 55' ' ' VAL . 71.5 t80 -71.38 124.99 25.81 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.265 0.626 . . . . 0.0 109.799 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.525 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 21.4 mmm180 -109.3 -49.65 3.09 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.804 0.441 . . . . 0.0 110.499 -173.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.605 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -164.72 169.14 17.19 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.225 1.01 . . . . 0.0 109.237 -177.766 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.495 ' HA ' HG21 ' A' ' 55' ' ' VAL . 13.8 p -138.19 166.16 24.85 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.669 0.788 . . . . 0.0 112.04 -171.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -112.49 134.62 53.92 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 171.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -84.63 -5.75 59.33 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.962 0.905 . . . . 0.0 112.231 -172.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -141.27 -22.17 0.26 Allowed Glycine 0 C--N 1.347 1.149 0 CA-C-N 116.099 -0.5 . . . . 0.0 113.002 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.619 HG22 ' HD2' ' A' ' 54' ' ' PRO . 5.2 mm -98.66 118.34 63.24 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -173.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -59.75 -32.07 95.05 Favored 'Trans proline' 0 CA--C 1.583 2.972 0 N-CA-C 117.884 2.225 . . . . 0.0 117.884 -175.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.619 ' HD2' HG22 ' A' ' 52' ' ' ILE . 60.9 Cg_endo -71.06 107.76 2.17 Favored 'Trans proline' 0 C--N 1.387 2.567 0 CA-C-N 122.94 2.086 . . . . 0.0 112.297 171.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.505 HG23 ' HE1' ' A' ' 45' ' ' PHE . 5.5 p -90.9 143.33 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 124.841 1.256 . . . . 0.0 111.0 171.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.605 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 1.9 mp0 -93.79 131.83 38.77 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-O 121.29 0.567 . . . . 0.0 110.225 -176.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.436 HG11 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -139.39 137.54 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 125.639 1.576 . . . . 0.0 108.106 -178.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 56.2 t80 -81.36 109.06 15.5 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -177.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.434 ' HB2' HG21 ' A' ' 62' ' ' THR . 85.8 m95 -93.51 117.81 30.56 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.72 0.808 . . . . 0.0 109.299 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -61.38 -25.88 67.47 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.05 0.94 . . . . 0.0 111.462 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.6 t -60.46 -45.13 94.82 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.436 1.094 . . . . 0.0 111.75 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.434 HG21 ' HB2' ' A' ' 59' ' ' TRP . 7.1 t -105.88 -9.81 16.97 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.912 0.885 . . . . 0.0 110.711 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.79 16.5 79.96 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 114.24 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -152.77 165.12 36.33 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.412 0.625 . . . . 0.0 111.844 -173.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.56 HG23 ' HB3' ' A' ' 56' ' ' GLN . 2.7 m -88.45 120.37 29.77 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.309 -177.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -127.1 157.68 39.04 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.455 0.645 . . . . 0.0 110.661 -173.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.619 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 12.1 m-90 -83.94 116.61 22.88 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.505 1.522 . . . . 0.0 109.816 -173.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.436 HG22 HD13 ' A' ' 73' ' ' LEU . 7.1 m -130.12 158.36 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.897 0.879 . . . . 0.0 109.738 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.457 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 11.4 t-80 -86.79 147.87 25.65 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.953 0.501 . . . . 0.0 110.287 -177.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 81.3 m95 -57.2 -50.41 72.96 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.002 0.921 . . . . 0.0 111.571 -178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -72.78 -1.45 16.6 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.607 0.763 . . . . 0.0 112.005 -176.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.575 ' HA ' HD11 ' A' ' 31' ' ' LEU . 43.0 mtp -120.58 14.39 11.84 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.173 0.989 . . . . 0.0 110.756 -178.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.436 HD13 HG22 ' A' ' 68' ' ' VAL . 33.8 tp -123.37 124.37 42.78 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.91 0.884 . . . . 0.0 109.415 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.538 ' HB2' HD23 ' A' ' 31' ' ' LEU . 10.8 tp10 -106.52 142.97 35.3 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.387 1.075 . . . . 0.0 109.56 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 26.8 pt -113.84 128.57 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 121.085 0.469 . . . . 0.0 112.009 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.409 HD22 ' HB2' ' A' ' 29' ' ' ARG . 3.9 mm? -114.32 5.95 15.94 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.966 0.906 . . . . 0.0 110.215 172.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.338 0 CA-C-O 119.352 -0.693 . . . . 0.0 112.565 176.879 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.0 t80 . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 120.652 0.263 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.44 -38.25 90.81 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.625 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 4.5 mp0 -72.32 -31.59 65.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.617 -0.791 . . . . 0.0 109.757 178.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -67.37 -50.43 59.79 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 123.542 0.737 . . . . 0.0 110.533 178.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 m -63.65 -36.83 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 123.555 0.535 . . . . 0.0 109.964 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.46 -34.41 61.44 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.12 0.968 . . . . 0.0 110.742 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 58.0 mm-40 -84.11 -37.41 22.05 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.042 0.537 . . . . 0.0 111.112 -175.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.423 HG23 HD12 ' A' ' 75' ' ' ILE . 11.7 t -102.48 3.74 37.93 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.539 0.736 . . . . 0.0 112.414 -172.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.435 ' HA ' ' SD ' ' A' ' 26' ' ' MET . 8.8 mt -75.15 108.16 7.72 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.948 0.499 . . . . 0.0 109.672 174.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 39.7 mt-30 -85.8 130.72 49.62 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 123.657 0.783 . . . . 0.0 108.914 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.83 82.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 123.333 2.689 . . . . 0.0 113.52 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.36 17.73 1.55 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.721 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.582 ' HB3' ' HB2' ' A' ' 23' ' ' GLN . 14.2 ptm -91.35 173.78 7.73 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.677 0.751 . . . . 0.0 111.267 -175.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.603 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 14.8 tpt85 -96.25 131.42 42.75 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.109 -169.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.54 154.36 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 124.375 1.07 . . . . 0.0 111.396 -167.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -129.7 147.05 51.45 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.71 1.604 . . . . 0.0 108.092 169.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.418 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 32.9 tpp -98.41 129.45 45.05 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.011 0.924 . . . . 0.0 108.724 170.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 74' ' ' GLU . 3.8 pp -106.88 2.38 25.34 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -176.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -140.6 172.37 12.81 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.543 0.337 . . . . 0.0 110.152 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -83.46 140.74 32.16 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 122.001 -0.437 . . . . 0.0 110.798 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.41 173.2 11.54 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.377 1.071 . . . . 0.0 110.427 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -50.57 -44.5 56.76 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.392 1.477 . . . . 0.0 112.674 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -138.23 4.19 2.44 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.455 0.702 . . . . 0.0 111.776 -175.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.2 mp -119.57 145.12 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.5 m -112.33 162.95 14.97 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 123.312 0.645 . . . . 0.0 109.887 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.3 118.69 9.03 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.193 0.597 . . . . 0.0 109.815 173.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.87 0.74 28.77 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 116.435 -0.348 . . . . 0.0 113.221 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -88.95 156.4 18.91 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.043 0.449 . . . . 0.0 110.647 173.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -123.97 148.56 46.84 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.392 -169.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -145.42 -170.06 14.08 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.091 -175.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -135.57 137.0 41.56 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.599 ' HZ ' ' HB3' ' A' ' 48' ' ' SER . 87.6 t80 -76.55 118.85 19.63 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.413 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 21.4 mmm-85 -105.3 -47.08 4.05 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -175.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 46' ' ' ARG . 0.4 OUTLIER -152.86 158.66 42.5 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.959 -176.175 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.599 ' HB3' ' HZ ' ' A' ' 45' ' ' PHE . 77.4 p -116.46 175.69 5.45 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.846 0.858 . . . . 0.0 110.699 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.4 HD22 HE22 ' A' ' 56' ' ' GLN . 83.0 m-20 -129.04 130.25 46.34 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.859 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -76.19 -28.62 57.34 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.473 0.709 . . . . 0.0 111.693 -177.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -136.09 1.24 3.4 Favored Glycine 0 C--N 1.348 1.248 0 O-C-N 123.665 0.603 . . . . 0.0 114.093 -175.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.2 mm -111.26 103.74 55.32 Favored Pre-proline 0 N--CA 1.483 1.179 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -55.39 -37.52 94.64 Favored 'Trans proline' 0 CA--C 1.577 2.67 0 C-N-CA 122.374 2.05 . . . . 0.0 116.565 -179.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.721 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 71.8 Cg_endo -73.84 98.68 1.09 Allowed 'Trans proline' 0 C--N 1.384 2.399 0 CA-C-N 122.598 1.963 . . . . 0.0 112.097 169.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.516 HG22 ' HA ' ' A' ' 48' ' ' SER . 7.6 p -83.37 150.46 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 125.126 1.37 . . . . 0.0 111.588 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.4 HE22 HD22 ' A' ' 49' ' ' ASN . 1.7 mp0 -90.86 127.79 36.5 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.197 0.599 . . . . 0.0 110.362 -175.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.19 134.2 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.315 1.446 . . . . 0.0 107.722 178.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 69.3 t80 -81.28 107.81 14.37 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.5 ' HB2' HG21 ' A' ' 62' ' ' THR . 83.5 m95 -92.76 123.4 36.01 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.888 0.875 . . . . 0.0 109.408 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -63.85 -29.04 70.27 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.777 0.673 . . . . 0.0 111.128 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.8 t -61.93 -46.71 88.12 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.166 0.986 . . . . 0.0 112.018 -175.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.5 HG21 ' HB2' ' A' ' 59' ' ' TRP . 9.8 t -98.6 -14.06 20.09 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.658 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.78 16.61 74.82 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 116.126 -0.488 . . . . 0.0 114.165 176.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -152.14 165.85 33.5 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.409 0.623 . . . . 0.0 111.547 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -87.01 114.44 23.63 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.368 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -124.83 153.82 41.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.671 0.748 . . . . 0.0 110.391 -173.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.721 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 7.8 m0 -83.87 116.82 22.94 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.102 -172.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.9 m -131.21 149.35 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -76.22 147.64 38.23 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 59.1 m95 -53.11 -38.93 63.04 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 124.118 0.967 . . . . 0.0 111.453 -178.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -67.59 -28.41 67.74 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -175.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.415 ' HA ' HD11 ' A' ' 31' ' ' LEU . 4.9 mpp? -96.15 -5.56 40.37 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.497 0.319 . . . . 0.0 111.494 176.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.3 tt -90.1 122.23 32.88 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 174.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.581 ' HB2' HD23 ' A' ' 31' ' ' LEU . 35.1 tt0 -110.73 149.14 30.93 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.507 1.123 . . . . 0.0 108.698 174.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.423 HD12 HG23 ' A' ' 21' ' ' THR . 34.7 pt -99.72 125.28 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 170.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.41 HD12 ' NH1' ' A' ' 27' ' ' ARG . 4.1 tt -97.56 -60.86 1.48 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.603 ' HA3' ' HB3' ' A' ' 27' ' ' ARG . . . . . . . . 0 C--N 1.346 1.088 0 O-C-N 124.438 1.086 . . . . 0.0 113.778 -168.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.7 t80 . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.3 -37.86 80.84 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.059 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -70.38 -34.21 72.32 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.438 0.695 . . . . 0.0 110.068 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -69.92 -49.68 49.56 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.201 0.6 . . . . 0.0 111.511 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.0 m -59.11 -37.91 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 123.515 0.51 . . . . 0.0 110.772 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -54.48 -34.97 62.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.065 0.946 . . . . 0.0 111.835 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 42.1 mm-40 -81.63 -42.36 20.13 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.907 -175.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.6 t -92.14 3.34 55.51 Favored 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 123.416 0.687 . . . . 0.0 112.175 -174.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.67 122.18 22.81 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 122.99 0.516 . . . . 0.0 110.2 177.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -104.2 132.43 20.99 Favored Pre-proline 0 N--CA 1.488 1.456 0 C-N-CA 123.832 0.853 . . . . 0.0 110.573 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.78 89.97 0.29 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.98 2.453 . . . . 0.0 111.245 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.8 -6.03 4.8 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.939 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 6.8 ptp -80.67 153.04 28.14 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 173.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -85.66 163.1 18.49 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.1 m -133.99 171.14 18.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.417 ' HB2' ' HB2' ' A' ' 76' ' ' LEU . 2.5 tmt_? -136.58 138.35 41.15 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.528 ' HA ' ' HE2' ' A' ' 30' ' ' MET . 3.0 tpt -85.65 111.15 19.82 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.239 1.016 . . . . 0.0 108.974 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 72' ' ' MET . 4.5 pp -91.04 -15.67 29.18 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 117.778 0.263 . . . . 0.0 111.248 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 30' ' ' MET . 21.3 t70 -125.75 151.91 46.05 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.753 0.821 . . . . 0.0 109.363 -176.171 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -80.45 119.34 23.01 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.663 0.385 . . . . 0.0 110.048 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -106.66 173.28 6.39 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.725 1.21 . . . . 0.0 111.645 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -48.09 -58.79 4.0 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.364 1.466 . . . . 0.0 112.484 -175.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -121.67 5.54 10.03 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.077 0.951 . . . . 0.0 111.39 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mp -120.0 133.29 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 173.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.6 m -99.92 155.44 17.68 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.992 0.517 . . . . 0.0 109.854 177.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.89 115.86 6.44 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.55 -29.23 3.31 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -172.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -74.51 157.36 35.65 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.51 0.724 . . . . 0.0 111.756 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.406 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 41.5 mt-10 -115.73 153.68 30.94 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.782 0.833 . . . . 0.0 111.057 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.83 -170.26 11.88 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.866 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -139.0 140.93 38.32 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 170.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.45 ' HA ' HG13 ' A' ' 57' ' ' VAL . 84.5 t80 -76.71 121.78 23.78 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.037 0.535 . . . . 0.0 110.645 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.523 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 19.9 mmm180 -108.51 -48.39 3.34 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.324 0.65 . . . . 0.0 110.141 -174.272 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.523 ' NE2' ' HB2' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -158.91 161.13 36.74 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.154 0.982 . . . . 0.0 109.636 -177.764 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.495 ' HA ' HG21 ' A' ' 55' ' ' VAL . 14.5 p -130.96 171.63 12.99 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.877 0.846 . . . . 0.0 111.896 -176.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.539 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 1.0 OUTLIER -147.93 119.23 7.82 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.576 -1.647 . . . . 0.0 108.198 -178.498 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -83.23 -30.31 27.78 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.453 0.701 . . . . 0.0 110.621 -173.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.8 -23.84 22.09 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.782 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.539 ' HB ' ' HB2' ' A' ' 49' ' ' ASN . 42.8 mm -102.28 113.31 65.92 Favored Pre-proline 0 N--CA 1.482 1.159 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -64.76 -29.28 59.51 Favored 'Trans proline' 0 CA--C 1.581 2.859 0 N-CA-C 118.088 2.303 . . . . 0.0 118.088 -177.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.577 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 93.3 Cg_endo -80.36 108.61 2.19 Favored 'Trans proline' 0 C--N 1.379 2.15 0 CA-C-N 123.376 2.242 . . . . 0.0 112.084 168.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.495 HG21 ' HA ' ' A' ' 48' ' ' SER . 7.7 p -81.08 146.69 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.031 0.933 . . . . 0.0 110.71 172.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.513 ' HB3' HG23 ' A' ' 65' ' ' THR . 1.9 mp0 -93.74 127.91 39.69 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-O 121.191 0.519 . . . . 0.0 109.604 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.45 HG13 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -138.26 135.19 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 125.448 1.499 . . . . 0.0 108.052 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 47.6 t80 -80.92 106.76 13.18 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -177.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.471 ' HB2' HG21 ' A' ' 62' ' ' THR . 86.5 m95 -89.9 123.06 33.51 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.796 0.838 . . . . 0.0 109.811 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 16.9 pt20 -62.17 -28.11 69.43 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.19 0.996 . . . . 0.0 111.663 175.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.9 t -63.86 -44.49 92.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.853 0.861 . . . . 0.0 111.766 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.471 HG21 ' HB2' ' A' ' 59' ' ' TRP . 8.9 t -105.24 -6.01 20.12 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.494 0.718 . . . . 0.0 111.246 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.32 15.93 80.03 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 114.438 0.535 . . . . 0.0 114.438 175.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -152.83 165.94 33.81 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.323 0.582 . . . . 0.0 112.053 -172.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.513 HG23 ' HB3' ' A' ' 56' ' ' GLN . 2.0 m -87.26 117.99 26.39 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.141 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -125.86 156.82 39.01 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.461 0.648 . . . . 0.0 110.651 -171.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.577 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 11.9 m-90 -84.37 111.53 19.52 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.62 1.568 . . . . 0.0 109.488 -173.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.25 149.65 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.492 0.717 . . . . 0.0 110.092 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -78.5 146.61 34.28 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.766 0.426 . . . . 0.0 110.491 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -61.07 -46.17 91.73 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.57 0.748 . . . . 0.0 112.071 -176.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -67.95 -22.22 65.05 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.17 0.588 . . . . 0.0 111.266 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.472 ' HA ' HD12 ' A' ' 31' ' ' LEU . 38.5 mtp -101.85 13.28 35.27 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.764 1.226 . . . . 0.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -117.84 125.71 51.05 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -105.44 150.99 24.8 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 173.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.4 pt -111.15 116.16 51.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.717 0.807 . . . . 0.0 110.11 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.417 ' HB2' ' HB2' ' A' ' 29' ' ' ARG . 18.1 tp -100.65 -1.2 35.9 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.179 0.592 . . . . 0.0 109.918 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.789 0 CA-C-O 119.139 -0.811 . . . . 0.0 114.012 174.592 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 62.4 t80 . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.82 -34.89 83.95 Favored Glycine 0 C--N 1.341 0.812 0 O-C-N 123.623 0.577 . . . . 0.0 112.797 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 44.6 mp0 -71.3 -41.4 69.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 123.945 0.898 . . . . 0.0 109.445 177.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.424 ' O ' HG21 ' A' ' 21' ' ' THR . 18.8 t80 -59.36 -51.17 71.07 Favored 'General case' 0 C--N 1.358 0.958 0 O-C-N 123.85 0.719 . . . . 0.0 110.964 178.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.7 m -63.17 -40.1 87.77 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -58.49 -47.48 83.96 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 124.003 0.815 . . . . 0.0 110.873 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.498 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 22.6 mm-40 -64.52 -46.37 83.2 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.714 0.293 . . . . 0.0 110.868 -175.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.424 HG21 ' O ' ' A' ' 17' ' ' TYR . 14.7 t -93.15 13.07 22.15 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.457 0.703 . . . . 0.0 111.93 -175.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.731 HD11 ' SD ' ' A' ' 26' ' ' MET . 0.1 OUTLIER -70.94 114.96 9.53 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.91 0.484 . . . . 0.0 109.723 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.642 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 50.0 mt-30 -87.98 137.94 31.24 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.696 0.798 . . . . 0.0 110.777 -177.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.422 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 29.8 Cg_exo -62.74 88.16 0.12 Allowed 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.39 2.727 . . . . 0.0 113.118 177.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.72 40.96 1.79 Allowed Glycine 0 C--N 1.35 1.309 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.731 ' SD ' HD11 ' A' ' 22' ' ' LEU . 20.3 ptm -98.82 177.66 5.21 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.719 0.771 . . . . 0.0 110.814 -177.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -96.56 122.03 39.04 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.19 1.396 . . . . 0.0 108.942 -177.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.0 m -117.0 171.74 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.146 0.578 . . . . 0.0 109.607 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -143.01 143.26 31.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.103 1.361 . . . . 0.0 107.705 -176.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.497 ' HA ' ' HE2' ' A' ' 30' ' ' MET . 1.7 tpt -88.3 125.53 34.72 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 72' ' ' MET . 4.4 pp -105.38 -9.74 17.39 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.627 0.371 . . . . 0.0 111.085 178.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -125.16 156.14 38.86 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.336 0.655 . . . . 0.0 110.27 -175.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -87.23 121.01 29.1 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.217 0.607 . . . . 0.0 109.752 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.535 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 10.4 m-85 -110.68 173.39 6.35 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.512 1.125 . . . . 0.0 111.772 -175.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -50.41 -52.86 33.9 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.435 1.494 . . . . 0.0 111.401 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.533 ' HG3' HG13 ' A' ' 37' ' ' ILE . 10.0 pt-20 -117.3 -19.2 9.69 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.815 -174.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 34' ' ' TYR . 4.6 mt -104.89 145.75 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.45 1.1 . . . . 0.0 108.995 -176.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 m -110.72 152.29 26.74 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.48 113.66 4.88 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 138.17 -29.1 2.65 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 119.569 -0.573 . . . . 0.0 113.711 -178.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -90.42 160.68 15.93 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 118.06 0.93 . . . . 0.0 111.927 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -109.26 159.99 16.5 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.922 0.889 . . . . 0.0 111.641 -164.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -141.64 -176.14 15.69 Favored Glycine 0 C--O 1.241 0.58 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.481 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -133.97 140.52 46.79 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 174.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.519 ' HA ' HG12 ' A' ' 57' ' ' VAL . 78.1 t80 -72.37 121.96 20.38 Favored 'General case' 0 C--N 1.342 0.261 0 O-C-N 123.494 0.496 . . . . 0.0 110.244 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.509 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 7.5 mmm180 -108.35 -47.76 3.46 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -177.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.525 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -166.31 151.24 8.07 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.05 0.94 . . . . 0.0 109.561 179.061 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.417 ' HA ' HG23 ' A' ' 55' ' ' VAL . 30.8 p -118.02 178.23 4.5 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.234 1.014 . . . . 0.0 111.004 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -130.14 121.62 26.66 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 168.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -64.29 -40.63 96.35 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.315 0.646 . . . . 0.0 112.096 -167.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -121.16 12.68 9.72 Favored Glycine 0 N--CA 1.471 1.031 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.91 -176.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.548 HG22 ' HD2' ' A' ' 54' ' ' PRO . 19.7 mm -121.51 110.47 33.87 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 176.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -59.94 -29.03 88.44 Favored 'Trans proline' 0 CA--C 1.577 2.664 0 N-CA-C 118.901 2.616 . . . . 0.0 118.901 -171.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.548 ' HD2' HG22 ' A' ' 52' ' ' ILE . 55.3 Cg_endo -69.32 105.3 1.39 Allowed 'Trans proline' 0 C--N 1.381 2.269 0 CA-C-N 123.112 2.147 . . . . 0.0 112.092 172.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 48' ' ' SER . 3.2 p -89.53 138.77 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.238 1.015 . . . . 0.0 109.923 169.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.525 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.1 mp0 -92.73 124.1 36.49 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -134.65 142.37 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.913 1.285 . . . . 0.0 108.631 -179.19 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -84.84 107.66 17.12 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.54 ' HB2' HG21 ' A' ' 62' ' ' THR . 83.2 m95 -91.06 127.46 36.49 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.751 0.821 . . . . 0.0 110.133 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -21.37 63.63 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.762 0.664 . . . . 0.0 112.01 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.9 t -65.99 -46.28 78.59 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.08 0.552 . . . . 0.0 112.132 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.54 HG21 ' HB2' ' A' ' 59' ' ' TRP . 9.9 t -97.41 -16.14 20.34 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.816 0.846 . . . . 0.0 110.351 -177.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.18 15.68 80.72 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.494 -0.615 . . . . 0.0 114.037 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -151.4 176.99 10.73 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 117.632 0.716 . . . . 0.0 111.252 -174.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.08 138.52 31.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.38 1.072 . . . . 0.0 109.268 178.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -141.8 156.48 45.56 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.06 0.457 . . . . 0.0 110.966 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 -83.07 106.72 15.12 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.777 1.231 . . . . 0.0 109.98 -177.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.6 m -121.19 156.77 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.226 0.61 . . . . 0.0 110.129 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -89.44 146.48 24.62 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.697 0.799 . . . . 0.0 109.675 -176.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -56.17 -49.3 74.41 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.866 0.866 . . . . 0.0 112.607 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -70.06 -19.97 63.26 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.428 0.691 . . . . 0.0 111.582 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.476 ' HE2' ' OH ' ' A' ' 34' ' ' TYR . 31.2 mtp -100.26 1.55 41.88 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.708 0.803 . . . . 0.0 111.23 176.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.0 tt -104.48 130.71 52.38 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.617 1.167 . . . . 0.0 108.235 170.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HB2' HD21 ' A' ' 31' ' ' LEU . 41.3 tt0 -107.45 146.89 31.16 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.103 0.961 . . . . 0.0 108.746 173.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.1 pt -111.56 121.09 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-O 120.831 0.348 . . . . 0.0 110.116 170.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.9 mt -121.0 14.57 11.51 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.845 0.858 . . . . 0.0 110.396 174.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.117 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.375 172.958 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.1 t80 . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.5 -44.93 39.28 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-O 121.785 0.658 . . . . 0.0 113.357 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -70.92 -26.19 63.09 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.191 0.596 . . . . 0.0 109.682 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -71.28 -49.22 45.15 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.456 1.102 . . . . 0.0 111.585 174.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 m -62.71 -33.99 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 122.563 0.345 . . . . 0.0 110.426 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.85 -33.35 49.18 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.22 1.008 . . . . 0.0 110.545 177.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -80.66 -53.42 6.54 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.208 0.603 . . . . 0.0 110.577 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.5 t -90.94 17.07 8.32 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.649 0.78 . . . . 0.0 112.463 -167.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.642 HD11 ' SD ' ' A' ' 26' ' ' MET . 0.2 OUTLIER -76.24 149.76 37.13 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 173.25 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.498 HE21 ' N ' ' A' ' 23' ' ' GLN . 0.0 OUTLIER -117.69 140.24 27.34 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.252 1.021 . . . . 0.0 109.612 177.045 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.447 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 72.8 Cg_endo -72.68 78.98 1.98 Allowed 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.34 2.693 . . . . 0.0 113.429 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.67 28.31 0.82 Allowed Glycine 0 C--N 1.352 1.422 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.642 ' SD ' HD11 ' A' ' 22' ' ' LEU . 27.8 ptm -98.95 170.84 8.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.241 0.616 . . . . 0.0 111.29 -176.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -82.76 124.3 30.13 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.179 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.0 m -116.45 170.47 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.475 ' HE ' ' HG2' ' A' ' 42' ' ' GLU . 21.4 tpp85 -138.41 153.57 48.89 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -175.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' MET . . . . . 0.433 ' HE1' ' HB2' ' A' ' 34' ' ' TYR . 11.4 tpt -97.26 124.57 41.41 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.2 tp -96.23 -9.69 29.8 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.456 0.702 . . . . 0.0 111.258 -173.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 30' ' ' MET . 12.2 t70 -151.22 157.03 42.1 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.282 0.633 . . . . 0.0 109.325 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -73.43 142.16 46.9 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.433 ' HB2' ' HE1' ' A' ' 30' ' ' MET . 0.6 OUTLIER -132.44 172.19 12.8 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.979 0.511 . . . . 0.0 110.434 -177.025 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -40.74 -55.53 2.39 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 126.178 1.791 . . . . 0.0 113.05 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -124.19 0.4 8.41 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.552 -172.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.6 mt -118.71 138.72 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 124.142 0.977 . . . . 0.0 108.508 -175.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.2 m -87.9 150.94 23.19 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 122.915 0.486 . . . . 0.0 110.426 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.17 119.71 11.94 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 171.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.71 11.91 54.31 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.969 -177.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -79.56 153.49 29.45 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.91 0.484 . . . . 0.0 110.079 175.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.475 ' HG2' ' HE ' ' A' ' 29' ' ' ARG . 48.5 mt-10 -112.62 120.44 41.57 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.929 0.492 . . . . 0.0 110.601 -176.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.94 -172.6 21.87 Favored Glycine 0 C--O 1.243 0.683 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.569 173.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -134.04 138.21 45.2 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 171.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.457 ' HA ' HG13 ' A' ' 57' ' ' VAL . 64.1 t80 -70.47 123.27 21.37 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.532 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 21.7 mmm180 -106.36 -49.41 3.35 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -177.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.549 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -167.71 167.29 13.34 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.929 -179.406 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 72.3 p -141.51 -179.93 6.44 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.825 0.85 . . . . 0.0 110.922 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -122.64 121.76 37.2 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 168.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -68.92 -28.0 66.26 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.279 1.032 . . . . 0.0 112.071 -172.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -102.15 -34.51 4.23 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.981 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.531 HG23 ' HD2' ' A' ' 54' ' ' PRO . 12.7 mm -98.44 113.72 64.47 Favored Pre-proline 0 N--CA 1.481 1.088 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -171.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.78 -25.73 74.83 Favored 'Trans proline' 0 CA--C 1.577 2.667 0 N-CA-C 118.831 2.589 . . . . 0.0 118.831 -169.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.531 ' HD2' HG23 ' A' ' 52' ' ' ILE . 45.6 Cg_endo -67.14 110.22 1.93 Allowed 'Trans proline' 0 C--N 1.385 2.492 0 CA-C-N 123.597 2.32 . . . . 0.0 111.594 169.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.78 141.67 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.134 0.974 . . . . 0.0 110.152 170.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . 0.549 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 1.6 mp0 -93.32 121.34 34.6 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.457 HG13 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -135.87 137.2 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.977 1.311 . . . . 0.0 108.403 -177.136 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -83.59 106.08 15.03 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.484 ' HB2' HG21 ' A' ' 62' ' ' THR . 87.5 m95 -95.6 131.62 41.62 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.367 1.067 . . . . 0.0 110.326 -176.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -69.36 -25.05 63.99 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 123.847 0.717 . . . . 0.0 112.268 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.8 t -59.65 -44.17 93.64 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.348 0.594 . . . . 0.0 110.881 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.484 HG21 ' HB2' ' A' ' 59' ' ' TRP . 10.1 t -105.16 -14.49 15.37 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.957 -1.019 . . . . 0.0 111.826 -174.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.13 15.83 81.13 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.111 -0.495 . . . . 0.0 114.097 178.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -152.94 173.46 15.36 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.317 0.579 . . . . 0.0 111.578 -172.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.1 132.67 34.22 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.14 1.376 . . . . 0.0 109.576 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -141.5 158.11 44.27 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.265 0.555 . . . . 0.0 111.695 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -88.2 115.75 25.92 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.497 1.519 . . . . 0.0 109.776 -174.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.81 147.53 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.861 0.865 . . . . 0.0 109.251 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.523 ' HD2' ' H ' ' A' ' 71' ' ' HIS . 15.5 t60 -73.3 146.88 45.0 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -54.1 -31.26 51.51 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.57 1.548 . . . . 0.0 113.863 -177.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . 0.523 ' H ' ' HD2' ' A' ' 69' ' ' HIS . 59.1 t-80 -79.39 -18.11 52.99 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.731 0.812 . . . . 0.0 111.191 -173.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.5 mtm -100.31 4.84 44.35 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.484 0.714 . . . . 0.0 110.655 171.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 tt -103.68 120.32 40.69 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 170.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -105.19 129.09 53.65 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.314 1.046 . . . . 0.0 108.235 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.9 pt -96.54 115.44 35.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.543 0.687 . . . . 0.0 109.896 175.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.1 tp -127.11 11.1 6.99 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.125 0.97 . . . . 0.0 109.181 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 1.663 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.949 171.252 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 79.8 t80 . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 120.858 0.361 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.48 -32.76 84.22 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.034 -0.984 . . . . 0.0 112.931 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.524 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 41.2 tt0 -62.86 -48.94 76.84 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.098 0.559 . . . . 0.0 110.274 173.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.412 ' O ' HG22 ' A' ' 21' ' ' THR . 10.3 t80 -57.51 -50.42 73.14 Favored 'General case' 0 C--N 1.358 0.971 0 O-C-N 124.017 0.823 . . . . 0.0 110.838 -176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.466 ' HB ' HD23 ' A' ' 22' ' ' LEU . 29.5 m -67.74 -39.01 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 O-C-N 123.535 0.522 . . . . 0.0 110.645 -177.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -56.91 -31.25 64.72 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.153 0.581 . . . . 0.0 111.723 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 26.4 mm-40 -81.94 -40.57 22.07 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.191 -177.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 17' ' ' TYR . 12.5 t -100.46 -6.06 26.13 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -168.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.482 HD13 ' SD ' ' A' ' 26' ' ' MET . 1.1 mm? -69.7 107.79 3.61 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 118.164 0.438 . . . . 0.0 110.612 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -87.46 142.45 33.1 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.08 0.952 . . . . 0.0 110.498 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.5 ' HA ' ' HD1' ' A' ' 45' ' ' PHE . 34.7 Cg_exo -59.59 79.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.531 2.821 . . . . 0.0 114.061 176.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.33 19.32 1.22 Allowed Glycine 0 C--N 1.353 1.525 0 CA-C-O 119.534 -0.592 . . . . 0.0 113.015 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.482 ' SD ' HD13 ' A' ' 22' ' ' LEU . 4.7 ptp -93.91 174.68 7.04 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 117.704 0.752 . . . . 0.0 110.876 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -97.02 126.97 42.54 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.747 1.219 . . . . 0.0 109.055 -171.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.441 HG12 HD11 ' A' ' 22' ' ' LEU . 5.7 m -116.03 172.34 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.676 0.791 . . . . 0.0 109.999 -174.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -144.58 140.95 29.1 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.173 1.389 . . . . 0.0 108.329 -172.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.4 tpt -98.95 112.15 24.34 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 74' ' ' GLU . 4.7 pp -89.48 -3.7 58.26 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -140.7 154.01 46.18 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.63 127.04 32.2 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.221 0.534 . . . . 0.0 110.144 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.471 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -107.06 172.68 6.69 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.734 0.813 . . . . 0.0 110.989 -178.439 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -50.11 -35.78 26.99 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.818 1.647 . . . . 0.0 113.237 -172.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -138.58 3.6 2.31 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.859 0.864 . . . . 0.0 111.182 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.471 ' HB ' ' HB2' ' A' ' 34' ' ' TYR . 7.2 mt -118.78 144.19 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.438 1.095 . . . . 0.0 108.503 -172.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 m -91.77 153.69 19.44 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.85 0.46 . . . . 0.0 110.909 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.11 116.14 12.18 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 166.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.7 -5.71 29.48 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.346 -172.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -79.17 156.23 28.31 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.748 0.419 . . . . 0.0 110.108 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -129.88 158.21 40.12 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.252 0.621 . . . . 0.0 111.136 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -149.26 -166.88 13.5 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.501 -172.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -135.47 139.26 43.93 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.5 ' HD1' ' HA ' ' A' ' 24' ' ' PRO . 38.7 t80 -69.13 119.52 13.55 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -103.65 -46.96 4.38 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.48 ' OE1' ' HB2' ' A' ' 56' ' ' GLN . 0.5 OUTLIER -172.21 156.92 4.05 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.734 1.214 . . . . 0.0 108.885 176.421 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.7 p -127.39 178.2 6.22 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.473 0.709 . . . . 0.0 110.335 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 . . . . . 0 C--O 1.238 0.499 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 170.013 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo . . . . . 0 CA--C 1.577 2.656 0 N-CA-C 118.361 2.408 . . . . 0.0 118.361 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 28.9 Cg_endo -61.68 107.75 0.55 Allowed 'Trans proline' 0 C--N 1.384 2.415 0 CA-C-N 123.101 2.143 . . . . 0.0 112.51 175.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.04 136.46 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.28 1.032 . . . . 0.0 109.502 169.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.546 ' HB3' HG22 ' A' ' 65' ' ' THR . 1.8 mp0 -90.4 123.35 34.05 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -137.03 136.75 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.0 1.32 . . . . 0.0 108.546 -174.91 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -82.53 105.58 13.69 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -175.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.486 ' HB2' HG22 ' A' ' 62' ' ' THR . 95.6 m95 -90.14 130.61 36.27 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.064 0.946 . . . . 0.0 110.432 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -70.31 -31.33 68.61 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 123.863 0.727 . . . . 0.0 112.727 -174.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.6 t -70.08 -46.08 65.68 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 117.951 0.341 . . . . 0.0 111.536 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.486 HG22 ' HB2' ' A' ' 59' ' ' TRP . 9.8 t -86.45 -18.13 32.5 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 122.736 0.414 . . . . 0.0 110.676 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.8 19.71 78.69 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-O 119.727 -0.485 . . . . 0.0 114.277 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -153.04 165.0 36.95 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.317 0.579 . . . . 0.0 112.244 -173.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.546 HG22 ' HB3' ' A' ' 56' ' ' GLN . 2.1 m -87.05 121.63 29.78 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.933 -177.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -130.64 157.15 43.53 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.964 0.411 . . . . 0.0 111.283 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 12.3 m-90 -79.02 114.34 17.88 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.714 1.205 . . . . 0.0 110.191 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.461 HG21 HD23 ' A' ' 73' ' ' LEU . 11.6 m -129.05 155.34 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 122.838 0.455 . . . . 0.0 110.652 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -89.47 147.06 24.21 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.736 0.814 . . . . 0.0 110.169 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -59.82 -42.36 93.33 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.428 0.691 . . . . 0.0 112.59 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -66.99 -24.94 66.09 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 117.661 0.21 . . . . 0.0 111.336 -176.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 71.4 mtm -99.88 -1.82 36.43 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.732 0.413 . . . . 0.0 111.62 175.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.461 HD23 HG21 ' A' ' 68' ' ' VAL . 2.5 tm? -92.66 121.23 33.87 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 172.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.522 ' HB2' HD23 ' A' ' 31' ' ' LEU . 39.6 tt0 -115.69 151.59 34.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.882 1.273 . . . . 0.0 108.458 176.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.435 HG21 ' SD ' ' A' ' 26' ' ' MET . 10.7 pt . . . . . 0 N--CA 1.483 1.177 0 CA-C-N 118.433 0.56 . . . . 0.0 110.723 169.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.4 t80 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.02 -31.77 81.99 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.893 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 12.1 tp10 -69.14 -48.05 63.42 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.41 ' O ' HG22 ' A' ' 21' ' ' THR . 42.0 t80 -59.06 -49.92 76.05 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 114.986 -1.007 . . . . 0.0 111.396 -177.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.8 -40.67 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 123.677 0.611 . . . . 0.0 110.721 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -57.64 -36.31 71.67 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.507 0.723 . . . . 0.0 111.932 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 23.5 mm-40 -80.21 -35.79 35.77 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.009 0.524 . . . . 0.0 111.171 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 17' ' ' TYR . 14.8 t -101.04 7.82 43.24 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.806 0.443 . . . . 0.0 112.117 -176.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.97 113.98 11.76 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.489 ' HB3' ' HB3' ' A' ' 26' ' ' MET . 34.3 tt0 -87.44 134.71 35.57 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.06 0.944 . . . . 0.0 109.673 -176.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.51 ' HA ' ' CD1' ' A' ' 45' ' ' PHE . 52.7 Cg_endo -64.81 80.3 0.18 Allowed 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 123.151 2.567 . . . . 0.0 113.457 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.99 26.44 1.54 Allowed Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.057 175.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.489 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 24.6 ptm -96.53 168.97 10.22 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.608 0.718 . . . . 0.0 110.54 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.437 ' HD2' ' HB3' ' A' ' 42' ' ' GLU . 18.6 tpp180 -90.01 126.31 35.71 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.851 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.476 HG12 HG22 ' A' ' 75' ' ' ILE . 8.0 m -116.44 171.02 5.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 C-N-CA 124.209 1.003 . . . . 0.0 108.833 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.451 ' HD2' ' N ' ' A' ' 30' ' ' MET . 2.6 tmm_? -137.29 143.93 42.41 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.451 ' N ' ' HD2' ' A' ' 29' ' ' ARG . 1.9 tpt -92.77 112.68 24.72 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.642 0.777 . . . . 0.0 109.133 -177.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 74' ' ' GLU . 4.4 pp -89.19 -9.58 50.29 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.571 0.348 . . . . 0.0 111.547 -178.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -127.02 162.62 25.6 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.944 0.898 . . . . 0.0 109.344 -174.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.43 146.19 25.96 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.553 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 13.8 m-85 -133.53 173.07 11.9 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.645 0.778 . . . . 0.0 111.117 -176.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -50.93 -47.4 61.03 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.15 1.38 . . . . 0.0 112.043 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -131.09 -1.35 4.08 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.696 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 34' ' ' TYR . 3.9 mp -112.64 143.02 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.2 t -103.32 154.5 19.31 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.263 0.625 . . . . 0.0 109.751 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.83 114.18 6.93 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.406 ' HA2' HH11 ' A' ' 29' ' ' ARG . . . 124.58 -17.54 7.33 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.314 -176.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.62 154.71 41.59 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.209 0.603 . . . . 0.0 111.259 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.437 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 45.0 mt-10 -112.79 138.61 49.37 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.601 0.761 . . . . 0.0 110.813 -175.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.56 -176.74 14.59 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.99 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -135.36 137.18 42.1 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.515 ' HA ' HG12 ' A' ' 57' ' ' VAL . 60.4 t80 -69.65 120.35 15.29 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.9 mmm-85 -107.42 -47.52 3.63 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.469 ' OE1' ' HB2' ' A' ' 56' ' ' GLN . 0.5 OUTLIER -169.06 166.38 10.99 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.252 1.021 . . . . 0.0 109.398 178.624 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 92.3 p -152.93 -179.18 7.43 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.689 0.757 . . . . 0.0 111.509 -176.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 . . . . . 0 CA--C 1.545 0.766 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 168.509 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 CA--C 1.584 2.982 0 N-CA-C 119.221 2.739 . . . . 0.0 119.221 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.95 106.24 0.63 Allowed 'Trans proline' 0 C--N 1.389 2.692 0 CA-C-N 123.558 2.306 . . . . 0.0 113.054 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 p -95.44 132.3 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.318 167.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.469 ' HB2' ' OE1' ' A' ' 47' ' ' GLN . 2.1 mp0 -92.12 124.62 36.34 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -134.71 139.05 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.09 1.356 . . . . 0.0 108.636 -174.906 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -81.52 107.13 14.03 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.562 0.745 . . . . 0.0 109.731 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.424 ' NE1' HG23 ' A' ' 57' ' ' VAL . 93.0 m95 -93.83 130.1 39.99 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.944 0.898 . . . . 0.0 110.618 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -71.17 -26.25 62.89 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 123.965 0.791 . . . . 0.0 112.508 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.3 t -62.62 -45.85 90.96 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.047 0.451 . . . . 0.0 111.401 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.9 t -99.16 -12.19 20.69 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.913 0.885 . . . . 0.0 110.36 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.18 22.31 74.34 Favored Glycine 0 C--N 1.352 1.458 0 CA-C-N 115.966 -0.561 . . . . 0.0 114.17 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -151.35 172.45 15.89 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 117.324 0.562 . . . . 0.0 111.202 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.11 139.64 31.57 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.268 1.027 . . . . 0.0 109.102 -175.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -144.71 155.41 43.55 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.056 0.455 . . . . 0.0 111.139 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -79.75 120.73 24.44 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.033 1.333 . . . . 0.0 109.351 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 73' ' ' LEU . 6.7 m -131.44 160.91 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.206 0.602 . . . . 0.0 109.665 176.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 72' ' ' MET . 46.7 t60 -93.86 145.83 24.33 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.734 0.813 . . . . 0.0 108.826 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -60.15 -46.88 88.18 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.396 0.678 . . . . 0.0 112.501 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -73.15 -19.4 61.13 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.16 0.584 . . . . 0.0 111.003 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.471 ' HA ' HD11 ' A' ' 31' ' ' LEU . 46.5 mtp -98.32 2.64 48.3 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.252 1.021 . . . . 0.0 110.668 176.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.457 HD13 HG21 ' A' ' 68' ' ' VAL . 58.5 tp -111.03 133.78 53.15 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.518 1.127 . . . . 0.0 109.142 176.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.488 ' HB2' HD23 ' A' ' 31' ' ' LEU . 35.5 tt0 -107.25 152.56 23.94 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 172.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.476 HG22 HG12 ' A' ' 28' ' ' VAL . 21.7 pt . . . . . 0 N--CA 1.476 0.868 0 C-N-CA 122.905 0.482 . . . . 0.0 109.801 166.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 55.4 t80 . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 110.907 -0.034 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.91 -40.71 95.54 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.363 0.414 . . . . 0.0 113.247 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 25.7 tt0 -71.36 -36.09 71.35 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.925 0.49 . . . . 0.0 110.348 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -64.47 -49.49 71.22 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.096 0.958 . . . . 0.0 111.255 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.8 m -63.45 -39.63 86.03 Favored 'Isoleucine or valine' 0 C--N 1.354 0.77 0 O-C-N 123.65 0.593 . . . . 0.0 110.316 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -55.81 -38.77 70.43 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.196 0.599 . . . . 0.0 111.202 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 23.9 mm-40 -78.66 -38.94 38.27 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.408 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.6 t -94.11 2.06 56.04 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -173.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.49 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.2 OUTLIER -71.11 127.99 34.42 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 118.114 0.415 . . . . 0.0 109.944 176.448 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 50.9 mt-30 -116.41 133.67 22.95 Favored Pre-proline 0 N--CA 1.488 1.443 0 C-N-CA 124.26 1.024 . . . . 0.0 109.775 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 23' ' ' GLN . 24.1 Cg_exo -63.03 90.55 0.13 Allowed 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 123.227 2.618 . . . . 0.0 112.805 -175.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.61 8.06 3.26 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 116.147 -0.478 . . . . 0.0 112.782 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.49 ' SD ' HD13 ' A' ' 22' ' ' LEU . 9.8 ptp -87.33 157.48 19.27 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 173.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -87.27 157.19 19.36 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.748 0.785 . . . . 0.0 109.342 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.546 HG12 HG22 ' A' ' 75' ' ' ILE . 9.5 m -133.88 173.63 14.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.405 ' NE ' ' HA2' ' A' ' 40' ' ' GLY . 3.6 tmt_? -151.21 145.84 25.67 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 31.9 tpp -98.43 126.95 44.15 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.009 0.924 . . . . 0.0 110.297 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.598 HD23 ' HB2' ' A' ' 74' ' ' GLU . 3.9 pp -95.47 -7.63 37.62 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.221 0.608 . . . . 0.0 111.857 -176.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 30' ' ' MET . 21.7 t70 -132.64 168.47 18.22 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.449 0.7 . . . . 0.0 110.411 -174.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -80.19 130.69 35.4 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 122.137 -0.352 . . . . 0.0 110.248 175.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.464 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 1.2 m-85 -120.07 171.79 8.21 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.045 0.938 . . . . 0.0 110.433 176.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -50.44 -49.51 54.77 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.497 1.519 . . . . 0.0 113.009 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -126.17 0.38 7.13 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.645 0.778 . . . . 0.0 111.318 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.477 HD11 ' HB3' ' A' ' 66' ' ' TYR . 4.9 mt -116.56 126.37 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.1 m -89.43 155.17 19.49 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.26 113.36 3.54 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.405 ' HA2' ' NE ' ' A' ' 29' ' ' ARG . . . 124.37 -21.92 6.72 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.22 -177.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.415 ' OD2' ' HB3' ' A' ' 59' ' ' TRP . 28.4 t0 -62.19 142.45 57.65 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.301 0.64 . . . . 0.0 112.07 -176.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -104.1 148.29 26.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.256 1.022 . . . . 0.0 110.761 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.63 -173.85 13.09 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.434 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -134.91 140.69 45.96 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.487 ' HA ' HG12 ' A' ' 57' ' ' VAL . 59.3 t80 -71.63 119.75 16.24 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 123.864 0.727 . . . . 0.0 110.08 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -107.58 -47.68 3.57 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -164.42 157.18 17.1 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.338 1.055 . . . . 0.0 109.412 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.469 ' HA ' HG23 ' A' ' 55' ' ' VAL . 29.8 p -117.4 178.31 4.42 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.914 0.886 . . . . 0.0 111.169 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 . . . . . 0 C--O 1.236 0.375 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.61 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo . . . . . 0 CA--C 1.581 2.832 0 N-CA-C 118.074 2.298 . . . . 0.0 118.074 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.514 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 43.1 Cg_endo -68.51 109.09 1.97 Allowed 'Trans proline' 0 C--N 1.384 2.401 0 CA-C-N 123.325 2.223 . . . . 0.0 111.827 169.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 48' ' ' SER . 3.2 p -90.34 141.62 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.621 1.168 . . . . 0.0 110.478 171.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -93.33 125.17 37.8 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.549 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.487 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -138.89 138.45 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.167 1.387 . . . . 0.0 108.538 -176.581 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -81.96 106.67 14.06 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.46 ' HB2' HG22 ' A' ' 62' ' ' THR . 97.6 m95 -91.73 130.49 37.51 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.579 1.152 . . . . 0.0 110.647 -176.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.23 -26.93 60.53 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -174.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.3 t -72.6 -41.49 65.56 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.025 0.375 . . . . 0.0 111.378 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.48 HG23 ' H ' ' A' ' 64' ' ' ARG . 10.5 t -87.76 -30.78 20.03 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 122.783 0.433 . . . . 0.0 109.843 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.58 16.76 58.07 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.911 -0.586 . . . . 0.0 114.096 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.48 ' H ' HG23 ' A' ' 62' ' ' THR . 0.0 OUTLIER -151.75 175.37 12.47 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.593 0.757 . . . . 0.0 112.032 -177.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.47 132.96 33.8 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.882 1.273 . . . . 0.0 109.716 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.477 ' HB3' HD11 ' A' ' 37' ' ' ILE . 12.7 t80 -138.82 156.99 46.88 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.09 0.472 . . . . 0.0 111.028 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 12.9 m-90 -83.51 113.74 21.0 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.128 1.371 . . . . 0.0 109.744 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.421 HG21 HD13 ' A' ' 73' ' ' LEU . 17.0 m -130.15 154.55 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.326 0.651 . . . . 0.0 110.546 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -80.62 145.5 31.66 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.994 0.518 . . . . 0.0 110.352 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -59.51 -45.59 91.29 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.526 0.731 . . . . 0.0 112.042 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -70.56 -25.36 63.05 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.528 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 74.7 mtm -93.2 1.27 57.17 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.745 0.418 . . . . 0.0 111.13 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.421 HD13 HG21 ' A' ' 68' ' ' VAL . 26.5 tp -97.11 118.82 34.39 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 174.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.598 ' HB2' HD23 ' A' ' 31' ' ' LEU . 42.9 tt0 -108.2 108.4 19.42 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.975 0.91 . . . . 0.0 108.924 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.546 HG22 HG12 ' A' ' 28' ' ' VAL . 17.9 pt . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 121.737 0.779 . . . . 0.0 111.415 -174.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.1 t80 . . . . . 0 N--CA 1.481 1.118 0 CA-C-O 120.823 0.344 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.62 -42.99 87.01 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.147 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 3.8 mp0 -71.05 -22.49 62.12 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.769 0.827 . . . . 0.0 111.735 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -70.95 -50.99 28.54 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.27 0.228 . . . . 0.0 110.792 170.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.8 m -66.63 -41.55 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -169.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -55.78 -30.29 61.05 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.336 0.654 . . . . 0.0 112.706 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 11.3 mm100 -78.32 -36.93 45.7 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.056 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.2 t -94.36 -0.36 54.96 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.45 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.6 OUTLIER -72.1 117.61 13.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 122.039 -0.413 . . . . 0.0 110.738 177.074 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -96.86 135.66 22.01 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 124.112 0.965 . . . . 0.0 110.253 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 27.9 Cg_exo -62.97 82.19 0.11 Allowed 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.657 2.905 . . . . 0.0 113.188 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.03 15.92 1.64 Allowed Glycine 0 C--N 1.345 1.056 0 CA-C-N 116.4 -0.363 . . . . 0.0 112.467 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.45 ' SD ' HD13 ' A' ' 22' ' ' LEU . 5.3 ptp -90.7 163.75 14.39 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.539 0.685 . . . . 0.0 110.298 176.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 25.2 tpt180 -83.73 129.02 34.95 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.192 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 m -115.62 172.03 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -141.63 141.94 33.42 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.228 1.411 . . . . 0.0 108.272 -172.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.3 tpt -86.43 110.53 19.79 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.3 tp -81.13 -29.44 34.77 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.061 0.544 . . . . 0.0 110.599 -175.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -143.1 151.75 41.08 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -66.33 151.0 48.01 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.062 0.545 . . . . 0.0 111.51 -168.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -133.15 172.16 13.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.636 0.774 . . . . 0.0 111.436 -174.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -49.23 -47.8 46.08 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.037 1.735 . . . . 0.0 112.483 -175.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -129.99 2.88 4.82 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.995 0.918 . . . . 0.0 111.32 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -118.56 143.87 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.4 m -98.98 148.76 23.67 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.907 0.483 . . . . 0.0 110.208 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.1 117.48 5.59 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.998 0.519 . . . . 0.0 110.076 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.28 -15.93 20.17 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.487 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.98 151.06 43.51 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 117.265 0.533 . . . . 0.0 109.856 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -118.34 146.37 44.42 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.403 0.62 . . . . 0.0 110.939 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.445 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . -127.9 -165.36 11.83 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.252 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -136.27 142.64 43.97 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.449 ' HA ' HG12 ' A' ' 57' ' ' VAL . 75.4 t80 -75.57 119.58 19.81 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.416 0.686 . . . . 0.0 110.276 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -108.06 -49.6 3.18 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -164.82 163.67 21.17 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.44 1.096 . . . . 0.0 109.271 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.418 ' HB3' HG23 ' A' ' 55' ' ' VAL . 87.8 p -161.95 179.74 7.79 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 122.088 0.947 . . . . 0.0 112.517 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 . . . . . 0 C--O 1.239 0.536 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 167.309 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 CA--C 1.578 2.678 0 N-CA-C 118.848 2.595 . . . . 0.0 118.848 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.66 101.75 0.27 Allowed 'Trans proline' 0 C--N 1.389 2.662 0 CA-C-N 123.256 2.199 . . . . 0.0 112.199 171.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.418 HG23 ' HB3' ' A' ' 48' ' ' SER . 2.1 p -89.11 135.3 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.722 168.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.474 ' HB3' HG22 ' A' ' 65' ' ' THR . 2.0 mp0 -91.01 121.89 33.21 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -135.27 136.6 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.91 1.284 . . . . 0.0 108.411 -176.686 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -82.38 106.18 14.04 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.849 0.46 . . . . 0.0 109.917 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.408 ' HB2' HG22 ' A' ' 62' ' ' THR . 84.6 m95 -94.11 131.0 40.08 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.053 0.941 . . . . 0.0 110.535 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -71.04 -24.8 62.42 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.5 p -62.03 -45.75 92.22 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.414 0.626 . . . . 0.0 111.53 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.408 HG22 ' HB2' ' A' ' 59' ' ' TRP . 9.8 t -99.51 -17.87 17.69 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.367 -176.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.59 19.21 74.12 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-O 119.789 -0.45 . . . . 0.0 113.961 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -152.27 170.12 20.83 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.499 0.666 . . . . 0.0 111.216 -175.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.474 HG22 ' HB3' ' A' ' 56' ' ' GLN . 1.3 m -86.52 129.14 34.97 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.773 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -131.99 154.71 49.05 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.268 0.556 . . . . 0.0 111.612 -174.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -85.18 100.48 11.78 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.396 1.478 . . . . 0.0 109.427 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.8 m -116.94 162.02 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 122.744 0.418 . . . . 0.0 110.348 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -91.59 147.79 22.75 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.301 0.641 . . . . 0.0 109.846 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -58.84 -45.66 89.54 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.363 1.065 . . . . 0.0 113.291 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -66.44 -21.59 66.2 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.431 0.693 . . . . 0.0 111.797 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 76.3 mtm -101.94 9.66 40.37 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.2 0.6 . . . . 0.0 111.248 174.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.7 tt -109.64 120.62 43.05 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 172.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -106.86 150.22 26.61 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.903 1.281 . . . . 0.0 107.774 171.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.2 pt . . . . . 0 N--CA 1.485 1.295 0 CA-C-N 119.123 0.874 . . . . 0.0 111.818 174.734 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 75.1 t80 . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.539 0.209 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.56 -28.81 71.95 Favored Glycine 0 C--N 1.354 1.563 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.6 176.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.27 -47.73 59.98 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.963 0.505 . . . . 0.0 110.406 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -58.08 -50.21 74.25 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.055 0.847 . . . . 0.0 110.925 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.5 m -66.23 -37.3 79.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.311 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -31.36 59.19 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.72 0.808 . . . . 0.0 110.687 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -91.96 -47.98 7.01 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.573 0.749 . . . . 0.0 111.2 -174.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.9 t -79.13 -11.99 59.99 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -173.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.415 HD12 ' CG ' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -68.71 112.17 5.28 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 117.917 0.326 . . . . 0.0 110.575 177.674 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -97.53 132.81 24.52 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 123.875 0.87 . . . . 0.0 109.771 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.01 84.45 0.25 Allowed 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 123.021 2.48 . . . . 0.0 112.666 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 143.68 -0.68 1.25 Allowed Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.826 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.8 ptp -88.73 154.56 20.19 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -85.28 157.91 20.45 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 m -128.69 173.3 13.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.728 -1.123 . . . . 0.0 108.316 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.537 ' HD3' ' HA2' ' A' ' 40' ' ' GLY . 3.6 tmm_? -141.54 136.6 31.29 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.2 tpt -76.82 111.45 12.36 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.511 1.124 . . . . 0.0 109.279 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 41.2 tp -69.88 -36.53 75.52 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.137 0.575 . . . . 0.0 111.0 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -141.34 150.92 43.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.668 0.787 . . . . 0.0 109.18 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -65.58 129.88 41.33 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.831 0.707 . . . . 0.0 111.234 -170.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -106.97 173.58 6.26 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.128 0.971 . . . . 0.0 110.749 -177.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -47.41 -44.95 24.98 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.813 1.645 . . . . 0.0 113.386 -175.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -131.36 7.33 4.55 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.885 0.874 . . . . 0.0 111.058 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.23 144.79 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.825 0.85 . . . . 0.0 109.391 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.4 m -93.44 147.33 23.05 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.076 0.55 . . . . 0.0 110.543 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.48 117.86 8.6 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.537 ' HA2' ' HD3' ' A' ' 29' ' ' ARG . . . 115.16 -18.95 15.56 Favored Glycine 0 N--CA 1.469 0.862 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -66.64 144.45 56.39 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.606 0.762 . . . . 0.0 110.648 178.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -109.1 144.14 37.52 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.407 0.623 . . . . 0.0 110.659 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.65 -168.43 12.32 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.639 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -137.18 142.49 42.15 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 169.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 48' ' ' SER . 85.4 t80 -88.31 118.23 27.78 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.924 0.889 . . . . 0.0 109.451 177.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.94 -47.17 2.79 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.317 0.247 . . . . 0.0 111.286 175.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -136.86 150.66 48.4 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.606 0.362 . . . . 0.0 110.407 -177.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.447 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 64.4 p -145.12 165.28 28.74 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.638 0.775 . . . . 0.0 111.745 -177.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 CA--C 1.541 0.626 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 173.776 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 CA--C 1.579 2.747 0 N-CA-C 118.292 2.382 . . . . 0.0 118.292 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.648 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 57.4 Cg_endo -71.36 109.09 2.52 Favored 'Trans proline' 0 C--N 1.383 2.393 0 CA-C-N 123.523 2.294 . . . . 0.0 112.241 169.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' A' ' 48' ' ' SER . 6.4 p -86.93 144.45 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.061 0.944 . . . . 0.0 110.774 173.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -89.64 122.63 32.95 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.14 136.16 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -80.93 104.12 11.22 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -176.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.507 ' HB2' HG22 ' A' ' 62' ' ' THR . 88.6 m95 -92.01 130.03 37.84 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.434 1.094 . . . . 0.0 109.745 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -70.01 -34.87 73.86 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 123.61 0.569 . . . . 0.0 111.775 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.1 t -60.65 -45.18 95.07 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.666 0.386 . . . . 0.0 111.371 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.507 HG22 ' HB2' ' A' ' 59' ' ' TRP . 8.9 t -90.88 -16.68 27.76 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.762 0.425 . . . . 0.0 110.984 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.78 14.56 80.82 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 119.612 -0.549 . . . . 0.0 114.206 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -152.77 176.83 11.36 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 117.439 0.619 . . . . 0.0 110.9 -172.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 p -84.91 136.84 33.46 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.006 0.522 . . . . 0.0 109.727 173.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -134.89 156.02 49.68 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 123.886 0.742 . . . . 0.0 110.041 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.648 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 14.9 m-90 -87.6 101.37 13.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.34 1.456 . . . . 0.0 109.498 -173.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.3 m -117.09 153.27 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.147 0.579 . . . . 0.0 109.7 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -85.19 146.71 26.96 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -58.91 -40.13 83.61 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.886 0.875 . . . . 0.0 112.764 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -69.69 -20.76 63.55 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 123.316 0.646 . . . . 0.0 112.164 -176.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 69.4 mtm -106.1 14.29 27.94 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 122.973 0.509 . . . . 0.0 111.424 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.414 HD22 HD21 ' A' ' 22' ' ' LEU . 8.3 tt -104.53 121.69 44.01 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 172.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -106.6 152.7 23.38 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 171.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.7 pt . . . . . 0 N--CA 1.475 0.824 0 C-N-CA 122.864 0.465 . . . . 0.0 111.71 174.405 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.2 t80 . . . . . 0 N--CA 1.486 1.361 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.89 -30.4 77.9 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 114.443 -1.253 . . . . 0.0 113.71 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 26.5 tt0 -70.34 -41.79 72.73 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 175.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -60.37 -49.57 77.07 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.243 0.617 . . . . 0.0 111.148 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.417 ' HA ' HG22 ' A' ' 21' ' ' THR . 34.2 m -64.94 -36.45 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 O-C-N 123.397 0.435 . . . . 0.0 110.493 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.1 -30.97 60.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.676 0.79 . . . . 0.0 111.27 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 10.3 mm100 -80.32 -52.8 7.27 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.774 0.429 . . . . 0.0 110.771 177.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.417 HG22 ' HA ' ' A' ' 18' ' ' VAL . 10.8 t -82.8 -7.42 59.66 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -167.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.559 HD12 ' HB2' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -69.43 107.13 3.21 Favored 'General case' 0 CA--C 1.558 1.251 0 CA-C-N 118.519 0.599 . . . . 0.0 110.801 176.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -88.37 134.26 34.88 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 124.143 0.977 . . . . 0.0 110.226 176.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.91 90.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.117 2.545 . . . . 0.0 112.227 171.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.14 -2.38 3.92 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.996 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.1 ptp -87.79 164.81 15.74 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 117.353 0.577 . . . . 0.0 110.57 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.62 140.01 31.06 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.699 1.199 . . . . 0.0 109.821 -173.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.441 HG12 HD11 ' A' ' 22' ' ' LEU . 4.4 m -117.19 172.83 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.816 0.846 . . . . 0.0 109.187 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -145.07 143.92 30.69 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.558 1.143 . . . . 0.0 108.651 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.1 tpp -97.62 139.1 34.03 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 122.779 0.431 . . . . 0.0 110.696 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 74' ' ' GLU . 3.3 pp -112.87 -7.42 13.76 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.235 1.014 . . . . 0.0 111.676 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -127.13 172.2 10.74 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.244 1.018 . . . . 0.0 109.58 -174.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -91.11 143.09 27.05 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.797 -0.565 . . . . 0.0 110.629 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.412 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 8.7 m-85 -133.28 171.77 13.59 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.984 1.313 . . . . 0.0 110.231 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -45.93 -46.98 16.4 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.367 1.467 . . . . 0.0 112.266 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -139.08 1.84 2.06 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.85 0.86 . . . . 0.0 111.398 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 34' ' ' TYR . 5.0 mp -115.1 146.45 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 174.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.0 m -130.74 164.25 25.51 Favored 'General case' 0 C--O 1.245 0.819 0 O-C-N 121.988 -0.445 . . . . 0.0 110.051 172.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.29 114.63 2.5 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 123.788 0.68 . . . . 0.0 110.286 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.28 -34.35 2.95 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.399 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.405 ' HB3' HG23 ' A' ' 37' ' ' ILE . 50.5 t0 -65.09 145.84 55.77 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.033 0.533 . . . . 0.0 110.192 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -120.4 146.29 46.34 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.998 0.919 . . . . 0.0 110.357 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.7 -167.52 12.4 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.126 -178.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -136.89 141.38 42.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 171.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.559 ' HB2' HD12 ' A' ' 22' ' ' LEU . 76.8 t80 -74.97 119.66 19.45 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.877 0.471 . . . . 0.0 109.988 178.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -108.99 -49.22 3.16 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.679 0.791 . . . . 0.0 109.592 -173.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -161.7 164.04 29.35 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.48 1.112 . . . . 0.0 109.056 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 16.3 p -132.07 168.56 17.75 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.622 0.769 . . . . 0.0 112.01 -175.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 . . . . . 0 C--O 1.238 0.495 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 164.768 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo . . . . . 0 CA--C 1.576 2.605 0 N-CA-C 117.775 2.183 . . . . 0.0 117.775 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.55 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 66.5 Cg_endo -76.35 111.42 3.26 Favored 'Trans proline' 0 C--N 1.377 2.062 0 CA-C-N 122.851 2.054 . . . . 0.0 112.295 165.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 p -84.38 142.95 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.598 1.159 . . . . 0.0 110.076 169.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.456 ' HB3' HG22 ' A' ' 65' ' ' THR . 2.0 mp0 -92.32 122.69 35.02 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -136.3 138.11 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.892 1.277 . . . . 0.0 108.566 -178.222 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -82.88 104.68 13.29 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.503 ' HB2' HG22 ' A' ' 62' ' ' THR . 89.2 m95 -86.29 128.17 34.88 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.977 0.911 . . . . 0.0 109.684 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -71.71 -23.62 61.67 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -173.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.0 t -78.08 -44.68 25.56 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.48 0.582 . . . . 0.0 111.326 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 59' ' ' TRP . 11.0 t -85.3 -18.94 32.39 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-O 121.006 0.432 . . . . 0.0 110.453 176.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.38 22.07 73.97 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-N 115.867 -0.606 . . . . 0.0 114.465 174.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -153.18 168.41 26.03 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 117.459 0.63 . . . . 0.0 111.999 -174.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.456 HG22 ' HB3' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -86.8 126.18 34.45 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.554 1.142 . . . . 0.0 109.215 -176.243 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -135.56 157.43 46.9 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.286 0.565 . . . . 0.0 111.42 -173.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.55 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 12.4 m-90 -86.28 111.22 20.23 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.389 1.476 . . . . 0.0 109.58 -174.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 54' ' ' PRO . 13.4 m -131.67 150.67 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.126 0.57 . . . . 0.0 110.013 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -78.51 146.6 34.25 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 122.677 0.391 . . . . 0.0 110.964 -175.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -59.54 -48.77 80.36 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.332 1.053 . . . . 0.0 112.013 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -68.04 -27.91 66.94 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.283 0.563 . . . . 0.0 110.438 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.507 ' HA ' HD11 ' A' ' 31' ' ' LEU . 38.8 mtp -93.69 9.09 38.39 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.068 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.7 tp -112.22 120.05 40.45 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 123.728 0.811 . . . . 0.0 108.842 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.531 ' HB2' HD23 ' A' ' 31' ' ' LEU . 39.0 tt0 -107.56 135.89 48.26 Favored 'General case' 0 C--O 1.207 -1.14 0 C-N-CA 124.733 1.213 . . . . 0.0 107.789 175.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.401 HD13 HD22 ' A' ' 22' ' ' LEU . 20.4 pt . . . . . 0 N--CA 1.482 1.165 0 CA-C-N 119.73 1.15 . . . . 0.0 111.914 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 41.1 t80 . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.904 0.383 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.15 -29.86 75.74 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.83 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 44.0 tt0 -72.92 -38.48 66.84 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -62.38 -48.32 80.25 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.165 0.586 . . . . 0.0 111.222 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.47 ' HB ' HD23 ' A' ' 22' ' ' LEU . 33.0 m -62.1 -37.25 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -29.99 62.97 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.984 0.914 . . . . 0.0 110.454 178.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 10.6 mm100 -78.88 -47.33 16.73 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.988 0.515 . . . . 0.0 110.101 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 t -96.96 4.52 51.51 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -166.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.485 HD13 ' SD ' ' A' ' 26' ' ' MET . 2.0 mm? -87.59 115.28 24.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.818 -0.551 . . . . 0.0 111.574 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 26' ' ' MET . 1.4 mp0 -92.94 137.24 23.94 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 124.003 0.921 . . . . 0.0 109.688 171.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.56 86.68 0.21 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.472 2.115 . . . . 0.0 111.371 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 144.71 4.55 0.62 Allowed Glycine 0 C--N 1.347 1.171 0 CA-C-N 115.737 -0.665 . . . . 0.0 113.065 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.67 ' SD ' HG21 ' A' ' 75' ' ' ILE . 6.2 ptp -95.01 175.52 6.6 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 117.345 0.573 . . . . 0.0 110.827 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -99.52 128.4 45.63 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.058 1.343 . . . . 0.0 109.815 -170.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -115.58 171.36 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.589 0.756 . . . . 0.0 109.655 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.516 ' HA ' ' HG2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -144.0 126.95 16.37 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -174.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -78.89 121.91 25.45 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.515 HD23 ' HB2' ' A' ' 74' ' ' GLU . 4.2 pp -105.6 14.09 28.98 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 117.945 0.339 . . . . 0.0 111.34 176.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -137.04 172.37 13.11 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.144 0.978 . . . . 0.0 111.327 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -97.35 140.53 31.67 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.889 0.876 . . . . 0.0 110.107 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -134.41 173.66 11.39 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.677 1.191 . . . . 0.0 111.421 -176.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -46.34 -45.03 17.35 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.585 1.554 . . . . 0.0 111.955 175.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -140.84 -1.95 1.37 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.183 -171.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.402 HG23 ' OD2' ' A' ' 41' ' ' ASP . 3.8 mp -116.22 147.58 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 124.251 1.021 . . . . 0.0 108.344 175.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.1 m -127.49 160.96 29.89 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.958 0.503 . . . . 0.0 109.674 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.1 113.89 4.83 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.17 -61.04 0.56 Allowed Glycine 0 C--N 1.343 0.947 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -172.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.402 ' OD2' HG23 ' A' ' 37' ' ' ILE . 4.9 p-10 -77.33 148.72 35.48 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.4 0.619 . . . . 0.0 110.632 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.516 ' HG2' ' HA ' ' A' ' 29' ' ' ARG . 42.4 mt-10 -125.62 161.34 27.45 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.014 -161.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.75 -171.97 12.64 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.887 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -133.07 135.87 45.58 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.506 ' HA ' HG12 ' A' ' 57' ' ' VAL . 16.3 t80 -72.66 121.37 19.68 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.531 0.732 . . . . 0.0 109.258 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -107.32 -46.37 3.89 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -175.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -152.86 159.56 43.03 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.851 0.861 . . . . 0.0 110.071 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 64.7 p -119.58 173.39 7.03 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.72 0.808 . . . . 0.0 111.205 -176.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.4 m120 . . . . . 0 N--CA 1.471 0.615 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.429 -178.884 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo . . . . . 0 CA--C 1.576 2.61 0 N-CA-C 116.71 1.773 . . . . 0.0 116.71 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.69 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 96.1 Cg_endo -75.68 97.5 1.11 Allowed 'Trans proline' 0 C--N 1.384 2.444 0 CA-C-N 122.411 1.897 . . . . 0.0 112.397 169.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.8 p -90.64 153.27 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.004 0.922 . . . . 0.0 111.297 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -96.76 129.9 44.1 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.237 0.615 . . . . 0.0 111.665 -172.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.506 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -139.85 141.79 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 125.743 1.617 . . . . 0.0 108.788 178.313 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -81.2 107.25 13.84 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.913 0.885 . . . . 0.0 109.143 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.526 ' HB2' HG22 ' A' ' 62' ' ' THR . 99.0 m95 -90.9 133.82 34.95 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.147 0.979 . . . . 0.0 111.097 -177.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -59.57 -35.19 73.78 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 124.04 0.837 . . . . 0.0 111.535 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.9 p -66.8 -45.31 78.81 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.653 0.781 . . . . 0.0 112.221 -173.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.526 HG22 ' HB2' ' A' ' 59' ' ' TRP . 10.6 t -104.84 -9.4 18.06 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.175 0.59 . . . . 0.0 111.695 -174.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.52 21.6 72.69 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 114.291 0.476 . . . . 0.0 114.291 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -151.8 176.08 11.78 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.277 0.631 . . . . 0.0 110.665 -176.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 2.1 p -85.23 129.62 34.77 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.066 0.547 . . . . 0.0 109.969 175.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -130.13 158.54 39.41 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.314 0.578 . . . . 0.0 110.196 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.69 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 18.7 m-90 -81.59 104.82 12.28 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.796 1.239 . . . . 0.0 110.782 -176.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.5 m -126.21 156.84 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.063 0.545 . . . . 0.0 110.33 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.479 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 9.1 t-160 -84.44 147.51 27.06 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 122.939 0.496 . . . . 0.0 110.944 -174.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -59.94 -47.01 87.55 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.898 0.879 . . . . 0.0 111.253 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -66.32 -25.85 67.03 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.56 0.744 . . . . 0.0 111.471 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.479 ' SD ' ' HB3' ' A' ' 69' ' ' HIS . 59.5 mtp -95.14 -2.42 49.91 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.954 0.902 . . . . 0.0 111.676 -171.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 pp -110.07 157.73 19.03 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 167.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.515 ' HB2' HD23 ' A' ' 31' ' ' LEU . 30.7 tt0 -138.13 137.13 37.38 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 125.074 1.35 . . . . 0.0 108.231 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.67 HG21 ' SD ' ' A' ' 26' ' ' MET . 7.2 pt . . . . . 0 CA--C 1.537 0.45 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 169.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 40.8 t80 . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.61 -26.63 71.05 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 114.59 -1.186 . . . . 0.0 113.401 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 15.1 tp10 -71.45 -47.34 56.4 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -58.38 -50.01 75.18 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.955 0.784 . . . . 0.0 111.052 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.2 m -67.59 -36.35 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.833 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -54.96 -34.59 63.42 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.405 0.682 . . . . 0.0 111.333 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 48.5 mm-40 -85.06 -48.69 8.95 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.074 -176.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 t -85.98 -9.98 55.9 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -168.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.496 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.2 OUTLIER -66.89 107.21 2.13 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 118.589 0.631 . . . . 0.0 110.176 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -94.75 132.72 27.9 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 124.016 0.926 . . . . 0.0 110.424 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.2 84.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.388 2.725 . . . . 0.0 113.868 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 141.05 4.8 1.07 Allowed Glycine 0 C--N 1.343 0.944 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.759 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.496 ' SD ' HD13 ' A' ' 22' ' ' LEU . 5.4 ptp -91.89 166.82 12.53 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 117.479 0.64 . . . . 0.0 110.717 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -88.76 134.84 33.79 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.595 1.158 . . . . 0.0 109.375 -174.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.0 m -117.15 172.31 5.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -151.01 140.01 21.03 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.7 tpp -85.94 128.94 34.95 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.142 0.496 . . . . 0.0 110.863 -175.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 23.2 tp -106.03 -5.79 19.24 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.868 0.867 . . . . 0.0 111.365 -173.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -138.27 160.66 38.9 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.537 0.735 . . . . 0.0 111.136 -174.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -82.74 127.39 33.38 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -122.49 171.36 9.15 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.07 0.948 . . . . 0.0 111.409 -174.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -49.66 -45.4 48.58 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.542 1.537 . . . . 0.0 111.847 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -132.16 -5.4 3.45 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.684 -170.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mt -118.74 140.74 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.7 t -100.85 153.53 19.4 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 172.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.4 115.26 4.93 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.78 -36.1 2.22 Favored Glycine 0 C--N 1.338 0.694 0 O-C-N 123.665 0.603 . . . . 0.0 112.089 -175.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -63.24 141.62 58.7 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.23 0.612 . . . . 0.0 111.608 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -102.45 161.62 13.57 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.672 0.789 . . . . 0.0 111.13 -175.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.83 -170.2 19.59 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.466 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -135.3 137.81 42.84 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 48' ' ' SER . 57.4 t80 -85.23 119.6 25.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.927 173.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.79 -45.95 2.86 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 122.236 0.214 . . . . 0.0 111.198 172.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.85 163.54 23.39 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.917 0.487 . . . . 0.0 110.056 -177.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 37.8 t -148.86 168.52 22.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.596 0.758 . . . . 0.0 112.265 -167.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.3 m120 . . . . . 0 CA--C 1.542 0.662 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 164.191 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 CA--C 1.581 2.828 0 N-CA-C 118.111 2.312 . . . . 0.0 118.111 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.455 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 58.6 Cg_endo -72.57 106.5 2.11 Favored 'Trans proline' 0 C--N 1.383 2.354 0 CA-C-N 123.084 2.137 . . . . 0.0 112.521 170.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.544 HG23 ' HA ' ' A' ' 48' ' ' SER . 8.9 p -86.49 146.12 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.642 168.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -91.94 128.14 37.67 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.91 136.47 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.269 1.028 . . . . 0.0 108.485 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -81.88 108.68 15.6 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.507 ' HB2' HG22 ' A' ' 62' ' ' THR . 95.3 m95 -93.15 131.0 38.61 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.941 0.896 . . . . 0.0 110.864 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -63.81 -27.28 69.07 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 124.133 0.896 . . . . 0.0 110.66 172.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.8 t -65.49 -47.04 77.41 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 124.369 1.068 . . . . 0.0 112.055 -173.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.507 HG22 ' HB2' ' A' ' 59' ' ' TRP . 6.6 t -103.28 -14.48 16.3 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.002 0.921 . . . . 0.0 110.458 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.84 14.14 82.35 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.86 -0.609 . . . . 0.0 113.688 178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -150.26 172.01 16.05 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.266 0.555 . . . . 0.0 110.979 -174.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.43 124.52 33.51 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.629 1.172 . . . . 0.0 108.917 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -128.27 154.51 45.81 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.184 0.516 . . . . 0.0 110.763 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 14.4 m-90 -81.04 111.27 17.36 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.358 -1.292 . . . . 0.0 109.736 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.9 m -126.81 159.15 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.026 0.53 . . . . 0.0 109.838 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.3 t-80 -86.81 147.11 25.96 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.386 0.674 . . . . 0.0 110.124 -174.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -61.41 -48.5 80.9 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.084 0.554 . . . . 0.0 111.691 -178.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -69.3 -11.43 60.8 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.447 0.699 . . . . 0.0 111.734 -177.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 34.8 mtp -113.62 10.03 17.97 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.233 1.013 . . . . 0.0 110.787 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.9 tp -113.82 121.42 43.97 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 124.211 1.004 . . . . 0.0 108.708 176.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -107.84 132.44 53.42 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.911 0.885 . . . . 0.0 110.028 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.401 HD13 HD22 ' A' ' 22' ' ' LEU . 28.8 pt . . . . . 0 N--CA 1.478 0.96 0 O-C-N 121.824 -0.548 . . . . 0.0 111.012 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.1 t80 . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.49 -36.83 84.58 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-O 121.409 0.449 . . . . 0.0 112.963 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.469 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 8.3 mp0 -71.26 -42.56 68.63 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.805 0.842 . . . . 0.0 109.132 176.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -60.28 -48.91 79.73 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 124.183 0.927 . . . . 0.0 111.798 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.8 m -64.06 -38.31 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 123.264 0.353 . . . . 0.0 110.572 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -56.13 -32.44 64.23 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.266 0.626 . . . . 0.0 111.103 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 41.8 mm-40 -77.16 -51.78 10.4 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.575 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.2 t -87.69 5.54 39.26 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.618 0.767 . . . . 0.0 112.383 -170.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -72.17 108.83 5.55 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.311 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.461 ' HB3' ' HB3' ' A' ' 26' ' ' MET . 35.1 tt0 -87.31 131.86 43.0 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 123.686 0.794 . . . . 0.0 110.179 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.441 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 72.4 Cg_exo -53.12 88.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.682 2.921 . . . . 0.0 113.031 170.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.73 22.86 5.23 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.155 170.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.461 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 3.8 ptp -89.39 168.73 11.99 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.256 0.551 . . . . 0.0 110.387 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -86.95 147.08 25.91 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.838 1.255 . . . . 0.0 108.967 -176.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.522 HG22 HG22 ' A' ' 75' ' ' ILE . 55.9 t -130.71 164.08 34.73 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 C-N-CA 124.444 1.098 . . . . 0.0 109.469 -172.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.418 ' HD2' ' N ' ' A' ' 30' ' ' MET . 3.5 tmm_? -142.7 145.65 33.59 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.376 1.47 . . . . 0.0 107.607 172.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.418 ' N ' ' HD2' ' A' ' 29' ' ' ARG . 4.4 tpt -85.18 112.26 20.55 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.137 0.575 . . . . 0.0 109.734 -175.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 39.0 tp -86.46 -20.02 28.74 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.339 0.656 . . . . 0.0 111.682 -174.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -136.67 155.12 50.31 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.741 0.416 . . . . 0.0 110.29 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -76.51 138.98 40.58 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.933 0.493 . . . . 0.0 110.339 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -131.21 171.42 13.32 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.306 1.042 . . . . 0.0 110.822 -172.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -48.58 -58.76 4.22 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.126 1.37 . . . . 0.0 112.032 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -117.96 -1.0 11.55 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.11 0.964 . . . . 0.0 111.402 -175.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mp -118.18 139.86 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.6 m -104.79 152.48 22.52 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.72 114.24 3.88 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.99 -36.12 2.1 Favored Glycine 0 C--N 1.346 1.131 0 O-C-N 123.488 0.493 . . . . 0.0 112.36 -173.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -61.61 147.82 44.44 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.198 0.599 . . . . 0.0 111.753 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -102.23 155.46 18.2 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.337 0.655 . . . . 0.0 111.009 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -140.32 -175.73 14.67 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.835 -175.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -139.33 138.54 36.74 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.562 ' HA ' HG12 ' A' ' 57' ' ' VAL . 87.1 t80 -71.07 122.4 20.01 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 122.685 0.394 . . . . 0.0 110.015 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -108.75 -48.57 3.28 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -176.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -167.19 155.46 9.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.364 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.8 p -123.11 179.4 4.7 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.135 0.974 . . . . 0.0 109.955 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 172.343 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.478 ' HA ' ' CD1' ' A' ' 70' ' ' TRP . 13.6 Cg_endo . . . . . 0 CA--C 1.584 2.982 0 N-CA-C 118.172 2.335 . . . . 0.0 118.172 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.84 101.45 0.79 Allowed 'Trans proline' 0 C--N 1.394 2.941 0 CA-C-N 122.736 2.013 . . . . 0.0 112.558 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 p -94.43 140.52 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.944 0.898 . . . . 0.0 109.918 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.448 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 2.1 mp0 -93.65 122.81 36.49 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.381 0.672 . . . . 0.0 109.72 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -132.78 140.63 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 125.262 1.425 . . . . 0.0 108.825 -178.522 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -79.38 108.1 12.64 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.506 ' HB2' HG22 ' A' ' 62' ' ' THR . 93.8 m95 -91.65 131.36 37.1 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.943 0.897 . . . . 0.0 110.066 177.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -59.41 -31.85 69.64 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.223 1.009 . . . . 0.0 111.688 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.7 t -67.55 -45.63 75.09 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.695 0.798 . . . . 0.0 112.07 -172.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.506 HG22 ' HB2' ' A' ' 59' ' ' TRP . 6.1 t -97.68 -21.24 17.12 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.32 0.648 . . . . 0.0 110.988 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.8 18.66 69.7 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.783 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -151.95 -176.93 5.85 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.138 0.575 . . . . 0.0 110.579 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 56' ' ' GLN . 5.2 p -86.03 144.38 27.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.503 0.721 . . . . 0.0 110.753 173.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -140.0 154.47 47.15 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.198 0.599 . . . . 0.0 109.942 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -81.4 111.99 18.26 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.555 1.142 . . . . 0.0 109.959 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.689 HG21 HD13 ' A' ' 73' ' ' LEU . 19.1 m -126.03 159.98 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.185 0.594 . . . . 0.0 110.772 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.513 ' HB3' ' HB2' ' A' ' 72' ' ' MET . 14.9 t-80 -91.14 147.04 23.34 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.283 1.033 . . . . 0.0 109.475 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.478 ' CD1' ' HA ' ' A' ' 53' ' ' PRO . 97.2 m95 -64.99 -45.99 83.3 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.013 0.525 . . . . 0.0 111.917 -175.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -70.47 -17.26 62.97 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.077 0.465 . . . . 0.0 111.678 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.513 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 21.3 mtp -104.16 14.19 30.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.526 1.13 . . . . 0.0 110.502 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.689 HD13 HG21 ' A' ' 68' ' ' VAL . 29.1 tp -119.19 121.26 39.33 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.298 1.039 . . . . 0.0 108.578 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -112.68 119.81 39.37 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.522 HG22 HG22 ' A' ' 28' ' ' VAL . 14.0 pt . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 121.488 0.661 . . . . 0.0 110.533 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.8 t80 . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.77 -36.43 91.18 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.497 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 33.6 tt0 -63.24 -47.45 82.42 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 171.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -57.83 -51.97 67.41 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.376 1.048 . . . . 0.0 111.854 -173.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.7 m -67.13 -37.88 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 O-C-N 123.789 0.681 . . . . 0.0 110.764 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.78 -34.17 67.37 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.575 0.75 . . . . 0.0 110.225 177.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 25.4 mm-40 -79.29 -50.01 11.57 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.815 0.446 . . . . 0.0 111.068 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.1 t -90.84 3.97 53.04 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -169.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.83 125.09 25.87 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 26' ' ' MET . 21.3 tt0 -90.96 139.63 25.95 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 124.145 0.978 . . . . 0.0 109.384 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' HA ' ' CD1' ' A' ' 45' ' ' PHE . 25.9 Cg_exo -63.63 84.62 0.13 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.742 2.294 . . . . 0.0 112.922 172.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.59 31.51 1.79 Allowed Glycine 0 C--N 1.353 1.49 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 171.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.501 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 25.9 ptm -100.59 174.61 6.0 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.268 0.556 . . . . 0.0 109.857 177.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.423 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 19.1 tpt180 -91.05 130.6 36.94 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 124.349 1.059 . . . . 0.0 108.995 -173.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.5 m -116.45 173.23 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.439 0.696 . . . . 0.0 109.33 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.07 137.15 25.79 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -171.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.6 tpt -82.62 111.61 18.74 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 55.2 tp -80.39 -38.59 30.01 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.176 0.591 . . . . 0.0 110.698 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -126.86 154.04 44.91 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.212 0.605 . . . . 0.0 110.553 -175.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.99 119.47 17.27 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.337 0.655 . . . . 0.0 110.605 -174.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -102.6 173.46 6.33 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.386 1.074 . . . . 0.0 111.502 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -45.61 -52.1 11.11 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 126.174 1.79 . . . . 0.0 112.2 -175.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -124.9 -11.41 7.15 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.462 -177.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.2 mp -102.21 132.19 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.7 m -94.48 148.66 22.02 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.496 0.318 . . . . 0.0 110.39 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.8 115.73 4.61 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.94 -18.93 8.43 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 123.479 0.487 . . . . 0.0 112.452 -172.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -75.24 155.21 37.02 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.156 0.582 . . . . 0.0 109.57 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -126.7 154.29 44.31 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.582 0.706 . . . . 0.0 111.165 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.423 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . -137.42 -169.5 11.65 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.815 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -137.22 144.34 42.76 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.542 ' CD1' ' HA ' ' A' ' 24' ' ' PRO . 51.1 t80 -69.62 121.86 17.96 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.443 0.697 . . . . 0.0 109.31 177.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -108.95 -43.75 4.14 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.479 ' OE1' ' HB2' ' A' ' 56' ' ' GLN . 0.5 OUTLIER -170.78 172.68 5.59 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.354 1.461 . . . . 0.0 107.895 177.237 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -157.18 179.8 8.93 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.748 0.785 . . . . 0.0 112.317 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 . . . . . 0 CA--C 1.544 0.742 0 CA-C-N 114.076 -1.42 . . . . 0.0 107.633 171.984 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo . . . . . 0 CA--C 1.579 2.731 0 N-CA-C 118.961 2.639 . . . . 0.0 118.961 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.1 110.15 2.55 Favored 'Trans proline' 0 C--N 1.372 1.772 0 CA-C-N 122.925 2.08 . . . . 0.0 113.316 173.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.94 139.46 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.303 1.041 . . . . 0.0 109.82 167.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.479 ' HB2' ' OE1' ' A' ' 47' ' ' GLN . 1.7 mp0 -91.94 122.05 34.1 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -135.82 136.24 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.571 1.149 . . . . 0.0 108.819 -177.561 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 59.9 t80 -82.01 106.42 13.9 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.45 ' HB2' HG22 ' A' ' 62' ' ' THR . 89.0 m95 -90.29 130.71 36.37 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.426 1.09 . . . . 0.0 110.125 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -69.51 -37.93 77.36 Favored 'General case' 0 CA--C 1.554 1.099 0 O-C-N 123.842 0.714 . . . . 0.0 112.679 -173.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.1 t -69.59 -43.19 73.31 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.436 0.294 . . . . 0.0 111.677 -174.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 59' ' ' TRP . 11.4 t -86.18 -17.13 35.71 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.794 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.48 18.32 76.08 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 114.539 0.576 . . . . 0.0 114.539 172.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -152.8 166.55 31.91 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.229 0.538 . . . . 0.0 112.086 -172.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 1.4 m -85.67 130.79 34.47 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.841 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -137.16 148.91 46.92 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.885 0.374 . . . . 0.0 110.688 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.461 ' CD1' ' HG3' ' A' ' 56' ' ' GLN . 11.1 m0 -76.76 114.15 15.21 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.462 1.105 . . . . 0.0 109.323 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.445 HG21 HD13 ' A' ' 73' ' ' LEU . 18.6 m -126.46 156.47 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.112 0.565 . . . . 0.0 109.676 175.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -86.07 145.92 26.85 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -63.09 -42.7 99.67 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.219 0.608 . . . . 0.0 111.768 -175.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -68.11 -14.42 62.97 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.538 0.735 . . . . 0.0 111.995 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 72.3 mtm -113.03 16.95 19.19 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.406 0.682 . . . . 0.0 110.958 174.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.445 HD13 HG21 ' A' ' 68' ' ' VAL . 40.6 tp -114.83 122.14 45.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.305 0.642 . . . . 0.0 109.295 176.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -105.23 147.29 28.2 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.409 1.084 . . . . 0.0 108.367 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.0 pt . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 121.378 0.609 . . . . 0.0 110.222 173.159 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.404 ' OH ' ' HA ' ' A' ' 74' ' ' GLU . 64.5 t80 . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.469 0.176 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.0 -38.86 63.9 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.904 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.563 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 3.2 mp0 -70.91 -37.6 72.95 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -58.44 -49.12 78.45 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.913 0.758 . . . . 0.0 111.417 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 27.0 m -62.58 -38.96 82.82 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.84 -40.64 84.8 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.141 0.576 . . . . 0.0 109.846 177.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 11.0 mm100 -66.76 -40.0 88.1 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.313 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.4 t -110.53 13.08 22.73 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -169.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.621 HD12 ' SD ' ' A' ' 26' ' ' MET . 18.1 tp -87.55 110.93 20.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.858 -0.527 . . . . 0.0 110.428 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.612 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 38.7 mt-30 -87.84 141.44 31.65 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 124.203 1.001 . . . . 0.0 109.892 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.89 85.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.972 2.448 . . . . 0.0 111.728 173.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.64 73.71 1.19 Allowed Glycine 0 C--N 1.342 0.905 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.797 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.621 ' SD ' HD12 ' A' ' 22' ' ' LEU . 21.8 ptm -118.78 -58.32 1.97 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 118.465 -0.779 . . . . 0.0 112.044 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.468 ' H ' ' HG3' ' A' ' 26' ' ' MET . 24.8 tpt180 146.08 122.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 128.088 2.555 . . . . 0.0 107.929 173.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 m -118.14 171.74 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-O 121.326 0.584 . . . . 0.0 110.206 177.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -148.81 150.34 32.89 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.719 1.608 . . . . 0.0 107.529 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.1 tpt -90.33 111.89 23.26 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 34.4 tp -77.41 -33.16 55.06 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.421 0.689 . . . . 0.0 110.912 -174.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -145.29 153.99 41.87 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.627 0.771 . . . . 0.0 109.072 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.46 142.03 58.09 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.52 0.728 . . . . 0.0 111.573 -172.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -126.33 171.76 10.69 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.818 0.847 . . . . 0.0 110.921 -175.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -47.37 -37.81 11.93 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.728 1.611 . . . . 0.0 113.233 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -139.94 -0.01 1.73 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.494 -171.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 mt -119.83 141.01 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.224 1.01 . . . . 0.0 109.19 -175.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.4 p -91.41 142.35 27.77 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.059 0.544 . . . . 0.0 109.969 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.39 117.39 5.61 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.665 0.386 . . . . 0.0 110.069 171.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.92 -4.27 28.88 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 123.542 0.526 . . . . 0.0 112.537 -175.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -77.34 156.57 31.19 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.165 0.586 . . . . 0.0 109.658 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 51.0 mt-10 -113.15 157.26 21.88 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.752 0.787 . . . . 0.0 111.596 -178.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -146.25 -172.53 16.66 Favored Glycine 0 C--O 1.244 0.756 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.046 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -138.2 141.34 40.01 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 170.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.443 ' HE1' ' HB3' ' A' ' 48' ' ' SER . 32.8 t80 -70.58 120.45 16.23 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.639 0.776 . . . . 0.0 110.207 176.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -108.85 -47.63 3.42 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.804 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.424 ' OE1' ' HB2' ' A' ' 56' ' ' GLN . 0.5 OUTLIER -163.78 155.86 17.23 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.537 1.135 . . . . 0.0 109.316 -177.12 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.443 ' HB3' ' HE1' ' A' ' 45' ' ' PHE . 41.4 p -132.09 179.03 6.34 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.715 0.806 . . . . 0.0 110.772 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.1 m120 . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.089 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 CA--C 1.571 2.345 0 N-CA-C 117.933 2.244 . . . . 0.0 117.933 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.638 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 55.9 Cg_endo -67.36 111.99 2.45 Favored 'Trans proline' 0 C--N 1.378 2.124 0 CA-C-N 123.297 2.213 . . . . 0.0 111.649 171.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 p -81.54 141.44 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.467 1.107 . . . . 0.0 110.689 171.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.569 ' HB3' HG22 ' A' ' 65' ' ' THR . 1.5 mp0 -90.17 126.85 35.95 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.446 HG23 ' NE1' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -138.26 137.34 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 125.16 1.384 . . . . 0.0 108.817 -177.548 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -82.03 105.78 13.41 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.24 0.616 . . . . 0.0 109.818 -175.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.489 ' HB2' HG22 ' A' ' 62' ' ' THR . 91.7 m95 -92.58 132.62 36.7 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.34 1.056 . . . . 0.0 111.2 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 13.6 pt20 -69.2 -28.33 66.28 Favored 'General case' 0 CA--C 1.55 0.967 0 O-C-N 124.141 0.901 . . . . 0.0 112.078 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.0 t -64.37 -46.46 83.27 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.05 0.387 . . . . 0.0 112.01 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.489 HG22 ' HB2' ' A' ' 59' ' ' TRP . 10.2 t -98.17 -12.08 22.08 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.543 0.737 . . . . 0.0 110.756 -176.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.3 16.09 79.94 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-N 115.986 -0.552 . . . . 0.0 113.898 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -151.9 170.69 19.22 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.345 0.593 . . . . 0.0 111.682 -174.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.569 HG22 ' HB3' ' A' ' 56' ' ' GLN . 1.7 m -87.0 120.06 27.86 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.271 -177.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -127.95 157.13 41.43 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.75 0.42 . . . . 0.0 111.152 -175.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.638 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 4.3 m-90 -75.65 120.67 21.37 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.456 1.102 . . . . 0.0 110.649 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.482 HG21 HD13 ' A' ' 73' ' ' LEU . 6.3 m -135.41 147.89 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 173.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -78.95 148.21 32.72 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.928 0.491 . . . . 0.0 110.496 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -54.47 -49.66 69.56 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.282 1.033 . . . . 0.0 112.305 -178.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -74.83 -13.11 60.53 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.073 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 29.1 mtp -106.76 13.88 27.44 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.857 0.863 . . . . 0.0 110.356 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.482 HD13 HG21 ' A' ' 68' ' ' VAL . 53.6 tp -116.18 131.32 56.98 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.641 1.177 . . . . 0.0 108.799 176.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HA ' ' OH ' ' A' ' 14' ' ' TYR . 10.9 tp10 -106.12 140.89 38.38 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.753 1.221 . . . . 0.0 108.234 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 pt . . . . . 0 N--CA 1.489 1.477 0 CA-C-N 118.435 0.562 . . . . 0.0 111.52 175.558 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.1 t80 . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.49 -42.05 74.62 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 121.512 0.506 . . . . 0.0 112.601 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 8.4 mp0 -69.33 -34.33 74.48 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 176.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -65.22 -49.73 68.56 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 123.866 0.728 . . . . 0.0 111.891 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.4 m -59.62 -38.86 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 123.319 0.387 . . . . 0.0 110.435 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -54.71 -35.47 63.67 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.364 0.665 . . . . 0.0 111.493 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.55 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 43.4 mm-40 -82.36 -36.25 27.02 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.463 -172.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.8 t -109.24 4.22 22.55 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.853 0.461 . . . . 0.0 112.142 -172.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.512 HD13 HG22 ' A' ' 75' ' ' ILE . 16.7 tp -86.08 116.73 24.47 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 122.007 -0.433 . . . . 0.0 109.994 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -92.01 137.47 25.15 Favored Pre-proline 0 N--CA 1.481 1.095 0 C-N-CA 124.207 1.003 . . . . 0.0 111.136 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.2 92.41 0.39 Allowed 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.017 2.478 . . . . 0.0 112.105 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.0 -8.22 4.15 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.661 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 5.5 ptp -92.46 166.5 12.51 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -88.17 162.7 16.56 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-O 121.896 0.855 . . . . 0.0 110.305 -171.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.6 m -131.64 175.65 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.061 176.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -143.89 146.07 32.75 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -174.424 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.5 tpt -98.05 118.17 34.05 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.777 0.831 . . . . 0.0 110.043 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.8 mt -74.94 -43.39 54.4 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.417 0.687 . . . . 0.0 112.066 -177.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -129.5 163.99 24.71 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -67.09 120.53 13.85 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.292 0.568 . . . . 0.0 110.889 -176.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.03 173.12 6.98 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.988 0.915 . . . . 0.0 110.384 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -47.79 -48.07 30.52 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.348 1.459 . . . . 0.0 113.542 -176.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -128.31 8.5 6.03 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.306 0.642 . . . . 0.0 111.571 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -120.07 143.56 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.3 m -99.46 154.02 18.55 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.561 0.619 . . . . 0.0 109.848 174.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.6 118.3 6.89 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.623 0.769 . . . . 0.0 110.068 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.53 -10.39 23.87 Favored Glycine 0 C--N 1.341 0.834 0 O-C-N 123.331 0.395 . . . . 0.0 113.237 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -79.95 157.26 26.9 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 120.948 0.404 . . . . 0.0 110.725 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 45.0 mt-10 -120.55 159.95 24.19 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.038 -174.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -141.7 -167.76 11.35 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.647 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -138.52 140.13 39.0 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 170.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.446 ' HA ' HG12 ' A' ' 57' ' ' VAL . 55.6 t80 -79.7 121.31 25.16 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.225 0.61 . . . . 0.0 110.102 176.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -108.26 -47.91 3.45 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -155.47 151.08 27.3 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.754 0.821 . . . . 0.0 110.109 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.491 ' HA ' HG23 ' A' ' 55' ' ' VAL . 48.6 p -117.49 162.63 17.66 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.091 0.956 . . . . 0.0 111.123 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.3 m120 . . . . . 0 C--O 1.237 0.427 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 160.355 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo . . . . . 0 CA--C 1.583 2.949 0 N-CA-C 118.268 2.372 . . . . 0.0 118.268 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.523 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 39.4 Cg_endo -67.56 105.87 1.16 Allowed 'Trans proline' 0 C--N 1.389 2.67 0 CA-C-N 123.56 2.307 . . . . 0.0 111.793 169.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' A' ' 48' ' ' SER . 6.4 p -86.59 145.84 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.467 1.107 . . . . 0.0 110.709 176.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -92.22 122.08 34.36 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -133.89 136.68 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.857 1.263 . . . . 0.0 108.752 178.855 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -81.09 108.65 14.94 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.514 ' HB2' HG22 ' A' ' 62' ' ' THR . 94.5 m95 -93.52 131.14 39.04 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.849 0.86 . . . . 0.0 110.898 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 18.4 pt20 -61.72 -27.21 68.55 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 124.114 0.883 . . . . 0.0 110.977 169.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.3 t -60.46 -45.16 94.71 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.609 1.164 . . . . 0.0 112.307 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.514 HG22 ' HB2' ' A' ' 59' ' ' TRP . 8.6 t -113.09 -10.74 13.41 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.685 0.794 . . . . 0.0 111.265 -174.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.45 13.89 82.74 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 116.359 -0.382 . . . . 0.0 113.91 178.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -152.47 173.65 14.86 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.274 0.559 . . . . 0.0 111.387 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.05 126.78 34.98 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.557 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -128.67 155.35 45.17 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 120.984 0.421 . . . . 0.0 111.059 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.523 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 10.1 m-90 -82.09 108.66 15.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.991 1.316 . . . . 0.0 109.732 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 m -125.97 151.54 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.128 0.571 . . . . 0.0 109.73 177.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -80.32 146.42 31.59 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -54.89 -45.37 74.65 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.833 1.253 . . . . 0.0 113.293 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -72.54 -22.39 61.02 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -173.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 70.7 mtm -93.39 -6.28 47.53 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.205 0.602 . . . . 0.0 111.424 174.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 tt -90.93 123.56 34.53 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 171.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 29' ' ' ARG . 40.4 tt0 -104.04 143.58 32.7 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.512 HG22 HD13 ' A' ' 22' ' ' LEU . 37.5 pt . . . . . 0 CA--C 1.546 0.789 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.4 t80 . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.08 -30.18 75.49 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.802 -0.635 . . . . 0.0 113.028 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 8.3 tp10 -72.28 -47.47 49.81 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 171.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.422 ' O ' HG22 ' A' ' 21' ' ' THR . 38.5 t80 -57.45 -48.78 78.26 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.294 1.038 . . . . 0.0 111.256 -172.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 m -58.29 -43.31 85.82 Favored 'Isoleucine or valine' 0 C--N 1.35 0.612 0 O-C-N 123.729 0.643 . . . . 0.0 110.259 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -62.12 -31.51 71.98 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.458 0.703 . . . . 0.0 111.189 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 79.5 mm-40 -82.22 -32.32 29.84 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.188 0.595 . . . . 0.0 111.519 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 17' ' ' TYR . 14.2 t -107.79 8.35 28.73 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.944 0.498 . . . . 0.0 111.966 -175.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.608 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.1 OUTLIER -67.66 117.83 10.12 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.062 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.723 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 9.8 mm100 -86.23 133.4 40.77 Favored Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.14 87.4 0.73 Allowed 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.875 2.383 . . . . 0.0 112.261 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.24 23.99 2.8 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.723 ' HB3' ' HB2' ' A' ' 23' ' ' GLN . 16.8 ptm -91.69 168.48 11.45 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.194 0.597 . . . . 0.0 110.118 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 ppp_? -90.3 147.14 23.69 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.797 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.4 t -129.28 164.88 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 124.937 1.295 . . . . 0.0 107.648 -169.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -149.53 133.13 16.76 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.0 tpt -82.81 112.59 19.78 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.782 0.833 . . . . 0.0 109.869 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.652 HD23 ' HB2' ' A' ' 74' ' ' GLU . 4.0 pp -85.9 -2.88 58.7 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 122.862 0.465 . . . . 0.0 111.19 176.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -124.79 162.87 23.37 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.198 0.999 . . . . 0.0 109.427 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -98.76 117.3 32.92 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -106.17 173.26 6.39 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.527 1.131 . . . . 0.0 112.175 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -51.71 -44.95 63.37 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.818 1.647 . . . . 0.0 112.455 -175.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.63 3.95 3.59 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.969 0.908 . . . . 0.0 111.396 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 mp -118.41 137.39 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 175.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.3 m -99.32 155.07 17.71 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.24 0.473 . . . . 0.0 109.919 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.17 114.15 5.68 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.31 -26.54 3.91 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 123.572 0.545 . . . . 0.0 112.402 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -69.94 158.22 36.0 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.234 0.613 . . . . 0.0 112.494 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -116.94 157.31 25.94 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 123.832 0.853 . . . . 0.0 111.552 -177.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.15 -173.75 14.97 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.731 -176.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -136.04 142.52 44.41 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 171.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 48' ' ' SER . 91.4 t80 -87.28 118.29 26.6 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.004 0.922 . . . . 0.0 110.059 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.32 -47.57 3.09 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 120.803 0.335 . . . . 0.0 110.653 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -145.77 161.93 38.81 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.61 0.764 . . . . 0.0 109.375 -175.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.426 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 53.4 p -158.64 169.28 24.76 Favored 'General case' 0 C--O 1.239 0.53 0 O-C-N 123.777 0.673 . . . . 0.0 111.988 -171.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 . . . . . 0 CA--C 1.541 0.6 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 171.888 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo . . . . . 0 CA--C 1.573 2.429 0 N-CA-C 117.767 2.18 . . . . 0.0 117.767 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.605 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 49.2 Cg_endo -70.37 107.82 2.06 Favored 'Trans proline' 0 C--N 1.383 2.393 0 CA-C-N 123.145 2.159 . . . . 0.0 111.702 168.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.3 p -85.68 141.43 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.326 1.05 . . . . 0.0 110.311 171.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -87.99 122.67 31.86 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.39 136.15 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.43 1.092 . . . . 0.0 108.544 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -81.53 108.03 14.78 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -176.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -92.87 131.05 38.24 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.699 0.799 . . . . 0.0 111.115 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -62.69 -31.3 72.17 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.928 0.891 . . . . 0.0 111.427 172.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.5 t -60.07 -43.74 95.26 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.82 1.248 . . . . 0.0 111.808 -172.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.1 t -113.07 -8.93 13.6 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.163 -174.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.02 15.39 81.19 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 116.351 -0.386 . . . . 0.0 114.028 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -151.65 169.6 21.75 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.528 0.68 . . . . 0.0 111.598 -172.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.21 123.42 32.2 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.267 -176.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -126.74 155.67 42.38 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.523 0.678 . . . . 0.0 110.809 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.605 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 9.3 m-90 -89.37 111.97 22.96 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.465 1.506 . . . . 0.0 109.288 -172.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.4 m -129.51 153.17 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.279 0.632 . . . . 0.0 110.51 -176.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -80.56 147.09 30.94 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.811 0.444 . . . . 0.0 110.734 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -59.42 -49.35 78.13 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.268 1.027 . . . . 0.0 112.929 -176.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -67.81 -23.18 65.16 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.164 0.585 . . . . 0.0 111.625 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.509 ' HA ' HD11 ' A' ' 31' ' ' LEU . 40.2 mtp -95.82 -4.13 44.36 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.573 1.149 . . . . 0.0 111.095 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.4 tt -93.95 141.07 28.94 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 172.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.652 ' HB2' HD23 ' A' ' 31' ' ' LEU . 39.4 tt0 -125.82 135.35 51.89 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.819 0.848 . . . . 0.0 108.902 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.1 pt . . . . . 0 N--CA 1.479 1.025 0 CA-C-O 121.235 0.54 . . . . 0.0 110.512 177.455 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.1 t80 . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.22 -34.65 86.47 Favored Glycine 0 C--N 1.344 1.007 0 O-C-N 123.279 0.362 . . . . 0.0 113.244 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 7.2 tp10 -73.74 -38.93 64.59 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.637 0.375 . . . . 0.0 110.411 174.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -57.99 -50.29 73.92 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.975 0.91 . . . . 0.0 111.417 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.533 ' HB ' HD23 ' A' ' 22' ' ' LEU . 28.1 m -62.52 -37.81 79.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 O-C-N 124.345 1.028 . . . . 0.0 110.657 -177.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -42.11 70.6 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.136 0.574 . . . . 0.0 109.678 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 50.2 mm-40 -82.95 -29.52 29.04 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.461 -170.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 t -102.33 -2.43 28.98 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.533 HD23 ' HB ' ' A' ' 18' ' ' VAL . 0.9 OUTLIER -81.04 117.13 21.37 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 118.33 0.514 . . . . 0.0 110.946 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -102.43 140.21 20.92 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 124.041 0.936 . . . . 0.0 109.508 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.48 87.85 0.34 Allowed 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.48 2.12 . . . . 0.0 111.232 174.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 148.2 2.19 0.44 Allowed Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.153 176.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.437 ' SD ' HD13 ' A' ' 22' ' ' LEU . 12.3 ptp -96.63 165.45 12.14 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.706 0.753 . . . . 0.0 111.296 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.495 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 20.6 tpt180 -91.51 128.46 37.34 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.828 1.251 . . . . 0.0 109.316 -171.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 m -116.28 170.96 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.631 0.773 . . . . 0.0 109.546 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.57 HH11 ' HA2' ' A' ' 40' ' ' GLY . 2.2 tmm_? -152.31 131.17 12.48 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.459 1.104 . . . . 0.0 108.083 -178.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.46 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 31.6 tpp -88.64 127.29 35.56 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.805 0.842 . . . . 0.0 111.195 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.495 HD23 ' HB2' ' A' ' 74' ' ' GLU . 3.3 pp -102.34 3.75 38.3 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.569 0.748 . . . . 0.0 112.153 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 30' ' ' MET . 29.6 t70 -126.76 164.13 22.01 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.779 0.832 . . . . 0.0 109.764 -178.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -95.96 117.09 29.96 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.886 -0.509 . . . . 0.0 110.015 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -111.16 170.52 8.05 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.0 1.32 . . . . 0.0 109.442 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -40.91 -55.33 2.52 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 125.919 1.688 . . . . 0.0 112.996 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -126.19 3.1 7.13 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.743 0.817 . . . . 0.0 111.47 -175.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -119.64 101.61 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.409 0.684 . . . . 0.0 109.167 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -78.82 150.58 32.28 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.89 115.55 3.78 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.347 0.659 . . . . 0.0 110.757 -175.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.57 ' HA2' HH11 ' A' ' 29' ' ' ARG . . . 127.78 -14.45 6.36 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.86 -176.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -73.42 154.24 40.08 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.645 0.378 . . . . 0.0 111.58 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -114.88 159.26 20.89 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.726 0.811 . . . . 0.0 110.702 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.495 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . -151.94 -171.65 19.89 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.391 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -134.98 142.67 46.51 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.477 ' CG ' HD12 ' A' ' 22' ' ' LEU . 20.9 t80 -80.01 122.58 26.92 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.499 0.719 . . . . 0.0 109.326 -176.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.416 ' HB2' ' OE1' ' A' ' 47' ' ' GLN . 12.2 mmm180 -108.4 -45.76 3.83 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.315 0.578 . . . . 0.0 109.726 -171.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.416 ' OE1' ' HB2' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -151.71 157.22 41.75 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.85 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.2 p -118.37 157.75 26.54 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 123.873 0.733 . . . . 0.0 110.642 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.529 0.138 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 175.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo . . . . . 0 CA--C 1.576 2.619 0 N-CA-C 116.195 1.575 . . . . 0.0 116.195 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.734 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 92.3 Cg_endo -79.53 98.25 1.14 Allowed 'Trans proline' 0 C--N 1.382 2.296 0 CA-C-N 122.371 1.883 . . . . 0.0 111.861 166.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 p -82.55 154.51 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.333 1.053 . . . . 0.0 111.829 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -94.86 128.81 41.89 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.151 0.58 . . . . 0.0 110.585 -172.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -140.66 140.45 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 125.298 1.439 . . . . 0.0 108.627 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -81.8 106.84 14.05 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.46 ' CH2' ' HB2' ' A' ' 30' ' ' MET . 96.2 m95 -88.77 130.97 35.25 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.314 1.046 . . . . 0.0 110.374 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -69.52 -26.66 64.63 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.705 0.802 . . . . 0.0 112.171 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.6 t -68.89 -44.22 73.67 Favored 'General case' 0 C--N 1.357 0.929 0 CA-C-O 120.69 0.281 . . . . 0.0 111.178 -177.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.2 t -94.88 -30.32 14.24 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.397 0.679 . . . . 0.0 111.681 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.68 23.54 30.52 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-O 119.733 -0.482 . . . . 0.0 114.271 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -154.19 176.87 11.75 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 117.439 0.62 . . . . 0.0 111.754 -175.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 2.0 p -83.59 142.35 30.9 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 172.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -144.98 154.76 42.89 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.35 0.595 . . . . 0.0 110.096 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.734 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 16.3 m-90 -81.98 115.68 21.25 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.01 -176.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.438 HG21 ' HZ2' ' A' ' 59' ' ' TRP . 19.9 m -137.68 145.11 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.365 0.666 . . . . 0.0 109.687 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.519 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 9.5 t-80 -69.44 147.06 51.46 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.607 0.363 . . . . 0.0 110.841 -177.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.452 ' O ' HG21 ' A' ' 18' ' ' VAL . 90.4 m95 -59.45 -45.78 90.62 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.546 0.738 . . . . 0.0 111.634 -176.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -65.18 -23.26 67.05 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.502 0.721 . . . . 0.0 111.918 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.519 ' SD ' ' HB3' ' A' ' 69' ' ' HIS . 33.8 mtp -90.04 -14.2 34.36 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.223 1.009 . . . . 0.0 111.077 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.4 tt -90.78 122.01 33.15 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.495 ' HB2' HD23 ' A' ' 31' ' ' LEU . 35.3 tt0 -123.12 125.23 44.78 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.296 1.039 . . . . 0.0 109.212 -176.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.463 HD13 HD22 ' A' ' 22' ' ' LEU . 12.2 pt . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 121.314 0.578 . . . . 0.0 111.609 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 55.3 t80 . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.59 -36.91 88.92 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-O 122.029 0.794 . . . . 0.0 112.717 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 2.5 mp0 -73.78 -33.08 64.09 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.027 -1.086 . . . . 0.0 110.246 177.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -68.63 -49.41 59.39 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.825 0.85 . . . . 0.0 110.837 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.573 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 20.9 m -59.11 -39.14 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 O-C-N 123.779 0.675 . . . . 0.0 110.135 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -57.57 -38.7 75.28 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.141 0.976 . . . . 0.0 111.55 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 52.9 mm-40 -78.2 -43.03 29.64 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.412 0.285 . . . . 0.0 111.282 -176.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.1 t -88.66 2.0 54.03 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.109 0.563 . . . . 0.0 112.384 -174.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.573 ' HB2' ' O ' ' A' ' 18' ' ' VAL . 12.7 tp -76.72 124.99 28.49 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.455 0.702 . . . . 0.0 111.176 -173.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -113.6 124.89 30.38 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 123.736 0.815 . . . . 0.0 109.617 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.47 85.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 124.24 3.293 . . . . 0.0 114.547 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.61 26.8 1.54 Allowed Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.837 174.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.508 ' SD ' HD12 ' A' ' 22' ' ' LEU . 4.5 ptp -91.73 175.63 6.83 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.436 0.636 . . . . 0.0 110.844 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.0 tpt85 -94.61 126.55 39.98 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.931 -170.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.465 HG22 HG22 ' A' ' 75' ' ' ILE . 41.6 t -119.01 160.07 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 C-N-CA 124.572 1.149 . . . . 0.0 111.26 -167.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.5 tpp85 -140.71 151.87 44.85 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 126.673 1.989 . . . . 0.0 108.567 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.9 tpt -94.89 115.5 27.54 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.481 0.712 . . . . 0.0 109.524 177.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 74' ' ' GLU . 38.8 tp -83.68 -29.03 27.93 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.192 0.597 . . . . 0.0 111.149 -177.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -137.19 154.6 50.17 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.754 0.422 . . . . 0.0 110.777 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -65.29 144.44 57.14 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.677 0.791 . . . . 0.0 111.588 -176.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -133.12 175.34 9.47 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.964 1.306 . . . . 0.0 110.275 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.57 -51.85 67.82 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.01 1.324 . . . . 0.0 111.706 -173.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -119.23 0.1 11.12 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.836 0.855 . . . . 0.0 111.741 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mp -119.89 146.03 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.248 1.019 . . . . 0.0 108.487 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.7 m -112.01 160.2 17.71 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 119.242 0.928 . . . . 0.0 110.025 173.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.24 117.67 8.16 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.38 -30.67 4.89 Favored Glycine 0 C--N 1.343 0.926 0 O-C-N 123.551 0.532 . . . . 0.0 111.993 -174.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -67.73 153.4 43.79 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.482 0.713 . . . . 0.0 111.012 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -127.19 154.83 44.31 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.536 0.684 . . . . 0.0 112.178 -166.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.66 -169.77 12.92 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.458 -171.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -136.58 140.5 42.93 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 172.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.535 ' HA ' HG12 ' A' ' 57' ' ' VAL . 30.8 t80 -72.64 124.21 24.81 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 123.63 0.581 . . . . 0.0 110.579 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -109.14 -47.99 3.34 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.678 0.391 . . . . 0.0 111.216 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.403 ' OE1' ' HB2' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -167.43 147.67 5.32 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.725 0.81 . . . . 0.0 110.03 -179.318 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.449 ' HA ' HG23 ' A' ' 55' ' ' VAL . 38.9 p -117.76 173.22 6.87 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.665 0.786 . . . . 0.0 111.429 -175.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 . . . . . 0 CA--C 1.537 0.447 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.768 175.157 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo . . . . . 0 CA--C 1.575 2.564 0 N-CA-C 117.648 2.134 . . . . 0.0 117.648 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.512 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 59.0 Cg_endo -70.79 111.04 2.92 Favored 'Trans proline' 0 C--N 1.386 2.501 0 CA-C-N 122.744 2.016 . . . . 0.0 112.351 171.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.53 HG11 HD22 ' A' ' 73' ' ' LEU . 3.0 p -91.33 137.22 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.281 1.032 . . . . 0.0 109.656 166.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.403 ' HB2' ' OE1' ' A' ' 47' ' ' GLN . 1.9 mp0 -90.14 126.79 35.92 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 122.983 0.513 . . . . 0.0 109.888 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.535 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -135.52 137.22 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 124.923 1.289 . . . . 0.0 108.773 -177.933 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -81.47 108.45 15.07 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.503 ' HB2' HG22 ' A' ' 62' ' ' THR . 85.4 m95 -93.08 128.06 38.85 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.87 0.868 . . . . 0.0 110.049 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -67.49 -23.47 65.49 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 123.671 0.607 . . . . 0.0 110.887 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.7 t -60.63 -44.98 95.72 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 124.659 1.184 . . . . 0.0 111.764 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 59' ' ' TRP . 8.7 t -108.02 -6.36 16.6 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.975 0.91 . . . . 0.0 110.777 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.25 13.67 76.74 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 116.134 -0.485 . . . . 0.0 113.869 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -151.4 173.97 13.9 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.321 0.56 . . . . 0.0 111.032 -175.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.11 136.3 33.27 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.132 -175.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -137.76 157.41 46.5 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.657 0.741 . . . . 0.0 111.036 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 15.8 m-90 -83.73 108.75 16.99 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.816 1.646 . . . . 0.0 110.089 -176.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 m -123.82 157.75 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 122.796 0.438 . . . . 0.0 110.93 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -87.43 148.94 24.76 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.576 0.75 . . . . 0.0 110.495 -175.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.411 ' HH2' ' HB2' ' A' ' 48' ' ' SER . 75.3 m95 -61.85 -43.8 98.11 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.671 0.788 . . . . 0.0 111.939 -176.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -73.1 -11.66 60.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.689 0.396 . . . . 0.0 111.408 -176.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 70.5 mtm -114.33 6.35 16.05 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.058 0.943 . . . . 0.0 110.622 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.53 HD22 HG11 ' A' ' 55' ' ' VAL . 35.9 tp -92.01 119.49 31.77 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 170.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . 41.8 tt0 -121.48 128.02 51.66 Favored 'General case' 0 C--O 1.212 -0.92 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.465 HG22 HG22 ' A' ' 28' ' ' VAL . 15.3 pt . . . . . 0 N--CA 1.478 0.964 0 CA-C-O 121.417 0.627 . . . . 0.0 111.461 -176.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.3 t80 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.61 0.243 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.79 -40.26 58.43 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.523 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 2.2 mp0 -69.97 -26.09 63.93 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.647 0.779 . . . . 0.0 110.788 177.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -75.11 -50.11 17.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.736 0.814 . . . . 0.0 110.671 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.2 m -63.97 -34.61 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 123.516 0.51 . . . . 0.0 110.265 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.5 tm0? -54.59 -31.28 56.63 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.442 1.097 . . . . 0.0 111.03 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 49.4 mm-40 -88.97 -44.67 10.25 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.982 0.513 . . . . 0.0 111.015 -176.23 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.8 t -83.8 -17.91 39.45 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -171.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.539 HD23 ' SD ' ' A' ' 26' ' ' MET . 10.9 mt -66.2 118.64 10.2 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.163 0.585 . . . . 0.0 111.341 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -110.99 140.84 23.14 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.726 1.21 . . . . 0.0 110.157 -176.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.22 85.01 0.34 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.32 2.68 . . . . 0.0 112.41 -177.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.8 2.6 1.41 Allowed Glycine 0 C--N 1.342 0.907 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.696 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.539 ' SD ' HD23 ' A' ' 22' ' ' LEU . 6.0 ptp -85.96 168.91 13.73 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 121.455 0.645 . . . . 0.0 111.224 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.413 ' NH1' ' HB3' ' A' ' 42' ' ' GLU . 15.7 tpt85 -99.84 123.21 43.85 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.772 1.229 . . . . 0.0 110.066 -168.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.412 HG21 HG11 ' A' ' 57' ' ' VAL . 3.7 m -118.77 174.21 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.696 0.798 . . . . 0.0 110.832 -174.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.531 ' HG2' ' HG2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -149.11 140.4 23.18 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.165 1.386 . . . . 0.0 107.836 -172.726 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.4 tpt -94.81 113.69 25.47 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.931 0.892 . . . . 0.0 109.671 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.625 HD11 ' HA ' ' A' ' 72' ' ' MET . 3.6 pp -97.73 4.24 49.97 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.721 0.409 . . . . 0.0 111.678 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -133.07 162.43 31.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.156 0.583 . . . . 0.0 109.965 -170.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -89.04 122.6 32.54 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.259 0.624 . . . . 0.0 109.694 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -121.25 170.56 9.47 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.565 0.698 . . . . 0.0 112.292 -176.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -53.54 -49.03 68.51 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 113.781 -1.554 . . . . 0.0 112.178 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -128.67 1.45 5.5 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.404 0.682 . . . . 0.0 111.412 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.2 mp -118.92 144.85 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.5 m -112.0 156.59 21.9 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 122.871 0.468 . . . . 0.0 109.758 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.3 116.7 6.91 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.06 -25.37 5.52 Favored Glycine 0 N--CA 1.469 0.883 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -173.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -76.85 155.21 33.14 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.144 0.578 . . . . 0.0 110.693 175.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.531 ' HG2' ' HG2' ' A' ' 29' ' ' ARG . 51.3 mt-10 -135.13 155.26 51.02 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.848 0.859 . . . . 0.0 110.225 -169.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -147.58 -166.0 12.27 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.049 -170.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -136.52 137.4 40.26 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.584 0.754 . . . . 0.0 109.374 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.498 ' HE1' HG21 ' A' ' 55' ' ' VAL . 71.5 t80 -71.38 124.99 25.81 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.265 0.626 . . . . 0.0 109.799 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -109.3 -49.65 3.09 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.804 0.441 . . . . 0.0 110.499 -173.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.469 ' OE1' ' HB2' ' A' ' 56' ' ' GLN . 0.4 OUTLIER -164.72 169.14 17.19 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.225 1.01 . . . . 0.0 109.237 -177.766 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.491 ' HA ' HG23 ' A' ' 55' ' ' VAL . 13.8 p -138.19 166.16 24.85 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.669 0.788 . . . . 0.0 112.04 -171.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.1 m120 . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 171.018 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HA ' ' HE1' ' A' ' 70' ' ' TRP . 21.1 Cg_endo . . . . . 0 CA--C 1.583 2.972 0 N-CA-C 117.884 2.225 . . . . 0.0 117.884 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.633 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 60.9 Cg_endo -71.06 107.76 2.17 Favored 'Trans proline' 0 C--N 1.387 2.567 0 CA-C-N 122.94 2.086 . . . . 0.0 112.297 171.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.498 HG21 ' HE1' ' A' ' 45' ' ' PHE . 5.5 p -90.9 143.33 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 124.841 1.256 . . . . 0.0 111.0 171.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.616 ' HB3' HG22 ' A' ' 65' ' ' THR . 1.7 mp0 -93.79 131.83 38.77 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-O 121.29 0.567 . . . . 0.0 110.225 -176.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.482 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -139.39 137.54 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 125.639 1.576 . . . . 0.0 108.106 -178.422 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -81.36 109.06 15.5 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -177.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.448 ' HB2' HG22 ' A' ' 62' ' ' THR . 85.8 m95 -93.51 117.81 30.56 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.72 0.808 . . . . 0.0 109.299 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -61.38 -25.88 67.47 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.05 0.94 . . . . 0.0 111.462 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.6 t -60.46 -45.13 94.82 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.436 1.094 . . . . 0.0 111.75 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 59' ' ' TRP . 7.1 t -105.88 -9.81 16.97 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.912 0.885 . . . . 0.0 110.711 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.79 16.5 79.96 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 114.24 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -152.77 165.12 36.33 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.412 0.625 . . . . 0.0 111.844 -173.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.616 HG22 ' HB3' ' A' ' 56' ' ' GLN . 2.7 m -88.45 120.37 29.77 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.309 -177.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -127.1 157.68 39.04 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.455 0.645 . . . . 0.0 110.661 -173.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.633 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 12.1 m-90 -83.94 116.61 22.88 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.505 1.522 . . . . 0.0 109.816 -173.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.462 HG21 HD13 ' A' ' 73' ' ' LEU . 7.1 m -130.12 158.36 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.897 0.879 . . . . 0.0 109.738 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.457 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 11.4 t-80 -86.79 147.87 25.65 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.953 0.501 . . . . 0.0 110.287 -177.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.427 ' HE1' ' HA ' ' A' ' 53' ' ' PRO . 81.3 m95 -57.2 -50.41 72.96 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.002 0.921 . . . . 0.0 111.571 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -72.78 -1.45 16.6 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.607 0.763 . . . . 0.0 112.005 -176.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.625 ' HA ' HD11 ' A' ' 31' ' ' LEU . 43.0 mtp -120.58 14.39 11.84 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.173 0.989 . . . . 0.0 110.756 -178.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.462 HD13 HG21 ' A' ' 68' ' ' VAL . 33.8 tp -123.37 124.37 42.78 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.91 0.884 . . . . 0.0 109.415 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.557 ' HB2' HD23 ' A' ' 31' ' ' LEU . 10.8 tp10 -106.52 142.97 35.3 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.387 1.075 . . . . 0.0 109.56 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 26.8 pt . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 121.085 0.469 . . . . 0.0 112.009 178.653 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.0 t80 . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 120.652 0.263 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.44 -38.25 90.81 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.625 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 4.5 mp0 -72.32 -31.59 65.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.617 -0.791 . . . . 0.0 109.757 178.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.408 ' O ' HG22 ' A' ' 21' ' ' THR . 11.4 t80 -67.37 -50.43 59.79 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 123.542 0.737 . . . . 0.0 110.533 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 m -63.65 -36.83 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 123.555 0.535 . . . . 0.0 109.964 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.46 -34.41 61.44 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.12 0.968 . . . . 0.0 110.742 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.535 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 58.0 mm-40 -84.11 -37.41 22.05 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.042 0.537 . . . . 0.0 111.112 -175.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.459 HG23 HD13 ' A' ' 75' ' ' ILE . 11.7 t -102.48 3.74 37.93 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.539 0.736 . . . . 0.0 112.414 -172.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.429 ' HA ' ' SD ' ' A' ' 26' ' ' MET . 8.8 mt -75.15 108.16 7.72 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.948 0.499 . . . . 0.0 109.672 174.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.586 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 39.7 mt-30 -85.8 130.72 49.62 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 123.657 0.783 . . . . 0.0 108.914 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.83 82.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 123.333 2.689 . . . . 0.0 113.52 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.36 17.73 1.55 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.721 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.586 ' HB3' ' HB2' ' A' ' 23' ' ' GLN . 14.2 ptm -91.35 173.78 7.73 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.677 0.751 . . . . 0.0 111.267 -175.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.8 tpt85 -96.25 131.42 42.75 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.109 -169.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.54 154.36 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 124.375 1.07 . . . . 0.0 111.396 -167.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -129.7 147.05 51.45 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.71 1.604 . . . . 0.0 108.092 169.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.426 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 32.9 tpp -98.41 129.45 45.05 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.011 0.924 . . . . 0.0 108.724 170.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.636 HD23 ' HB2' ' A' ' 74' ' ' GLU . 3.8 pp -106.88 2.38 25.34 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -176.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -140.6 172.37 12.81 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.543 0.337 . . . . 0.0 110.152 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -83.46 140.74 32.16 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 122.001 -0.437 . . . . 0.0 110.798 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.41 173.2 11.54 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.377 1.071 . . . . 0.0 110.427 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -50.57 -44.5 56.76 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.392 1.477 . . . . 0.0 112.674 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -138.23 4.19 2.44 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.455 0.702 . . . . 0.0 111.776 -175.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.2 mp -119.57 145.12 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.5 m -112.33 162.95 14.97 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 123.312 0.645 . . . . 0.0 109.887 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.3 118.69 9.03 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.193 0.597 . . . . 0.0 109.815 173.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.87 0.74 28.77 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 116.435 -0.348 . . . . 0.0 113.221 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -88.95 156.4 18.91 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.043 0.449 . . . . 0.0 110.647 173.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -123.97 148.56 46.84 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.392 -169.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -145.42 -170.06 14.08 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.091 -175.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -135.57 137.0 41.56 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.606 ' HZ ' ' HB3' ' A' ' 48' ' ' SER . 87.6 t80 -76.55 118.85 19.63 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.4 mmm-85 -105.3 -47.08 4.05 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -175.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -152.86 158.66 42.5 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.959 -176.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.606 ' HB3' ' HZ ' ' A' ' 45' ' ' PHE . 77.4 p -116.46 175.69 5.45 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.846 0.858 . . . . 0.0 110.699 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.9 m120 . . . . . 0 C--O 1.237 0.42 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.859 179.133 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.403 ' HA ' ' HE1' ' A' ' 70' ' ' TRP . 12.7 Cg_endo . . . . . 0 CA--C 1.577 2.67 0 N-CA-C 116.565 1.717 . . . . 0.0 116.565 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.736 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 71.8 Cg_endo -73.84 98.68 1.09 Allowed 'Trans proline' 0 C--N 1.384 2.399 0 CA-C-N 122.598 1.963 . . . . 0.0 112.097 169.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.546 HG23 ' HA ' ' A' ' 48' ' ' SER . 7.6 p -83.37 150.46 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 125.126 1.37 . . . . 0.0 111.588 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -90.86 127.79 36.5 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.197 0.599 . . . . 0.0 110.362 -175.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.19 134.2 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.315 1.446 . . . . 0.0 107.722 178.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 69.3 t80 -81.28 107.81 14.37 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.531 ' HB2' HG22 ' A' ' 62' ' ' THR . 83.5 m95 -92.76 123.4 36.01 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.888 0.875 . . . . 0.0 109.408 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -63.85 -29.04 70.27 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.777 0.673 . . . . 0.0 111.128 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.8 t -61.93 -46.71 88.12 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.166 0.986 . . . . 0.0 112.018 -175.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.531 HG22 ' HB2' ' A' ' 59' ' ' TRP . 9.8 t -98.6 -14.06 20.09 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.658 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.78 16.61 74.82 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 116.126 -0.488 . . . . 0.0 114.165 176.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -152.14 165.85 33.5 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.409 0.623 . . . . 0.0 111.547 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -87.01 114.44 23.63 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.368 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -124.83 153.82 41.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.671 0.748 . . . . 0.0 110.391 -173.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.736 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 7.8 m0 -83.87 116.82 22.94 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.102 -172.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.9 m -131.21 149.35 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -76.22 147.64 38.23 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.403 ' HE1' ' HA ' ' A' ' 53' ' ' PRO . 59.1 m95 -53.11 -38.93 63.04 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 124.118 0.967 . . . . 0.0 111.453 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -67.59 -28.41 67.74 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -175.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.411 ' HA ' HD11 ' A' ' 31' ' ' LEU . 4.9 mpp? -96.15 -5.56 40.37 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.497 0.319 . . . . 0.0 111.494 176.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.3 tt -90.1 122.23 32.88 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 174.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.636 ' HB2' HD23 ' A' ' 31' ' ' LEU . 35.1 tt0 -110.73 149.14 30.93 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.507 1.123 . . . . 0.0 108.698 174.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.459 HD13 HG23 ' A' ' 21' ' ' THR . 34.7 pt . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.7 t80 . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.3 -37.86 80.84 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.059 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -70.38 -34.21 72.32 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.438 0.695 . . . . 0.0 110.068 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -69.92 -49.68 49.56 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.201 0.6 . . . . 0.0 111.511 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.0 m -59.11 -37.91 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 123.515 0.51 . . . . 0.0 110.772 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -54.48 -34.97 62.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.065 0.946 . . . . 0.0 111.835 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 42.1 mm-40 -81.63 -42.36 20.13 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.907 -175.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.6 t -92.14 3.34 55.51 Favored 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 123.416 0.687 . . . . 0.0 112.175 -174.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -74.67 122.18 22.81 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 122.99 0.516 . . . . 0.0 110.2 177.522 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -104.2 132.43 20.99 Favored Pre-proline 0 N--CA 1.488 1.456 0 C-N-CA 123.832 0.853 . . . . 0.0 110.573 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.78 89.97 0.29 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.98 2.453 . . . . 0.0 111.245 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.8 -6.03 4.8 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.939 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 6.8 ptp -80.67 153.04 28.14 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 173.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -85.66 163.1 18.49 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.1 m -133.99 171.14 18.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -136.58 138.35 41.15 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.445 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 3.0 tpt -85.65 111.15 19.82 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.239 1.016 . . . . 0.0 108.974 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.485 HD11 ' HA ' ' A' ' 72' ' ' MET . 4.5 pp -91.04 -15.67 29.18 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 117.778 0.263 . . . . 0.0 111.248 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 30' ' ' MET . 21.3 t70 -125.75 151.91 46.05 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.753 0.821 . . . . 0.0 109.363 -176.171 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -80.45 119.34 23.01 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.663 0.385 . . . . 0.0 110.048 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -106.66 173.28 6.39 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.725 1.21 . . . . 0.0 111.645 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -48.09 -58.79 4.0 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.364 1.466 . . . . 0.0 112.484 -175.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -121.67 5.54 10.03 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.077 0.951 . . . . 0.0 111.39 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mp -120.0 133.29 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 173.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.6 m -99.92 155.44 17.68 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.992 0.517 . . . . 0.0 109.854 177.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.89 115.86 6.44 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.55 -29.23 3.31 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -172.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -74.51 157.36 35.65 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.51 0.724 . . . . 0.0 111.756 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 41.5 mt-10 -115.73 153.68 30.94 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.782 0.833 . . . . 0.0 111.057 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.83 -170.26 11.88 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.866 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -139.0 140.93 38.32 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 170.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.464 ' HA ' HG12 ' A' ' 57' ' ' VAL . 84.5 t80 -76.71 121.78 23.78 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.037 0.535 . . . . 0.0 110.645 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -108.51 -48.39 3.34 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.324 0.65 . . . . 0.0 110.141 -174.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -158.91 161.13 36.74 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.154 0.982 . . . . 0.0 109.636 -177.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.498 ' HA ' HG23 ' A' ' 55' ' ' VAL . 14.5 p -130.96 171.63 12.99 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.877 0.846 . . . . 0.0 111.896 -176.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.543 0.688 0 CA-C-N 113.576 -1.647 . . . . 0.0 108.198 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo . . . . . 0 CA--C 1.581 2.859 0 N-CA-C 118.088 2.303 . . . . 0.0 118.088 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.593 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 93.3 Cg_endo -80.36 108.61 2.19 Favored 'Trans proline' 0 C--N 1.379 2.15 0 CA-C-N 123.376 2.242 . . . . 0.0 112.084 168.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.498 HG23 ' HA ' ' A' ' 48' ' ' SER . 7.7 p -81.08 146.69 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.031 0.933 . . . . 0.0 110.71 172.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.559 ' HB3' HG22 ' A' ' 65' ' ' THR . 1.7 mp0 -93.74 127.91 39.69 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-O 121.191 0.519 . . . . 0.0 109.604 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.464 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -138.26 135.19 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 125.448 1.499 . . . . 0.0 108.052 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 47.6 t80 -80.92 106.76 13.18 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -177.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.489 ' HB2' HG22 ' A' ' 62' ' ' THR . 86.5 m95 -89.9 123.06 33.51 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.796 0.838 . . . . 0.0 109.811 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 16.9 pt20 -62.17 -28.11 69.43 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.19 0.996 . . . . 0.0 111.663 175.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.9 t -63.86 -44.49 92.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.853 0.861 . . . . 0.0 111.766 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.489 HG22 ' HB2' ' A' ' 59' ' ' TRP . 8.9 t -105.24 -6.01 20.12 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.494 0.718 . . . . 0.0 111.246 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.32 15.93 80.03 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 114.438 0.535 . . . . 0.0 114.438 175.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -152.83 165.94 33.81 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.323 0.582 . . . . 0.0 112.053 -172.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.559 HG22 ' HB3' ' A' ' 56' ' ' GLN . 2.0 m -87.26 117.99 26.39 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.141 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -125.86 156.82 39.01 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.461 0.648 . . . . 0.0 110.651 -171.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.593 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 11.9 m-90 -84.37 111.53 19.52 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.62 1.568 . . . . 0.0 109.488 -173.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.25 149.65 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.492 0.717 . . . . 0.0 110.092 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -78.5 146.61 34.28 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.766 0.426 . . . . 0.0 110.491 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -61.07 -46.17 91.73 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.57 0.748 . . . . 0.0 112.071 -176.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 58.4 t60 -67.95 -22.22 65.05 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.17 0.588 . . . . 0.0 111.266 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.485 ' HA ' HD11 ' A' ' 31' ' ' LEU . 38.5 mtp -101.85 13.28 35.27 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.764 1.226 . . . . 0.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -117.84 125.71 51.05 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -105.44 150.99 24.8 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 173.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.4 pt . . . . . 0 CA--C 1.54 0.574 0 C-N-CA 123.717 0.807 . . . . 0.0 110.11 176.212 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 62.4 t80 . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.82 -34.89 83.95 Favored Glycine 0 C--N 1.341 0.812 0 O-C-N 123.623 0.577 . . . . 0.0 112.797 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 44.6 mp0 -71.3 -41.4 69.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 123.945 0.898 . . . . 0.0 109.445 177.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.44 ' O ' HG22 ' A' ' 21' ' ' THR . 18.8 t80 -59.36 -51.17 71.07 Favored 'General case' 0 C--N 1.358 0.958 0 O-C-N 123.85 0.719 . . . . 0.0 110.964 178.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.7 m -63.17 -40.1 87.77 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -58.49 -47.48 83.96 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 124.003 0.815 . . . . 0.0 110.873 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 22.6 mm-40 -64.52 -46.37 83.2 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.714 0.293 . . . . 0.0 110.868 -175.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 17' ' ' TYR . 14.7 t -93.15 13.07 22.15 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.457 0.703 . . . . 0.0 111.93 -175.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.729 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.1 OUTLIER -70.94 114.96 9.53 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.91 0.484 . . . . 0.0 109.723 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.654 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 50.0 mt-30 -87.98 137.94 31.24 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.696 0.798 . . . . 0.0 110.777 -177.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.476 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 29.8 Cg_exo -62.74 88.16 0.12 Allowed 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.39 2.727 . . . . 0.0 113.118 177.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.72 40.96 1.79 Allowed Glycine 0 C--N 1.35 1.309 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.729 ' SD ' HD13 ' A' ' 22' ' ' LEU . 20.3 ptm -98.82 177.66 5.21 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.719 0.771 . . . . 0.0 110.814 -177.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -96.56 122.03 39.04 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.19 1.396 . . . . 0.0 108.942 -177.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.0 m -117.0 171.74 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.146 0.578 . . . . 0.0 109.607 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -143.01 143.26 31.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.103 1.361 . . . . 0.0 107.705 -176.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.7 tpt -88.3 125.53 34.72 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.465 HD11 ' HA ' ' A' ' 72' ' ' MET . 4.4 pp -105.38 -9.74 17.39 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.627 0.371 . . . . 0.0 111.085 178.044 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -125.16 156.14 38.86 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.336 0.655 . . . . 0.0 110.27 -175.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -87.23 121.01 29.1 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.217 0.607 . . . . 0.0 109.752 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.553 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 10.4 m-85 -110.68 173.39 6.35 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.512 1.125 . . . . 0.0 111.772 -175.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -50.41 -52.86 33.9 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.435 1.494 . . . . 0.0 111.401 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.526 ' HG3' HG13 ' A' ' 37' ' ' ILE . 10.0 pt-20 -117.3 -19.2 9.69 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.815 -174.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 34' ' ' TYR . 4.6 mt -104.89 145.75 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.45 1.1 . . . . 0.0 108.995 -176.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 m -110.72 152.29 26.74 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.48 113.66 4.88 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 138.17 -29.1 2.65 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 119.569 -0.573 . . . . 0.0 113.711 -178.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -90.42 160.68 15.93 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 118.06 0.93 . . . . 0.0 111.927 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -109.26 159.99 16.5 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.922 0.889 . . . . 0.0 111.641 -164.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -141.64 -176.14 15.69 Favored Glycine 0 C--O 1.241 0.58 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.481 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -133.97 140.52 46.79 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 174.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.539 ' HA ' HG12 ' A' ' 57' ' ' VAL . 78.1 t80 -72.37 121.96 20.38 Favored 'General case' 0 C--N 1.342 0.261 0 O-C-N 123.494 0.496 . . . . 0.0 110.244 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -108.35 -47.76 3.46 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -177.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.31 151.24 8.07 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.05 0.94 . . . . 0.0 109.561 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.42 ' HA ' HG23 ' A' ' 55' ' ' VAL . 30.8 p -118.02 178.23 4.5 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.234 1.014 . . . . 0.0 111.004 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 168.466 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo . . . . . 0 CA--C 1.577 2.664 0 N-CA-C 118.901 2.616 . . . . 0.0 118.901 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.32 105.3 1.39 Allowed 'Trans proline' 0 C--N 1.381 2.269 0 CA-C-N 123.112 2.147 . . . . 0.0 112.092 172.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.42 HG23 ' HA ' ' A' ' 48' ' ' SER . 3.2 p -89.53 138.77 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.238 1.015 . . . . 0.0 109.923 169.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -92.73 124.1 36.49 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -134.65 142.37 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.913 1.285 . . . . 0.0 108.631 -179.19 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -84.84 107.66 17.12 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.564 ' HB2' HG22 ' A' ' 62' ' ' THR . 83.2 m95 -91.06 127.46 36.49 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.751 0.821 . . . . 0.0 110.133 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -21.37 63.63 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.762 0.664 . . . . 0.0 112.01 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.9 t -65.99 -46.28 78.59 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.08 0.552 . . . . 0.0 112.132 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.564 HG22 ' HB2' ' A' ' 59' ' ' TRP . 9.9 t -97.41 -16.14 20.34 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.816 0.846 . . . . 0.0 110.351 -177.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.18 15.68 80.72 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.494 -0.615 . . . . 0.0 114.037 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -151.4 176.99 10.73 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 117.632 0.716 . . . . 0.0 111.252 -174.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.08 138.52 31.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.38 1.072 . . . . 0.0 109.268 178.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -141.8 156.48 45.56 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.06 0.457 . . . . 0.0 110.966 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 -83.07 106.72 15.12 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.777 1.231 . . . . 0.0 109.98 -177.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.6 m -121.19 156.77 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.226 0.61 . . . . 0.0 110.129 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -89.44 146.48 24.62 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.697 0.799 . . . . 0.0 109.675 -176.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -56.17 -49.3 74.41 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.866 0.866 . . . . 0.0 112.607 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -70.06 -19.97 63.26 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.428 0.691 . . . . 0.0 111.582 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.465 ' HA ' HD11 ' A' ' 31' ' ' LEU . 31.2 mtp -100.26 1.55 41.88 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.708 0.803 . . . . 0.0 111.23 176.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.0 tt -104.48 130.71 52.38 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.617 1.167 . . . . 0.0 108.235 170.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.42 ' HB2' HD23 ' A' ' 31' ' ' LEU . 41.3 tt0 -107.45 146.89 31.16 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.103 0.961 . . . . 0.0 108.746 173.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.1 pt . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 120.831 0.348 . . . . 0.0 110.116 170.951 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.1 t80 . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.5 -44.93 39.28 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-O 121.785 0.658 . . . . 0.0 113.357 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -70.92 -26.19 63.09 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.191 0.596 . . . . 0.0 109.682 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -71.28 -49.22 45.15 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.456 1.102 . . . . 0.0 111.585 174.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 m -62.71 -33.99 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 122.563 0.345 . . . . 0.0 110.426 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.85 -33.35 49.18 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.22 1.008 . . . . 0.0 110.545 177.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -80.66 -53.42 6.54 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.208 0.603 . . . . 0.0 110.577 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.5 t -90.94 17.07 8.32 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.649 0.78 . . . . 0.0 112.463 -167.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.66 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.2 OUTLIER -76.24 149.76 37.13 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 173.25 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -117.69 140.24 27.34 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.252 1.021 . . . . 0.0 109.612 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.509 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 72.8 Cg_endo -72.68 78.98 1.98 Allowed 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.34 2.693 . . . . 0.0 113.429 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.67 28.31 0.82 Allowed Glycine 0 C--N 1.352 1.422 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.66 ' SD ' HD13 ' A' ' 22' ' ' LEU . 27.8 ptm -98.95 170.84 8.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.241 0.616 . . . . 0.0 111.29 -176.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -82.76 124.3 30.13 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.179 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.0 m -116.45 170.47 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.472 ' HE ' ' HG2' ' A' ' 42' ' ' GLU . 21.4 tpp85 -138.41 153.57 48.89 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -175.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' MET . . . . . 0.436 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 11.4 tpt -97.26 124.57 41.41 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.2 tp -96.23 -9.69 29.8 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.456 0.702 . . . . 0.0 111.258 -173.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 30' ' ' MET . 12.2 t70 -151.22 157.03 42.1 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.282 0.633 . . . . 0.0 109.325 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -73.43 142.16 46.9 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -132.44 172.19 12.8 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.979 0.511 . . . . 0.0 110.434 -177.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -40.74 -55.53 2.39 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 126.178 1.791 . . . . 0.0 113.05 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -124.19 0.4 8.41 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.552 -172.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.6 mt -118.71 138.72 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 124.142 0.977 . . . . 0.0 108.508 -175.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.2 m -87.9 150.94 23.19 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 122.915 0.486 . . . . 0.0 110.426 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.17 119.71 11.94 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 171.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.71 11.91 54.31 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.969 -177.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -79.56 153.49 29.45 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.91 0.484 . . . . 0.0 110.079 175.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.472 ' HG2' ' HE ' ' A' ' 29' ' ' ARG . 48.5 mt-10 -112.62 120.44 41.57 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.929 0.492 . . . . 0.0 110.601 -176.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.94 -172.6 21.87 Favored Glycine 0 C--O 1.243 0.683 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.569 173.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -134.04 138.21 45.2 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 171.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.509 ' HD2' ' HA ' ' A' ' 24' ' ' PRO . 64.1 t80 -70.47 123.27 21.37 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -106.36 -49.41 3.35 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.417 ' OE1' ' HB2' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -167.71 167.29 13.34 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.929 -179.406 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 72.3 p -141.51 -179.93 6.44 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.825 0.85 . . . . 0.0 110.922 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.0 m120 . . . . . 0 CA--C 1.539 0.543 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 168.988 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.435 ' HB2' ' CD2' ' A' ' 69' ' ' HIS . 38.8 Cg_endo . . . . . 0 CA--C 1.577 2.667 0 N-CA-C 118.831 2.589 . . . . 0.0 118.831 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.14 110.22 1.93 Allowed 'Trans proline' 0 C--N 1.385 2.492 0 CA-C-N 123.597 2.32 . . . . 0.0 111.594 169.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.78 141.67 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.134 0.974 . . . . 0.0 110.152 170.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.417 ' HB2' ' OE1' ' A' ' 47' ' ' GLN . 1.4 mp0 -93.32 121.34 34.6 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.472 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -135.87 137.2 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.977 1.311 . . . . 0.0 108.403 -177.136 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -83.59 106.08 15.03 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.494 ' HB2' HG22 ' A' ' 62' ' ' THR . 87.5 m95 -95.6 131.62 41.62 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.367 1.067 . . . . 0.0 110.326 -176.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -69.36 -25.05 63.99 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 123.847 0.717 . . . . 0.0 112.268 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.8 t -59.65 -44.17 93.64 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.348 0.594 . . . . 0.0 110.881 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.494 HG22 ' HB2' ' A' ' 59' ' ' TRP . 10.1 t -105.16 -14.49 15.37 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.957 -1.019 . . . . 0.0 111.826 -174.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.13 15.83 81.13 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.111 -0.495 . . . . 0.0 114.097 178.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -152.94 173.46 15.36 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.317 0.579 . . . . 0.0 111.578 -172.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.1 132.67 34.22 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.14 1.376 . . . . 0.0 109.576 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -141.5 158.11 44.27 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.265 0.555 . . . . 0.0 111.695 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -88.2 115.75 25.92 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.497 1.519 . . . . 0.0 109.776 -174.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.81 147.53 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.861 0.865 . . . . 0.0 109.251 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.435 ' CD2' ' HB2' ' A' ' 53' ' ' PRO . 63.4 t-80 -73.3 146.88 45.0 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -54.1 -31.26 51.51 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.57 1.548 . . . . 0.0 113.863 -177.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -79.39 -18.11 52.99 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.731 0.812 . . . . 0.0 111.191 -173.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.5 mtm -100.31 4.84 44.35 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.484 0.714 . . . . 0.0 110.655 171.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 tt -103.68 120.32 40.69 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 170.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -105.19 129.09 53.65 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.314 1.046 . . . . 0.0 108.235 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.9 pt . . . . . 0 CA--C 1.54 0.592 0 CA-C-O 121.543 0.687 . . . . 0.0 109.896 175.613 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 79.8 t80 . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 120.858 0.361 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.48 -32.76 84.22 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.034 -0.984 . . . . 0.0 112.931 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.524 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 41.2 tt0 -62.86 -48.94 76.84 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.098 0.559 . . . . 0.0 110.274 173.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.412 ' O ' HG22 ' A' ' 21' ' ' THR . 10.3 t80 -57.51 -50.42 73.14 Favored 'General case' 0 C--N 1.358 0.971 0 O-C-N 124.017 0.823 . . . . 0.0 110.838 -176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.466 ' HB ' HD23 ' A' ' 22' ' ' LEU . 29.5 m -67.74 -39.01 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 O-C-N 123.535 0.522 . . . . 0.0 110.645 -177.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -56.91 -31.25 64.72 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.153 0.581 . . . . 0.0 111.723 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 26.4 mm-40 -81.94 -40.57 22.07 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.191 -177.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 17' ' ' TYR . 12.5 t -100.46 -6.06 26.13 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -168.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.482 HD13 ' SD ' ' A' ' 26' ' ' MET . 1.1 mm? -69.7 107.79 3.61 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 118.164 0.438 . . . . 0.0 110.612 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -87.46 142.45 33.1 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.08 0.952 . . . . 0.0 110.498 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.5 ' HA ' ' HD1' ' A' ' 45' ' ' PHE . 34.7 Cg_exo -59.59 79.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.531 2.821 . . . . 0.0 114.061 176.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.33 19.32 1.22 Allowed Glycine 0 C--N 1.353 1.525 0 CA-C-O 119.534 -0.592 . . . . 0.0 113.015 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.482 ' SD ' HD13 ' A' ' 22' ' ' LEU . 4.7 ptp -93.91 174.68 7.04 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 117.704 0.752 . . . . 0.0 110.876 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.618 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 21.4 tpt180 -97.02 126.97 42.54 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.747 1.219 . . . . 0.0 109.055 -171.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.441 HG12 HD11 ' A' ' 22' ' ' LEU . 5.7 m -116.03 172.34 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.676 0.791 . . . . 0.0 109.999 -174.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -144.58 140.95 29.1 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.173 1.389 . . . . 0.0 108.329 -172.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.4 tpt -98.95 112.15 24.34 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 74' ' ' GLU . 4.7 pp -89.48 -3.7 58.26 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -140.7 154.01 46.18 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.63 127.04 32.2 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.221 0.534 . . . . 0.0 110.144 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.471 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -107.06 172.68 6.69 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.734 0.813 . . . . 0.0 110.989 -178.439 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -50.11 -35.78 26.99 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.818 1.647 . . . . 0.0 113.237 -172.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -138.58 3.6 2.31 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.859 0.864 . . . . 0.0 111.182 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.471 ' HB ' ' HB2' ' A' ' 34' ' ' TYR . 7.2 mt -118.78 144.19 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.438 1.095 . . . . 0.0 108.503 -172.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 m -91.77 153.69 19.44 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.85 0.46 . . . . 0.0 110.909 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.11 116.14 12.18 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 166.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.7 -5.71 29.48 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.346 -172.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -79.17 156.23 28.31 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.748 0.419 . . . . 0.0 110.108 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -129.88 158.21 40.12 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.252 0.621 . . . . 0.0 111.136 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -149.26 -166.88 13.5 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.501 -172.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -135.47 139.26 43.93 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.5 ' HD1' ' HA ' ' A' ' 24' ' ' PRO . 38.7 t80 -69.13 119.52 13.55 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 -103.65 -46.96 4.38 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.48 ' OE1' ' HB2' ' A' ' 56' ' ' GLN . 0.5 OUTLIER -172.21 156.92 4.05 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.734 1.214 . . . . 0.0 108.885 176.421 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.7 p -127.39 178.2 6.22 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.473 0.709 . . . . 0.0 110.335 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 31.6 m-80 -118.31 136.27 53.8 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 170.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -67.93 -52.71 32.98 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.226 0.61 . . . . 0.0 110.898 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.29 -23.31 32.18 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-N 115.18 -0.918 . . . . 0.0 113.282 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.549 HG22 ' HD2' ' A' ' 54' ' ' PRO . 5.9 mm -101.68 114.06 65.7 Favored Pre-proline 0 N--CA 1.479 0.988 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -177.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -59.51 -33.55 97.11 Favored 'Trans proline' 0 CA--C 1.577 2.656 0 N-CA-C 118.361 2.408 . . . . 0.0 118.361 -174.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.549 ' HD2' HG22 ' A' ' 52' ' ' ILE . 28.9 Cg_endo -61.68 107.75 0.55 Allowed 'Trans proline' 0 C--N 1.384 2.415 0 CA-C-N 123.101 2.143 . . . . 0.0 112.51 175.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.04 136.46 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.28 1.032 . . . . 0.0 109.502 169.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.546 ' HB3' HG22 ' A' ' 65' ' ' THR . 1.8 mp0 -90.4 123.35 34.05 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -137.03 136.75 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.0 1.32 . . . . 0.0 108.546 -174.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -82.53 105.58 13.69 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -175.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.486 ' HB2' HG22 ' A' ' 62' ' ' THR . 95.6 m95 -90.14 130.61 36.27 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.064 0.946 . . . . 0.0 110.432 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -70.31 -31.33 68.61 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 123.863 0.727 . . . . 0.0 112.727 -174.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.6 t -70.08 -46.08 65.68 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 117.951 0.341 . . . . 0.0 111.536 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.486 HG22 ' HB2' ' A' ' 59' ' ' TRP . 9.8 t -86.45 -18.13 32.5 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 122.736 0.414 . . . . 0.0 110.676 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.8 19.71 78.69 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-O 119.727 -0.485 . . . . 0.0 114.277 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -153.04 165.0 36.95 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.317 0.579 . . . . 0.0 112.244 -173.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.546 HG22 ' HB3' ' A' ' 56' ' ' GLN . 2.1 m -87.05 121.63 29.78 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.933 -177.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -130.64 157.15 43.53 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.964 0.411 . . . . 0.0 111.283 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 12.3 m-90 -79.02 114.34 17.88 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.714 1.205 . . . . 0.0 110.191 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.461 HG21 HD23 ' A' ' 73' ' ' LEU . 11.6 m -129.05 155.34 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 122.838 0.455 . . . . 0.0 110.652 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -89.47 147.06 24.21 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.736 0.814 . . . . 0.0 110.169 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -59.82 -42.36 93.33 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.428 0.691 . . . . 0.0 112.59 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -66.99 -24.94 66.09 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 117.661 0.21 . . . . 0.0 111.336 -176.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 71.4 mtm -99.88 -1.82 36.43 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.732 0.413 . . . . 0.0 111.62 175.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.461 HD23 HG21 ' A' ' 68' ' ' VAL . 2.5 tm? -92.66 121.23 33.87 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 172.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.522 ' HB2' HD23 ' A' ' 31' ' ' LEU . 39.6 tt0 -115.69 151.59 34.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.882 1.273 . . . . 0.0 108.458 176.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.435 HG21 ' SD ' ' A' ' 26' ' ' MET . 10.7 pt -114.18 123.2 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 118.433 0.56 . . . . 0.0 110.723 169.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 84.0 mt -121.7 3.73 10.08 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.971 0.908 . . . . 0.0 109.838 173.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.618 ' HA3' ' HB3' ' A' ' 27' ' ' ARG . . . . . . . . 0 C--N 1.352 1.466 0 O-C-N 123.659 0.599 . . . . 0.0 113.197 176.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.4 t80 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.02 -31.77 81.99 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.893 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 12.1 tp10 -69.14 -48.05 63.42 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.41 ' O ' HG22 ' A' ' 21' ' ' THR . 42.0 t80 -59.06 -49.92 76.05 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 114.986 -1.007 . . . . 0.0 111.396 -177.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.8 -40.67 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 123.677 0.611 . . . . 0.0 110.721 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -57.64 -36.31 71.67 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.507 0.723 . . . . 0.0 111.932 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 23.5 mm-40 -80.21 -35.79 35.77 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.009 0.524 . . . . 0.0 111.171 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 17' ' ' TYR . 14.8 t -101.04 7.82 43.24 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.806 0.443 . . . . 0.0 112.117 -176.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.97 113.98 11.76 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.489 ' HB3' ' HB3' ' A' ' 26' ' ' MET . 34.3 tt0 -87.44 134.71 35.57 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.06 0.944 . . . . 0.0 109.673 -176.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.51 ' HA ' ' CD1' ' A' ' 45' ' ' PHE . 52.7 Cg_endo -64.81 80.3 0.18 Allowed 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 123.151 2.567 . . . . 0.0 113.457 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.99 26.44 1.54 Allowed Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.057 175.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.489 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 24.6 ptm -96.53 168.97 10.22 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.608 0.718 . . . . 0.0 110.54 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.56 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 18.6 tpp180 -90.01 126.31 35.71 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.851 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.476 HG12 HG22 ' A' ' 75' ' ' ILE . 8.0 m -116.44 171.02 5.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 C-N-CA 124.209 1.003 . . . . 0.0 108.833 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.451 ' HD2' ' N ' ' A' ' 30' ' ' MET . 2.6 tmm_? -137.29 143.93 42.41 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.451 ' N ' ' HD2' ' A' ' 29' ' ' ARG . 1.9 tpt -92.77 112.68 24.72 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.642 0.777 . . . . 0.0 109.133 -177.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 74' ' ' GLU . 4.4 pp -89.19 -9.58 50.29 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.571 0.348 . . . . 0.0 111.547 -178.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -127.02 162.62 25.6 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.944 0.898 . . . . 0.0 109.344 -174.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.43 146.19 25.96 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.553 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 13.8 m-85 -133.53 173.07 11.9 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.645 0.778 . . . . 0.0 111.117 -176.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -50.93 -47.4 61.03 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.15 1.38 . . . . 0.0 112.043 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -131.09 -1.35 4.08 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.696 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 34' ' ' TYR . 3.9 mp -112.64 143.02 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.2 t -103.32 154.5 19.31 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.263 0.625 . . . . 0.0 109.751 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.83 114.18 6.93 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.406 ' HA2' HH11 ' A' ' 29' ' ' ARG . . . 124.58 -17.54 7.33 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.314 -176.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.62 154.71 41.59 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.209 0.603 . . . . 0.0 111.259 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.437 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 45.0 mt-10 -112.79 138.61 49.37 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.601 0.761 . . . . 0.0 110.813 -175.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.56 -176.74 14.59 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.99 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -135.36 137.18 42.1 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.515 ' HA ' HG12 ' A' ' 57' ' ' VAL . 60.4 t80 -69.65 120.35 15.29 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 9.9 mmm-85 -107.42 -47.52 3.63 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.469 ' OE1' ' HB2' ' A' ' 56' ' ' GLN . 0.5 OUTLIER -169.06 166.38 10.99 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.252 1.021 . . . . 0.0 109.398 178.624 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 92.3 p -152.93 -179.18 7.43 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.689 0.757 . . . . 0.0 111.509 -176.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 18.8 m-80 -121.71 122.59 39.9 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 168.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -84.02 1.41 43.93 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.72 -29.56 1.15 Allowed Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 175.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.578 HG22 ' HD2' ' A' ' 54' ' ' PRO . 5.1 mm -105.22 127.0 29.51 Favored Pre-proline 0 N--CA 1.482 1.164 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.9 -29.04 75.81 Favored 'Trans proline' 0 CA--C 1.584 2.982 0 N-CA-C 119.221 2.739 . . . . 0.0 119.221 -171.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.578 ' HD2' HG22 ' A' ' 52' ' ' ILE . 37.6 Cg_endo -63.95 106.24 0.63 Allowed 'Trans proline' 0 C--N 1.389 2.692 0 CA-C-N 123.558 2.306 . . . . 0.0 113.054 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 p -95.44 132.3 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.318 167.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.469 ' HB2' ' OE1' ' A' ' 47' ' ' GLN . 2.1 mp0 -92.12 124.62 36.34 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -134.71 139.05 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.09 1.356 . . . . 0.0 108.636 -174.906 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -81.52 107.13 14.03 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.562 0.745 . . . . 0.0 109.731 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.424 ' NE1' HG23 ' A' ' 57' ' ' VAL . 93.0 m95 -93.83 130.1 39.99 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.944 0.898 . . . . 0.0 110.618 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -71.17 -26.25 62.89 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 123.965 0.791 . . . . 0.0 112.508 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.3 t -62.62 -45.85 90.96 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.047 0.451 . . . . 0.0 111.401 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.9 t -99.16 -12.19 20.69 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.913 0.885 . . . . 0.0 110.36 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.18 22.31 74.34 Favored Glycine 0 C--N 1.352 1.458 0 CA-C-N 115.966 -0.561 . . . . 0.0 114.17 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -151.35 172.45 15.89 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 117.324 0.562 . . . . 0.0 111.202 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.11 139.64 31.57 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.268 1.027 . . . . 0.0 109.102 -175.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -144.71 155.41 43.55 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.056 0.455 . . . . 0.0 111.139 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -79.75 120.73 24.44 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.033 1.333 . . . . 0.0 109.351 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 73' ' ' LEU . 6.7 m -131.44 160.91 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.206 0.602 . . . . 0.0 109.665 176.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 72' ' ' MET . 46.7 t60 -93.86 145.83 24.33 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.734 0.813 . . . . 0.0 108.826 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -60.15 -46.88 88.18 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.396 0.678 . . . . 0.0 112.501 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -73.15 -19.4 61.13 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.16 0.584 . . . . 0.0 111.003 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.471 ' HA ' HD11 ' A' ' 31' ' ' LEU . 46.5 mtp -98.32 2.64 48.3 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.252 1.021 . . . . 0.0 110.668 176.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.457 HD13 HG21 ' A' ' 68' ' ' VAL . 58.5 tp -111.03 133.78 53.15 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.518 1.127 . . . . 0.0 109.142 176.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.488 ' HB2' HD23 ' A' ' 31' ' ' LEU . 35.5 tt0 -107.25 152.56 23.94 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 172.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.476 HG22 HG12 ' A' ' 28' ' ' VAL . 21.7 pt -111.99 137.64 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 122.905 0.482 . . . . 0.0 109.801 166.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 tt -159.98 96.71 1.24 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.56 ' HA3' ' HB3' ' A' ' 27' ' ' ARG . . . . . . . . 0 CA--C 1.528 0.849 0 CA-C-O 118.823 -0.987 . . . . 0.0 112.127 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 55.4 t80 . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 110.907 -0.034 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.91 -40.71 95.54 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.363 0.414 . . . . 0.0 113.247 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 25.7 tt0 -71.36 -36.09 71.35 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.925 0.49 . . . . 0.0 110.348 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -64.47 -49.49 71.22 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.096 0.958 . . . . 0.0 111.255 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.8 m -63.45 -39.63 86.03 Favored 'Isoleucine or valine' 0 C--N 1.354 0.77 0 O-C-N 123.65 0.593 . . . . 0.0 110.316 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -55.81 -38.77 70.43 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.196 0.599 . . . . 0.0 111.202 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 23.9 mm-40 -78.66 -38.94 38.27 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.408 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.6 t -94.11 2.06 56.04 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -173.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.49 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.2 OUTLIER -71.11 127.99 34.42 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 118.114 0.415 . . . . 0.0 109.944 176.448 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 50.9 mt-30 -116.41 133.67 22.95 Favored Pre-proline 0 N--CA 1.488 1.443 0 C-N-CA 124.26 1.024 . . . . 0.0 109.775 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 23' ' ' GLN . 24.1 Cg_exo -63.03 90.55 0.13 Allowed 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 123.227 2.618 . . . . 0.0 112.805 -175.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.61 8.06 3.26 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 116.147 -0.478 . . . . 0.0 112.782 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.49 ' SD ' HD13 ' A' ' 22' ' ' LEU . 9.8 ptp -87.33 157.48 19.27 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 173.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -87.27 157.19 19.36 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.748 0.785 . . . . 0.0 109.342 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.546 HG12 HG22 ' A' ' 75' ' ' ILE . 9.5 m -133.88 173.63 14.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.423 ' HB3' HD13 ' A' ' 76' ' ' LEU . 3.6 tmt_? -151.21 145.84 25.67 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 31.9 tpp -98.43 126.95 44.15 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.009 0.924 . . . . 0.0 110.297 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.598 HD23 ' HB2' ' A' ' 74' ' ' GLU . 3.9 pp -95.47 -7.63 37.62 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.221 0.608 . . . . 0.0 111.857 -176.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 30' ' ' MET . 21.7 t70 -132.64 168.47 18.22 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.449 0.7 . . . . 0.0 110.411 -174.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -80.19 130.69 35.4 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 122.137 -0.352 . . . . 0.0 110.248 175.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.464 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 1.2 m-85 -120.07 171.79 8.21 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.045 0.938 . . . . 0.0 110.433 176.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -50.44 -49.51 54.77 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.497 1.519 . . . . 0.0 113.009 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -126.17 0.38 7.13 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.645 0.778 . . . . 0.0 111.318 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.477 HD11 ' HB3' ' A' ' 66' ' ' TYR . 4.9 mt -116.56 126.37 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.1 m -89.43 155.17 19.49 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.26 113.36 3.54 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.405 ' HA2' ' NE ' ' A' ' 29' ' ' ARG . . . 124.37 -21.92 6.72 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.22 -177.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.415 ' OD2' ' HB3' ' A' ' 59' ' ' TRP . 28.4 t0 -62.19 142.45 57.65 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.301 0.64 . . . . 0.0 112.07 -176.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -104.1 148.29 26.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.256 1.022 . . . . 0.0 110.761 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.63 -173.85 13.09 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.434 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -134.91 140.69 45.96 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.487 ' HA ' HG12 ' A' ' 57' ' ' VAL . 59.3 t80 -71.63 119.75 16.24 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 123.864 0.727 . . . . 0.0 110.08 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -107.58 -47.68 3.57 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -174.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -164.42 157.18 17.1 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.338 1.055 . . . . 0.0 109.412 177.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.469 ' HA ' HG23 ' A' ' 55' ' ' VAL . 29.8 p -117.4 178.31 4.42 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.914 0.886 . . . . 0.0 111.169 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 27.9 m-80 -132.14 120.98 23.02 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -72.27 -33.38 67.43 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.212 0.605 . . . . 0.0 111.22 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -105.71 -8.28 35.05 Favored Glycine 0 C--N 1.346 1.124 0 O-C-N 123.773 0.67 . . . . 0.0 113.537 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.586 HG22 ' HD2' ' A' ' 54' ' ' PRO . 13.1 mm -118.94 112.57 36.38 Favored Pre-proline 0 N--CA 1.486 1.366 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.88 -29.89 89.0 Favored 'Trans proline' 0 CA--C 1.581 2.832 0 N-CA-C 118.074 2.298 . . . . 0.0 118.074 -175.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.586 ' HD2' HG22 ' A' ' 52' ' ' ILE . 43.1 Cg_endo -68.51 109.09 1.97 Allowed 'Trans proline' 0 C--N 1.384 2.401 0 CA-C-N 123.325 2.223 . . . . 0.0 111.827 169.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 48' ' ' SER . 3.2 p -90.34 141.62 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.621 1.168 . . . . 0.0 110.478 171.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -93.33 125.17 37.8 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.549 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.487 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -138.89 138.45 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.167 1.387 . . . . 0.0 108.538 -176.581 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -81.96 106.67 14.06 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.46 ' HB2' HG22 ' A' ' 62' ' ' THR . 97.6 m95 -91.73 130.49 37.51 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.579 1.152 . . . . 0.0 110.647 -176.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.23 -26.93 60.53 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -174.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.3 t -72.6 -41.49 65.56 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.025 0.375 . . . . 0.0 111.378 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.48 HG23 ' H ' ' A' ' 64' ' ' ARG . 10.5 t -87.76 -30.78 20.03 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 122.783 0.433 . . . . 0.0 109.843 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.58 16.76 58.07 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.911 -0.586 . . . . 0.0 114.096 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.48 ' H ' HG23 ' A' ' 62' ' ' THR . 0.0 OUTLIER -151.75 175.37 12.47 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.593 0.757 . . . . 0.0 112.032 -177.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.47 132.96 33.8 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.882 1.273 . . . . 0.0 109.716 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.477 ' HB3' HD11 ' A' ' 37' ' ' ILE . 12.7 t80 -138.82 156.99 46.88 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.09 0.472 . . . . 0.0 111.028 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 12.9 m-90 -83.51 113.74 21.0 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.128 1.371 . . . . 0.0 109.744 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.421 HG21 HD13 ' A' ' 73' ' ' LEU . 17.0 m -130.15 154.55 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.326 0.651 . . . . 0.0 110.546 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -80.62 145.5 31.66 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.994 0.518 . . . . 0.0 110.352 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -59.51 -45.59 91.29 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.526 0.731 . . . . 0.0 112.042 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -70.56 -25.36 63.05 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.528 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 74.7 mtm -93.2 1.27 57.17 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.745 0.418 . . . . 0.0 111.13 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.421 HD13 HG21 ' A' ' 68' ' ' VAL . 26.5 tp -97.11 118.82 34.39 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 174.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.598 ' HB2' HD23 ' A' ' 31' ' ' LEU . 42.9 tt0 -108.2 108.4 19.42 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.975 0.91 . . . . 0.0 108.924 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.546 HG22 HG12 ' A' ' 28' ' ' VAL . 17.9 pt -89.62 115.59 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-O 121.737 0.779 . . . . 0.0 111.415 -174.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.423 HD13 ' HB3' ' A' ' 29' ' ' ARG . 10.9 mp -98.84 3.24 47.3 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.228 1.011 . . . . 0.0 110.247 173.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.532 0 C-N-CA 123.292 0.472 . . . . 0.0 112.785 174.613 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.1 t80 . . . . . 0 N--CA 1.481 1.118 0 CA-C-O 120.823 0.344 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.62 -42.99 87.01 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.147 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 3.8 mp0 -71.05 -22.49 62.12 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.769 0.827 . . . . 0.0 111.735 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -70.95 -50.99 28.54 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.27 0.228 . . . . 0.0 110.792 170.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.8 m -66.63 -41.55 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -169.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -55.78 -30.29 61.05 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.336 0.654 . . . . 0.0 112.706 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 11.3 mm100 -78.32 -36.93 45.7 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.056 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.2 t -94.36 -0.36 54.96 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.45 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.6 OUTLIER -72.1 117.61 13.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 122.039 -0.413 . . . . 0.0 110.738 177.074 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -96.86 135.66 22.01 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 124.112 0.965 . . . . 0.0 110.253 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 27.9 Cg_exo -62.97 82.19 0.11 Allowed 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.657 2.905 . . . . 0.0 113.188 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.03 15.92 1.64 Allowed Glycine 0 C--N 1.345 1.056 0 CA-C-N 116.4 -0.363 . . . . 0.0 112.467 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.45 ' SD ' HD13 ' A' ' 22' ' ' LEU . 5.3 ptp -90.7 163.75 14.39 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.539 0.685 . . . . 0.0 110.298 176.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.569 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 25.2 tpt180 -83.73 129.02 34.95 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.192 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 m -115.62 172.03 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -141.63 141.94 33.42 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.228 1.411 . . . . 0.0 108.272 -172.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.3 tpt -86.43 110.53 19.79 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.3 tp -81.13 -29.44 34.77 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.061 0.544 . . . . 0.0 110.599 -175.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -143.1 151.75 41.08 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -66.33 151.0 48.01 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.062 0.545 . . . . 0.0 111.51 -168.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -133.15 172.16 13.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.636 0.774 . . . . 0.0 111.436 -174.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -49.23 -47.8 46.08 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.037 1.735 . . . . 0.0 112.483 -175.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -129.99 2.88 4.82 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.995 0.918 . . . . 0.0 111.32 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -118.56 143.87 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.4 m -98.98 148.76 23.67 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.907 0.483 . . . . 0.0 110.208 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.1 117.48 5.59 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.998 0.519 . . . . 0.0 110.076 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.28 -15.93 20.17 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.487 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.98 151.06 43.51 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 117.265 0.533 . . . . 0.0 109.856 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -118.34 146.37 44.42 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.403 0.62 . . . . 0.0 110.939 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.445 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . -127.9 -165.36 11.83 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.252 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -136.27 142.64 43.97 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.449 ' HA ' HG12 ' A' ' 57' ' ' VAL . 75.4 t80 -75.57 119.58 19.81 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.416 0.686 . . . . 0.0 110.276 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -108.06 -49.6 3.18 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -175.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -164.82 163.67 21.17 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.44 1.096 . . . . 0.0 109.271 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.418 ' HB3' HG23 ' A' ' 55' ' ' VAL . 87.8 p -161.95 179.74 7.79 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 122.088 0.947 . . . . 0.0 112.517 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.445 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 3.2 m-80 -133.49 128.95 36.47 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 167.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -78.3 -33.7 49.2 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.642 0.377 . . . . 0.0 110.798 -177.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.5 -32.7 15.3 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.721 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' ' 49' ' ' ASN . 35.3 mm -100.15 100.62 12.09 Favored Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 175.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -62.47 -22.14 73.66 Favored 'Trans proline' 0 CA--C 1.578 2.678 0 N-CA-C 118.848 2.595 . . . . 0.0 118.848 -165.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.66 101.75 0.27 Allowed 'Trans proline' 0 C--N 1.389 2.662 0 CA-C-N 123.256 2.199 . . . . 0.0 112.199 171.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.418 HG23 ' HB3' ' A' ' 48' ' ' SER . 2.1 p -89.11 135.3 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.722 168.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.474 ' HB3' HG22 ' A' ' 65' ' ' THR . 2.0 mp0 -91.01 121.89 33.21 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -135.27 136.6 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.91 1.284 . . . . 0.0 108.411 -176.686 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -82.38 106.18 14.04 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.849 0.46 . . . . 0.0 109.917 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.408 ' HB2' HG22 ' A' ' 62' ' ' THR . 84.6 m95 -94.11 131.0 40.08 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.053 0.941 . . . . 0.0 110.535 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -71.04 -24.8 62.42 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.5 p -62.03 -45.75 92.22 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.414 0.626 . . . . 0.0 111.53 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.408 HG22 ' HB2' ' A' ' 59' ' ' TRP . 9.8 t -99.51 -17.87 17.69 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.367 -176.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.59 19.21 74.12 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-O 119.789 -0.45 . . . . 0.0 113.961 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -152.27 170.12 20.83 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.499 0.666 . . . . 0.0 111.216 -175.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.474 HG22 ' HB3' ' A' ' 56' ' ' GLN . 1.3 m -86.52 129.14 34.97 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.773 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -131.99 154.71 49.05 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.268 0.556 . . . . 0.0 111.612 -174.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -85.18 100.48 11.78 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.396 1.478 . . . . 0.0 109.427 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.8 m -116.94 162.02 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 122.744 0.418 . . . . 0.0 110.348 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -91.59 147.79 22.75 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.301 0.641 . . . . 0.0 109.846 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -58.84 -45.66 89.54 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.363 1.065 . . . . 0.0 113.291 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -66.44 -21.59 66.2 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.431 0.693 . . . . 0.0 111.797 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 76.3 mtm -101.94 9.66 40.37 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.2 0.6 . . . . 0.0 111.248 174.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.7 tt -109.64 120.62 43.05 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 172.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -106.86 150.22 26.61 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.903 1.281 . . . . 0.0 107.774 171.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.2 pt -113.96 116.65 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 CA-C-N 119.123 0.874 . . . . 0.0 111.818 174.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 66.0 mt -102.49 11.56 37.74 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.743 0.817 . . . . 0.0 110.182 170.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.569 ' HA2' ' HB3' ' A' ' 27' ' ' ARG . . . . . . . . 0 C--N 1.352 1.425 0 CA-C-O 119.147 -0.807 . . . . 0.0 113.308 174.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 75.1 t80 . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.539 0.209 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.56 -28.81 71.95 Favored Glycine 0 C--N 1.354 1.563 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.6 176.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.27 -47.73 59.98 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.963 0.505 . . . . 0.0 110.406 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -58.08 -50.21 74.25 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.055 0.847 . . . . 0.0 110.925 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.5 m -66.23 -37.3 79.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.311 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -31.36 59.19 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.72 0.808 . . . . 0.0 110.687 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -91.96 -47.98 7.01 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.573 0.749 . . . . 0.0 111.2 -174.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.9 t -79.13 -11.99 59.99 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -173.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.415 HD12 ' CG ' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -68.71 112.17 5.28 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 117.917 0.326 . . . . 0.0 110.575 177.674 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -97.53 132.81 24.52 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 123.875 0.87 . . . . 0.0 109.771 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.01 84.45 0.25 Allowed 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 123.021 2.48 . . . . 0.0 112.666 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 143.68 -0.68 1.25 Allowed Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.826 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.8 ptp -88.73 154.56 20.19 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -85.28 157.91 20.45 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 m -128.69 173.3 13.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.728 -1.123 . . . . 0.0 108.316 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.537 ' HD3' ' HA2' ' A' ' 40' ' ' GLY . 3.6 tmm_? -141.54 136.6 31.29 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.2 tpt -76.82 111.45 12.36 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.511 1.124 . . . . 0.0 109.279 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 41.2 tp -69.88 -36.53 75.52 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.137 0.575 . . . . 0.0 111.0 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -141.34 150.92 43.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.668 0.787 . . . . 0.0 109.18 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -65.58 129.88 41.33 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.831 0.707 . . . . 0.0 111.234 -170.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -106.97 173.58 6.26 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.128 0.971 . . . . 0.0 110.749 -177.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -47.41 -44.95 24.98 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.813 1.645 . . . . 0.0 113.386 -175.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -131.36 7.33 4.55 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.885 0.874 . . . . 0.0 111.058 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.23 144.79 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.825 0.85 . . . . 0.0 109.391 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.4 m -93.44 147.33 23.05 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.076 0.55 . . . . 0.0 110.543 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.48 117.86 8.6 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.537 ' HA2' ' HD3' ' A' ' 29' ' ' ARG . . . 115.16 -18.95 15.56 Favored Glycine 0 N--CA 1.469 0.862 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -66.64 144.45 56.39 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.606 0.762 . . . . 0.0 110.648 178.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -109.1 144.14 37.52 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.407 0.623 . . . . 0.0 110.659 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.65 -168.43 12.32 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.639 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -137.18 142.49 42.15 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 169.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 48' ' ' SER . 85.4 t80 -88.31 118.23 27.78 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.924 0.889 . . . . 0.0 109.451 177.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.94 -47.17 2.79 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.317 0.247 . . . . 0.0 111.286 175.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -136.86 150.66 48.4 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.606 0.362 . . . . 0.0 110.407 -177.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.447 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 64.4 p -145.12 165.28 28.74 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.638 0.775 . . . . 0.0 111.745 -177.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 6.7 m120 -124.42 121.47 35.0 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 173.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -79.02 -30.58 44.29 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.015 0.526 . . . . 0.0 110.382 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.27 -34.63 9.41 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.78 177.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 13.8 mm -100.64 106.58 44.16 Favored Pre-proline 0 N--CA 1.479 1.004 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.59 -25.34 79.17 Favored 'Trans proline' 0 CA--C 1.579 2.747 0 N-CA-C 118.292 2.382 . . . . 0.0 118.292 -171.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.648 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 57.4 Cg_endo -71.36 109.09 2.52 Favored 'Trans proline' 0 C--N 1.383 2.393 0 CA-C-N 123.523 2.294 . . . . 0.0 112.241 169.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' A' ' 48' ' ' SER . 6.4 p -86.93 144.45 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.061 0.944 . . . . 0.0 110.774 173.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -89.64 122.63 32.95 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.14 136.16 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -80.93 104.12 11.22 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -176.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.507 ' HB2' HG22 ' A' ' 62' ' ' THR . 88.6 m95 -92.01 130.03 37.84 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.434 1.094 . . . . 0.0 109.745 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -70.01 -34.87 73.86 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 123.61 0.569 . . . . 0.0 111.775 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.1 t -60.65 -45.18 95.07 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.666 0.386 . . . . 0.0 111.371 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.507 HG22 ' HB2' ' A' ' 59' ' ' TRP . 8.9 t -90.88 -16.68 27.76 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.762 0.425 . . . . 0.0 110.984 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.78 14.56 80.82 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 119.612 -0.549 . . . . 0.0 114.206 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -152.77 176.83 11.36 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 117.439 0.619 . . . . 0.0 110.9 -172.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 p -84.91 136.84 33.46 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.006 0.522 . . . . 0.0 109.727 173.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -134.89 156.02 49.68 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 123.886 0.742 . . . . 0.0 110.041 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.648 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 14.9 m-90 -87.6 101.37 13.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.34 1.456 . . . . 0.0 109.498 -173.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.3 m -117.09 153.27 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.147 0.579 . . . . 0.0 109.7 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -85.19 146.71 26.96 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -58.91 -40.13 83.61 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.886 0.875 . . . . 0.0 112.764 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -69.69 -20.76 63.55 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 123.316 0.646 . . . . 0.0 112.164 -176.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 69.4 mtm -106.1 14.29 27.94 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 122.973 0.509 . . . . 0.0 111.424 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.414 HD22 HD21 ' A' ' 22' ' ' LEU . 8.3 tt -104.53 121.69 44.01 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 172.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -106.6 152.7 23.38 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 171.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.7 pt -113.71 126.17 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 122.864 0.465 . . . . 0.0 111.71 174.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.3 mt -104.44 6.74 35.17 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.457 0.703 . . . . 0.0 110.017 167.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.584 0 O-C-N 123.773 0.67 . . . . 0.0 112.448 174.626 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.2 t80 . . . . . 0 N--CA 1.486 1.361 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.89 -30.4 77.9 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 114.443 -1.253 . . . . 0.0 113.71 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 26.5 tt0 -70.34 -41.79 72.73 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 175.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -60.37 -49.57 77.07 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.243 0.617 . . . . 0.0 111.148 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.417 ' HA ' HG22 ' A' ' 21' ' ' THR . 34.2 m -64.94 -36.45 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 O-C-N 123.397 0.435 . . . . 0.0 110.493 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -55.1 -30.97 60.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.676 0.79 . . . . 0.0 111.27 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 10.3 mm100 -80.32 -52.8 7.27 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.774 0.429 . . . . 0.0 110.771 177.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.417 HG22 ' HA ' ' A' ' 18' ' ' VAL . 10.8 t -82.8 -7.42 59.66 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -167.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.559 HD12 ' HB2' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -69.43 107.13 3.21 Favored 'General case' 0 CA--C 1.558 1.251 0 CA-C-N 118.519 0.599 . . . . 0.0 110.801 176.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -88.37 134.26 34.88 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 124.143 0.977 . . . . 0.0 110.226 176.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.91 90.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.117 2.545 . . . . 0.0 112.227 171.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.14 -2.38 3.92 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.996 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.1 ptp -87.79 164.81 15.74 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 117.353 0.577 . . . . 0.0 110.57 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.62 140.01 31.06 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.699 1.199 . . . . 0.0 109.821 -173.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.441 HG12 HD11 ' A' ' 22' ' ' LEU . 4.4 m -117.19 172.83 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.816 0.846 . . . . 0.0 109.187 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -145.07 143.92 30.69 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.558 1.143 . . . . 0.0 108.651 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.1 tpp -97.62 139.1 34.03 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 122.779 0.431 . . . . 0.0 110.696 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 74' ' ' GLU . 3.3 pp -112.87 -7.42 13.76 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.235 1.014 . . . . 0.0 111.676 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -127.13 172.2 10.74 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.244 1.018 . . . . 0.0 109.58 -174.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -91.11 143.09 27.05 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.797 -0.565 . . . . 0.0 110.629 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.412 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 8.7 m-85 -133.28 171.77 13.59 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.984 1.313 . . . . 0.0 110.231 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -45.93 -46.98 16.4 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.367 1.467 . . . . 0.0 112.266 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -139.08 1.84 2.06 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.85 0.86 . . . . 0.0 111.398 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 34' ' ' TYR . 5.0 mp -115.1 146.45 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 174.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.0 m -130.74 164.25 25.51 Favored 'General case' 0 C--O 1.245 0.819 0 O-C-N 121.988 -0.445 . . . . 0.0 110.051 172.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.29 114.63 2.5 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 123.788 0.68 . . . . 0.0 110.286 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.28 -34.35 2.95 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.399 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.405 ' HB3' HG23 ' A' ' 37' ' ' ILE . 50.5 t0 -65.09 145.84 55.77 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.033 0.533 . . . . 0.0 110.192 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -120.4 146.29 46.34 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.998 0.919 . . . . 0.0 110.357 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.7 -167.52 12.4 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.126 -178.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -136.89 141.38 42.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 171.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.559 ' HB2' HD12 ' A' ' 22' ' ' LEU . 76.8 t80 -74.97 119.66 19.45 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.877 0.471 . . . . 0.0 109.988 178.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 -108.99 -49.22 3.16 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.679 0.791 . . . . 0.0 109.592 -173.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -161.7 164.04 29.35 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.48 1.112 . . . . 0.0 109.056 177.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 16.3 p -132.07 168.56 17.75 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.622 0.769 . . . . 0.0 112.01 -175.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.432 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 14.6 m-80 -137.14 121.47 18.13 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 164.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -75.12 -38.75 60.99 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -177.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.52 -18.35 45.53 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.418 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.472 HG22 ' HD2' ' A' ' 54' ' ' PRO . 20.5 mm -104.27 102.49 33.24 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 173.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -60.55 -22.41 72.12 Favored 'Trans proline' 0 CA--C 1.576 2.605 0 N-CA-C 117.775 2.183 . . . . 0.0 117.775 -171.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.55 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 66.5 Cg_endo -76.35 111.42 3.26 Favored 'Trans proline' 0 C--N 1.377 2.062 0 CA-C-N 122.851 2.054 . . . . 0.0 112.295 165.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 p -84.38 142.95 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.598 1.159 . . . . 0.0 110.076 169.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.456 ' HB3' HG22 ' A' ' 65' ' ' THR . 2.0 mp0 -92.32 122.69 35.02 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -136.3 138.11 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.892 1.277 . . . . 0.0 108.566 -178.222 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -82.88 104.68 13.29 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.503 ' HB2' HG22 ' A' ' 62' ' ' THR . 89.2 m95 -86.29 128.17 34.88 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.977 0.911 . . . . 0.0 109.684 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -71.71 -23.62 61.67 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -173.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.0 t -78.08 -44.68 25.56 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.48 0.582 . . . . 0.0 111.326 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 59' ' ' TRP . 11.0 t -85.3 -18.94 32.39 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-O 121.006 0.432 . . . . 0.0 110.453 176.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.38 22.07 73.97 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-N 115.867 -0.606 . . . . 0.0 114.465 174.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -153.18 168.41 26.03 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 117.459 0.63 . . . . 0.0 111.999 -174.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.456 HG22 ' HB3' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -86.8 126.18 34.45 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.554 1.142 . . . . 0.0 109.215 -176.243 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -135.56 157.43 46.9 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.286 0.565 . . . . 0.0 111.42 -173.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.55 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 12.4 m-90 -86.28 111.22 20.23 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.389 1.476 . . . . 0.0 109.58 -174.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 54' ' ' PRO . 13.4 m -131.67 150.67 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.126 0.57 . . . . 0.0 110.013 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -78.51 146.6 34.25 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 122.677 0.391 . . . . 0.0 110.964 -175.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -59.54 -48.77 80.36 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.332 1.053 . . . . 0.0 112.013 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 76.6 t60 -68.04 -27.91 66.94 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.283 0.563 . . . . 0.0 110.438 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.507 ' HA ' HD11 ' A' ' 31' ' ' LEU . 38.8 mtp -93.69 9.09 38.39 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.068 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.7 tp -112.22 120.05 40.45 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 123.728 0.811 . . . . 0.0 108.842 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.531 ' HB2' HD23 ' A' ' 31' ' ' LEU . 39.0 tt0 -107.56 135.89 48.26 Favored 'General case' 0 C--O 1.207 -1.14 0 C-N-CA 124.733 1.213 . . . . 0.0 107.789 175.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.401 HD13 HD22 ' A' ' 22' ' ' LEU . 20.4 pt -111.73 119.01 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 119.73 1.15 . . . . 0.0 111.914 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.3 mp -96.38 -0.94 48.64 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.469 1.108 . . . . 0.0 110.629 173.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.298 0 CA-C-O 119.726 -0.486 . . . . 0.0 112.732 174.641 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 41.1 t80 . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.904 0.383 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.15 -29.86 75.74 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.83 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 44.0 tt0 -72.92 -38.48 66.84 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -62.38 -48.32 80.25 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.165 0.586 . . . . 0.0 111.222 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.47 ' HB ' HD23 ' A' ' 22' ' ' LEU . 33.0 m -62.1 -37.25 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -29.99 62.97 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.984 0.914 . . . . 0.0 110.454 178.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 10.6 mm100 -78.88 -47.33 16.73 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.988 0.515 . . . . 0.0 110.101 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 t -96.96 4.52 51.51 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -166.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.485 HD13 ' SD ' ' A' ' 26' ' ' MET . 2.0 mm? -87.59 115.28 24.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.818 -0.551 . . . . 0.0 111.574 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 26' ' ' MET . 1.4 mp0 -92.94 137.24 23.94 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 124.003 0.921 . . . . 0.0 109.688 171.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.56 86.68 0.21 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.472 2.115 . . . . 0.0 111.371 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 144.71 4.55 0.62 Allowed Glycine 0 C--N 1.347 1.171 0 CA-C-N 115.737 -0.665 . . . . 0.0 113.065 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.67 ' SD ' HG21 ' A' ' 75' ' ' ILE . 6.2 ptp -95.01 175.52 6.6 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 117.345 0.573 . . . . 0.0 110.827 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -99.52 128.4 45.63 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.058 1.343 . . . . 0.0 109.815 -170.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -115.58 171.36 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.589 0.756 . . . . 0.0 109.655 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.516 ' HA ' ' HG2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -144.0 126.95 16.37 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -174.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -78.89 121.91 25.45 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.515 HD23 ' HB2' ' A' ' 74' ' ' GLU . 4.2 pp -105.6 14.09 28.98 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 117.945 0.339 . . . . 0.0 111.34 176.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -137.04 172.37 13.11 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.144 0.978 . . . . 0.0 111.327 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -97.35 140.53 31.67 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.889 0.876 . . . . 0.0 110.107 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -134.41 173.66 11.39 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.677 1.191 . . . . 0.0 111.421 -176.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -46.34 -45.03 17.35 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.585 1.554 . . . . 0.0 111.955 175.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -140.84 -1.95 1.37 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.183 -171.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.402 HG23 ' OD2' ' A' ' 41' ' ' ASP . 3.8 mp -116.22 147.58 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 124.251 1.021 . . . . 0.0 108.344 175.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.1 m -127.49 160.96 29.89 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.958 0.503 . . . . 0.0 109.674 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.1 113.89 4.83 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.17 -61.04 0.56 Allowed Glycine 0 C--N 1.343 0.947 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -172.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.402 ' OD2' HG23 ' A' ' 37' ' ' ILE . 4.9 p-10 -77.33 148.72 35.48 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.4 0.619 . . . . 0.0 110.632 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.516 ' HG2' ' HA ' ' A' ' 29' ' ' ARG . 42.4 mt-10 -125.62 161.34 27.45 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.014 -161.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.75 -171.97 12.64 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.887 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -133.07 135.87 45.58 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.506 ' HA ' HG12 ' A' ' 57' ' ' VAL . 16.3 t80 -72.66 121.37 19.68 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.531 0.732 . . . . 0.0 109.258 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.9 mmm180 -107.32 -46.37 3.89 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -175.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -152.86 159.56 43.03 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.851 0.861 . . . . 0.0 110.071 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 64.7 p -119.58 173.39 7.03 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.72 0.808 . . . . 0.0 111.205 -176.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -126.88 138.88 53.38 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.429 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -62.11 -38.81 90.31 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.925 0.89 . . . . 0.0 112.223 -176.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.26 26.58 0.24 Allowed Glycine 0 C--N 1.345 1.044 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.711 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.7 mm -101.19 108.52 55.19 Favored Pre-proline 0 N--CA 1.477 0.886 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.16 -39.31 91.61 Favored 'Trans proline' 0 CA--C 1.576 2.61 0 C-N-CA 122.638 2.225 . . . . 0.0 116.71 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.69 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 96.1 Cg_endo -75.68 97.5 1.11 Allowed 'Trans proline' 0 C--N 1.384 2.444 0 CA-C-N 122.411 1.897 . . . . 0.0 112.397 169.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.8 p -90.64 153.27 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.004 0.922 . . . . 0.0 111.297 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -96.76 129.9 44.1 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.237 0.615 . . . . 0.0 111.665 -172.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.506 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -139.85 141.79 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 125.743 1.617 . . . . 0.0 108.788 178.313 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -81.2 107.25 13.84 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.913 0.885 . . . . 0.0 109.143 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.526 ' HB2' HG22 ' A' ' 62' ' ' THR . 99.0 m95 -90.9 133.82 34.95 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.147 0.979 . . . . 0.0 111.097 -177.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -59.57 -35.19 73.78 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 124.04 0.837 . . . . 0.0 111.535 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.9 p -66.8 -45.31 78.81 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.653 0.781 . . . . 0.0 112.221 -173.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.526 HG22 ' HB2' ' A' ' 59' ' ' TRP . 10.6 t -104.84 -9.4 18.06 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.175 0.59 . . . . 0.0 111.695 -174.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.52 21.6 72.69 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 114.291 0.476 . . . . 0.0 114.291 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -151.8 176.08 11.78 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.277 0.631 . . . . 0.0 110.665 -176.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 2.1 p -85.23 129.62 34.77 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.066 0.547 . . . . 0.0 109.969 175.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -130.13 158.54 39.41 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.314 0.578 . . . . 0.0 110.196 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.69 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 18.7 m-90 -81.59 104.82 12.28 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.796 1.239 . . . . 0.0 110.782 -176.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.5 m -126.21 156.84 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.063 0.545 . . . . 0.0 110.33 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.479 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 9.1 t-160 -84.44 147.51 27.06 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 122.939 0.496 . . . . 0.0 110.944 -174.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -59.94 -47.01 87.55 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.898 0.879 . . . . 0.0 111.253 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -66.32 -25.85 67.03 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.56 0.744 . . . . 0.0 111.471 -178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.479 ' SD ' ' HB3' ' A' ' 69' ' ' HIS . 59.5 mtp -95.14 -2.42 49.91 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.954 0.902 . . . . 0.0 111.676 -171.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 pp -110.07 157.73 19.03 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 167.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.515 ' HB2' HD23 ' A' ' 31' ' ' LEU . 30.7 tt0 -138.13 137.13 37.38 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 125.074 1.35 . . . . 0.0 108.231 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.67 HG21 ' SD ' ' A' ' 26' ' ' MET . 7.2 pt -85.72 112.19 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 169.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 31.4 tp -119.09 6.71 11.29 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.416 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.458 0 CA-C-O 119.447 -0.64 . . . . 0.0 113.021 179.769 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 40.8 t80 . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.61 -26.63 71.05 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 114.59 -1.186 . . . . 0.0 113.401 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 15.1 tp10 -71.45 -47.34 56.4 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -58.38 -50.01 75.18 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.955 0.784 . . . . 0.0 111.052 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.2 m -67.59 -36.35 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.833 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -54.96 -34.59 63.42 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.405 0.682 . . . . 0.0 111.333 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 48.5 mm-40 -85.06 -48.69 8.95 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.074 -176.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 t -85.98 -9.98 55.9 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -168.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.496 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.2 OUTLIER -66.89 107.21 2.13 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 118.589 0.631 . . . . 0.0 110.176 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -94.75 132.72 27.9 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 124.016 0.926 . . . . 0.0 110.424 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.2 84.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.388 2.725 . . . . 0.0 113.868 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 141.05 4.8 1.07 Allowed Glycine 0 C--N 1.343 0.944 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.759 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.496 ' SD ' HD13 ' A' ' 22' ' ' LEU . 5.4 ptp -91.89 166.82 12.53 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 117.479 0.64 . . . . 0.0 110.717 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -88.76 134.84 33.79 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.595 1.158 . . . . 0.0 109.375 -174.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.0 m -117.15 172.31 5.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -151.01 140.01 21.03 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.7 tpp -85.94 128.94 34.95 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.142 0.496 . . . . 0.0 110.863 -175.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 23.2 tp -106.03 -5.79 19.24 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.868 0.867 . . . . 0.0 111.365 -173.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -138.27 160.66 38.9 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.537 0.735 . . . . 0.0 111.136 -174.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -82.74 127.39 33.38 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -122.49 171.36 9.15 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.07 0.948 . . . . 0.0 111.409 -174.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -49.66 -45.4 48.58 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.542 1.537 . . . . 0.0 111.847 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -132.16 -5.4 3.45 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.684 -170.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mt -118.74 140.74 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.7 t -100.85 153.53 19.4 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 172.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.4 115.26 4.93 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.78 -36.1 2.22 Favored Glycine 0 C--N 1.338 0.694 0 O-C-N 123.665 0.603 . . . . 0.0 112.089 -175.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -63.24 141.62 58.7 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.23 0.612 . . . . 0.0 111.608 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -102.45 161.62 13.57 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.672 0.789 . . . . 0.0 111.13 -175.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.83 -170.2 19.59 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.466 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -135.3 137.81 42.84 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 48' ' ' SER . 57.4 t80 -85.23 119.6 25.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.927 173.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.79 -45.95 2.86 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 122.236 0.214 . . . . 0.0 111.198 172.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.85 163.54 23.39 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.917 0.487 . . . . 0.0 110.056 -177.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 37.8 t -148.86 168.52 22.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.596 0.758 . . . . 0.0 112.265 -167.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -137.36 118.52 14.48 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 164.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -89.91 -3.81 57.86 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.024 0.53 . . . . 0.0 111.761 -175.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -117.77 -25.4 3.1 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.023 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.641 HG22 ' HD2' ' A' ' 54' ' ' PRO . 7.2 mm -104.7 118.54 56.16 Favored Pre-proline 0 CA--C 1.557 1.212 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.39 -29.02 84.84 Favored 'Trans proline' 0 CA--C 1.581 2.828 0 N-CA-C 118.111 2.312 . . . . 0.0 118.111 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.641 ' HD2' HG22 ' A' ' 52' ' ' ILE . 58.6 Cg_endo -72.57 106.5 2.11 Favored 'Trans proline' 0 C--N 1.383 2.354 0 CA-C-N 123.084 2.137 . . . . 0.0 112.521 170.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.544 HG23 ' HA ' ' A' ' 48' ' ' SER . 8.9 p -86.49 146.12 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.642 168.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -91.94 128.14 37.67 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.91 136.47 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.269 1.028 . . . . 0.0 108.485 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -81.88 108.68 15.6 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.507 ' HB2' HG22 ' A' ' 62' ' ' THR . 95.3 m95 -93.15 131.0 38.61 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.941 0.896 . . . . 0.0 110.864 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -63.81 -27.28 69.07 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 124.133 0.896 . . . . 0.0 110.66 172.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.8 t -65.49 -47.04 77.41 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 124.369 1.068 . . . . 0.0 112.055 -173.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.507 HG22 ' HB2' ' A' ' 59' ' ' TRP . 6.6 t -103.28 -14.48 16.3 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.002 0.921 . . . . 0.0 110.458 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.84 14.14 82.35 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.86 -0.609 . . . . 0.0 113.688 178.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -150.26 172.01 16.05 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.266 0.555 . . . . 0.0 110.979 -174.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.43 124.52 33.51 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.629 1.172 . . . . 0.0 108.917 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -128.27 154.51 45.81 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.184 0.516 . . . . 0.0 110.763 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 14.4 m-90 -81.04 111.27 17.36 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.358 -1.292 . . . . 0.0 109.736 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.9 m -126.81 159.15 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.026 0.53 . . . . 0.0 109.838 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 33.3 t-80 -86.81 147.11 25.96 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.386 0.674 . . . . 0.0 110.124 -174.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -61.41 -48.5 80.9 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.084 0.554 . . . . 0.0 111.691 -178.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -69.3 -11.43 60.8 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.447 0.699 . . . . 0.0 111.734 -177.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 34.8 mtp -113.62 10.03 17.97 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.233 1.013 . . . . 0.0 110.787 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.9 tp -113.82 121.42 43.97 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 124.211 1.004 . . . . 0.0 108.708 176.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -107.84 132.44 53.42 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.911 0.885 . . . . 0.0 110.028 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.401 HD13 HD22 ' A' ' 22' ' ' LEU . 28.8 pt -113.03 134.69 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.824 -0.548 . . . . 0.0 111.012 172.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -98.32 7.73 45.82 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.65 0.78 . . . . 0.0 109.514 168.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.935 0 C-N-CA 124.308 0.956 . . . . 0.0 113.764 179.675 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.1 t80 . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.49 -36.83 84.58 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-O 121.409 0.449 . . . . 0.0 112.963 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.469 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 8.3 mp0 -71.26 -42.56 68.63 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.805 0.842 . . . . 0.0 109.132 176.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -60.28 -48.91 79.73 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 124.183 0.927 . . . . 0.0 111.798 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.8 m -64.06 -38.31 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 123.264 0.353 . . . . 0.0 110.572 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -56.13 -32.44 64.23 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.266 0.626 . . . . 0.0 111.103 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 41.8 mm-40 -77.16 -51.78 10.4 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.575 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.2 t -87.69 5.54 39.26 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.618 0.767 . . . . 0.0 112.383 -170.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -72.17 108.83 5.55 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.311 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.461 ' HB3' ' HB3' ' A' ' 26' ' ' MET . 35.1 tt0 -87.31 131.86 43.0 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 123.686 0.794 . . . . 0.0 110.179 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.441 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 72.4 Cg_exo -53.12 88.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.682 2.921 . . . . 0.0 113.031 170.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.73 22.86 5.23 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.155 170.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.461 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 3.8 ptp -89.39 168.73 11.99 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.256 0.551 . . . . 0.0 110.387 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.436 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 1.4 ttt180 -86.95 147.08 25.91 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.838 1.255 . . . . 0.0 108.967 -176.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.522 HG22 HG22 ' A' ' 75' ' ' ILE . 55.9 t -130.71 164.08 34.73 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 C-N-CA 124.444 1.098 . . . . 0.0 109.469 -172.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.418 ' HD2' ' N ' ' A' ' 30' ' ' MET . 3.5 tmm_? -142.7 145.65 33.59 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.376 1.47 . . . . 0.0 107.607 172.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.418 ' N ' ' HD2' ' A' ' 29' ' ' ARG . 4.4 tpt -85.18 112.26 20.55 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.137 0.575 . . . . 0.0 109.734 -175.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 39.0 tp -86.46 -20.02 28.74 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.339 0.656 . . . . 0.0 111.682 -174.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -136.67 155.12 50.31 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.741 0.416 . . . . 0.0 110.29 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -76.51 138.98 40.58 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.933 0.493 . . . . 0.0 110.339 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -131.21 171.42 13.32 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.306 1.042 . . . . 0.0 110.822 -172.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -48.58 -58.76 4.22 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.126 1.37 . . . . 0.0 112.032 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -117.96 -1.0 11.55 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.11 0.964 . . . . 0.0 111.402 -175.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mp -118.18 139.86 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.6 m -104.79 152.48 22.52 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.72 114.24 3.88 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.99 -36.12 2.1 Favored Glycine 0 C--N 1.346 1.131 0 O-C-N 123.488 0.493 . . . . 0.0 112.36 -173.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -61.61 147.82 44.44 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.198 0.599 . . . . 0.0 111.753 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -102.23 155.46 18.2 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.337 0.655 . . . . 0.0 111.009 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -140.32 -175.73 14.67 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.835 -175.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -139.33 138.54 36.74 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.562 ' HA ' HG12 ' A' ' 57' ' ' VAL . 87.1 t80 -71.07 122.4 20.01 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 122.685 0.394 . . . . 0.0 110.015 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 22.8 mmm180 -108.75 -48.57 3.28 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -176.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -167.19 155.46 9.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.364 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.8 p -123.11 179.4 4.7 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.135 0.974 . . . . 0.0 109.955 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -107.84 140.07 41.49 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 172.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -51.43 -22.43 3.03 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -168.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -173.65 30.67 0.1 OUTLIER Glycine 0 N--CA 1.467 0.761 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 176.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.627 HG22 ' HD2' ' A' ' 54' ' ' PRO . 4.9 mm -117.09 130.02 24.91 Favored Pre-proline 0 N--CA 1.477 0.904 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.478 ' HA ' ' CD1' ' A' ' 70' ' ' TRP . 13.6 Cg_endo -55.43 -40.77 83.71 Favored 'Trans proline' 0 CA--C 1.584 2.982 0 C-N-CA 122.842 2.361 . . . . 0.0 118.172 -175.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.627 ' HD2' HG22 ' A' ' 52' ' ' ILE . 57.7 Cg_endo -68.84 101.45 0.79 Allowed 'Trans proline' 0 C--N 1.394 2.941 0 CA-C-N 122.736 2.013 . . . . 0.0 112.558 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 p -94.43 140.52 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.944 0.898 . . . . 0.0 109.918 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.448 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 2.1 mp0 -93.65 122.81 36.49 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.381 0.672 . . . . 0.0 109.72 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -132.78 140.63 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 125.262 1.425 . . . . 0.0 108.825 -178.522 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -79.38 108.1 12.64 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.506 ' HB2' HG22 ' A' ' 62' ' ' THR . 93.8 m95 -91.65 131.36 37.1 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.943 0.897 . . . . 0.0 110.066 177.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -59.41 -31.85 69.64 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.223 1.009 . . . . 0.0 111.688 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.7 t -67.55 -45.63 75.09 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.695 0.798 . . . . 0.0 112.07 -172.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.506 HG22 ' HB2' ' A' ' 59' ' ' TRP . 6.1 t -97.68 -21.24 17.12 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.32 0.648 . . . . 0.0 110.988 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.8 18.66 69.7 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.783 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -151.95 -176.93 5.85 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.138 0.575 . . . . 0.0 110.579 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 56' ' ' GLN . 5.2 p -86.03 144.38 27.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.503 0.721 . . . . 0.0 110.753 173.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -140.0 154.47 47.15 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.198 0.599 . . . . 0.0 109.942 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -81.4 111.99 18.26 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.555 1.142 . . . . 0.0 109.959 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.689 HG21 HD13 ' A' ' 73' ' ' LEU . 19.1 m -126.03 159.98 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.185 0.594 . . . . 0.0 110.772 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.513 ' HB3' ' HB2' ' A' ' 72' ' ' MET . 14.9 t-80 -91.14 147.04 23.34 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.283 1.033 . . . . 0.0 109.475 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.478 ' CD1' ' HA ' ' A' ' 53' ' ' PRO . 97.2 m95 -64.99 -45.99 83.3 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.013 0.525 . . . . 0.0 111.917 -175.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.8 t60 -70.47 -17.26 62.97 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.077 0.465 . . . . 0.0 111.678 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.513 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 21.3 mtp -104.16 14.19 30.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.526 1.13 . . . . 0.0 110.502 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.689 HD13 HG21 ' A' ' 68' ' ' VAL . 29.1 tp -119.19 121.26 39.33 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.298 1.039 . . . . 0.0 108.578 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -112.68 119.81 39.37 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.522 HG22 HG22 ' A' ' 28' ' ' VAL . 14.0 pt -86.81 117.54 31.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.488 0.661 . . . . 0.0 110.533 175.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 16.8 tp -96.22 15.17 21.73 Favored 'General case' 0 CA--C 1.556 1.173 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.121 174.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 27' ' ' ARG . . . . . . . . 0 C--N 1.36 1.892 0 C-N-CA 123.741 0.686 . . . . 0.0 112.681 170.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.8 t80 . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.77 -36.43 91.18 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.497 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 33.6 tt0 -63.24 -47.45 82.42 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 171.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -57.83 -51.97 67.41 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.376 1.048 . . . . 0.0 111.854 -173.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.7 m -67.13 -37.88 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 O-C-N 123.789 0.681 . . . . 0.0 110.764 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.78 -34.17 67.37 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.575 0.75 . . . . 0.0 110.225 177.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 25.4 mm-40 -79.29 -50.01 11.57 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.815 0.446 . . . . 0.0 111.068 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.1 t -90.84 3.97 53.04 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -169.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.83 125.09 25.87 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 26' ' ' MET . 21.3 tt0 -90.96 139.63 25.95 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 124.145 0.978 . . . . 0.0 109.384 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' HA ' ' CD1' ' A' ' 45' ' ' PHE . 25.9 Cg_exo -63.63 84.62 0.13 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.742 2.294 . . . . 0.0 112.922 172.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.59 31.51 1.79 Allowed Glycine 0 C--N 1.353 1.49 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 171.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.501 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 25.9 ptm -100.59 174.61 6.0 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.268 0.556 . . . . 0.0 109.857 177.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.677 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 19.1 tpt180 -91.05 130.6 36.94 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 124.349 1.059 . . . . 0.0 108.995 -173.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.5 m -116.45 173.23 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.439 0.696 . . . . 0.0 109.33 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.07 137.15 25.79 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -171.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.6 tpt -82.62 111.61 18.74 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 55.2 tp -80.39 -38.59 30.01 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.176 0.591 . . . . 0.0 110.698 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -126.86 154.04 44.91 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.212 0.605 . . . . 0.0 110.553 -175.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.99 119.47 17.27 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.337 0.655 . . . . 0.0 110.605 -174.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -102.6 173.46 6.33 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.386 1.074 . . . . 0.0 111.502 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -45.61 -52.1 11.11 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 126.174 1.79 . . . . 0.0 112.2 -175.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -124.9 -11.41 7.15 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.462 -177.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.2 mp -102.21 132.19 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.7 m -94.48 148.66 22.02 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.496 0.318 . . . . 0.0 110.39 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.8 115.73 4.61 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.94 -18.93 8.43 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 123.479 0.487 . . . . 0.0 112.452 -172.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -75.24 155.21 37.02 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.156 0.582 . . . . 0.0 109.57 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -126.7 154.29 44.31 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.582 0.706 . . . . 0.0 111.165 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.423 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . -137.42 -169.5 11.65 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.815 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -137.22 144.34 42.76 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.542 ' CD1' ' HA ' ' A' ' 24' ' ' PRO . 51.1 t80 -69.62 121.86 17.96 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.443 0.697 . . . . 0.0 109.31 177.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 10.2 mmm180 -108.95 -43.75 4.14 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -178.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.479 ' OE1' ' HB2' ' A' ' 56' ' ' GLN . 0.5 OUTLIER -170.78 172.68 5.59 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.354 1.461 . . . . 0.0 107.895 177.237 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -157.18 179.8 8.93 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.748 0.785 . . . . 0.0 112.317 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -126.46 126.55 43.95 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.076 -1.42 . . . . 0.0 107.633 171.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -73.51 -44.55 57.46 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.195 0.598 . . . . 0.0 110.72 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.98 -27.51 25.96 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.189 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.62 HG22 ' HD2' ' A' ' 54' ' ' PRO . 9.0 mm -100.55 118.72 60.42 Favored Pre-proline 0 CA--C 1.554 1.111 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -176.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -60.4 -31.01 92.13 Favored 'Trans proline' 0 CA--C 1.579 2.731 0 N-CA-C 118.961 2.639 . . . . 0.0 118.961 -172.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.62 ' HD2' HG22 ' A' ' 52' ' ' ILE . 56.8 Cg_endo -70.1 110.15 2.55 Favored 'Trans proline' 0 C--N 1.372 1.772 0 CA-C-N 122.925 2.08 . . . . 0.0 113.316 173.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.94 139.46 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.303 1.041 . . . . 0.0 109.82 167.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.479 ' HB2' ' OE1' ' A' ' 47' ' ' GLN . 1.7 mp0 -91.94 122.05 34.1 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -135.82 136.24 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.571 1.149 . . . . 0.0 108.819 -177.561 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 59.9 t80 -82.01 106.42 13.9 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.45 ' HB2' HG22 ' A' ' 62' ' ' THR . 89.0 m95 -90.29 130.71 36.37 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.426 1.09 . . . . 0.0 110.125 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -69.51 -37.93 77.36 Favored 'General case' 0 CA--C 1.554 1.099 0 O-C-N 123.842 0.714 . . . . 0.0 112.679 -173.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.1 t -69.59 -43.19 73.31 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.436 0.294 . . . . 0.0 111.677 -174.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 59' ' ' TRP . 11.4 t -86.18 -17.13 35.71 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.794 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.48 18.32 76.08 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 114.539 0.576 . . . . 0.0 114.539 172.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -152.8 166.55 31.91 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.229 0.538 . . . . 0.0 112.086 -172.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 1.4 m -85.67 130.79 34.47 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.841 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -137.16 148.91 46.92 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.885 0.374 . . . . 0.0 110.688 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.461 ' CD1' ' HG3' ' A' ' 56' ' ' GLN . 11.1 m0 -76.76 114.15 15.21 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.462 1.105 . . . . 0.0 109.323 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.445 HG21 HD13 ' A' ' 73' ' ' LEU . 18.6 m -126.46 156.47 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.112 0.565 . . . . 0.0 109.676 175.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -86.07 145.92 26.85 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -63.09 -42.7 99.67 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.219 0.608 . . . . 0.0 111.768 -175.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -68.11 -14.42 62.97 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.538 0.735 . . . . 0.0 111.995 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 72.3 mtm -113.03 16.95 19.19 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.406 0.682 . . . . 0.0 110.958 174.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.445 HD13 HG21 ' A' ' 68' ' ' VAL . 40.6 tp -114.83 122.14 45.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.305 0.642 . . . . 0.0 109.295 176.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -105.23 147.29 28.2 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.409 1.084 . . . . 0.0 108.367 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.0 pt -112.43 115.95 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 121.378 0.609 . . . . 0.0 110.222 173.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.6 tp -136.62 101.66 4.69 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.677 ' HA3' ' HB3' ' A' ' 27' ' ' ARG . . . . . . . . 0 C--N 1.341 0.858 0 CA-C-O 119.432 -0.649 . . . . 0.0 112.465 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.404 ' OH ' ' HA ' ' A' ' 74' ' ' GLU . 64.5 t80 . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.469 0.176 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.0 -38.86 63.9 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.904 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.563 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 3.2 mp0 -70.91 -37.6 72.95 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -58.44 -49.12 78.45 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.913 0.758 . . . . 0.0 111.417 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 27.0 m -62.58 -38.96 82.82 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -58.84 -40.64 84.8 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.141 0.576 . . . . 0.0 109.846 177.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 11.0 mm100 -66.76 -40.0 88.1 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.313 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.4 t -110.53 13.08 22.73 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -169.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.621 HD12 ' SD ' ' A' ' 26' ' ' MET . 18.1 tp -87.55 110.93 20.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.858 -0.527 . . . . 0.0 110.428 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.612 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 38.7 mt-30 -87.84 141.44 31.65 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 124.203 1.001 . . . . 0.0 109.892 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.89 85.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.972 2.448 . . . . 0.0 111.728 173.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.64 73.71 1.19 Allowed Glycine 0 C--N 1.342 0.905 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.797 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.621 ' SD ' HD12 ' A' ' 22' ' ' LEU . 21.8 ptm -118.78 -58.32 1.97 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 118.465 -0.779 . . . . 0.0 112.044 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.578 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 24.8 tpt180 146.08 122.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 128.088 2.555 . . . . 0.0 107.929 173.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 m -118.14 171.74 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-O 121.326 0.584 . . . . 0.0 110.206 177.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.693 ' HB2' HD22 ' A' ' 76' ' ' LEU . 7.1 tpt180 -148.81 150.34 32.89 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.719 1.608 . . . . 0.0 107.529 -169.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.1 tpt -90.33 111.89 23.26 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 34.4 tp -77.41 -33.16 55.06 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.421 0.689 . . . . 0.0 110.912 -174.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -145.29 153.99 41.87 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.627 0.771 . . . . 0.0 109.072 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.46 142.03 58.09 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.52 0.728 . . . . 0.0 111.573 -172.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -126.33 171.76 10.69 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.818 0.847 . . . . 0.0 110.921 -175.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -47.37 -37.81 11.93 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.728 1.611 . . . . 0.0 113.233 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -139.94 -0.01 1.73 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.494 -171.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 mt -119.83 141.01 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.224 1.01 . . . . 0.0 109.19 -175.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.4 p -91.41 142.35 27.77 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.059 0.544 . . . . 0.0 109.969 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.39 117.39 5.61 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.665 0.386 . . . . 0.0 110.069 171.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.92 -4.27 28.88 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 123.542 0.526 . . . . 0.0 112.537 -175.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -77.34 156.57 31.19 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.165 0.586 . . . . 0.0 109.658 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 51.0 mt-10 -113.15 157.26 21.88 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.752 0.787 . . . . 0.0 111.596 -178.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -146.25 -172.53 16.66 Favored Glycine 0 C--O 1.244 0.756 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.046 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -138.2 141.34 40.01 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 170.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.443 ' HE1' ' HB3' ' A' ' 48' ' ' SER . 32.8 t80 -70.58 120.45 16.23 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.639 0.776 . . . . 0.0 110.207 176.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 -108.85 -47.63 3.42 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.804 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.424 ' OE1' ' HB2' ' A' ' 56' ' ' GLN . 0.5 OUTLIER -163.78 155.86 17.23 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.537 1.135 . . . . 0.0 109.316 -177.12 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.443 ' HB3' ' HE1' ' A' ' 45' ' ' PHE . 41.4 p -132.09 179.03 6.34 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.715 0.806 . . . . 0.0 110.772 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 3.1 m120 -139.51 132.7 29.78 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -86.49 -30.94 21.6 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.363 0.665 . . . . 0.0 110.054 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.62 -35.99 27.33 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.926 175.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 26.2 mm -106.74 100.97 34.13 Favored Pre-proline 0 N--CA 1.485 1.317 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -56.25 -30.65 81.13 Favored 'Trans proline' 0 CA--C 1.571 2.345 0 C-N-CA 122.746 2.297 . . . . 0.0 117.933 -173.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.638 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 55.9 Cg_endo -67.36 111.99 2.45 Favored 'Trans proline' 0 C--N 1.378 2.124 0 CA-C-N 123.297 2.213 . . . . 0.0 111.649 171.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 p -81.54 141.44 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.467 1.107 . . . . 0.0 110.689 171.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.569 ' HB3' HG22 ' A' ' 65' ' ' THR . 1.5 mp0 -90.17 126.85 35.95 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.446 HG23 ' NE1' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -138.26 137.34 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 125.16 1.384 . . . . 0.0 108.817 -177.548 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -82.03 105.78 13.41 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.24 0.616 . . . . 0.0 109.818 -175.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.489 ' HB2' HG22 ' A' ' 62' ' ' THR . 91.7 m95 -92.58 132.62 36.7 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.34 1.056 . . . . 0.0 111.2 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 13.6 pt20 -69.2 -28.33 66.28 Favored 'General case' 0 CA--C 1.55 0.967 0 O-C-N 124.141 0.901 . . . . 0.0 112.078 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.0 t -64.37 -46.46 83.27 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.05 0.387 . . . . 0.0 112.01 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.489 HG22 ' HB2' ' A' ' 59' ' ' TRP . 10.2 t -98.17 -12.08 22.08 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.543 0.737 . . . . 0.0 110.756 -176.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.3 16.09 79.94 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-N 115.986 -0.552 . . . . 0.0 113.898 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -151.9 170.69 19.22 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.345 0.593 . . . . 0.0 111.682 -174.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.569 HG22 ' HB3' ' A' ' 56' ' ' GLN . 1.7 m -87.0 120.06 27.86 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.271 -177.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -127.95 157.13 41.43 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.75 0.42 . . . . 0.0 111.152 -175.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.638 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 4.3 m-90 -75.65 120.67 21.37 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.456 1.102 . . . . 0.0 110.649 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.482 HG21 HD13 ' A' ' 73' ' ' LEU . 6.3 m -135.41 147.89 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 173.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -78.95 148.21 32.72 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.928 0.491 . . . . 0.0 110.496 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -54.47 -49.66 69.56 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.282 1.033 . . . . 0.0 112.305 -178.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -74.83 -13.11 60.53 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.073 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 29.1 mtp -106.76 13.88 27.44 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.857 0.863 . . . . 0.0 110.356 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.482 HD13 HG21 ' A' ' 68' ' ' VAL . 53.6 tp -116.18 131.32 56.98 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.641 1.177 . . . . 0.0 108.799 176.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HA ' ' OH ' ' A' ' 14' ' ' TYR . 10.9 tp10 -106.12 140.89 38.38 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.753 1.221 . . . . 0.0 108.234 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 pt -115.4 148.43 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-N 118.435 0.562 . . . . 0.0 111.52 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.693 HD22 ' HB2' ' A' ' 29' ' ' ARG . 2.1 pt? -152.08 35.94 0.54 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.839 0.856 . . . . 0.0 109.559 178.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' A' ' 27' ' ' ARG . . . . . . . . 0 CA--C 1.537 1.459 0 CA-C-O 118.666 -1.074 . . . . 0.0 115.534 -173.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.1 t80 . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.49 -42.05 74.62 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 121.512 0.506 . . . . 0.0 112.601 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 8.4 mp0 -69.33 -34.33 74.48 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 176.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -65.22 -49.73 68.56 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 123.866 0.728 . . . . 0.0 111.891 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.4 m -59.62 -38.86 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 123.319 0.387 . . . . 0.0 110.435 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -54.71 -35.47 63.67 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.364 0.665 . . . . 0.0 111.493 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.55 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 43.4 mm-40 -82.36 -36.25 27.02 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.463 -172.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.8 t -109.24 4.22 22.55 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.853 0.461 . . . . 0.0 112.142 -172.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.512 HD13 HG22 ' A' ' 75' ' ' ILE . 16.7 tp -86.08 116.73 24.47 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 122.007 -0.433 . . . . 0.0 109.994 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -92.01 137.47 25.15 Favored Pre-proline 0 N--CA 1.481 1.095 0 C-N-CA 124.207 1.003 . . . . 0.0 111.136 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.2 92.41 0.39 Allowed 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.017 2.478 . . . . 0.0 112.105 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.0 -8.22 4.15 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.661 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 5.5 ptp -92.46 166.5 12.51 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -88.17 162.7 16.56 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-O 121.896 0.855 . . . . 0.0 110.305 -171.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.6 m -131.64 175.65 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.061 176.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -143.89 146.07 32.75 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -174.424 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.5 tpt -98.05 118.17 34.05 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.777 0.831 . . . . 0.0 110.043 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.8 mt -74.94 -43.39 54.4 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.417 0.687 . . . . 0.0 112.066 -177.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -129.5 163.99 24.71 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -67.09 120.53 13.85 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.292 0.568 . . . . 0.0 110.889 -176.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.03 173.12 6.98 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.988 0.915 . . . . 0.0 110.384 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -47.79 -48.07 30.52 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.348 1.459 . . . . 0.0 113.542 -176.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -128.31 8.5 6.03 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.306 0.642 . . . . 0.0 111.571 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -120.07 143.56 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.3 m -99.46 154.02 18.55 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.561 0.619 . . . . 0.0 109.848 174.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.6 118.3 6.89 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.623 0.769 . . . . 0.0 110.068 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.53 -10.39 23.87 Favored Glycine 0 C--N 1.341 0.834 0 O-C-N 123.331 0.395 . . . . 0.0 113.237 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -79.95 157.26 26.9 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 120.948 0.404 . . . . 0.0 110.725 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 45.0 mt-10 -120.55 159.95 24.19 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.038 -174.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -141.7 -167.76 11.35 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.647 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -138.52 140.13 39.0 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 170.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.446 ' HA ' HG12 ' A' ' 57' ' ' VAL . 55.6 t80 -79.7 121.31 25.16 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.225 0.61 . . . . 0.0 110.102 176.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -108.26 -47.91 3.45 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -155.47 151.08 27.3 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.754 0.821 . . . . 0.0 110.109 -176.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.491 ' HA ' HG23 ' A' ' 55' ' ' VAL . 48.6 p -117.49 162.63 17.66 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.091 0.956 . . . . 0.0 111.123 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 7.3 m120 -124.46 121.47 34.96 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 160.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -89.87 -27.12 20.11 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.538 0.735 . . . . 0.0 109.943 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.32 -28.08 34.48 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.125 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 3.1 mp -114.31 102.43 54.82 Favored Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -178.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.4 -26.12 81.98 Favored 'Trans proline' 0 CA--C 1.583 2.949 0 N-CA-C 118.268 2.372 . . . . 0.0 118.268 -170.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.523 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 39.4 Cg_endo -67.56 105.87 1.16 Allowed 'Trans proline' 0 C--N 1.389 2.67 0 CA-C-N 123.56 2.307 . . . . 0.0 111.793 169.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' A' ' 48' ' ' SER . 6.4 p -86.59 145.84 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.467 1.107 . . . . 0.0 110.709 176.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -92.22 122.08 34.36 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -133.89 136.68 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.857 1.263 . . . . 0.0 108.752 178.855 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -81.09 108.65 14.94 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.514 ' HB2' HG22 ' A' ' 62' ' ' THR . 94.5 m95 -93.52 131.14 39.04 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.849 0.86 . . . . 0.0 110.898 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 18.4 pt20 -61.72 -27.21 68.55 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 124.114 0.883 . . . . 0.0 110.977 169.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.3 t -60.46 -45.16 94.71 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.609 1.164 . . . . 0.0 112.307 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.514 HG22 ' HB2' ' A' ' 59' ' ' TRP . 8.6 t -113.09 -10.74 13.41 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.685 0.794 . . . . 0.0 111.265 -174.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.45 13.89 82.74 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 116.359 -0.382 . . . . 0.0 113.91 178.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -152.47 173.65 14.86 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.274 0.559 . . . . 0.0 111.387 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.05 126.78 34.98 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.557 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -128.67 155.35 45.17 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 120.984 0.421 . . . . 0.0 111.059 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.523 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 10.1 m-90 -82.09 108.66 15.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.991 1.316 . . . . 0.0 109.732 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 m -125.97 151.54 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.128 0.571 . . . . 0.0 109.73 177.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -80.32 146.42 31.59 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -54.89 -45.37 74.65 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.833 1.253 . . . . 0.0 113.293 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -72.54 -22.39 61.02 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -173.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 70.7 mtm -93.39 -6.28 47.53 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.205 0.602 . . . . 0.0 111.424 174.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 tt -90.93 123.56 34.53 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 171.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 29' ' ' ARG . 40.4 tt0 -104.04 143.58 32.7 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.512 HG22 HD13 ' A' ' 22' ' ' LEU . 37.5 pt -105.91 117.16 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.0 mt -112.97 5.28 17.19 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.214 0.605 . . . . 0.0 110.831 173.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.311 0 CA-C-O 118.922 -0.932 . . . . 0.0 112.132 -179.215 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.4 t80 . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.08 -30.18 75.49 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.802 -0.635 . . . . 0.0 113.028 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 8.3 tp10 -72.28 -47.47 49.81 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 171.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.422 ' O ' HG22 ' A' ' 21' ' ' THR . 38.5 t80 -57.45 -48.78 78.26 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.294 1.038 . . . . 0.0 111.256 -172.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 m -58.29 -43.31 85.82 Favored 'Isoleucine or valine' 0 C--N 1.35 0.612 0 O-C-N 123.729 0.643 . . . . 0.0 110.259 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -62.12 -31.51 71.98 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.458 0.703 . . . . 0.0 111.189 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 79.5 mm-40 -82.22 -32.32 29.84 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.188 0.595 . . . . 0.0 111.519 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 17' ' ' TYR . 14.2 t -107.79 8.35 28.73 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.944 0.498 . . . . 0.0 111.966 -175.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.608 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.1 OUTLIER -67.66 117.83 10.12 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.062 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.723 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 9.8 mm100 -86.23 133.4 40.77 Favored Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.14 87.4 0.73 Allowed 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.875 2.383 . . . . 0.0 112.261 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.24 23.99 2.8 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.723 ' HB3' ' HB2' ' A' ' 23' ' ' GLN . 16.8 ptm -91.69 168.48 11.45 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.194 0.597 . . . . 0.0 110.118 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 ppp_? -90.3 147.14 23.69 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.797 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.4 t -129.28 164.88 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 124.937 1.295 . . . . 0.0 107.648 -169.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -149.53 133.13 16.76 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.0 tpt -82.81 112.59 19.78 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.782 0.833 . . . . 0.0 109.869 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.652 HD23 ' HB2' ' A' ' 74' ' ' GLU . 4.0 pp -85.9 -2.88 58.7 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 122.862 0.465 . . . . 0.0 111.19 176.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -124.79 162.87 23.37 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.198 0.999 . . . . 0.0 109.427 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -98.76 117.3 32.92 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -106.17 173.26 6.39 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.527 1.131 . . . . 0.0 112.175 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -51.71 -44.95 63.37 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.818 1.647 . . . . 0.0 112.455 -175.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.63 3.95 3.59 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.969 0.908 . . . . 0.0 111.396 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 mp -118.41 137.39 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 175.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.3 m -99.32 155.07 17.71 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.24 0.473 . . . . 0.0 109.919 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.17 114.15 5.68 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.31 -26.54 3.91 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 123.572 0.545 . . . . 0.0 112.402 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -69.94 158.22 36.0 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.234 0.613 . . . . 0.0 112.494 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -116.94 157.31 25.94 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 123.832 0.853 . . . . 0.0 111.552 -177.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.15 -173.75 14.97 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.731 -176.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -136.04 142.52 44.41 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 171.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 48' ' ' SER . 91.4 t80 -87.28 118.29 26.6 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.004 0.922 . . . . 0.0 110.059 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.32 -47.57 3.09 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 120.803 0.335 . . . . 0.0 110.653 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -145.77 161.93 38.81 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.61 0.764 . . . . 0.0 109.375 -175.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.426 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 53.4 p -158.64 169.28 24.76 Favored 'General case' 0 C--O 1.239 0.53 0 O-C-N 123.777 0.673 . . . . 0.0 111.988 -171.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.422 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 7.5 m-80 -139.13 139.66 37.7 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 171.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -93.62 -33.33 13.74 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.945 0.498 . . . . 0.0 110.319 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.11 -31.01 40.07 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.943 174.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.422 ' HB ' ' HB2' ' A' ' 49' ' ' ASN . 3.6 mp -104.33 99.8 19.09 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.27 -24.68 72.04 Favored 'Trans proline' 0 CA--C 1.573 2.429 0 N-CA-C 117.767 2.18 . . . . 0.0 117.767 -171.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.605 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 49.2 Cg_endo -70.37 107.82 2.06 Favored 'Trans proline' 0 C--N 1.383 2.393 0 CA-C-N 123.145 2.159 . . . . 0.0 111.702 168.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.3 p -85.68 141.43 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.326 1.05 . . . . 0.0 110.311 171.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -87.99 122.67 31.86 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.39 136.15 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.43 1.092 . . . . 0.0 108.544 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -81.53 108.03 14.78 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -176.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -92.87 131.05 38.24 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.699 0.799 . . . . 0.0 111.115 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -62.69 -31.3 72.17 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.928 0.891 . . . . 0.0 111.427 172.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.5 t -60.07 -43.74 95.26 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.82 1.248 . . . . 0.0 111.808 -172.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.1 t -113.07 -8.93 13.6 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.163 -174.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.02 15.39 81.19 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 116.351 -0.386 . . . . 0.0 114.028 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -151.65 169.6 21.75 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.528 0.68 . . . . 0.0 111.598 -172.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.21 123.42 32.2 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.267 -176.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -126.74 155.67 42.38 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.523 0.678 . . . . 0.0 110.809 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.605 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 9.3 m-90 -89.37 111.97 22.96 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.465 1.506 . . . . 0.0 109.288 -172.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.4 m -129.51 153.17 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.279 0.632 . . . . 0.0 110.51 -176.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -80.56 147.09 30.94 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.811 0.444 . . . . 0.0 110.734 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -59.42 -49.35 78.13 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.268 1.027 . . . . 0.0 112.929 -176.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -67.81 -23.18 65.16 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.164 0.585 . . . . 0.0 111.625 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.509 ' HA ' HD11 ' A' ' 31' ' ' LEU . 40.2 mtp -95.82 -4.13 44.36 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.573 1.149 . . . . 0.0 111.095 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.4 tt -93.95 141.07 28.94 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 172.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.652 ' HB2' HD23 ' A' ' 31' ' ' LEU . 39.4 tt0 -125.82 135.35 51.89 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.819 0.848 . . . . 0.0 108.902 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.1 pt -110.69 117.18 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-O 121.235 0.54 . . . . 0.0 110.512 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.4 mp -92.14 -6.65 50.37 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.189 0.996 . . . . 0.0 110.309 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.249 0 CA-C-O 118.853 -0.971 . . . . 0.0 111.771 176.698 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.1 t80 . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.22 -34.65 86.47 Favored Glycine 0 C--N 1.344 1.007 0 O-C-N 123.279 0.362 . . . . 0.0 113.244 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 7.2 tp10 -73.74 -38.93 64.59 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.637 0.375 . . . . 0.0 110.411 174.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -57.99 -50.29 73.92 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.975 0.91 . . . . 0.0 111.417 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.533 ' HB ' HD23 ' A' ' 22' ' ' LEU . 28.1 m -62.52 -37.81 79.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 O-C-N 124.345 1.028 . . . . 0.0 110.657 -177.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -42.11 70.6 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.136 0.574 . . . . 0.0 109.678 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 50.2 mm-40 -82.95 -29.52 29.04 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.461 -170.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 t -102.33 -2.43 28.98 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.533 HD23 ' HB ' ' A' ' 18' ' ' VAL . 0.9 OUTLIER -81.04 117.13 21.37 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 118.33 0.514 . . . . 0.0 110.946 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -102.43 140.21 20.92 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 124.041 0.936 . . . . 0.0 109.508 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.48 87.85 0.34 Allowed 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.48 2.12 . . . . 0.0 111.232 174.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 148.2 2.19 0.44 Allowed Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.153 176.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.437 ' SD ' HD13 ' A' ' 22' ' ' LEU . 12.3 ptp -96.63 165.45 12.14 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.706 0.753 . . . . 0.0 111.296 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.495 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 20.6 tpt180 -91.51 128.46 37.34 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.828 1.251 . . . . 0.0 109.316 -171.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 m -116.28 170.96 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.631 0.773 . . . . 0.0 109.546 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.57 HH11 ' HA2' ' A' ' 40' ' ' GLY . 2.2 tmm_? -152.31 131.17 12.48 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.459 1.104 . . . . 0.0 108.083 -178.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.46 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 31.6 tpp -88.64 127.29 35.56 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.805 0.842 . . . . 0.0 111.195 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.495 HD23 ' HB2' ' A' ' 74' ' ' GLU . 3.3 pp -102.34 3.75 38.3 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.569 0.748 . . . . 0.0 112.153 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 30' ' ' MET . 29.6 t70 -126.76 164.13 22.01 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.779 0.832 . . . . 0.0 109.764 -178.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -95.96 117.09 29.96 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.886 -0.509 . . . . 0.0 110.015 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -111.16 170.52 8.05 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.0 1.32 . . . . 0.0 109.442 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -40.91 -55.33 2.52 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 125.919 1.688 . . . . 0.0 112.996 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -126.19 3.1 7.13 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.743 0.817 . . . . 0.0 111.47 -175.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -119.64 101.61 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.409 0.684 . . . . 0.0 109.167 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -78.82 150.58 32.28 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.89 115.55 3.78 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.347 0.659 . . . . 0.0 110.757 -175.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.57 ' HA2' HH11 ' A' ' 29' ' ' ARG . . . 127.78 -14.45 6.36 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.86 -176.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -73.42 154.24 40.08 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.645 0.378 . . . . 0.0 111.58 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -114.88 159.26 20.89 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.726 0.811 . . . . 0.0 110.702 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.495 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . -151.94 -171.65 19.89 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.391 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -134.98 142.67 46.51 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.477 ' CG ' HD12 ' A' ' 22' ' ' LEU . 20.9 t80 -80.01 122.58 26.92 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.499 0.719 . . . . 0.0 109.326 -176.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.416 ' HB2' ' OE1' ' A' ' 47' ' ' GLN . 12.2 mmm180 -108.4 -45.76 3.83 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.315 0.578 . . . . 0.0 109.726 -171.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.416 ' OE1' ' HB2' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -151.71 157.22 41.75 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.85 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.2 p -118.37 157.75 26.54 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 123.873 0.733 . . . . 0.0 110.642 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -153.68 118.37 4.97 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 175.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -100.19 -15.6 18.07 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.277 1.031 . . . . 0.0 110.319 -170.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.16 -20.14 59.6 Favored Glycine 0 C--N 1.349 1.275 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 168.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.8 mp -114.73 98.94 50.96 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.23 -31.09 92.75 Favored 'Trans proline' 0 CA--C 1.576 2.619 0 C-N-CA 122.106 1.871 . . . . 0.0 116.195 -177.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.734 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 92.3 Cg_endo -79.53 98.25 1.14 Allowed 'Trans proline' 0 C--N 1.382 2.296 0 CA-C-N 122.371 1.883 . . . . 0.0 111.861 166.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 14.5 p -82.55 154.51 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.333 1.053 . . . . 0.0 111.829 -178.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -94.86 128.81 41.89 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.151 0.58 . . . . 0.0 110.585 -172.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -140.66 140.45 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 125.298 1.439 . . . . 0.0 108.627 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -81.8 106.84 14.05 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.46 ' CH2' ' HB2' ' A' ' 30' ' ' MET . 96.2 m95 -88.77 130.97 35.25 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.314 1.046 . . . . 0.0 110.374 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -69.52 -26.66 64.63 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.705 0.802 . . . . 0.0 112.171 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.6 t -68.89 -44.22 73.67 Favored 'General case' 0 C--N 1.357 0.929 0 CA-C-O 120.69 0.281 . . . . 0.0 111.178 -177.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.2 t -94.88 -30.32 14.24 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.397 0.679 . . . . 0.0 111.681 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.68 23.54 30.52 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-O 119.733 -0.482 . . . . 0.0 114.271 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -154.19 176.87 11.75 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 117.439 0.62 . . . . 0.0 111.754 -175.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 2.0 p -83.59 142.35 30.9 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 172.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -144.98 154.76 42.89 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.35 0.595 . . . . 0.0 110.096 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.734 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 16.3 m-90 -81.98 115.68 21.25 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.01 -176.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.438 HG21 ' HZ2' ' A' ' 59' ' ' TRP . 19.9 m -137.68 145.11 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.365 0.666 . . . . 0.0 109.687 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.519 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 9.5 t-80 -69.44 147.06 51.46 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.607 0.363 . . . . 0.0 110.841 -177.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.452 ' O ' HG21 ' A' ' 18' ' ' VAL . 90.4 m95 -59.45 -45.78 90.62 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.546 0.738 . . . . 0.0 111.634 -176.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -65.18 -23.26 67.05 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.502 0.721 . . . . 0.0 111.918 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.519 ' SD ' ' HB3' ' A' ' 69' ' ' HIS . 33.8 mtp -90.04 -14.2 34.36 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.223 1.009 . . . . 0.0 111.077 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.4 tt -90.78 122.01 33.15 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.495 ' HB2' HD23 ' A' ' 31' ' ' LEU . 35.3 tt0 -123.12 125.23 44.78 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.296 1.039 . . . . 0.0 109.212 -176.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.463 HD13 HD22 ' A' ' 22' ' ' LEU . 12.2 pt -100.28 118.75 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 121.314 0.578 . . . . 0.0 111.609 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 mp -106.56 9.23 31.51 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 165.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.434 0 CA-C-O 119.193 -0.782 . . . . 0.0 112.964 -175.201 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 55.3 t80 . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.59 -36.91 88.92 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-O 122.029 0.794 . . . . 0.0 112.717 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 2.5 mp0 -73.78 -33.08 64.09 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.027 -1.086 . . . . 0.0 110.246 177.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -68.63 -49.41 59.39 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.825 0.85 . . . . 0.0 110.837 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.573 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 20.9 m -59.11 -39.14 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 O-C-N 123.779 0.675 . . . . 0.0 110.135 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -57.57 -38.7 75.28 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.141 0.976 . . . . 0.0 111.55 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 52.9 mm-40 -78.2 -43.03 29.64 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.412 0.285 . . . . 0.0 111.282 -176.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.1 t -88.66 2.0 54.03 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.109 0.563 . . . . 0.0 112.384 -174.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.573 ' HB2' ' O ' ' A' ' 18' ' ' VAL . 12.7 tp -76.72 124.99 28.49 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.455 0.702 . . . . 0.0 111.176 -173.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -113.6 124.89 30.38 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 123.736 0.815 . . . . 0.0 109.617 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.47 85.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 124.24 3.293 . . . . 0.0 114.547 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.61 26.8 1.54 Allowed Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.837 174.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.508 ' SD ' HD12 ' A' ' 22' ' ' LEU . 4.5 ptp -91.73 175.63 6.83 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.436 0.636 . . . . 0.0 110.844 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.0 tpt85 -94.61 126.55 39.98 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.931 -170.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.465 HG22 HG22 ' A' ' 75' ' ' ILE . 41.6 t -119.01 160.07 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 C-N-CA 124.572 1.149 . . . . 0.0 111.26 -167.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.5 tpp85 -140.71 151.87 44.85 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 126.673 1.989 . . . . 0.0 108.567 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.9 tpt -94.89 115.5 27.54 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.481 0.712 . . . . 0.0 109.524 177.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 74' ' ' GLU . 38.8 tp -83.68 -29.03 27.93 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.192 0.597 . . . . 0.0 111.149 -177.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -137.19 154.6 50.17 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.754 0.422 . . . . 0.0 110.777 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -65.29 144.44 57.14 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.677 0.791 . . . . 0.0 111.588 -176.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -133.12 175.34 9.47 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.964 1.306 . . . . 0.0 110.275 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.57 -51.85 67.82 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.01 1.324 . . . . 0.0 111.706 -173.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -119.23 0.1 11.12 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.836 0.855 . . . . 0.0 111.741 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mp -119.89 146.03 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.248 1.019 . . . . 0.0 108.487 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.7 m -112.01 160.2 17.71 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 119.242 0.928 . . . . 0.0 110.025 173.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.24 117.67 8.16 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.38 -30.67 4.89 Favored Glycine 0 C--N 1.343 0.926 0 O-C-N 123.551 0.532 . . . . 0.0 111.993 -174.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -67.73 153.4 43.79 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.482 0.713 . . . . 0.0 111.012 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -127.19 154.83 44.31 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.536 0.684 . . . . 0.0 112.178 -166.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.66 -169.77 12.92 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.458 -171.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -136.58 140.5 42.93 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 172.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.535 ' HA ' HG12 ' A' ' 57' ' ' VAL . 30.8 t80 -72.64 124.21 24.81 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 123.63 0.581 . . . . 0.0 110.579 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -109.14 -47.99 3.34 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.678 0.391 . . . . 0.0 111.216 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.403 ' OE1' ' HB2' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -167.43 147.67 5.32 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.725 0.81 . . . . 0.0 110.03 -179.318 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.449 ' HA ' HG23 ' A' ' 55' ' ' VAL . 38.9 p -117.76 173.22 6.87 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.665 0.786 . . . . 0.0 111.429 -175.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -128.71 119.95 25.57 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.768 175.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -88.37 71.17 9.08 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.409 0.623 . . . . 0.0 109.631 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.42 -27.68 0.97 Allowed Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.918 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.594 HG22 ' HD2' ' A' ' 54' ' ' PRO . 6.7 mm -103.45 118.71 57.0 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.57 -34.1 85.71 Favored 'Trans proline' 0 CA--C 1.575 2.564 0 N-CA-C 117.648 2.134 . . . . 0.0 117.648 -174.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.594 ' HD2' HG22 ' A' ' 52' ' ' ILE . 59.0 Cg_endo -70.79 111.04 2.92 Favored 'Trans proline' 0 C--N 1.386 2.501 0 CA-C-N 122.744 2.016 . . . . 0.0 112.351 171.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.53 HG11 HD22 ' A' ' 73' ' ' LEU . 3.0 p -91.33 137.22 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.281 1.032 . . . . 0.0 109.656 166.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.403 ' HB2' ' OE1' ' A' ' 47' ' ' GLN . 1.9 mp0 -90.14 126.79 35.92 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 122.983 0.513 . . . . 0.0 109.888 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.535 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -135.52 137.22 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 124.923 1.289 . . . . 0.0 108.773 -177.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -81.47 108.45 15.07 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.503 ' HB2' HG22 ' A' ' 62' ' ' THR . 85.4 m95 -93.08 128.06 38.85 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.87 0.868 . . . . 0.0 110.049 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -67.49 -23.47 65.49 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 123.671 0.607 . . . . 0.0 110.887 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.7 t -60.63 -44.98 95.72 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 124.659 1.184 . . . . 0.0 111.764 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 59' ' ' TRP . 8.7 t -108.02 -6.36 16.6 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.975 0.91 . . . . 0.0 110.777 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.25 13.67 76.74 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 116.134 -0.485 . . . . 0.0 113.869 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -151.4 173.97 13.9 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.321 0.56 . . . . 0.0 111.032 -175.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.11 136.3 33.27 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.132 -175.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -137.76 157.41 46.5 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.657 0.741 . . . . 0.0 111.036 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 15.8 m-90 -83.73 108.75 16.99 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.816 1.646 . . . . 0.0 110.089 -176.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 m -123.82 157.75 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 122.796 0.438 . . . . 0.0 110.93 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 37.7 t60 -87.43 148.94 24.76 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.576 0.75 . . . . 0.0 110.495 -175.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.411 ' HH2' ' HB2' ' A' ' 48' ' ' SER . 75.3 m95 -61.85 -43.8 98.11 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.671 0.788 . . . . 0.0 111.939 -176.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -73.1 -11.66 60.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.689 0.396 . . . . 0.0 111.408 -176.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 70.5 mtm -114.33 6.35 16.05 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.058 0.943 . . . . 0.0 110.622 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.53 HD22 HG11 ' A' ' 55' ' ' VAL . 35.9 tp -92.01 119.49 31.77 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 170.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . 41.8 tt0 -121.48 128.02 51.66 Favored 'General case' 0 C--O 1.212 -0.92 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.465 HG22 HG22 ' A' ' 28' ' ' VAL . 15.3 pt -110.96 115.02 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-O 121.417 0.627 . . . . 0.0 111.461 -176.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -106.81 80.69 1.47 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 170.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.723 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.827 -178.293 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.3 t80 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.61 0.243 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.79 -40.26 58.43 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.523 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 2.2 mp0 -69.97 -26.09 63.93 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.647 0.779 . . . . 0.0 110.788 177.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -75.11 -50.11 17.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.736 0.814 . . . . 0.0 110.671 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.2 m -63.97 -34.61 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 123.516 0.51 . . . . 0.0 110.265 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 17.5 tm0? -54.59 -31.28 56.63 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.442 1.097 . . . . 0.0 111.03 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 49.4 mm-40 -88.97 -44.67 10.25 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.982 0.513 . . . . 0.0 111.015 -176.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.8 t -83.8 -17.91 39.45 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -171.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.539 HD23 ' SD ' ' A' ' 26' ' ' MET . 10.9 mt -66.2 118.64 10.2 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.163 0.585 . . . . 0.0 111.341 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -110.99 140.84 23.14 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.726 1.21 . . . . 0.0 110.157 -176.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.22 85.01 0.34 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.32 2.68 . . . . 0.0 112.41 -177.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.8 2.6 1.41 Allowed Glycine 0 C--N 1.342 0.907 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.696 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.539 ' SD ' HD23 ' A' ' 22' ' ' LEU . 6.0 ptp -85.96 168.91 13.73 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 121.455 0.645 . . . . 0.0 111.224 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.413 ' NH1' ' HB3' ' A' ' 42' ' ' GLU . 15.7 tpt85 -99.84 123.21 43.85 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.772 1.229 . . . . 0.0 110.066 -168.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.412 HG21 HG11 ' A' ' 57' ' ' VAL . 3.7 m -118.77 174.21 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.696 0.798 . . . . 0.0 110.832 -174.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.531 ' HG2' ' HG2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -149.11 140.4 23.18 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.165 1.386 . . . . 0.0 107.836 -172.726 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.4 tpt -94.81 113.69 25.47 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.931 0.892 . . . . 0.0 109.671 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.625 HD11 ' HA ' ' A' ' 72' ' ' MET . 3.6 pp -97.73 4.24 49.97 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.721 0.409 . . . . 0.0 111.678 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -133.07 162.43 31.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.156 0.583 . . . . 0.0 109.965 -170.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -89.04 122.6 32.54 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.259 0.624 . . . . 0.0 109.694 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -121.25 170.56 9.47 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.565 0.698 . . . . 0.0 112.292 -176.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -53.54 -49.03 68.51 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 113.781 -1.554 . . . . 0.0 112.178 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -128.67 1.45 5.5 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.404 0.682 . . . . 0.0 111.412 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.2 mp -118.92 144.85 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.5 m -112.0 156.59 21.9 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 122.871 0.468 . . . . 0.0 109.758 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.3 116.7 6.91 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.06 -25.37 5.52 Favored Glycine 0 N--CA 1.469 0.883 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -173.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -76.85 155.21 33.14 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.144 0.578 . . . . 0.0 110.693 175.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.531 ' HG2' ' HG2' ' A' ' 29' ' ' ARG . 51.3 mt-10 -135.13 155.26 51.02 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.848 0.859 . . . . 0.0 110.225 -169.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -147.58 -166.0 12.27 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.049 -170.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -136.52 137.4 40.26 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.584 0.754 . . . . 0.0 109.374 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.498 ' HE1' HG21 ' A' ' 55' ' ' VAL . 71.5 t80 -71.38 124.99 25.81 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.265 0.626 . . . . 0.0 109.799 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.4 mmm180 -109.3 -49.65 3.09 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.804 0.441 . . . . 0.0 110.499 -173.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.469 ' OE1' ' HB2' ' A' ' 56' ' ' GLN . 0.4 OUTLIER -164.72 169.14 17.19 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.225 1.01 . . . . 0.0 109.237 -177.766 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.491 ' HA ' HG23 ' A' ' 55' ' ' VAL . 13.8 p -138.19 166.16 24.85 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.669 0.788 . . . . 0.0 112.04 -171.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -112.49 134.62 53.92 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 171.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -84.63 -5.75 59.33 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.962 0.905 . . . . 0.0 112.231 -172.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -141.27 -22.17 0.26 Allowed Glycine 0 C--N 1.347 1.149 0 CA-C-N 116.099 -0.5 . . . . 0.0 113.002 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.642 HG22 ' HD2' ' A' ' 54' ' ' PRO . 5.2 mm -98.66 118.34 63.24 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -173.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HA ' ' HE1' ' A' ' 70' ' ' TRP . 21.1 Cg_endo -59.75 -32.07 95.05 Favored 'Trans proline' 0 CA--C 1.583 2.972 0 N-CA-C 117.884 2.225 . . . . 0.0 117.884 -175.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.642 ' HD2' HG22 ' A' ' 52' ' ' ILE . 60.9 Cg_endo -71.06 107.76 2.17 Favored 'Trans proline' 0 C--N 1.387 2.567 0 CA-C-N 122.94 2.086 . . . . 0.0 112.297 171.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.498 HG21 ' HE1' ' A' ' 45' ' ' PHE . 5.5 p -90.9 143.33 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 124.841 1.256 . . . . 0.0 111.0 171.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.616 ' HB3' HG22 ' A' ' 65' ' ' THR . 1.7 mp0 -93.79 131.83 38.77 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-O 121.29 0.567 . . . . 0.0 110.225 -176.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.482 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -139.39 137.54 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 125.639 1.576 . . . . 0.0 108.106 -178.422 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -81.36 109.06 15.5 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -177.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.448 ' HB2' HG22 ' A' ' 62' ' ' THR . 85.8 m95 -93.51 117.81 30.56 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.72 0.808 . . . . 0.0 109.299 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -61.38 -25.88 67.47 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.05 0.94 . . . . 0.0 111.462 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.6 t -60.46 -45.13 94.82 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.436 1.094 . . . . 0.0 111.75 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 59' ' ' TRP . 7.1 t -105.88 -9.81 16.97 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.912 0.885 . . . . 0.0 110.711 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.79 16.5 79.96 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 114.24 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -152.77 165.12 36.33 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.412 0.625 . . . . 0.0 111.844 -173.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.616 HG22 ' HB3' ' A' ' 56' ' ' GLN . 2.7 m -88.45 120.37 29.77 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.309 -177.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -127.1 157.68 39.04 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.455 0.645 . . . . 0.0 110.661 -173.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.633 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 12.1 m-90 -83.94 116.61 22.88 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.505 1.522 . . . . 0.0 109.816 -173.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.462 HG21 HD13 ' A' ' 73' ' ' LEU . 7.1 m -130.12 158.36 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.897 0.879 . . . . 0.0 109.738 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.457 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 11.4 t-80 -86.79 147.87 25.65 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.953 0.501 . . . . 0.0 110.287 -177.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.427 ' HE1' ' HA ' ' A' ' 53' ' ' PRO . 81.3 m95 -57.2 -50.41 72.96 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.002 0.921 . . . . 0.0 111.571 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -72.78 -1.45 16.6 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.607 0.763 . . . . 0.0 112.005 -176.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.625 ' HA ' HD11 ' A' ' 31' ' ' LEU . 43.0 mtp -120.58 14.39 11.84 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.173 0.989 . . . . 0.0 110.756 -178.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.462 HD13 HG21 ' A' ' 68' ' ' VAL . 33.8 tp -123.37 124.37 42.78 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.91 0.884 . . . . 0.0 109.415 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.557 ' HB2' HD23 ' A' ' 31' ' ' LEU . 10.8 tp10 -106.52 142.97 35.3 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.387 1.075 . . . . 0.0 109.56 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 26.8 pt -113.84 128.57 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 121.085 0.469 . . . . 0.0 112.009 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.416 HD23 ' HB2' ' A' ' 29' ' ' ARG . 3.9 mm? -114.32 5.95 15.94 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.966 0.906 . . . . 0.0 110.215 172.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.338 0 CA-C-O 119.352 -0.693 . . . . 0.0 112.565 176.879 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.0 t80 . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 120.652 0.263 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.44 -38.25 90.81 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.625 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 4.5 mp0 -72.32 -31.59 65.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.617 -0.791 . . . . 0.0 109.757 178.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.408 ' O ' HG22 ' A' ' 21' ' ' THR . 11.4 t80 -67.37 -50.43 59.79 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 123.542 0.737 . . . . 0.0 110.533 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 m -63.65 -36.83 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 123.555 0.535 . . . . 0.0 109.964 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.46 -34.41 61.44 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.12 0.968 . . . . 0.0 110.742 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.535 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 58.0 mm-40 -84.11 -37.41 22.05 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.042 0.537 . . . . 0.0 111.112 -175.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.459 HG23 HD13 ' A' ' 75' ' ' ILE . 11.7 t -102.48 3.74 37.93 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.539 0.736 . . . . 0.0 112.414 -172.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.429 ' HA ' ' SD ' ' A' ' 26' ' ' MET . 8.8 mt -75.15 108.16 7.72 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.948 0.499 . . . . 0.0 109.672 174.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.586 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 39.7 mt-30 -85.8 130.72 49.62 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 123.657 0.783 . . . . 0.0 108.914 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.83 82.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 123.333 2.689 . . . . 0.0 113.52 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.36 17.73 1.55 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.721 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.586 ' HB3' ' HB2' ' A' ' 23' ' ' GLN . 14.2 ptm -91.35 173.78 7.73 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.677 0.751 . . . . 0.0 111.267 -175.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.604 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 14.8 tpt85 -96.25 131.42 42.75 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.109 -169.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.54 154.36 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 124.375 1.07 . . . . 0.0 111.396 -167.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -129.7 147.05 51.45 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.71 1.604 . . . . 0.0 108.092 169.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.426 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 32.9 tpp -98.41 129.45 45.05 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.011 0.924 . . . . 0.0 108.724 170.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.636 HD23 ' HB2' ' A' ' 74' ' ' GLU . 3.8 pp -106.88 2.38 25.34 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -176.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -140.6 172.37 12.81 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.543 0.337 . . . . 0.0 110.152 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -83.46 140.74 32.16 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 122.001 -0.437 . . . . 0.0 110.798 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.41 173.2 11.54 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.377 1.071 . . . . 0.0 110.427 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -50.57 -44.5 56.76 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.392 1.477 . . . . 0.0 112.674 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -138.23 4.19 2.44 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.455 0.702 . . . . 0.0 111.776 -175.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.2 mp -119.57 145.12 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.5 m -112.33 162.95 14.97 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 123.312 0.645 . . . . 0.0 109.887 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.3 118.69 9.03 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.193 0.597 . . . . 0.0 109.815 173.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.87 0.74 28.77 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 116.435 -0.348 . . . . 0.0 113.221 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -88.95 156.4 18.91 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.043 0.449 . . . . 0.0 110.647 173.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -123.97 148.56 46.84 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.392 -169.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -145.42 -170.06 14.08 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.091 -175.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -135.57 137.0 41.56 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.606 ' HZ ' ' HB3' ' A' ' 48' ' ' SER . 87.6 t80 -76.55 118.85 19.63 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.4 mmm-85 -105.3 -47.08 4.05 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -175.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -152.86 158.66 42.5 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.959 -176.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.606 ' HB3' ' HZ ' ' A' ' 45' ' ' PHE . 77.4 p -116.46 175.69 5.45 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.846 0.858 . . . . 0.0 110.699 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -129.04 130.25 46.34 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.859 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -76.19 -28.62 57.34 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.473 0.709 . . . . 0.0 111.693 -177.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -136.09 1.24 3.4 Favored Glycine 0 C--N 1.348 1.248 0 O-C-N 123.665 0.603 . . . . 0.0 114.093 -175.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.2 mm -111.26 103.74 55.32 Favored Pre-proline 0 N--CA 1.483 1.179 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.403 ' HA ' ' HE1' ' A' ' 70' ' ' TRP . 12.7 Cg_endo -55.39 -37.52 94.64 Favored 'Trans proline' 0 CA--C 1.577 2.67 0 C-N-CA 122.374 2.05 . . . . 0.0 116.565 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.736 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 71.8 Cg_endo -73.84 98.68 1.09 Allowed 'Trans proline' 0 C--N 1.384 2.399 0 CA-C-N 122.598 1.963 . . . . 0.0 112.097 169.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.546 HG23 ' HA ' ' A' ' 48' ' ' SER . 7.6 p -83.37 150.46 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 125.126 1.37 . . . . 0.0 111.588 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -90.86 127.79 36.5 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.197 0.599 . . . . 0.0 110.362 -175.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.19 134.2 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.315 1.446 . . . . 0.0 107.722 178.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 69.3 t80 -81.28 107.81 14.37 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.531 ' HB2' HG22 ' A' ' 62' ' ' THR . 83.5 m95 -92.76 123.4 36.01 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.888 0.875 . . . . 0.0 109.408 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -63.85 -29.04 70.27 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.777 0.673 . . . . 0.0 111.128 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.8 t -61.93 -46.71 88.12 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.166 0.986 . . . . 0.0 112.018 -175.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.531 HG22 ' HB2' ' A' ' 59' ' ' TRP . 9.8 t -98.6 -14.06 20.09 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.658 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.78 16.61 74.82 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 116.126 -0.488 . . . . 0.0 114.165 176.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -152.14 165.85 33.5 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.409 0.623 . . . . 0.0 111.547 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -87.01 114.44 23.63 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.368 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -124.83 153.82 41.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.671 0.748 . . . . 0.0 110.391 -173.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.736 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 7.8 m0 -83.87 116.82 22.94 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.102 -172.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.9 m -131.21 149.35 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -76.22 147.64 38.23 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.403 ' HE1' ' HA ' ' A' ' 53' ' ' PRO . 59.1 m95 -53.11 -38.93 63.04 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 124.118 0.967 . . . . 0.0 111.453 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -67.59 -28.41 67.74 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -175.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.411 ' HA ' HD11 ' A' ' 31' ' ' LEU . 4.9 mpp? -96.15 -5.56 40.37 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.497 0.319 . . . . 0.0 111.494 176.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.3 tt -90.1 122.23 32.88 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 174.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.636 ' HB2' HD23 ' A' ' 31' ' ' LEU . 35.1 tt0 -110.73 149.14 30.93 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.507 1.123 . . . . 0.0 108.698 174.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.459 HD13 HG23 ' A' ' 21' ' ' THR . 34.7 pt -99.72 125.28 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 170.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.422 HD13 ' NH1' ' A' ' 27' ' ' ARG . 4.1 tt -97.56 -60.86 1.48 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.604 ' HA3' ' HB3' ' A' ' 27' ' ' ARG . . . . . . . . 0 C--N 1.346 1.088 0 O-C-N 124.438 1.086 . . . . 0.0 113.778 -168.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.7 t80 . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.3 -37.86 80.84 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.059 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -70.38 -34.21 72.32 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.438 0.695 . . . . 0.0 110.068 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -69.92 -49.68 49.56 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.201 0.6 . . . . 0.0 111.511 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.0 m -59.11 -37.91 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 123.515 0.51 . . . . 0.0 110.772 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -54.48 -34.97 62.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.065 0.946 . . . . 0.0 111.835 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 42.1 mm-40 -81.63 -42.36 20.13 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.907 -175.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.6 t -92.14 3.34 55.51 Favored 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 123.416 0.687 . . . . 0.0 112.175 -174.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -74.67 122.18 22.81 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 122.99 0.516 . . . . 0.0 110.2 177.522 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -104.2 132.43 20.99 Favored Pre-proline 0 N--CA 1.488 1.456 0 C-N-CA 123.832 0.853 . . . . 0.0 110.573 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.78 89.97 0.29 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.98 2.453 . . . . 0.0 111.245 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.8 -6.03 4.8 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.939 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 6.8 ptp -80.67 153.04 28.14 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 173.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -85.66 163.1 18.49 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.1 m -133.99 171.14 18.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.436 ' HB2' ' HB2' ' A' ' 76' ' ' LEU . 2.5 tmt_? -136.58 138.35 41.15 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.445 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 3.0 tpt -85.65 111.15 19.82 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.239 1.016 . . . . 0.0 108.974 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.485 HD11 ' HA ' ' A' ' 72' ' ' MET . 4.5 pp -91.04 -15.67 29.18 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 117.778 0.263 . . . . 0.0 111.248 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 30' ' ' MET . 21.3 t70 -125.75 151.91 46.05 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.753 0.821 . . . . 0.0 109.363 -176.171 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -80.45 119.34 23.01 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.663 0.385 . . . . 0.0 110.048 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -106.66 173.28 6.39 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.725 1.21 . . . . 0.0 111.645 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -48.09 -58.79 4.0 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.364 1.466 . . . . 0.0 112.484 -175.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -121.67 5.54 10.03 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.077 0.951 . . . . 0.0 111.39 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mp -120.0 133.29 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 173.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.6 m -99.92 155.44 17.68 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.992 0.517 . . . . 0.0 109.854 177.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.89 115.86 6.44 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.55 -29.23 3.31 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -172.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -74.51 157.36 35.65 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.51 0.724 . . . . 0.0 111.756 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 41.5 mt-10 -115.73 153.68 30.94 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.782 0.833 . . . . 0.0 111.057 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.83 -170.26 11.88 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.866 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -139.0 140.93 38.32 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 170.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.464 ' HA ' HG12 ' A' ' 57' ' ' VAL . 84.5 t80 -76.71 121.78 23.78 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.037 0.535 . . . . 0.0 110.645 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -108.51 -48.39 3.34 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.324 0.65 . . . . 0.0 110.141 -174.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -158.91 161.13 36.74 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.154 0.982 . . . . 0.0 109.636 -177.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.498 ' HA ' HG23 ' A' ' 55' ' ' VAL . 14.5 p -130.96 171.63 12.99 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.877 0.846 . . . . 0.0 111.896 -176.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.543 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 1.0 OUTLIER -147.93 119.23 7.82 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.576 -1.647 . . . . 0.0 108.198 -178.498 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -83.23 -30.31 27.78 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.453 0.701 . . . . 0.0 110.621 -173.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.8 -23.84 22.09 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.782 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.544 HG22 ' HD2' ' A' ' 54' ' ' PRO . 42.8 mm -102.28 113.31 65.92 Favored Pre-proline 0 N--CA 1.482 1.159 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -64.76 -29.28 59.51 Favored 'Trans proline' 0 CA--C 1.581 2.859 0 N-CA-C 118.088 2.303 . . . . 0.0 118.088 -177.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.593 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 93.3 Cg_endo -80.36 108.61 2.19 Favored 'Trans proline' 0 C--N 1.379 2.15 0 CA-C-N 123.376 2.242 . . . . 0.0 112.084 168.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.498 HG23 ' HA ' ' A' ' 48' ' ' SER . 7.7 p -81.08 146.69 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.031 0.933 . . . . 0.0 110.71 172.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.559 ' HB3' HG22 ' A' ' 65' ' ' THR . 1.7 mp0 -93.74 127.91 39.69 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-O 121.191 0.519 . . . . 0.0 109.604 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.464 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -138.26 135.19 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 125.448 1.499 . . . . 0.0 108.052 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 47.6 t80 -80.92 106.76 13.18 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -177.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.489 ' HB2' HG22 ' A' ' 62' ' ' THR . 86.5 m95 -89.9 123.06 33.51 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.796 0.838 . . . . 0.0 109.811 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 16.9 pt20 -62.17 -28.11 69.43 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.19 0.996 . . . . 0.0 111.663 175.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.9 t -63.86 -44.49 92.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.853 0.861 . . . . 0.0 111.766 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.489 HG22 ' HB2' ' A' ' 59' ' ' TRP . 8.9 t -105.24 -6.01 20.12 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.494 0.718 . . . . 0.0 111.246 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.32 15.93 80.03 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 114.438 0.535 . . . . 0.0 114.438 175.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -152.83 165.94 33.81 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.323 0.582 . . . . 0.0 112.053 -172.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.559 HG22 ' HB3' ' A' ' 56' ' ' GLN . 2.0 m -87.26 117.99 26.39 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.141 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -125.86 156.82 39.01 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.461 0.648 . . . . 0.0 110.651 -171.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.593 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 11.9 m-90 -84.37 111.53 19.52 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.62 1.568 . . . . 0.0 109.488 -173.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.25 149.65 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.492 0.717 . . . . 0.0 110.092 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -78.5 146.61 34.28 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.766 0.426 . . . . 0.0 110.491 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -61.07 -46.17 91.73 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.57 0.748 . . . . 0.0 112.071 -176.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 58.4 t60 -67.95 -22.22 65.05 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.17 0.588 . . . . 0.0 111.266 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.485 ' HA ' HD11 ' A' ' 31' ' ' LEU . 38.5 mtp -101.85 13.28 35.27 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.764 1.226 . . . . 0.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -117.84 125.71 51.05 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -105.44 150.99 24.8 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 173.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.4 pt -111.15 116.16 51.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.717 0.807 . . . . 0.0 110.11 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.436 ' HB2' ' HB2' ' A' ' 29' ' ' ARG . 18.1 tp -100.65 -1.2 35.9 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.179 0.592 . . . . 0.0 109.918 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.789 0 CA-C-O 119.139 -0.811 . . . . 0.0 114.012 174.592 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 62.4 t80 . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.82 -34.89 83.95 Favored Glycine 0 C--N 1.341 0.812 0 O-C-N 123.623 0.577 . . . . 0.0 112.797 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 44.6 mp0 -71.3 -41.4 69.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 123.945 0.898 . . . . 0.0 109.445 177.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.44 ' O ' HG22 ' A' ' 21' ' ' THR . 18.8 t80 -59.36 -51.17 71.07 Favored 'General case' 0 C--N 1.358 0.958 0 O-C-N 123.85 0.719 . . . . 0.0 110.964 178.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.7 m -63.17 -40.1 87.77 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -58.49 -47.48 83.96 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 124.003 0.815 . . . . 0.0 110.873 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 22.6 mm-40 -64.52 -46.37 83.2 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.714 0.293 . . . . 0.0 110.868 -175.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 17' ' ' TYR . 14.7 t -93.15 13.07 22.15 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.457 0.703 . . . . 0.0 111.93 -175.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.729 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.1 OUTLIER -70.94 114.96 9.53 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.91 0.484 . . . . 0.0 109.723 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.654 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 50.0 mt-30 -87.98 137.94 31.24 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.696 0.798 . . . . 0.0 110.777 -177.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.476 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 29.8 Cg_exo -62.74 88.16 0.12 Allowed 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.39 2.727 . . . . 0.0 113.118 177.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.72 40.96 1.79 Allowed Glycine 0 C--N 1.35 1.309 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.729 ' SD ' HD13 ' A' ' 22' ' ' LEU . 20.3 ptm -98.82 177.66 5.21 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.719 0.771 . . . . 0.0 110.814 -177.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -96.56 122.03 39.04 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.19 1.396 . . . . 0.0 108.942 -177.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.0 m -117.0 171.74 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.146 0.578 . . . . 0.0 109.607 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -143.01 143.26 31.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.103 1.361 . . . . 0.0 107.705 -176.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.7 tpt -88.3 125.53 34.72 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.465 HD11 ' HA ' ' A' ' 72' ' ' MET . 4.4 pp -105.38 -9.74 17.39 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.627 0.371 . . . . 0.0 111.085 178.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -125.16 156.14 38.86 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.336 0.655 . . . . 0.0 110.27 -175.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -87.23 121.01 29.1 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.217 0.607 . . . . 0.0 109.752 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.553 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 10.4 m-85 -110.68 173.39 6.35 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.512 1.125 . . . . 0.0 111.772 -175.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -50.41 -52.86 33.9 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.435 1.494 . . . . 0.0 111.401 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.526 ' HG3' HG13 ' A' ' 37' ' ' ILE . 10.0 pt-20 -117.3 -19.2 9.69 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.815 -174.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 34' ' ' TYR . 4.6 mt -104.89 145.75 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.45 1.1 . . . . 0.0 108.995 -176.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 m -110.72 152.29 26.74 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.48 113.66 4.88 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 138.17 -29.1 2.65 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 119.569 -0.573 . . . . 0.0 113.711 -178.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -90.42 160.68 15.93 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 118.06 0.93 . . . . 0.0 111.927 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -109.26 159.99 16.5 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.922 0.889 . . . . 0.0 111.641 -164.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -141.64 -176.14 15.69 Favored Glycine 0 C--O 1.241 0.58 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.481 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -133.97 140.52 46.79 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 174.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.539 ' HA ' HG12 ' A' ' 57' ' ' VAL . 78.1 t80 -72.37 121.96 20.38 Favored 'General case' 0 C--N 1.342 0.261 0 O-C-N 123.494 0.496 . . . . 0.0 110.244 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 7.5 mmm180 -108.35 -47.76 3.46 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -177.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.31 151.24 8.07 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.05 0.94 . . . . 0.0 109.561 179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.42 ' HA ' HG23 ' A' ' 55' ' ' VAL . 30.8 p -118.02 178.23 4.5 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.234 1.014 . . . . 0.0 111.004 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -130.14 121.62 26.66 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 168.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -64.29 -40.63 96.35 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.315 0.646 . . . . 0.0 112.096 -167.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -121.16 12.68 9.72 Favored Glycine 0 N--CA 1.471 1.031 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.91 -176.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.574 HG22 ' HD2' ' A' ' 54' ' ' PRO . 19.7 mm -121.51 110.47 33.87 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 176.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -59.94 -29.03 88.44 Favored 'Trans proline' 0 CA--C 1.577 2.664 0 N-CA-C 118.901 2.616 . . . . 0.0 118.901 -171.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.574 ' HD2' HG22 ' A' ' 52' ' ' ILE . 55.3 Cg_endo -69.32 105.3 1.39 Allowed 'Trans proline' 0 C--N 1.381 2.269 0 CA-C-N 123.112 2.147 . . . . 0.0 112.092 172.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.42 HG23 ' HA ' ' A' ' 48' ' ' SER . 3.2 p -89.53 138.77 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.238 1.015 . . . . 0.0 109.923 169.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -92.73 124.1 36.49 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -134.65 142.37 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.913 1.285 . . . . 0.0 108.631 -179.19 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -84.84 107.66 17.12 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.564 ' HB2' HG22 ' A' ' 62' ' ' THR . 83.2 m95 -91.06 127.46 36.49 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.751 0.821 . . . . 0.0 110.133 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -21.37 63.63 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.762 0.664 . . . . 0.0 112.01 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.9 t -65.99 -46.28 78.59 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.08 0.552 . . . . 0.0 112.132 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.564 HG22 ' HB2' ' A' ' 59' ' ' TRP . 9.9 t -97.41 -16.14 20.34 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.816 0.846 . . . . 0.0 110.351 -177.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.18 15.68 80.72 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.494 -0.615 . . . . 0.0 114.037 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -151.4 176.99 10.73 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 117.632 0.716 . . . . 0.0 111.252 -174.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.08 138.52 31.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.38 1.072 . . . . 0.0 109.268 178.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -141.8 156.48 45.56 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.06 0.457 . . . . 0.0 110.966 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 -83.07 106.72 15.12 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.777 1.231 . . . . 0.0 109.98 -177.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.6 m -121.19 156.77 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.226 0.61 . . . . 0.0 110.129 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 59.9 t-80 -89.44 146.48 24.62 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.697 0.799 . . . . 0.0 109.675 -176.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -56.17 -49.3 74.41 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.866 0.866 . . . . 0.0 112.607 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -70.06 -19.97 63.26 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.428 0.691 . . . . 0.0 111.582 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.465 ' HA ' HD11 ' A' ' 31' ' ' LEU . 31.2 mtp -100.26 1.55 41.88 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.708 0.803 . . . . 0.0 111.23 176.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.0 tt -104.48 130.71 52.38 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.617 1.167 . . . . 0.0 108.235 170.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.42 ' HB2' HD23 ' A' ' 31' ' ' LEU . 41.3 tt0 -107.45 146.89 31.16 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.103 0.961 . . . . 0.0 108.746 173.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.1 pt -111.56 121.09 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-O 120.831 0.348 . . . . 0.0 110.116 170.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.9 mt -121.0 14.57 11.51 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.845 0.858 . . . . 0.0 110.396 174.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.117 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.375 172.958 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.1 t80 . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.5 -44.93 39.28 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-O 121.785 0.658 . . . . 0.0 113.357 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -70.92 -26.19 63.09 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.191 0.596 . . . . 0.0 109.682 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -71.28 -49.22 45.15 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.456 1.102 . . . . 0.0 111.585 174.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 m -62.71 -33.99 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 122.563 0.345 . . . . 0.0 110.426 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.85 -33.35 49.18 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.22 1.008 . . . . 0.0 110.545 177.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -80.66 -53.42 6.54 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.208 0.603 . . . . 0.0 110.577 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.5 t -90.94 17.07 8.32 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.649 0.78 . . . . 0.0 112.463 -167.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.66 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.2 OUTLIER -76.24 149.76 37.13 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 173.25 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.9 mp0 -117.69 140.24 27.34 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.252 1.021 . . . . 0.0 109.612 177.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.509 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 72.8 Cg_endo -72.68 78.98 1.98 Allowed 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.34 2.693 . . . . 0.0 113.429 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.67 28.31 0.82 Allowed Glycine 0 C--N 1.352 1.422 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.66 ' SD ' HD13 ' A' ' 22' ' ' LEU . 27.8 ptm -98.95 170.84 8.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.241 0.616 . . . . 0.0 111.29 -176.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -82.76 124.3 30.13 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.179 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.0 m -116.45 170.47 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.472 ' HE ' ' HG2' ' A' ' 42' ' ' GLU . 21.4 tpp85 -138.41 153.57 48.89 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -175.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' MET . . . . . 0.436 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 11.4 tpt -97.26 124.57 41.41 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.2 tp -96.23 -9.69 29.8 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.456 0.702 . . . . 0.0 111.258 -173.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 30' ' ' MET . 12.2 t70 -151.22 157.03 42.1 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.282 0.633 . . . . 0.0 109.325 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -73.43 142.16 46.9 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -132.44 172.19 12.8 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.979 0.511 . . . . 0.0 110.434 -177.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -40.74 -55.53 2.39 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 126.178 1.791 . . . . 0.0 113.05 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -124.19 0.4 8.41 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.552 -172.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.6 mt -118.71 138.72 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 124.142 0.977 . . . . 0.0 108.508 -175.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.2 m -87.9 150.94 23.19 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 122.915 0.486 . . . . 0.0 110.426 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.17 119.71 11.94 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 171.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.71 11.91 54.31 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.969 -177.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -79.56 153.49 29.45 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.91 0.484 . . . . 0.0 110.079 175.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.472 ' HG2' ' HE ' ' A' ' 29' ' ' ARG . 48.5 mt-10 -112.62 120.44 41.57 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.929 0.492 . . . . 0.0 110.601 -176.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.94 -172.6 21.87 Favored Glycine 0 C--O 1.243 0.683 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.569 173.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -134.04 138.21 45.2 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 171.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.509 ' HD2' ' HA ' ' A' ' 24' ' ' PRO . 64.1 t80 -70.47 123.27 21.37 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 21.7 mmm180 -106.36 -49.41 3.35 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.417 ' OE1' ' HB2' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -167.71 167.29 13.34 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.929 -179.406 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 72.3 p -141.51 -179.93 6.44 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.825 0.85 . . . . 0.0 110.922 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -122.64 121.76 37.2 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 168.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -68.92 -28.0 66.26 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.279 1.032 . . . . 0.0 112.071 -172.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -102.15 -34.51 4.23 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.981 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.547 HG22 ' HD2' ' A' ' 54' ' ' PRO . 12.7 mm -98.44 113.72 64.47 Favored Pre-proline 0 N--CA 1.481 1.088 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -171.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.435 ' HB2' ' CD2' ' A' ' 69' ' ' HIS . 38.8 Cg_endo -62.78 -25.73 74.83 Favored 'Trans proline' 0 CA--C 1.577 2.667 0 N-CA-C 118.831 2.589 . . . . 0.0 118.831 -169.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.547 ' HD2' HG22 ' A' ' 52' ' ' ILE . 45.6 Cg_endo -67.14 110.22 1.93 Allowed 'Trans proline' 0 C--N 1.385 2.492 0 CA-C-N 123.597 2.32 . . . . 0.0 111.594 169.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.78 141.67 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.134 0.974 . . . . 0.0 110.152 170.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.417 ' HB2' ' OE1' ' A' ' 47' ' ' GLN . 1.4 mp0 -93.32 121.34 34.6 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.472 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -135.87 137.2 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.977 1.311 . . . . 0.0 108.403 -177.136 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -83.59 106.08 15.03 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.494 ' HB2' HG22 ' A' ' 62' ' ' THR . 87.5 m95 -95.6 131.62 41.62 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.367 1.067 . . . . 0.0 110.326 -176.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -69.36 -25.05 63.99 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 123.847 0.717 . . . . 0.0 112.268 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.8 t -59.65 -44.17 93.64 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.348 0.594 . . . . 0.0 110.881 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.494 HG22 ' HB2' ' A' ' 59' ' ' TRP . 10.1 t -105.16 -14.49 15.37 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.957 -1.019 . . . . 0.0 111.826 -174.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.13 15.83 81.13 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.111 -0.495 . . . . 0.0 114.097 178.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -152.94 173.46 15.36 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.317 0.579 . . . . 0.0 111.578 -172.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.1 132.67 34.22 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.14 1.376 . . . . 0.0 109.576 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -141.5 158.11 44.27 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.265 0.555 . . . . 0.0 111.695 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -88.2 115.75 25.92 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.497 1.519 . . . . 0.0 109.776 -174.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.81 147.53 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.861 0.865 . . . . 0.0 109.251 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.435 ' CD2' ' HB2' ' A' ' 53' ' ' PRO . 63.4 t-80 -73.3 146.88 45.0 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -54.1 -31.26 51.51 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.57 1.548 . . . . 0.0 113.863 -177.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -79.39 -18.11 52.99 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.731 0.812 . . . . 0.0 111.191 -173.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.5 mtm -100.31 4.84 44.35 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.484 0.714 . . . . 0.0 110.655 171.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 tt -103.68 120.32 40.69 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 170.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -105.19 129.09 53.65 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.314 1.046 . . . . 0.0 108.235 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.9 pt -96.54 115.44 35.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.543 0.687 . . . . 0.0 109.896 175.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.1 tp -127.11 11.1 6.99 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.125 0.97 . . . . 0.0 109.181 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 1.663 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.949 171.252 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 79.8 t80 . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 120.858 0.361 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.48 -32.76 84.22 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.034 -0.984 . . . . 0.0 112.931 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.524 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 41.2 tt0 -62.86 -48.94 76.84 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.098 0.559 . . . . 0.0 110.274 173.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.412 ' O ' HG22 ' A' ' 21' ' ' THR . 10.3 t80 -57.51 -50.42 73.14 Favored 'General case' 0 C--N 1.358 0.971 0 O-C-N 124.017 0.823 . . . . 0.0 110.838 -176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.466 ' HB ' HD23 ' A' ' 22' ' ' LEU . 29.5 m -67.74 -39.01 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 O-C-N 123.535 0.522 . . . . 0.0 110.645 -177.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -56.91 -31.25 64.72 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.153 0.581 . . . . 0.0 111.723 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 26.4 mm-40 -81.94 -40.57 22.07 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.191 -177.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 17' ' ' TYR . 12.5 t -100.46 -6.06 26.13 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -168.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.482 HD13 ' SD ' ' A' ' 26' ' ' MET . 1.1 mm? -69.7 107.79 3.61 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 118.164 0.438 . . . . 0.0 110.612 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -87.46 142.45 33.1 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.08 0.952 . . . . 0.0 110.498 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.5 ' HA ' ' HD1' ' A' ' 45' ' ' PHE . 34.7 Cg_exo -59.59 79.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.531 2.821 . . . . 0.0 114.061 176.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.33 19.32 1.22 Allowed Glycine 0 C--N 1.353 1.525 0 CA-C-O 119.534 -0.592 . . . . 0.0 113.015 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.482 ' SD ' HD13 ' A' ' 22' ' ' LEU . 4.7 ptp -93.91 174.68 7.04 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 117.704 0.752 . . . . 0.0 110.876 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 21.4 tpt180 -97.02 126.97 42.54 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.747 1.219 . . . . 0.0 109.055 -171.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.441 HG12 HD11 ' A' ' 22' ' ' LEU . 5.7 m -116.03 172.34 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.676 0.791 . . . . 0.0 109.999 -174.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -144.58 140.95 29.1 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.173 1.389 . . . . 0.0 108.329 -172.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.4 tpt -98.95 112.15 24.34 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 74' ' ' GLU . 4.7 pp -89.48 -3.7 58.26 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -140.7 154.01 46.18 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.63 127.04 32.2 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.221 0.534 . . . . 0.0 110.144 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.471 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -107.06 172.68 6.69 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.734 0.813 . . . . 0.0 110.989 -178.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -50.11 -35.78 26.99 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.818 1.647 . . . . 0.0 113.237 -172.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -138.58 3.6 2.31 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.859 0.864 . . . . 0.0 111.182 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.471 ' HB ' ' HB2' ' A' ' 34' ' ' TYR . 7.2 mt -118.78 144.19 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.438 1.095 . . . . 0.0 108.503 -172.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 m -91.77 153.69 19.44 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.85 0.46 . . . . 0.0 110.909 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.11 116.14 12.18 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 166.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.7 -5.71 29.48 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.346 -172.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -79.17 156.23 28.31 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.748 0.419 . . . . 0.0 110.108 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -129.88 158.21 40.12 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.252 0.621 . . . . 0.0 111.136 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -149.26 -166.88 13.5 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.501 -172.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -135.47 139.26 43.93 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.5 ' HD1' ' HA ' ' A' ' 24' ' ' PRO . 38.7 t80 -69.13 119.52 13.55 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.511 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 14.5 mmm180 -103.65 -46.96 4.38 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.628 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -172.21 156.92 4.05 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.734 1.214 . . . . 0.0 108.885 176.421 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.7 p -127.39 178.2 6.22 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.473 0.709 . . . . 0.0 110.335 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 . . . . . 0 C--O 1.238 0.499 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 170.013 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo . . . . . 0 CA--C 1.577 2.656 0 N-CA-C 118.361 2.408 . . . . 0.0 118.361 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.446 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 28.9 Cg_endo -61.68 107.75 0.55 Allowed 'Trans proline' 0 C--N 1.384 2.415 0 CA-C-N 123.101 2.143 . . . . 0.0 112.51 175.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.04 136.46 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.28 1.032 . . . . 0.0 109.502 169.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.628 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 1.8 mp0 -90.4 123.35 34.05 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -137.03 136.75 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.0 1.32 . . . . 0.0 108.546 -174.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -82.53 105.58 13.69 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -175.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.486 ' HB2' HG22 ' A' ' 62' ' ' THR . 95.6 m95 -90.14 130.61 36.27 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.064 0.946 . . . . 0.0 110.432 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -70.31 -31.33 68.61 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 123.863 0.727 . . . . 0.0 112.727 -174.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.6 t -70.08 -46.08 65.68 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 117.951 0.341 . . . . 0.0 111.536 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.486 HG22 ' HB2' ' A' ' 59' ' ' TRP . 9.8 t -86.45 -18.13 32.5 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 122.736 0.414 . . . . 0.0 110.676 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.8 19.71 78.69 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-O 119.727 -0.485 . . . . 0.0 114.277 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -153.04 165.0 36.95 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.317 0.579 . . . . 0.0 112.244 -173.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.546 HG22 ' HB3' ' A' ' 56' ' ' GLN . 2.1 m -87.05 121.63 29.78 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.933 -177.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -130.64 157.15 43.53 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.964 0.411 . . . . 0.0 111.283 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 12.3 m-90 -79.02 114.34 17.88 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.714 1.205 . . . . 0.0 110.191 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.461 HG21 HD23 ' A' ' 73' ' ' LEU . 11.6 m -129.05 155.34 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 122.838 0.455 . . . . 0.0 110.652 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -89.47 147.06 24.21 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.736 0.814 . . . . 0.0 110.169 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -59.82 -42.36 93.33 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.428 0.691 . . . . 0.0 112.59 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -66.99 -24.94 66.09 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 117.661 0.21 . . . . 0.0 111.336 -176.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 71.4 mtm -99.88 -1.82 36.43 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.732 0.413 . . . . 0.0 111.62 175.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.461 HD23 HG21 ' A' ' 68' ' ' VAL . 2.5 tm? -92.66 121.23 33.87 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 172.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.522 ' HB2' HD23 ' A' ' 31' ' ' LEU . 39.6 tt0 -115.69 151.59 34.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.882 1.273 . . . . 0.0 108.458 176.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.435 HG21 ' SD ' ' A' ' 26' ' ' MET . 10.7 pt . . . . . 0 N--CA 1.483 1.177 0 CA-C-N 118.433 0.56 . . . . 0.0 110.723 169.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.4 t80 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.02 -31.77 81.99 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.893 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 12.1 tp10 -69.14 -48.05 63.42 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.41 ' O ' HG22 ' A' ' 21' ' ' THR . 42.0 t80 -59.06 -49.92 76.05 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 114.986 -1.007 . . . . 0.0 111.396 -177.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.8 -40.67 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 123.677 0.611 . . . . 0.0 110.721 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -57.64 -36.31 71.67 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.507 0.723 . . . . 0.0 111.932 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 23.5 mm-40 -80.21 -35.79 35.77 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.009 0.524 . . . . 0.0 111.171 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 17' ' ' TYR . 14.8 t -101.04 7.82 43.24 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.806 0.443 . . . . 0.0 112.117 -176.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.97 113.98 11.76 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.489 ' HB3' ' HB3' ' A' ' 26' ' ' MET . 34.3 tt0 -87.44 134.71 35.57 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.06 0.944 . . . . 0.0 109.673 -176.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.51 ' HA ' ' CD1' ' A' ' 45' ' ' PHE . 52.7 Cg_endo -64.81 80.3 0.18 Allowed 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 123.151 2.567 . . . . 0.0 113.457 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.99 26.44 1.54 Allowed Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.057 175.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.489 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 24.6 ptm -96.53 168.97 10.22 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.608 0.718 . . . . 0.0 110.54 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.437 ' HD2' ' HB3' ' A' ' 42' ' ' GLU . 18.6 tpp180 -90.01 126.31 35.71 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.851 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.476 HG12 HG22 ' A' ' 75' ' ' ILE . 8.0 m -116.44 171.02 5.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 C-N-CA 124.209 1.003 . . . . 0.0 108.833 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.451 ' HD2' ' N ' ' A' ' 30' ' ' MET . 2.6 tmm_? -137.29 143.93 42.41 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.451 ' N ' ' HD2' ' A' ' 29' ' ' ARG . 1.9 tpt -92.77 112.68 24.72 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.642 0.777 . . . . 0.0 109.133 -177.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 74' ' ' GLU . 4.4 pp -89.19 -9.58 50.29 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.571 0.348 . . . . 0.0 111.547 -178.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -127.02 162.62 25.6 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.944 0.898 . . . . 0.0 109.344 -174.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.43 146.19 25.96 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.553 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 13.8 m-85 -133.53 173.07 11.9 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.645 0.778 . . . . 0.0 111.117 -176.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -50.93 -47.4 61.03 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.15 1.38 . . . . 0.0 112.043 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -131.09 -1.35 4.08 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.696 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 34' ' ' TYR . 3.9 mp -112.64 143.02 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.2 t -103.32 154.5 19.31 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.263 0.625 . . . . 0.0 109.751 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.83 114.18 6.93 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.406 ' HA2' HH11 ' A' ' 29' ' ' ARG . . . 124.58 -17.54 7.33 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.314 -176.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.62 154.71 41.59 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.209 0.603 . . . . 0.0 111.259 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.437 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 45.0 mt-10 -112.79 138.61 49.37 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.601 0.761 . . . . 0.0 110.813 -175.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.56 -176.74 14.59 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.99 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -135.36 137.18 42.1 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.515 ' HA ' HG12 ' A' ' 57' ' ' VAL . 60.4 t80 -69.65 120.35 15.29 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.496 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 9.9 mmm-85 -107.42 -47.52 3.63 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.619 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -169.06 166.38 10.99 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.252 1.021 . . . . 0.0 109.398 178.624 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 92.3 p -152.93 -179.18 7.43 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.689 0.757 . . . . 0.0 111.509 -176.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 . . . . . 0 CA--C 1.545 0.766 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 168.509 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo . . . . . 0 CA--C 1.584 2.982 0 N-CA-C 119.221 2.739 . . . . 0.0 119.221 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -63.95 106.24 0.63 Allowed 'Trans proline' 0 C--N 1.389 2.692 0 CA-C-N 123.558 2.306 . . . . 0.0 113.054 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 p -95.44 132.3 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.318 167.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.619 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.1 mp0 -92.12 124.62 36.34 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -134.71 139.05 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.09 1.356 . . . . 0.0 108.636 -174.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -81.52 107.13 14.03 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.562 0.745 . . . . 0.0 109.731 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.424 ' NE1' HG23 ' A' ' 57' ' ' VAL . 93.0 m95 -93.83 130.1 39.99 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.944 0.898 . . . . 0.0 110.618 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -71.17 -26.25 62.89 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 123.965 0.791 . . . . 0.0 112.508 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.3 t -62.62 -45.85 90.96 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.047 0.451 . . . . 0.0 111.401 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.9 t -99.16 -12.19 20.69 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.913 0.885 . . . . 0.0 110.36 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.18 22.31 74.34 Favored Glycine 0 C--N 1.352 1.458 0 CA-C-N 115.966 -0.561 . . . . 0.0 114.17 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -151.35 172.45 15.89 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 117.324 0.562 . . . . 0.0 111.202 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.11 139.64 31.57 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.268 1.027 . . . . 0.0 109.102 -175.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -144.71 155.41 43.55 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.056 0.455 . . . . 0.0 111.139 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -79.75 120.73 24.44 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.033 1.333 . . . . 0.0 109.351 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 73' ' ' LEU . 6.7 m -131.44 160.91 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.206 0.602 . . . . 0.0 109.665 176.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 72' ' ' MET . 46.7 t60 -93.86 145.83 24.33 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.734 0.813 . . . . 0.0 108.826 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -60.15 -46.88 88.18 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.396 0.678 . . . . 0.0 112.501 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -73.15 -19.4 61.13 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.16 0.584 . . . . 0.0 111.003 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.471 ' HA ' HD11 ' A' ' 31' ' ' LEU . 46.5 mtp -98.32 2.64 48.3 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.252 1.021 . . . . 0.0 110.668 176.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.457 HD13 HG21 ' A' ' 68' ' ' VAL . 58.5 tp -111.03 133.78 53.15 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.518 1.127 . . . . 0.0 109.142 176.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.488 ' HB2' HD23 ' A' ' 31' ' ' LEU . 35.5 tt0 -107.25 152.56 23.94 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 172.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.476 HG22 HG12 ' A' ' 28' ' ' VAL . 21.7 pt . . . . . 0 N--CA 1.476 0.868 0 C-N-CA 122.905 0.482 . . . . 0.0 109.801 166.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 55.4 t80 . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 110.907 -0.034 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.91 -40.71 95.54 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.363 0.414 . . . . 0.0 113.247 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 25.7 tt0 -71.36 -36.09 71.35 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.925 0.49 . . . . 0.0 110.348 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -64.47 -49.49 71.22 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.096 0.958 . . . . 0.0 111.255 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.8 m -63.45 -39.63 86.03 Favored 'Isoleucine or valine' 0 C--N 1.354 0.77 0 O-C-N 123.65 0.593 . . . . 0.0 110.316 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -55.81 -38.77 70.43 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.196 0.599 . . . . 0.0 111.202 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 23.9 mm-40 -78.66 -38.94 38.27 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.408 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.6 t -94.11 2.06 56.04 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -173.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.49 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.2 OUTLIER -71.11 127.99 34.42 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 118.114 0.415 . . . . 0.0 109.944 176.448 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 50.9 mt-30 -116.41 133.67 22.95 Favored Pre-proline 0 N--CA 1.488 1.443 0 C-N-CA 124.26 1.024 . . . . 0.0 109.775 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 23' ' ' GLN . 24.1 Cg_exo -63.03 90.55 0.13 Allowed 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 123.227 2.618 . . . . 0.0 112.805 -175.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.61 8.06 3.26 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 116.147 -0.478 . . . . 0.0 112.782 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.49 ' SD ' HD13 ' A' ' 22' ' ' LEU . 9.8 ptp -87.33 157.48 19.27 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 173.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -87.27 157.19 19.36 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.748 0.785 . . . . 0.0 109.342 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.546 HG12 HG22 ' A' ' 75' ' ' ILE . 9.5 m -133.88 173.63 14.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.405 ' NE ' ' HA2' ' A' ' 40' ' ' GLY . 3.6 tmt_? -151.21 145.84 25.67 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 31.9 tpp -98.43 126.95 44.15 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.009 0.924 . . . . 0.0 110.297 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.598 HD23 ' HB2' ' A' ' 74' ' ' GLU . 3.9 pp -95.47 -7.63 37.62 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.221 0.608 . . . . 0.0 111.857 -176.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 30' ' ' MET . 21.7 t70 -132.64 168.47 18.22 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.449 0.7 . . . . 0.0 110.411 -174.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -80.19 130.69 35.4 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 122.137 -0.352 . . . . 0.0 110.248 175.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.464 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 1.2 m-85 -120.07 171.79 8.21 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.045 0.938 . . . . 0.0 110.433 176.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -50.44 -49.51 54.77 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.497 1.519 . . . . 0.0 113.009 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -126.17 0.38 7.13 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.645 0.778 . . . . 0.0 111.318 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.477 HD11 ' HB3' ' A' ' 66' ' ' TYR . 4.9 mt -116.56 126.37 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.1 m -89.43 155.17 19.49 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.26 113.36 3.54 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.405 ' HA2' ' NE ' ' A' ' 29' ' ' ARG . . . 124.37 -21.92 6.72 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.22 -177.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.415 ' OD2' ' HB3' ' A' ' 59' ' ' TRP . 28.4 t0 -62.19 142.45 57.65 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.301 0.64 . . . . 0.0 112.07 -176.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -104.1 148.29 26.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.256 1.022 . . . . 0.0 110.761 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.63 -173.85 13.09 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.434 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -134.91 140.69 45.96 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.487 ' HA ' HG12 ' A' ' 57' ' ' VAL . 59.3 t80 -71.63 119.75 16.24 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 123.864 0.727 . . . . 0.0 110.08 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.5 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 11.4 mmm180 -107.58 -47.68 3.57 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -174.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.544 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -164.42 157.18 17.1 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.338 1.055 . . . . 0.0 109.412 177.179 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.469 ' HA ' HG23 ' A' ' 55' ' ' VAL . 29.8 p -117.4 178.31 4.42 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.914 0.886 . . . . 0.0 111.169 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 . . . . . 0 C--O 1.236 0.375 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.61 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo . . . . . 0 CA--C 1.581 2.832 0 N-CA-C 118.074 2.298 . . . . 0.0 118.074 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.514 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 43.1 Cg_endo -68.51 109.09 1.97 Allowed 'Trans proline' 0 C--N 1.384 2.401 0 CA-C-N 123.325 2.223 . . . . 0.0 111.827 169.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 48' ' ' SER . 3.2 p -90.34 141.62 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.621 1.168 . . . . 0.0 110.478 171.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.544 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.0 mp0 -93.33 125.17 37.8 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.549 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.487 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -138.89 138.45 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.167 1.387 . . . . 0.0 108.538 -176.581 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -81.96 106.67 14.06 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.46 ' HB2' HG22 ' A' ' 62' ' ' THR . 97.6 m95 -91.73 130.49 37.51 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.579 1.152 . . . . 0.0 110.647 -176.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.23 -26.93 60.53 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -174.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.3 t -72.6 -41.49 65.56 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.025 0.375 . . . . 0.0 111.378 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.48 HG23 ' H ' ' A' ' 64' ' ' ARG . 10.5 t -87.76 -30.78 20.03 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 122.783 0.433 . . . . 0.0 109.843 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.58 16.76 58.07 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.911 -0.586 . . . . 0.0 114.096 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.48 ' H ' HG23 ' A' ' 62' ' ' THR . 0.0 OUTLIER -151.75 175.37 12.47 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.593 0.757 . . . . 0.0 112.032 -177.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.47 132.96 33.8 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.882 1.273 . . . . 0.0 109.716 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.477 ' HB3' HD11 ' A' ' 37' ' ' ILE . 12.7 t80 -138.82 156.99 46.88 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.09 0.472 . . . . 0.0 111.028 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 12.9 m-90 -83.51 113.74 21.0 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.128 1.371 . . . . 0.0 109.744 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.421 HG21 HD13 ' A' ' 73' ' ' LEU . 17.0 m -130.15 154.55 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.326 0.651 . . . . 0.0 110.546 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -80.62 145.5 31.66 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.994 0.518 . . . . 0.0 110.352 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -59.51 -45.59 91.29 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.526 0.731 . . . . 0.0 112.042 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -70.56 -25.36 63.05 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.528 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 74.7 mtm -93.2 1.27 57.17 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.745 0.418 . . . . 0.0 111.13 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.421 HD13 HG21 ' A' ' 68' ' ' VAL . 26.5 tp -97.11 118.82 34.39 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 174.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.598 ' HB2' HD23 ' A' ' 31' ' ' LEU . 42.9 tt0 -108.2 108.4 19.42 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.975 0.91 . . . . 0.0 108.924 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.546 HG22 HG12 ' A' ' 28' ' ' VAL . 17.9 pt . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 121.737 0.779 . . . . 0.0 111.415 -174.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.1 t80 . . . . . 0 N--CA 1.481 1.118 0 CA-C-O 120.823 0.344 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.62 -42.99 87.01 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.147 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 3.8 mp0 -71.05 -22.49 62.12 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.769 0.827 . . . . 0.0 111.735 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -70.95 -50.99 28.54 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.27 0.228 . . . . 0.0 110.792 170.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.8 m -66.63 -41.55 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -169.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -55.78 -30.29 61.05 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.336 0.654 . . . . 0.0 112.706 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 56.5 mm-40 -78.32 -36.93 45.7 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.056 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.2 t -94.36 -0.36 54.96 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.45 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.6 OUTLIER -72.1 117.61 13.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 122.039 -0.413 . . . . 0.0 110.738 177.074 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -96.86 135.66 22.01 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 124.112 0.965 . . . . 0.0 110.253 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 27.9 Cg_exo -62.97 82.19 0.11 Allowed 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.657 2.905 . . . . 0.0 113.188 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.03 15.92 1.64 Allowed Glycine 0 C--N 1.345 1.056 0 CA-C-N 116.4 -0.363 . . . . 0.0 112.467 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.45 ' SD ' HD13 ' A' ' 22' ' ' LEU . 5.3 ptp -90.7 163.75 14.39 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.539 0.685 . . . . 0.0 110.298 176.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.445 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 25.2 tpt180 -83.73 129.02 34.95 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.192 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 m -115.62 172.03 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -141.63 141.94 33.42 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.228 1.411 . . . . 0.0 108.272 -172.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.3 tpt -86.43 110.53 19.79 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.3 tp -81.13 -29.44 34.77 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.061 0.544 . . . . 0.0 110.599 -175.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -143.1 151.75 41.08 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -66.33 151.0 48.01 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.062 0.545 . . . . 0.0 111.51 -168.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -133.15 172.16 13.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.636 0.774 . . . . 0.0 111.436 -174.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -49.23 -47.8 46.08 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.037 1.735 . . . . 0.0 112.483 -175.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -129.99 2.88 4.82 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.995 0.918 . . . . 0.0 111.32 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -118.56 143.87 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.4 m -98.98 148.76 23.67 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.907 0.483 . . . . 0.0 110.208 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.1 117.48 5.59 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.998 0.519 . . . . 0.0 110.076 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.28 -15.93 20.17 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.487 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.98 151.06 43.51 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 117.265 0.533 . . . . 0.0 109.856 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -118.34 146.37 44.42 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.403 0.62 . . . . 0.0 110.939 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.445 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . -127.9 -165.36 11.83 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.252 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -136.27 142.64 43.97 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.449 ' HA ' HG12 ' A' ' 57' ' ' VAL . 75.4 t80 -75.57 119.58 19.81 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.416 0.686 . . . . 0.0 110.276 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.546 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 11.9 mmm180 -108.06 -49.6 3.18 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -175.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.546 ' NE2' ' HB2' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -164.82 163.67 21.17 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.44 1.096 . . . . 0.0 109.271 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.418 ' HB3' HG23 ' A' ' 55' ' ' VAL . 87.8 p -161.95 179.74 7.79 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 122.088 0.947 . . . . 0.0 112.517 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 . . . . . 0 C--O 1.239 0.536 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 167.309 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 CA--C 1.578 2.678 0 N-CA-C 118.848 2.595 . . . . 0.0 118.848 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.66 101.75 0.27 Allowed 'Trans proline' 0 C--N 1.389 2.662 0 CA-C-N 123.256 2.199 . . . . 0.0 112.199 171.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.418 HG23 ' HB3' ' A' ' 48' ' ' SER . 2.1 p -89.11 135.3 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.722 168.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.53 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.0 mp0 -91.01 121.89 33.21 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -135.27 136.6 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.91 1.284 . . . . 0.0 108.411 -176.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -82.38 106.18 14.04 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.849 0.46 . . . . 0.0 109.917 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.408 ' HB2' HG22 ' A' ' 62' ' ' THR . 84.6 m95 -94.11 131.0 40.08 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.053 0.941 . . . . 0.0 110.535 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -71.04 -24.8 62.42 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.5 p -62.03 -45.75 92.22 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.414 0.626 . . . . 0.0 111.53 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.408 HG22 ' HB2' ' A' ' 59' ' ' TRP . 9.8 t -99.51 -17.87 17.69 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.367 -176.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.59 19.21 74.12 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-O 119.789 -0.45 . . . . 0.0 113.961 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -152.27 170.12 20.83 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.499 0.666 . . . . 0.0 111.216 -175.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.474 HG22 ' HB3' ' A' ' 56' ' ' GLN . 1.3 m -86.52 129.14 34.97 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.773 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -131.99 154.71 49.05 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.268 0.556 . . . . 0.0 111.612 -174.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -85.18 100.48 11.78 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.396 1.478 . . . . 0.0 109.427 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.8 m -116.94 162.02 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 122.744 0.418 . . . . 0.0 110.348 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.615 ' HD2' ' H ' ' A' ' 71' ' ' HIS . 8.8 t60 -91.59 147.79 22.75 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.301 0.641 . . . . 0.0 109.846 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -58.84 -45.66 89.54 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.363 1.065 . . . . 0.0 113.291 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.615 ' H ' ' HD2' ' A' ' 69' ' ' HIS . 57.5 t-80 -66.44 -21.59 66.2 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.431 0.693 . . . . 0.0 111.797 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 76.3 mtm -101.94 9.66 40.37 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.2 0.6 . . . . 0.0 111.248 174.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.7 tt -109.64 120.62 43.05 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 172.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -106.86 150.22 26.61 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.903 1.281 . . . . 0.0 107.774 171.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.2 pt . . . . . 0 N--CA 1.485 1.295 0 CA-C-N 119.123 0.874 . . . . 0.0 111.818 174.734 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 75.1 t80 . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.539 0.209 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.56 -28.81 71.95 Favored Glycine 0 C--N 1.354 1.563 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.6 176.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.27 -47.73 59.98 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.963 0.505 . . . . 0.0 110.406 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -58.08 -50.21 74.25 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.055 0.847 . . . . 0.0 110.925 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.5 m -66.23 -37.3 79.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.311 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -31.36 59.19 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.72 0.808 . . . . 0.0 110.687 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -91.96 -47.98 7.01 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.573 0.749 . . . . 0.0 111.2 -174.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.9 t -79.13 -11.99 59.99 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -173.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.415 HD12 ' CG ' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -68.71 112.17 5.28 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 117.917 0.326 . . . . 0.0 110.575 177.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -97.53 132.81 24.52 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 123.875 0.87 . . . . 0.0 109.771 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.01 84.45 0.25 Allowed 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 123.021 2.48 . . . . 0.0 112.666 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 143.68 -0.68 1.25 Allowed Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.826 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.8 ptp -88.73 154.56 20.19 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -85.28 157.91 20.45 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 m -128.69 173.3 13.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.728 -1.123 . . . . 0.0 108.316 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.537 ' HD3' ' HA2' ' A' ' 40' ' ' GLY . 3.6 tmm_? -141.54 136.6 31.29 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.2 tpt -76.82 111.45 12.36 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.511 1.124 . . . . 0.0 109.279 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 41.2 tp -69.88 -36.53 75.52 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.137 0.575 . . . . 0.0 111.0 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -141.34 150.92 43.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.668 0.787 . . . . 0.0 109.18 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -65.58 129.88 41.33 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.831 0.707 . . . . 0.0 111.234 -170.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -106.97 173.58 6.26 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.128 0.971 . . . . 0.0 110.749 -177.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -47.41 -44.95 24.98 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.813 1.645 . . . . 0.0 113.386 -175.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -131.36 7.33 4.55 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.885 0.874 . . . . 0.0 111.058 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.23 144.79 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.825 0.85 . . . . 0.0 109.391 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.4 m -93.44 147.33 23.05 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.076 0.55 . . . . 0.0 110.543 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.48 117.86 8.6 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.537 ' HA2' ' HD3' ' A' ' 29' ' ' ARG . . . 115.16 -18.95 15.56 Favored Glycine 0 N--CA 1.469 0.862 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -66.64 144.45 56.39 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.606 0.762 . . . . 0.0 110.648 178.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -109.1 144.14 37.52 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.407 0.623 . . . . 0.0 110.659 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.65 -168.43 12.32 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.639 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -137.18 142.49 42.15 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 169.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 48' ' ' SER . 85.4 t80 -88.31 118.23 27.78 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.924 0.889 . . . . 0.0 109.451 177.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.431 ' HG2' ' NE2' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -115.94 -47.17 2.79 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.317 0.247 . . . . 0.0 111.286 175.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.431 ' NE2' ' HG2' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -136.86 150.66 48.4 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.606 0.362 . . . . 0.0 110.407 -177.095 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.447 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 64.4 p -145.12 165.28 28.74 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.638 0.775 . . . . 0.0 111.745 -177.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 . . . . . 0 CA--C 1.541 0.626 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 173.776 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo . . . . . 0 CA--C 1.579 2.747 0 N-CA-C 118.292 2.382 . . . . 0.0 118.292 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.648 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 57.4 Cg_endo -71.36 109.09 2.52 Favored 'Trans proline' 0 C--N 1.383 2.393 0 CA-C-N 123.523 2.294 . . . . 0.0 112.241 169.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' A' ' 48' ' ' SER . 6.4 p -86.93 144.45 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.061 0.944 . . . . 0.0 110.774 173.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -89.64 122.63 32.95 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.14 136.16 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -80.93 104.12 11.22 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -176.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.507 ' HB2' HG22 ' A' ' 62' ' ' THR . 88.6 m95 -92.01 130.03 37.84 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.434 1.094 . . . . 0.0 109.745 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -70.01 -34.87 73.86 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 123.61 0.569 . . . . 0.0 111.775 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.1 t -60.65 -45.18 95.07 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.666 0.386 . . . . 0.0 111.371 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.507 HG22 ' HB2' ' A' ' 59' ' ' TRP . 8.9 t -90.88 -16.68 27.76 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.762 0.425 . . . . 0.0 110.984 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.78 14.56 80.82 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 119.612 -0.549 . . . . 0.0 114.206 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -152.77 176.83 11.36 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 117.439 0.619 . . . . 0.0 110.9 -172.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 p -84.91 136.84 33.46 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.006 0.522 . . . . 0.0 109.727 173.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -134.89 156.02 49.68 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 123.886 0.742 . . . . 0.0 110.041 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.648 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 14.9 m-90 -87.6 101.37 13.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.34 1.456 . . . . 0.0 109.498 -173.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.3 m -117.09 153.27 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.147 0.579 . . . . 0.0 109.7 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -85.19 146.71 26.96 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -58.91 -40.13 83.61 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.886 0.875 . . . . 0.0 112.764 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -69.69 -20.76 63.55 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 123.316 0.646 . . . . 0.0 112.164 -176.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 69.4 mtm -106.1 14.29 27.94 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 122.973 0.509 . . . . 0.0 111.424 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.414 HD22 HD21 ' A' ' 22' ' ' LEU . 8.3 tt -104.53 121.69 44.01 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 172.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -106.6 152.7 23.38 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 171.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.7 pt . . . . . 0 N--CA 1.475 0.824 0 C-N-CA 122.864 0.465 . . . . 0.0 111.71 174.405 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.2 t80 . . . . . 0 N--CA 1.486 1.361 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.89 -30.4 77.9 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 114.443 -1.253 . . . . 0.0 113.71 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 26.5 tt0 -70.34 -41.79 72.73 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 175.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -60.37 -49.57 77.07 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.243 0.617 . . . . 0.0 111.148 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.417 ' HA ' HG22 ' A' ' 21' ' ' THR . 34.2 m -64.94 -36.45 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 O-C-N 123.397 0.435 . . . . 0.0 110.493 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.1 -30.97 60.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.676 0.79 . . . . 0.0 111.27 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 43.8 mm-40 -80.32 -52.8 7.27 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.774 0.429 . . . . 0.0 110.771 177.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.417 HG22 ' HA ' ' A' ' 18' ' ' VAL . 10.8 t -82.8 -7.42 59.66 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -167.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.559 HD12 ' HB2' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -69.43 107.13 3.21 Favored 'General case' 0 CA--C 1.558 1.251 0 CA-C-N 118.519 0.599 . . . . 0.0 110.801 176.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -88.37 134.26 34.88 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 124.143 0.977 . . . . 0.0 110.226 176.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.91 90.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.117 2.545 . . . . 0.0 112.227 171.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.14 -2.38 3.92 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.996 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.1 ptp -87.79 164.81 15.74 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 117.353 0.577 . . . . 0.0 110.57 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.62 140.01 31.06 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.699 1.199 . . . . 0.0 109.821 -173.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.441 HG12 HD11 ' A' ' 22' ' ' LEU . 4.4 m -117.19 172.83 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.816 0.846 . . . . 0.0 109.187 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -145.07 143.92 30.69 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.558 1.143 . . . . 0.0 108.651 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.1 tpp -97.62 139.1 34.03 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 122.779 0.431 . . . . 0.0 110.696 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 74' ' ' GLU . 3.3 pp -112.87 -7.42 13.76 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.235 1.014 . . . . 0.0 111.676 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -127.13 172.2 10.74 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.244 1.018 . . . . 0.0 109.58 -174.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -91.11 143.09 27.05 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.797 -0.565 . . . . 0.0 110.629 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.412 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 8.7 m-85 -133.28 171.77 13.59 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.984 1.313 . . . . 0.0 110.231 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -45.93 -46.98 16.4 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.367 1.467 . . . . 0.0 112.266 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -139.08 1.84 2.06 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.85 0.86 . . . . 0.0 111.398 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 34' ' ' TYR . 5.0 mp -115.1 146.45 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 174.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.0 m -130.74 164.25 25.51 Favored 'General case' 0 C--O 1.245 0.819 0 O-C-N 121.988 -0.445 . . . . 0.0 110.051 172.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.29 114.63 2.5 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 123.788 0.68 . . . . 0.0 110.286 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.28 -34.35 2.95 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.399 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.405 ' HB3' HG23 ' A' ' 37' ' ' ILE . 50.5 t0 -65.09 145.84 55.77 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.033 0.533 . . . . 0.0 110.192 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -120.4 146.29 46.34 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.998 0.919 . . . . 0.0 110.357 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.7 -167.52 12.4 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.126 -178.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -136.89 141.38 42.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 171.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.559 ' HB2' HD12 ' A' ' 22' ' ' LEU . 76.8 t80 -74.97 119.66 19.45 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.877 0.471 . . . . 0.0 109.988 178.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.506 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 19.5 mmm180 -108.99 -49.22 3.16 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.679 0.791 . . . . 0.0 109.592 -173.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.52 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -161.7 164.04 29.35 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.48 1.112 . . . . 0.0 109.056 177.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 16.3 p -132.07 168.56 17.75 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.622 0.769 . . . . 0.0 112.01 -175.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 . . . . . 0 C--O 1.238 0.495 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 164.768 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo . . . . . 0 CA--C 1.576 2.605 0 N-CA-C 117.775 2.183 . . . . 0.0 117.775 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.55 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 66.5 Cg_endo -76.35 111.42 3.26 Favored 'Trans proline' 0 C--N 1.377 2.062 0 CA-C-N 122.851 2.054 . . . . 0.0 112.295 165.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 p -84.38 142.95 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.598 1.159 . . . . 0.0 110.076 169.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.52 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.0 mp0 -92.32 122.69 35.02 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -136.3 138.11 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.892 1.277 . . . . 0.0 108.566 -178.222 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -82.88 104.68 13.29 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.503 ' HB2' HG22 ' A' ' 62' ' ' THR . 89.2 m95 -86.29 128.17 34.88 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.977 0.911 . . . . 0.0 109.684 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -71.71 -23.62 61.67 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -173.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.0 t -78.08 -44.68 25.56 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.48 0.582 . . . . 0.0 111.326 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 59' ' ' TRP . 11.0 t -85.3 -18.94 32.39 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-O 121.006 0.432 . . . . 0.0 110.453 176.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.38 22.07 73.97 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-N 115.867 -0.606 . . . . 0.0 114.465 174.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -153.18 168.41 26.03 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 117.459 0.63 . . . . 0.0 111.999 -174.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.456 HG22 ' HB3' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -86.8 126.18 34.45 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.554 1.142 . . . . 0.0 109.215 -176.243 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -135.56 157.43 46.9 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.286 0.565 . . . . 0.0 111.42 -173.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.55 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 12.4 m-90 -86.28 111.22 20.23 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.389 1.476 . . . . 0.0 109.58 -174.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 54' ' ' PRO . 13.4 m -131.67 150.67 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.126 0.57 . . . . 0.0 110.013 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -78.51 146.6 34.25 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 122.677 0.391 . . . . 0.0 110.964 -175.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -59.54 -48.77 80.36 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.332 1.053 . . . . 0.0 112.013 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -68.04 -27.91 66.94 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.283 0.563 . . . . 0.0 110.438 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.507 ' HA ' HD11 ' A' ' 31' ' ' LEU . 38.8 mtp -93.69 9.09 38.39 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.068 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.7 tp -112.22 120.05 40.45 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 123.728 0.811 . . . . 0.0 108.842 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.531 ' HB2' HD23 ' A' ' 31' ' ' LEU . 39.0 tt0 -107.56 135.89 48.26 Favored 'General case' 0 C--O 1.207 -1.14 0 C-N-CA 124.733 1.213 . . . . 0.0 107.789 175.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.401 HD13 HD22 ' A' ' 22' ' ' LEU . 20.4 pt . . . . . 0 N--CA 1.482 1.165 0 CA-C-N 119.73 1.15 . . . . 0.0 111.914 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.411 ' HB3' ' CD2' ' A' ' 71' ' ' HIS . 41.1 t80 . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.904 0.383 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.15 -29.86 75.74 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.83 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 44.0 tt0 -72.92 -38.48 66.84 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -62.38 -48.32 80.25 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.165 0.586 . . . . 0.0 111.222 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.47 ' HB ' HD23 ' A' ' 22' ' ' LEU . 33.0 m -62.1 -37.25 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -29.99 62.97 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.984 0.914 . . . . 0.0 110.454 178.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 54.5 mm-40 -78.88 -47.33 16.73 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.988 0.515 . . . . 0.0 110.101 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 t -96.96 4.52 51.51 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -166.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.485 HD13 ' SD ' ' A' ' 26' ' ' MET . 2.0 mm? -87.59 115.28 24.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.818 -0.551 . . . . 0.0 111.574 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 26' ' ' MET . 1.4 mp0 -92.94 137.24 23.94 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 124.003 0.921 . . . . 0.0 109.688 171.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.56 86.68 0.21 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.472 2.115 . . . . 0.0 111.371 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 144.71 4.55 0.62 Allowed Glycine 0 C--N 1.347 1.171 0 CA-C-N 115.737 -0.665 . . . . 0.0 113.065 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.67 ' SD ' HG21 ' A' ' 75' ' ' ILE . 6.2 ptp -95.01 175.52 6.6 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 117.345 0.573 . . . . 0.0 110.827 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -99.52 128.4 45.63 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.058 1.343 . . . . 0.0 109.815 -170.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -115.58 171.36 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.589 0.756 . . . . 0.0 109.655 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.516 ' HA ' ' HG2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -144.0 126.95 16.37 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -174.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -78.89 121.91 25.45 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.515 HD23 ' HB2' ' A' ' 74' ' ' GLU . 4.2 pp -105.6 14.09 28.98 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 117.945 0.339 . . . . 0.0 111.34 176.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -137.04 172.37 13.11 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.144 0.978 . . . . 0.0 111.327 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -97.35 140.53 31.67 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.889 0.876 . . . . 0.0 110.107 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -134.41 173.66 11.39 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.677 1.191 . . . . 0.0 111.421 -176.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -46.34 -45.03 17.35 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.585 1.554 . . . . 0.0 111.955 175.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -140.84 -1.95 1.37 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.183 -171.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.402 HG23 ' OD2' ' A' ' 41' ' ' ASP . 3.8 mp -116.22 147.58 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 124.251 1.021 . . . . 0.0 108.344 175.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.1 m -127.49 160.96 29.89 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.958 0.503 . . . . 0.0 109.674 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.1 113.89 4.83 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.17 -61.04 0.56 Allowed Glycine 0 C--N 1.343 0.947 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -172.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.402 ' OD2' HG23 ' A' ' 37' ' ' ILE . 4.9 p-10 -77.33 148.72 35.48 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.4 0.619 . . . . 0.0 110.632 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.516 ' HG2' ' HA ' ' A' ' 29' ' ' ARG . 42.4 mt-10 -125.62 161.34 27.45 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.014 -161.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.75 -171.97 12.64 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.887 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -133.07 135.87 45.58 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.506 ' HA ' HG12 ' A' ' 57' ' ' VAL . 16.3 t80 -72.66 121.37 19.68 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.531 0.732 . . . . 0.0 109.258 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.519 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 7.9 mmm180 -107.32 -46.37 3.89 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -175.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.519 ' NE2' ' HB2' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -152.86 159.56 43.03 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.851 0.861 . . . . 0.0 110.071 -179.127 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 64.7 p -119.58 173.39 7.03 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.72 0.808 . . . . 0.0 111.205 -176.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 . . . . . 0 N--CA 1.471 0.615 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.429 -178.884 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo . . . . . 0 CA--C 1.576 2.61 0 N-CA-C 116.71 1.773 . . . . 0.0 116.71 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.69 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 96.1 Cg_endo -75.68 97.5 1.11 Allowed 'Trans proline' 0 C--N 1.384 2.444 0 CA-C-N 122.411 1.897 . . . . 0.0 112.397 169.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.8 p -90.64 153.27 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.004 0.922 . . . . 0.0 111.297 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -96.76 129.9 44.1 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.237 0.615 . . . . 0.0 111.665 -172.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.506 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -139.85 141.79 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 125.743 1.617 . . . . 0.0 108.788 178.313 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -81.2 107.25 13.84 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.913 0.885 . . . . 0.0 109.143 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.526 ' HB2' HG22 ' A' ' 62' ' ' THR . 99.0 m95 -90.9 133.82 34.95 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.147 0.979 . . . . 0.0 111.097 -177.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -59.57 -35.19 73.78 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 124.04 0.837 . . . . 0.0 111.535 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.9 p -66.8 -45.31 78.81 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.653 0.781 . . . . 0.0 112.221 -173.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.526 HG22 ' HB2' ' A' ' 59' ' ' TRP . 10.6 t -104.84 -9.4 18.06 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.175 0.59 . . . . 0.0 111.695 -174.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.52 21.6 72.69 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 114.291 0.476 . . . . 0.0 114.291 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -151.8 176.08 11.78 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.277 0.631 . . . . 0.0 110.665 -176.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 2.1 p -85.23 129.62 34.77 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.066 0.547 . . . . 0.0 109.969 175.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -130.13 158.54 39.41 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.314 0.578 . . . . 0.0 110.196 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.69 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 18.7 m-90 -81.59 104.82 12.28 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.796 1.239 . . . . 0.0 110.782 -176.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.5 m -126.21 156.84 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.063 0.545 . . . . 0.0 110.33 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.479 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 9.1 t-160 -84.44 147.51 27.06 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 122.939 0.496 . . . . 0.0 110.944 -174.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -59.94 -47.01 87.55 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.898 0.879 . . . . 0.0 111.253 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.411 ' CD2' ' HB3' ' A' ' 14' ' ' TYR . 58.1 t-80 -66.32 -25.85 67.03 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.56 0.744 . . . . 0.0 111.471 -178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.479 ' SD ' ' HB3' ' A' ' 69' ' ' HIS . 59.5 mtp -95.14 -2.42 49.91 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.954 0.902 . . . . 0.0 111.676 -171.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 pp -110.07 157.73 19.03 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 167.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.515 ' HB2' HD23 ' A' ' 31' ' ' LEU . 30.7 tt0 -138.13 137.13 37.38 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 125.074 1.35 . . . . 0.0 108.231 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.67 HG21 ' SD ' ' A' ' 26' ' ' MET . 7.2 pt . . . . . 0 CA--C 1.537 0.45 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 169.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 40.8 t80 . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.61 -26.63 71.05 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 114.59 -1.186 . . . . 0.0 113.401 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 15.1 tp10 -71.45 -47.34 56.4 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -58.38 -50.01 75.18 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.955 0.784 . . . . 0.0 111.052 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.2 m -67.59 -36.35 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.833 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -54.96 -34.59 63.42 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.405 0.682 . . . . 0.0 111.333 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 48.5 mm-40 -85.06 -48.69 8.95 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.074 -176.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 t -85.98 -9.98 55.9 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -168.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.496 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.2 OUTLIER -66.89 107.21 2.13 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 118.589 0.631 . . . . 0.0 110.176 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -94.75 132.72 27.9 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 124.016 0.926 . . . . 0.0 110.424 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.2 84.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.388 2.725 . . . . 0.0 113.868 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 141.05 4.8 1.07 Allowed Glycine 0 C--N 1.343 0.944 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.759 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.496 ' SD ' HD13 ' A' ' 22' ' ' LEU . 5.4 ptp -91.89 166.82 12.53 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 117.479 0.64 . . . . 0.0 110.717 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -88.76 134.84 33.79 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.595 1.158 . . . . 0.0 109.375 -174.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.0 m -117.15 172.31 5.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -151.01 140.01 21.03 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.7 tpp -85.94 128.94 34.95 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.142 0.496 . . . . 0.0 110.863 -175.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 23.2 tp -106.03 -5.79 19.24 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.868 0.867 . . . . 0.0 111.365 -173.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -138.27 160.66 38.9 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.537 0.735 . . . . 0.0 111.136 -174.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -82.74 127.39 33.38 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -122.49 171.36 9.15 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.07 0.948 . . . . 0.0 111.409 -174.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -49.66 -45.4 48.58 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.542 1.537 . . . . 0.0 111.847 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -132.16 -5.4 3.45 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.684 -170.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mt -118.74 140.74 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.7 t -100.85 153.53 19.4 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 172.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.4 115.26 4.93 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.78 -36.1 2.22 Favored Glycine 0 C--N 1.338 0.694 0 O-C-N 123.665 0.603 . . . . 0.0 112.089 -175.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -63.24 141.62 58.7 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.23 0.612 . . . . 0.0 111.608 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -102.45 161.62 13.57 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.672 0.789 . . . . 0.0 111.13 -175.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.83 -170.2 19.59 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.466 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -135.3 137.81 42.84 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 48' ' ' SER . 57.4 t80 -85.23 119.6 25.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.927 173.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.414 ' HG2' ' NE2' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -115.79 -45.95 2.86 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 122.236 0.214 . . . . 0.0 111.198 172.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.485 ' NE2' ' H ' ' A' ' 47' ' ' GLN . 0.5 OUTLIER -126.85 163.54 23.39 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.917 0.487 . . . . 0.0 110.056 -177.394 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 37.8 t -148.86 168.52 22.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.596 0.758 . . . . 0.0 112.265 -167.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 . . . . . 0 CA--C 1.542 0.662 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 164.191 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo . . . . . 0 CA--C 1.581 2.828 0 N-CA-C 118.111 2.312 . . . . 0.0 118.111 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.455 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 58.6 Cg_endo -72.57 106.5 2.11 Favored 'Trans proline' 0 C--N 1.383 2.354 0 CA-C-N 123.084 2.137 . . . . 0.0 112.521 170.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.544 HG23 ' HA ' ' A' ' 48' ' ' SER . 8.9 p -86.49 146.12 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.642 168.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -91.94 128.14 37.67 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.91 136.47 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.269 1.028 . . . . 0.0 108.485 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -81.88 108.68 15.6 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.507 ' HB2' HG22 ' A' ' 62' ' ' THR . 95.3 m95 -93.15 131.0 38.61 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.941 0.896 . . . . 0.0 110.864 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -63.81 -27.28 69.07 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 124.133 0.896 . . . . 0.0 110.66 172.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.8 t -65.49 -47.04 77.41 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 124.369 1.068 . . . . 0.0 112.055 -173.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.507 HG22 ' HB2' ' A' ' 59' ' ' TRP . 6.6 t -103.28 -14.48 16.3 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.002 0.921 . . . . 0.0 110.458 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.84 14.14 82.35 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.86 -0.609 . . . . 0.0 113.688 178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -150.26 172.01 16.05 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.266 0.555 . . . . 0.0 110.979 -174.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.43 124.52 33.51 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.629 1.172 . . . . 0.0 108.917 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -128.27 154.51 45.81 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.184 0.516 . . . . 0.0 110.763 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 14.4 m-90 -81.04 111.27 17.36 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.358 -1.292 . . . . 0.0 109.736 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.9 m -126.81 159.15 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.026 0.53 . . . . 0.0 109.838 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -86.81 147.11 25.96 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.386 0.674 . . . . 0.0 110.124 -174.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -61.41 -48.5 80.9 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.084 0.554 . . . . 0.0 111.691 -178.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -69.3 -11.43 60.8 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.447 0.699 . . . . 0.0 111.734 -177.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 34.8 mtp -113.62 10.03 17.97 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.233 1.013 . . . . 0.0 110.787 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.9 tp -113.82 121.42 43.97 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 124.211 1.004 . . . . 0.0 108.708 176.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -107.84 132.44 53.42 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.911 0.885 . . . . 0.0 110.028 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.401 HD13 HD22 ' A' ' 22' ' ' LEU . 28.8 pt . . . . . 0 N--CA 1.478 0.96 0 O-C-N 121.824 -0.548 . . . . 0.0 111.012 172.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.1 t80 . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.49 -36.83 84.58 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-O 121.409 0.449 . . . . 0.0 112.963 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.469 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 8.3 mp0 -71.26 -42.56 68.63 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.805 0.842 . . . . 0.0 109.132 176.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -60.28 -48.91 79.73 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 124.183 0.927 . . . . 0.0 111.798 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.8 m -64.06 -38.31 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 123.264 0.353 . . . . 0.0 110.572 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -56.13 -32.44 64.23 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.266 0.626 . . . . 0.0 111.103 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 41.8 mm-40 -77.16 -51.78 10.4 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.575 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.2 t -87.69 5.54 39.26 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.618 0.767 . . . . 0.0 112.383 -170.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -72.17 108.83 5.55 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.311 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.461 ' HB3' ' HB3' ' A' ' 26' ' ' MET . 35.1 tt0 -87.31 131.86 43.0 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 123.686 0.794 . . . . 0.0 110.179 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.441 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 72.4 Cg_exo -53.12 88.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.682 2.921 . . . . 0.0 113.031 170.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.73 22.86 5.23 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.155 170.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.461 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 3.8 ptp -89.39 168.73 11.99 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.256 0.551 . . . . 0.0 110.387 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -86.95 147.08 25.91 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.838 1.255 . . . . 0.0 108.967 -176.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.522 HG22 HG22 ' A' ' 75' ' ' ILE . 55.9 t -130.71 164.08 34.73 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 C-N-CA 124.444 1.098 . . . . 0.0 109.469 -172.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.418 ' HD2' ' N ' ' A' ' 30' ' ' MET . 3.5 tmm_? -142.7 145.65 33.59 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.376 1.47 . . . . 0.0 107.607 172.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.418 ' N ' ' HD2' ' A' ' 29' ' ' ARG . 4.4 tpt -85.18 112.26 20.55 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.137 0.575 . . . . 0.0 109.734 -175.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 39.0 tp -86.46 -20.02 28.74 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.339 0.656 . . . . 0.0 111.682 -174.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -136.67 155.12 50.31 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.741 0.416 . . . . 0.0 110.29 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -76.51 138.98 40.58 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.933 0.493 . . . . 0.0 110.339 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -131.21 171.42 13.32 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.306 1.042 . . . . 0.0 110.822 -172.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -48.58 -58.76 4.22 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.126 1.37 . . . . 0.0 112.032 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -117.96 -1.0 11.55 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.11 0.964 . . . . 0.0 111.402 -175.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mp -118.18 139.86 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.6 m -104.79 152.48 22.52 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.72 114.24 3.88 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.99 -36.12 2.1 Favored Glycine 0 C--N 1.346 1.131 0 O-C-N 123.488 0.493 . . . . 0.0 112.36 -173.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -61.61 147.82 44.44 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.198 0.599 . . . . 0.0 111.753 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -102.23 155.46 18.2 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.337 0.655 . . . . 0.0 111.009 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -140.32 -175.73 14.67 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.835 -175.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -139.33 138.54 36.74 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.562 ' HA ' HG12 ' A' ' 57' ' ' VAL . 87.1 t80 -71.07 122.4 20.01 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 122.685 0.394 . . . . 0.0 110.015 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.531 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 22.8 mmm180 -108.75 -48.57 3.28 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -176.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.531 ' NE2' ' HB2' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -167.19 155.46 9.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.364 179.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.8 p -123.11 179.4 4.7 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.135 0.974 . . . . 0.0 109.955 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 . . . . . 0 N--CA 1.468 0.441 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 172.343 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.478 ' HA ' ' CD1' ' A' ' 70' ' ' TRP . 13.6 Cg_endo . . . . . 0 CA--C 1.584 2.982 0 N-CA-C 118.172 2.335 . . . . 0.0 118.172 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.84 101.45 0.79 Allowed 'Trans proline' 0 C--N 1.394 2.941 0 CA-C-N 122.736 2.013 . . . . 0.0 112.558 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 p -94.43 140.52 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.944 0.898 . . . . 0.0 109.918 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.49 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.1 mp0 -93.65 122.81 36.49 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.381 0.672 . . . . 0.0 109.72 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -132.78 140.63 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 125.262 1.425 . . . . 0.0 108.825 -178.522 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -79.38 108.1 12.64 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.506 ' HB2' HG22 ' A' ' 62' ' ' THR . 93.8 m95 -91.65 131.36 37.1 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.943 0.897 . . . . 0.0 110.066 177.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -59.41 -31.85 69.64 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.223 1.009 . . . . 0.0 111.688 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.7 t -67.55 -45.63 75.09 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.695 0.798 . . . . 0.0 112.07 -172.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.506 HG22 ' HB2' ' A' ' 59' ' ' TRP . 6.1 t -97.68 -21.24 17.12 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.32 0.648 . . . . 0.0 110.988 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.8 18.66 69.7 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.783 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -151.95 -176.93 5.85 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.138 0.575 . . . . 0.0 110.579 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 56' ' ' GLN . 5.2 p -86.03 144.38 27.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.503 0.721 . . . . 0.0 110.753 173.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -140.0 154.47 47.15 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.198 0.599 . . . . 0.0 109.942 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -81.4 111.99 18.26 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.555 1.142 . . . . 0.0 109.959 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.689 HG21 HD13 ' A' ' 73' ' ' LEU . 19.1 m -126.03 159.98 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.185 0.594 . . . . 0.0 110.772 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.513 ' HB3' ' HB2' ' A' ' 72' ' ' MET . 14.9 t-80 -91.14 147.04 23.34 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.283 1.033 . . . . 0.0 109.475 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.478 ' CD1' ' HA ' ' A' ' 53' ' ' PRO . 97.2 m95 -64.99 -45.99 83.3 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.013 0.525 . . . . 0.0 111.917 -175.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -70.47 -17.26 62.97 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.077 0.465 . . . . 0.0 111.678 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.513 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 21.3 mtp -104.16 14.19 30.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.526 1.13 . . . . 0.0 110.502 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.689 HD13 HG21 ' A' ' 68' ' ' VAL . 29.1 tp -119.19 121.26 39.33 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.298 1.039 . . . . 0.0 108.578 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -112.68 119.81 39.37 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.522 HG22 HG22 ' A' ' 28' ' ' VAL . 14.0 pt . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 121.488 0.661 . . . . 0.0 110.533 175.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.8 t80 . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.77 -36.43 91.18 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.497 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 33.6 tt0 -63.24 -47.45 82.42 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 171.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -57.83 -51.97 67.41 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.376 1.048 . . . . 0.0 111.854 -173.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.7 m -67.13 -37.88 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 O-C-N 123.789 0.681 . . . . 0.0 110.764 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.78 -34.17 67.37 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.575 0.75 . . . . 0.0 110.225 177.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 25.4 mm-40 -79.29 -50.01 11.57 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.815 0.446 . . . . 0.0 111.068 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.1 t -90.84 3.97 53.04 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -169.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.83 125.09 25.87 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 26' ' ' MET . 21.3 tt0 -90.96 139.63 25.95 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 124.145 0.978 . . . . 0.0 109.384 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' HA ' ' CD1' ' A' ' 45' ' ' PHE . 25.9 Cg_exo -63.63 84.62 0.13 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.742 2.294 . . . . 0.0 112.922 172.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.59 31.51 1.79 Allowed Glycine 0 C--N 1.353 1.49 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 171.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.501 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 25.9 ptm -100.59 174.61 6.0 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.268 0.556 . . . . 0.0 109.857 177.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.423 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 19.1 tpt180 -91.05 130.6 36.94 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 124.349 1.059 . . . . 0.0 108.995 -173.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.5 m -116.45 173.23 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.439 0.696 . . . . 0.0 109.33 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.07 137.15 25.79 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -171.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.6 tpt -82.62 111.61 18.74 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 55.2 tp -80.39 -38.59 30.01 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.176 0.591 . . . . 0.0 110.698 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -126.86 154.04 44.91 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.212 0.605 . . . . 0.0 110.553 -175.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.99 119.47 17.27 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.337 0.655 . . . . 0.0 110.605 -174.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -102.6 173.46 6.33 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.386 1.074 . . . . 0.0 111.502 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -45.61 -52.1 11.11 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 126.174 1.79 . . . . 0.0 112.2 -175.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -124.9 -11.41 7.15 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.462 -177.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.2 mp -102.21 132.19 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.7 m -94.48 148.66 22.02 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.496 0.318 . . . . 0.0 110.39 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.8 115.73 4.61 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.94 -18.93 8.43 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 123.479 0.487 . . . . 0.0 112.452 -172.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -75.24 155.21 37.02 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.156 0.582 . . . . 0.0 109.57 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -126.7 154.29 44.31 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.582 0.706 . . . . 0.0 111.165 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.423 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . -137.42 -169.5 11.65 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.815 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -137.22 144.34 42.76 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.542 ' CD1' ' HA ' ' A' ' 24' ' ' PRO . 51.1 t80 -69.62 121.86 17.96 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.443 0.697 . . . . 0.0 109.31 177.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.503 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 10.2 mmm180 -108.95 -43.75 4.14 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.629 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -170.78 172.68 5.59 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.354 1.461 . . . . 0.0 107.895 177.237 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -157.18 179.8 8.93 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.748 0.785 . . . . 0.0 112.317 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 . . . . . 0 CA--C 1.544 0.742 0 CA-C-N 114.076 -1.42 . . . . 0.0 107.633 171.984 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo . . . . . 0 CA--C 1.579 2.731 0 N-CA-C 118.961 2.639 . . . . 0.0 118.961 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -70.1 110.15 2.55 Favored 'Trans proline' 0 C--N 1.372 1.772 0 CA-C-N 122.925 2.08 . . . . 0.0 113.316 173.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.94 139.46 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.303 1.041 . . . . 0.0 109.82 167.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.629 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 1.7 mp0 -91.94 122.05 34.1 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -135.82 136.24 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.571 1.149 . . . . 0.0 108.819 -177.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 59.9 t80 -82.01 106.42 13.9 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.45 ' HB2' HG22 ' A' ' 62' ' ' THR . 89.0 m95 -90.29 130.71 36.37 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.426 1.09 . . . . 0.0 110.125 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -69.51 -37.93 77.36 Favored 'General case' 0 CA--C 1.554 1.099 0 O-C-N 123.842 0.714 . . . . 0.0 112.679 -173.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.1 t -69.59 -43.19 73.31 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.436 0.294 . . . . 0.0 111.677 -174.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 59' ' ' TRP . 11.4 t -86.18 -17.13 35.71 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.794 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.48 18.32 76.08 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 114.539 0.576 . . . . 0.0 114.539 172.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -152.8 166.55 31.91 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.229 0.538 . . . . 0.0 112.086 -172.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 1.4 m -85.67 130.79 34.47 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.841 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -137.16 148.91 46.92 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.885 0.374 . . . . 0.0 110.688 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.461 ' CD1' ' HG3' ' A' ' 56' ' ' GLN . 11.1 m0 -76.76 114.15 15.21 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.462 1.105 . . . . 0.0 109.323 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.445 HG21 HD13 ' A' ' 73' ' ' LEU . 18.6 m -126.46 156.47 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.112 0.565 . . . . 0.0 109.676 175.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -86.07 145.92 26.85 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -63.09 -42.7 99.67 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.219 0.608 . . . . 0.0 111.768 -175.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -68.11 -14.42 62.97 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.538 0.735 . . . . 0.0 111.995 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 72.3 mtm -113.03 16.95 19.19 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.406 0.682 . . . . 0.0 110.958 174.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.445 HD13 HG21 ' A' ' 68' ' ' VAL . 40.6 tp -114.83 122.14 45.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.305 0.642 . . . . 0.0 109.295 176.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -105.23 147.29 28.2 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.409 1.084 . . . . 0.0 108.367 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.0 pt . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 121.378 0.609 . . . . 0.0 110.222 173.159 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.404 ' OH ' ' HA ' ' A' ' 74' ' ' GLU . 64.5 t80 . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.469 0.176 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.0 -38.86 63.9 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.904 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.563 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 3.2 mp0 -70.91 -37.6 72.95 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -58.44 -49.12 78.45 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.913 0.758 . . . . 0.0 111.417 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 27.0 m -62.58 -38.96 82.82 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -58.84 -40.64 84.8 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.141 0.576 . . . . 0.0 109.846 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 25.1 mm-40 -66.76 -40.0 88.1 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.313 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.4 t -110.53 13.08 22.73 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -169.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.621 HD12 ' SD ' ' A' ' 26' ' ' MET . 18.1 tp -87.55 110.93 20.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.858 -0.527 . . . . 0.0 110.428 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.612 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 38.7 mt-30 -87.84 141.44 31.65 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 124.203 1.001 . . . . 0.0 109.892 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.89 85.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.972 2.448 . . . . 0.0 111.728 173.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.64 73.71 1.19 Allowed Glycine 0 C--N 1.342 0.905 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.797 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.621 ' SD ' HD12 ' A' ' 22' ' ' LEU . 21.8 ptm -118.78 -58.32 1.97 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 118.465 -0.779 . . . . 0.0 112.044 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.468 ' H ' ' HG3' ' A' ' 26' ' ' MET . 24.8 tpt180 146.08 122.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 128.088 2.555 . . . . 0.0 107.929 173.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 m -118.14 171.74 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-O 121.326 0.584 . . . . 0.0 110.206 177.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -148.81 150.34 32.89 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.719 1.608 . . . . 0.0 107.529 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.1 tpt -90.33 111.89 23.26 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 34.4 tp -77.41 -33.16 55.06 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.421 0.689 . . . . 0.0 110.912 -174.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -145.29 153.99 41.87 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.627 0.771 . . . . 0.0 109.072 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.46 142.03 58.09 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.52 0.728 . . . . 0.0 111.573 -172.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -126.33 171.76 10.69 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.818 0.847 . . . . 0.0 110.921 -175.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -47.37 -37.81 11.93 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.728 1.611 . . . . 0.0 113.233 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -139.94 -0.01 1.73 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.494 -171.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 mt -119.83 141.01 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.224 1.01 . . . . 0.0 109.19 -175.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.4 p -91.41 142.35 27.77 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.059 0.544 . . . . 0.0 109.969 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.39 117.39 5.61 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.665 0.386 . . . . 0.0 110.069 171.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.92 -4.27 28.88 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 123.542 0.526 . . . . 0.0 112.537 -175.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -77.34 156.57 31.19 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.165 0.586 . . . . 0.0 109.658 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 51.0 mt-10 -113.15 157.26 21.88 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.752 0.787 . . . . 0.0 111.596 -178.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -146.25 -172.53 16.66 Favored Glycine 0 C--O 1.244 0.756 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.046 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -138.2 141.34 40.01 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 170.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.443 ' HE1' ' HB3' ' A' ' 48' ' ' SER . 32.8 t80 -70.58 120.45 16.23 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.639 0.776 . . . . 0.0 110.207 176.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.522 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 15.0 mmm180 -108.85 -47.63 3.42 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.804 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.575 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -163.78 155.86 17.23 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.537 1.135 . . . . 0.0 109.316 -177.12 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.443 ' HB3' ' HE1' ' A' ' 45' ' ' PHE . 41.4 p -132.09 179.03 6.34 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.715 0.806 . . . . 0.0 110.772 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.089 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo . . . . . 0 CA--C 1.571 2.345 0 N-CA-C 117.933 2.244 . . . . 0.0 117.933 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.638 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 55.9 Cg_endo -67.36 111.99 2.45 Favored 'Trans proline' 0 C--N 1.378 2.124 0 CA-C-N 123.297 2.213 . . . . 0.0 111.649 171.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 p -81.54 141.44 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.467 1.107 . . . . 0.0 110.689 171.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.575 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 1.7 mp0 -90.17 126.85 35.95 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.446 HG23 ' NE1' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -138.26 137.34 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 125.16 1.384 . . . . 0.0 108.817 -177.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -82.03 105.78 13.41 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.24 0.616 . . . . 0.0 109.818 -175.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.489 ' HB2' HG22 ' A' ' 62' ' ' THR . 91.7 m95 -92.58 132.62 36.7 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.34 1.056 . . . . 0.0 111.2 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 13.6 pt20 -69.2 -28.33 66.28 Favored 'General case' 0 CA--C 1.55 0.967 0 O-C-N 124.141 0.901 . . . . 0.0 112.078 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.0 t -64.37 -46.46 83.27 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.05 0.387 . . . . 0.0 112.01 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.489 HG22 ' HB2' ' A' ' 59' ' ' TRP . 10.2 t -98.17 -12.08 22.08 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.543 0.737 . . . . 0.0 110.756 -176.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.3 16.09 79.94 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-N 115.986 -0.552 . . . . 0.0 113.898 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -151.9 170.69 19.22 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.345 0.593 . . . . 0.0 111.682 -174.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.569 HG22 ' HB3' ' A' ' 56' ' ' GLN . 1.7 m -87.0 120.06 27.86 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.271 -177.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -127.95 157.13 41.43 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.75 0.42 . . . . 0.0 111.152 -175.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.638 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 4.3 m-90 -75.65 120.67 21.37 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.456 1.102 . . . . 0.0 110.649 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.482 HG21 HD13 ' A' ' 73' ' ' LEU . 6.3 m -135.41 147.89 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 173.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -78.95 148.21 32.72 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.928 0.491 . . . . 0.0 110.496 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -54.47 -49.66 69.56 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.282 1.033 . . . . 0.0 112.305 -178.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -74.83 -13.11 60.53 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.073 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 29.1 mtp -106.76 13.88 27.44 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.857 0.863 . . . . 0.0 110.356 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.482 HD13 HG21 ' A' ' 68' ' ' VAL . 53.6 tp -116.18 131.32 56.98 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.641 1.177 . . . . 0.0 108.799 176.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HA ' ' OH ' ' A' ' 14' ' ' TYR . 10.9 tp10 -106.12 140.89 38.38 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.753 1.221 . . . . 0.0 108.234 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 pt . . . . . 0 N--CA 1.489 1.477 0 CA-C-N 118.435 0.562 . . . . 0.0 111.52 175.558 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.1 t80 . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.49 -42.05 74.62 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 121.512 0.506 . . . . 0.0 112.601 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 8.4 mp0 -69.33 -34.33 74.48 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 176.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -65.22 -49.73 68.56 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 123.866 0.728 . . . . 0.0 111.891 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.4 m -59.62 -38.86 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 123.319 0.387 . . . . 0.0 110.435 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -54.71 -35.47 63.67 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.364 0.665 . . . . 0.0 111.493 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.55 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 43.4 mm-40 -82.36 -36.25 27.02 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.463 -172.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.8 t -109.24 4.22 22.55 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.853 0.461 . . . . 0.0 112.142 -172.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.512 HD13 HG22 ' A' ' 75' ' ' ILE . 16.7 tp -86.08 116.73 24.47 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 122.007 -0.433 . . . . 0.0 109.994 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -92.01 137.47 25.15 Favored Pre-proline 0 N--CA 1.481 1.095 0 C-N-CA 124.207 1.003 . . . . 0.0 111.136 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.2 92.41 0.39 Allowed 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.017 2.478 . . . . 0.0 112.105 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.0 -8.22 4.15 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.661 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 5.5 ptp -92.46 166.5 12.51 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -88.17 162.7 16.56 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-O 121.896 0.855 . . . . 0.0 110.305 -171.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.6 m -131.64 175.65 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.061 176.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -143.89 146.07 32.75 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -174.424 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.5 tpt -98.05 118.17 34.05 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.777 0.831 . . . . 0.0 110.043 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.8 mt -74.94 -43.39 54.4 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.417 0.687 . . . . 0.0 112.066 -177.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -129.5 163.99 24.71 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -67.09 120.53 13.85 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.292 0.568 . . . . 0.0 110.889 -176.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.03 173.12 6.98 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.988 0.915 . . . . 0.0 110.384 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -47.79 -48.07 30.52 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.348 1.459 . . . . 0.0 113.542 -176.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -128.31 8.5 6.03 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.306 0.642 . . . . 0.0 111.571 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -120.07 143.56 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.3 m -99.46 154.02 18.55 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.561 0.619 . . . . 0.0 109.848 174.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.6 118.3 6.89 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.623 0.769 . . . . 0.0 110.068 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.53 -10.39 23.87 Favored Glycine 0 C--N 1.341 0.834 0 O-C-N 123.331 0.395 . . . . 0.0 113.237 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -79.95 157.26 26.9 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 120.948 0.404 . . . . 0.0 110.725 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 45.0 mt-10 -120.55 159.95 24.19 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.038 -174.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -141.7 -167.76 11.35 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.647 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -138.52 140.13 39.0 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 170.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.446 ' HA ' HG12 ' A' ' 57' ' ' VAL . 55.6 t80 -79.7 121.31 25.16 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.225 0.61 . . . . 0.0 110.102 176.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -108.26 -47.91 3.45 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.408 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -155.47 151.08 27.3 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.754 0.821 . . . . 0.0 110.109 -176.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.491 ' HA ' HG23 ' A' ' 55' ' ' VAL . 48.6 p -117.49 162.63 17.66 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.091 0.956 . . . . 0.0 111.123 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 . . . . . 0 C--O 1.237 0.427 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 160.355 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo . . . . . 0 CA--C 1.583 2.949 0 N-CA-C 118.268 2.372 . . . . 0.0 118.268 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.523 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 39.4 Cg_endo -67.56 105.87 1.16 Allowed 'Trans proline' 0 C--N 1.389 2.67 0 CA-C-N 123.56 2.307 . . . . 0.0 111.793 169.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' A' ' 48' ' ' SER . 6.4 p -86.59 145.84 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.467 1.107 . . . . 0.0 110.709 176.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.408 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.0 mp0 -92.22 122.08 34.36 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -133.89 136.68 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.857 1.263 . . . . 0.0 108.752 178.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -81.09 108.65 14.94 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.514 ' HB2' HG22 ' A' ' 62' ' ' THR . 94.5 m95 -93.52 131.14 39.04 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.849 0.86 . . . . 0.0 110.898 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 18.4 pt20 -61.72 -27.21 68.55 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 124.114 0.883 . . . . 0.0 110.977 169.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.3 t -60.46 -45.16 94.71 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.609 1.164 . . . . 0.0 112.307 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.514 HG22 ' HB2' ' A' ' 59' ' ' TRP . 8.6 t -113.09 -10.74 13.41 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.685 0.794 . . . . 0.0 111.265 -174.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.45 13.89 82.74 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 116.359 -0.382 . . . . 0.0 113.91 178.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -152.47 173.65 14.86 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.274 0.559 . . . . 0.0 111.387 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.05 126.78 34.98 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.557 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -128.67 155.35 45.17 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 120.984 0.421 . . . . 0.0 111.059 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.523 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 10.1 m-90 -82.09 108.66 15.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.991 1.316 . . . . 0.0 109.732 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 m -125.97 151.54 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.128 0.571 . . . . 0.0 109.73 177.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -80.32 146.42 31.59 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -54.89 -45.37 74.65 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.833 1.253 . . . . 0.0 113.293 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -72.54 -22.39 61.02 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -173.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 70.7 mtm -93.39 -6.28 47.53 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.205 0.602 . . . . 0.0 111.424 174.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 tt -90.93 123.56 34.53 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 171.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 29' ' ' ARG . 40.4 tt0 -104.04 143.58 32.7 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.512 HG22 HD13 ' A' ' 22' ' ' LEU . 37.5 pt . . . . . 0 CA--C 1.546 0.789 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.4 t80 . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.08 -30.18 75.49 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.802 -0.635 . . . . 0.0 113.028 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 8.3 tp10 -72.28 -47.47 49.81 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 171.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.422 ' O ' HG22 ' A' ' 21' ' ' THR . 38.5 t80 -57.45 -48.78 78.26 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.294 1.038 . . . . 0.0 111.256 -172.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 m -58.29 -43.31 85.82 Favored 'Isoleucine or valine' 0 C--N 1.35 0.612 0 O-C-N 123.729 0.643 . . . . 0.0 110.259 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -62.12 -31.51 71.98 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.458 0.703 . . . . 0.0 111.189 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 79.5 mm-40 -82.22 -32.32 29.84 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.188 0.595 . . . . 0.0 111.519 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 17' ' ' TYR . 14.2 t -107.79 8.35 28.73 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.944 0.498 . . . . 0.0 111.966 -175.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.608 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.1 OUTLIER -67.66 117.83 10.12 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.062 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.723 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 9.8 mm100 -86.23 133.4 40.77 Favored Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.14 87.4 0.73 Allowed 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.875 2.383 . . . . 0.0 112.261 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.24 23.99 2.8 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.723 ' HB3' ' HB2' ' A' ' 23' ' ' GLN . 16.8 ptm -91.69 168.48 11.45 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.194 0.597 . . . . 0.0 110.118 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 ppp_? -90.3 147.14 23.69 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.797 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.4 t -129.28 164.88 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 124.937 1.295 . . . . 0.0 107.648 -169.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -149.53 133.13 16.76 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.0 tpt -82.81 112.59 19.78 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.782 0.833 . . . . 0.0 109.869 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.652 HD23 ' HB2' ' A' ' 74' ' ' GLU . 4.0 pp -85.9 -2.88 58.7 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 122.862 0.465 . . . . 0.0 111.19 176.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -124.79 162.87 23.37 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.198 0.999 . . . . 0.0 109.427 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -98.76 117.3 32.92 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -106.17 173.26 6.39 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.527 1.131 . . . . 0.0 112.175 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -51.71 -44.95 63.37 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.818 1.647 . . . . 0.0 112.455 -175.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.63 3.95 3.59 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.969 0.908 . . . . 0.0 111.396 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 mp -118.41 137.39 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 175.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.3 m -99.32 155.07 17.71 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.24 0.473 . . . . 0.0 109.919 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.17 114.15 5.68 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.31 -26.54 3.91 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 123.572 0.545 . . . . 0.0 112.402 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -69.94 158.22 36.0 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.234 0.613 . . . . 0.0 112.494 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -116.94 157.31 25.94 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 123.832 0.853 . . . . 0.0 111.552 -177.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.15 -173.75 14.97 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.731 -176.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -136.04 142.52 44.41 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 171.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 48' ' ' SER . 91.4 t80 -87.28 118.29 26.6 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.004 0.922 . . . . 0.0 110.059 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.402 ' HG2' HE22 ' A' ' 47' ' ' GLN . 0.0 OUTLIER -112.32 -47.57 3.09 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 120.803 0.335 . . . . 0.0 110.653 178.475 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.402 HE22 ' HG2' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -145.77 161.93 38.81 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.61 0.764 . . . . 0.0 109.375 -175.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.426 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 53.4 p -158.64 169.28 24.76 Favored 'General case' 0 C--O 1.239 0.53 0 O-C-N 123.777 0.673 . . . . 0.0 111.988 -171.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 7.5 m-80 . . . . . 0 CA--C 1.541 0.6 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 171.888 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo . . . . . 0 CA--C 1.573 2.429 0 N-CA-C 117.767 2.18 . . . . 0.0 117.767 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.605 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 49.2 Cg_endo -70.37 107.82 2.06 Favored 'Trans proline' 0 C--N 1.383 2.393 0 CA-C-N 123.145 2.159 . . . . 0.0 111.702 168.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.3 p -85.68 141.43 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.326 1.05 . . . . 0.0 110.311 171.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -87.99 122.67 31.86 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.39 136.15 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.43 1.092 . . . . 0.0 108.544 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -81.53 108.03 14.78 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -176.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -92.87 131.05 38.24 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.699 0.799 . . . . 0.0 111.115 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -62.69 -31.3 72.17 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.928 0.891 . . . . 0.0 111.427 172.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.5 t -60.07 -43.74 95.26 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.82 1.248 . . . . 0.0 111.808 -172.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.1 t -113.07 -8.93 13.6 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.163 -174.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.02 15.39 81.19 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 116.351 -0.386 . . . . 0.0 114.028 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -151.65 169.6 21.75 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.528 0.68 . . . . 0.0 111.598 -172.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.21 123.42 32.2 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.267 -176.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -126.74 155.67 42.38 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.523 0.678 . . . . 0.0 110.809 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.605 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 9.3 m-90 -89.37 111.97 22.96 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.465 1.506 . . . . 0.0 109.288 -172.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.4 m -129.51 153.17 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.279 0.632 . . . . 0.0 110.51 -176.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -80.56 147.09 30.94 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.811 0.444 . . . . 0.0 110.734 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -59.42 -49.35 78.13 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.268 1.027 . . . . 0.0 112.929 -176.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -67.81 -23.18 65.16 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.164 0.585 . . . . 0.0 111.625 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.509 ' HA ' HD11 ' A' ' 31' ' ' LEU . 40.2 mtp -95.82 -4.13 44.36 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.573 1.149 . . . . 0.0 111.095 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.4 tt -93.95 141.07 28.94 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 172.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.652 ' HB2' HD23 ' A' ' 31' ' ' LEU . 39.4 tt0 -125.82 135.35 51.89 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.819 0.848 . . . . 0.0 108.902 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.1 pt . . . . . 0 N--CA 1.479 1.025 0 CA-C-O 121.235 0.54 . . . . 0.0 110.512 177.455 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.1 t80 . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.22 -34.65 86.47 Favored Glycine 0 C--N 1.344 1.007 0 O-C-N 123.279 0.362 . . . . 0.0 113.244 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 7.2 tp10 -73.74 -38.93 64.59 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.637 0.375 . . . . 0.0 110.411 174.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -57.99 -50.29 73.92 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.975 0.91 . . . . 0.0 111.417 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.533 ' HB ' HD23 ' A' ' 22' ' ' LEU . 28.1 m -62.52 -37.81 79.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 O-C-N 124.345 1.028 . . . . 0.0 110.657 -177.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -42.11 70.6 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.136 0.574 . . . . 0.0 109.678 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 50.2 mm-40 -82.95 -29.52 29.04 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.461 -170.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 t -102.33 -2.43 28.98 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.533 HD23 ' HB ' ' A' ' 18' ' ' VAL . 0.9 OUTLIER -81.04 117.13 21.37 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 118.33 0.514 . . . . 0.0 110.946 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -102.43 140.21 20.92 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 124.041 0.936 . . . . 0.0 109.508 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.48 87.85 0.34 Allowed 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.48 2.12 . . . . 0.0 111.232 174.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 148.2 2.19 0.44 Allowed Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.153 176.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.437 ' SD ' HD13 ' A' ' 22' ' ' LEU . 12.3 ptp -96.63 165.45 12.14 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.706 0.753 . . . . 0.0 111.296 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.495 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 20.6 tpt180 -91.51 128.46 37.34 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.828 1.251 . . . . 0.0 109.316 -171.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 m -116.28 170.96 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.631 0.773 . . . . 0.0 109.546 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.57 HH11 ' HA2' ' A' ' 40' ' ' GLY . 2.2 tmm_? -152.31 131.17 12.48 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.459 1.104 . . . . 0.0 108.083 -178.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.46 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 31.6 tpp -88.64 127.29 35.56 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.805 0.842 . . . . 0.0 111.195 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.495 HD23 ' HB2' ' A' ' 74' ' ' GLU . 3.3 pp -102.34 3.75 38.3 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.569 0.748 . . . . 0.0 112.153 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 30' ' ' MET . 29.6 t70 -126.76 164.13 22.01 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.779 0.832 . . . . 0.0 109.764 -178.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -95.96 117.09 29.96 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.886 -0.509 . . . . 0.0 110.015 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -111.16 170.52 8.05 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.0 1.32 . . . . 0.0 109.442 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -40.91 -55.33 2.52 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 125.919 1.688 . . . . 0.0 112.996 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -126.19 3.1 7.13 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.743 0.817 . . . . 0.0 111.47 -175.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -119.64 101.61 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.409 0.684 . . . . 0.0 109.167 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -78.82 150.58 32.28 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.89 115.55 3.78 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.347 0.659 . . . . 0.0 110.757 -175.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.57 ' HA2' HH11 ' A' ' 29' ' ' ARG . . . 127.78 -14.45 6.36 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.86 -176.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -73.42 154.24 40.08 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.645 0.378 . . . . 0.0 111.58 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -114.88 159.26 20.89 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.726 0.811 . . . . 0.0 110.702 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.495 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . -151.94 -171.65 19.89 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.391 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -134.98 142.67 46.51 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.477 ' CG ' HD12 ' A' ' 22' ' ' LEU . 20.9 t80 -80.01 122.58 26.92 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.499 0.719 . . . . 0.0 109.326 -176.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.558 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 12.2 mmm180 -108.4 -45.76 3.83 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.315 0.578 . . . . 0.0 109.726 -171.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.558 ' NE2' ' HB2' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -151.71 157.22 41.75 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.85 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.2 p -118.37 157.75 26.54 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 123.873 0.733 . . . . 0.0 110.642 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.658 HD21 ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER . . . . . 0 CA--C 1.529 0.138 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 175.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo . . . . . 0 CA--C 1.576 2.619 0 N-CA-C 116.195 1.575 . . . . 0.0 116.195 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.734 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 92.3 Cg_endo -79.53 98.25 1.14 Allowed 'Trans proline' 0 C--N 1.382 2.296 0 CA-C-N 122.371 1.883 . . . . 0.0 111.861 166.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.658 ' HA ' HD21 ' A' ' 49' ' ' ASN . 14.5 p -82.55 154.51 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.333 1.053 . . . . 0.0 111.829 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -94.86 128.81 41.89 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.151 0.58 . . . . 0.0 110.585 -172.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -140.66 140.45 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 125.298 1.439 . . . . 0.0 108.627 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -81.8 106.84 14.05 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.46 ' CH2' ' HB2' ' A' ' 30' ' ' MET . 96.2 m95 -88.77 130.97 35.25 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.314 1.046 . . . . 0.0 110.374 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -69.52 -26.66 64.63 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.705 0.802 . . . . 0.0 112.171 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.6 t -68.89 -44.22 73.67 Favored 'General case' 0 C--N 1.357 0.929 0 CA-C-O 120.69 0.281 . . . . 0.0 111.178 -177.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.2 t -94.88 -30.32 14.24 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.397 0.679 . . . . 0.0 111.681 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.68 23.54 30.52 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-O 119.733 -0.482 . . . . 0.0 114.271 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -154.19 176.87 11.75 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 117.439 0.62 . . . . 0.0 111.754 -175.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 2.0 p -83.59 142.35 30.9 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 172.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -144.98 154.76 42.89 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.35 0.595 . . . . 0.0 110.096 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.734 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 16.3 m-90 -81.98 115.68 21.25 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.01 -176.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.438 HG21 ' HZ2' ' A' ' 59' ' ' TRP . 19.9 m -137.68 145.11 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.365 0.666 . . . . 0.0 109.687 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.519 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 9.5 t-80 -69.44 147.06 51.46 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.607 0.363 . . . . 0.0 110.841 -177.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.452 ' O ' HG21 ' A' ' 18' ' ' VAL . 90.4 m95 -59.45 -45.78 90.62 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.546 0.738 . . . . 0.0 111.634 -176.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -65.18 -23.26 67.05 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.502 0.721 . . . . 0.0 111.918 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.519 ' SD ' ' HB3' ' A' ' 69' ' ' HIS . 33.8 mtp -90.04 -14.2 34.36 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.223 1.009 . . . . 0.0 111.077 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.4 tt -90.78 122.01 33.15 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.495 ' HB2' HD23 ' A' ' 31' ' ' LEU . 35.3 tt0 -123.12 125.23 44.78 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.296 1.039 . . . . 0.0 109.212 -176.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.463 HD13 HD22 ' A' ' 22' ' ' LEU . 12.2 pt . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 121.314 0.578 . . . . 0.0 111.609 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 55.3 t80 . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.59 -36.91 88.92 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-O 122.029 0.794 . . . . 0.0 112.717 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 2.5 mp0 -73.78 -33.08 64.09 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.027 -1.086 . . . . 0.0 110.246 177.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -68.63 -49.41 59.39 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.825 0.85 . . . . 0.0 110.837 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.573 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 20.9 m -59.11 -39.14 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 O-C-N 123.779 0.675 . . . . 0.0 110.135 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -57.57 -38.7 75.28 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.141 0.976 . . . . 0.0 111.55 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 52.9 mm-40 -78.2 -43.03 29.64 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.412 0.285 . . . . 0.0 111.282 -176.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.1 t -88.66 2.0 54.03 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.109 0.563 . . . . 0.0 112.384 -174.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.573 ' HB2' ' O ' ' A' ' 18' ' ' VAL . 12.7 tp -76.72 124.99 28.49 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.455 0.702 . . . . 0.0 111.176 -173.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -113.6 124.89 30.38 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 123.736 0.815 . . . . 0.0 109.617 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.47 85.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 124.24 3.293 . . . . 0.0 114.547 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.61 26.8 1.54 Allowed Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.837 174.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.508 ' SD ' HD12 ' A' ' 22' ' ' LEU . 4.5 ptp -91.73 175.63 6.83 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.436 0.636 . . . . 0.0 110.844 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.0 tpt85 -94.61 126.55 39.98 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.931 -170.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.465 HG22 HG22 ' A' ' 75' ' ' ILE . 41.6 t -119.01 160.07 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 C-N-CA 124.572 1.149 . . . . 0.0 111.26 -167.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.5 tpp85 -140.71 151.87 44.85 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 126.673 1.989 . . . . 0.0 108.567 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.9 tpt -94.89 115.5 27.54 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.481 0.712 . . . . 0.0 109.524 177.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 74' ' ' GLU . 38.8 tp -83.68 -29.03 27.93 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.192 0.597 . . . . 0.0 111.149 -177.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -137.19 154.6 50.17 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.754 0.422 . . . . 0.0 110.777 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -65.29 144.44 57.14 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.677 0.791 . . . . 0.0 111.588 -176.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -133.12 175.34 9.47 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.964 1.306 . . . . 0.0 110.275 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.57 -51.85 67.82 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.01 1.324 . . . . 0.0 111.706 -173.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -119.23 0.1 11.12 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.836 0.855 . . . . 0.0 111.741 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mp -119.89 146.03 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.248 1.019 . . . . 0.0 108.487 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.7 m -112.01 160.2 17.71 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 119.242 0.928 . . . . 0.0 110.025 173.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.24 117.67 8.16 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.38 -30.67 4.89 Favored Glycine 0 C--N 1.343 0.926 0 O-C-N 123.551 0.532 . . . . 0.0 111.993 -174.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -67.73 153.4 43.79 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.482 0.713 . . . . 0.0 111.012 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -127.19 154.83 44.31 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.536 0.684 . . . . 0.0 112.178 -166.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.66 -169.77 12.92 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.458 -171.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -136.58 140.5 42.93 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 172.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.535 ' HA ' HG12 ' A' ' 57' ' ' VAL . 30.8 t80 -72.64 124.21 24.81 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 123.63 0.581 . . . . 0.0 110.579 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.494 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 11.1 mmm180 -109.14 -47.99 3.34 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.678 0.391 . . . . 0.0 111.216 -174.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.553 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -167.43 147.67 5.32 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.725 0.81 . . . . 0.0 110.03 -179.318 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.449 ' HA ' HG23 ' A' ' 55' ' ' VAL . 38.9 p -117.76 173.22 6.87 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.665 0.786 . . . . 0.0 111.429 -175.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 . . . . . 0 CA--C 1.537 0.447 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.768 175.157 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo . . . . . 0 CA--C 1.575 2.564 0 N-CA-C 117.648 2.134 . . . . 0.0 117.648 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.512 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 59.0 Cg_endo -70.79 111.04 2.92 Favored 'Trans proline' 0 C--N 1.386 2.501 0 CA-C-N 122.744 2.016 . . . . 0.0 112.351 171.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.53 HG11 HD22 ' A' ' 73' ' ' LEU . 3.0 p -91.33 137.22 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.281 1.032 . . . . 0.0 109.656 166.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.553 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 1.9 mp0 -90.14 126.79 35.92 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 122.983 0.513 . . . . 0.0 109.888 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.535 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -135.52 137.22 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 124.923 1.289 . . . . 0.0 108.773 -177.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -81.47 108.45 15.07 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.503 ' HB2' HG22 ' A' ' 62' ' ' THR . 85.4 m95 -93.08 128.06 38.85 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.87 0.868 . . . . 0.0 110.049 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -67.49 -23.47 65.49 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 123.671 0.607 . . . . 0.0 110.887 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.7 t -60.63 -44.98 95.72 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 124.659 1.184 . . . . 0.0 111.764 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 59' ' ' TRP . 8.7 t -108.02 -6.36 16.6 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.975 0.91 . . . . 0.0 110.777 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.25 13.67 76.74 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 116.134 -0.485 . . . . 0.0 113.869 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -151.4 173.97 13.9 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.321 0.56 . . . . 0.0 111.032 -175.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.11 136.3 33.27 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.132 -175.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -137.76 157.41 46.5 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.657 0.741 . . . . 0.0 111.036 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 15.8 m-90 -83.73 108.75 16.99 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.816 1.646 . . . . 0.0 110.089 -176.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 m -123.82 157.75 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 122.796 0.438 . . . . 0.0 110.93 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -87.43 148.94 24.76 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.576 0.75 . . . . 0.0 110.495 -175.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.411 ' HH2' ' HB2' ' A' ' 48' ' ' SER . 75.3 m95 -61.85 -43.8 98.11 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.671 0.788 . . . . 0.0 111.939 -176.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -73.1 -11.66 60.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.689 0.396 . . . . 0.0 111.408 -176.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 70.5 mtm -114.33 6.35 16.05 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.058 0.943 . . . . 0.0 110.622 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.53 HD22 HG11 ' A' ' 55' ' ' VAL . 35.9 tp -92.01 119.49 31.77 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 170.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . 41.8 tt0 -121.48 128.02 51.66 Favored 'General case' 0 C--O 1.212 -0.92 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.465 HG22 HG22 ' A' ' 28' ' ' VAL . 15.3 pt . . . . . 0 N--CA 1.478 0.964 0 CA-C-O 121.417 0.627 . . . . 0.0 111.461 -176.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.3 t80 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.61 0.243 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.79 -40.26 58.43 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.523 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 2.2 mp0 -69.97 -26.09 63.93 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.647 0.779 . . . . 0.0 110.788 177.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -75.11 -50.11 17.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.736 0.814 . . . . 0.0 110.671 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.2 m -63.97 -34.61 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 123.516 0.51 . . . . 0.0 110.265 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.431 HE21 ' NE2' ' A' ' 20' ' ' GLN . 0.7 OUTLIER -54.59 -31.28 56.63 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.442 1.097 . . . . 0.0 111.03 177.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 49.4 mm-40 -88.97 -44.67 10.25 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.982 0.513 . . . . 0.0 111.015 -176.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.8 t -83.8 -17.91 39.45 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -171.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.539 HD23 ' SD ' ' A' ' 26' ' ' MET . 10.9 mt -66.2 118.64 10.2 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.163 0.585 . . . . 0.0 111.341 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -110.99 140.84 23.14 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.726 1.21 . . . . 0.0 110.157 -176.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.22 85.01 0.34 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.32 2.68 . . . . 0.0 112.41 -177.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.8 2.6 1.41 Allowed Glycine 0 C--N 1.342 0.907 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.696 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.539 ' SD ' HD23 ' A' ' 22' ' ' LEU . 6.0 ptp -85.96 168.91 13.73 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 121.455 0.645 . . . . 0.0 111.224 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.413 ' NH1' ' HB3' ' A' ' 42' ' ' GLU . 15.7 tpt85 -99.84 123.21 43.85 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.772 1.229 . . . . 0.0 110.066 -168.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.412 HG21 HG11 ' A' ' 57' ' ' VAL . 3.7 m -118.77 174.21 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.696 0.798 . . . . 0.0 110.832 -174.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.531 ' HG2' ' HG2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -149.11 140.4 23.18 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.165 1.386 . . . . 0.0 107.836 -172.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.4 tpt -94.81 113.69 25.47 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.931 0.892 . . . . 0.0 109.671 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.625 HD11 ' HA ' ' A' ' 72' ' ' MET . 3.6 pp -97.73 4.24 49.97 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.721 0.409 . . . . 0.0 111.678 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -133.07 162.43 31.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.156 0.583 . . . . 0.0 109.965 -170.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -89.04 122.6 32.54 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.259 0.624 . . . . 0.0 109.694 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -121.25 170.56 9.47 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.565 0.698 . . . . 0.0 112.292 -176.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -53.54 -49.03 68.51 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 113.781 -1.554 . . . . 0.0 112.178 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -128.67 1.45 5.5 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.404 0.682 . . . . 0.0 111.412 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.2 mp -118.92 144.85 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.5 m -112.0 156.59 21.9 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 122.871 0.468 . . . . 0.0 109.758 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.3 116.7 6.91 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.06 -25.37 5.52 Favored Glycine 0 N--CA 1.469 0.883 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -173.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -76.85 155.21 33.14 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.144 0.578 . . . . 0.0 110.693 175.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.531 ' HG2' ' HG2' ' A' ' 29' ' ' ARG . 51.3 mt-10 -135.13 155.26 51.02 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.848 0.859 . . . . 0.0 110.225 -169.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -147.58 -166.0 12.27 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.049 -170.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -136.52 137.4 40.26 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.584 0.754 . . . . 0.0 109.374 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.498 ' HE1' HG21 ' A' ' 55' ' ' VAL . 71.5 t80 -71.38 124.99 25.81 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.265 0.626 . . . . 0.0 109.799 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.534 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 21.4 mmm180 -109.3 -49.65 3.09 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.804 0.441 . . . . 0.0 110.499 -173.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.619 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -164.72 169.14 17.19 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.225 1.01 . . . . 0.0 109.237 -177.766 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.491 ' HA ' HG23 ' A' ' 55' ' ' VAL . 13.8 p -138.19 166.16 24.85 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.669 0.788 . . . . 0.0 112.04 -171.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 . . . . . 0 N--CA 1.469 0.477 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 171.018 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HA ' ' HE1' ' A' ' 70' ' ' TRP . 21.1 Cg_endo . . . . . 0 CA--C 1.583 2.972 0 N-CA-C 117.884 2.225 . . . . 0.0 117.884 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.633 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 60.9 Cg_endo -71.06 107.76 2.17 Favored 'Trans proline' 0 C--N 1.387 2.567 0 CA-C-N 122.94 2.086 . . . . 0.0 112.297 171.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.498 HG21 ' HE1' ' A' ' 45' ' ' PHE . 5.5 p -90.9 143.33 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 124.841 1.256 . . . . 0.0 111.0 171.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.619 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 1.9 mp0 -93.79 131.83 38.77 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-O 121.29 0.567 . . . . 0.0 110.225 -176.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.482 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -139.39 137.54 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 125.639 1.576 . . . . 0.0 108.106 -178.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -81.36 109.06 15.5 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -177.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.448 ' HB2' HG22 ' A' ' 62' ' ' THR . 85.8 m95 -93.51 117.81 30.56 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.72 0.808 . . . . 0.0 109.299 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -61.38 -25.88 67.47 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.05 0.94 . . . . 0.0 111.462 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.6 t -60.46 -45.13 94.82 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.436 1.094 . . . . 0.0 111.75 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 59' ' ' TRP . 7.1 t -105.88 -9.81 16.97 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.912 0.885 . . . . 0.0 110.711 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.79 16.5 79.96 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 114.24 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -152.77 165.12 36.33 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.412 0.625 . . . . 0.0 111.844 -173.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.616 HG22 ' HB3' ' A' ' 56' ' ' GLN . 2.7 m -88.45 120.37 29.77 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.309 -177.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -127.1 157.68 39.04 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.455 0.645 . . . . 0.0 110.661 -173.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.633 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 12.1 m-90 -83.94 116.61 22.88 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.505 1.522 . . . . 0.0 109.816 -173.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.462 HG21 HD13 ' A' ' 73' ' ' LEU . 7.1 m -130.12 158.36 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.897 0.879 . . . . 0.0 109.738 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.457 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 11.4 t-80 -86.79 147.87 25.65 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.953 0.501 . . . . 0.0 110.287 -177.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.427 ' HE1' ' HA ' ' A' ' 53' ' ' PRO . 81.3 m95 -57.2 -50.41 72.96 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.002 0.921 . . . . 0.0 111.571 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -72.78 -1.45 16.6 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.607 0.763 . . . . 0.0 112.005 -176.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.625 ' HA ' HD11 ' A' ' 31' ' ' LEU . 43.0 mtp -120.58 14.39 11.84 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.173 0.989 . . . . 0.0 110.756 -178.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.462 HD13 HG21 ' A' ' 68' ' ' VAL . 33.8 tp -123.37 124.37 42.78 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.91 0.884 . . . . 0.0 109.415 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.557 ' HB2' HD23 ' A' ' 31' ' ' LEU . 10.8 tp10 -106.52 142.97 35.3 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.387 1.075 . . . . 0.0 109.56 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 26.8 pt . . . . . 0 N--CA 1.478 0.949 0 CA-C-O 121.085 0.469 . . . . 0.0 112.009 178.653 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.0 t80 . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 120.652 0.263 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.44 -38.25 90.81 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.625 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 4.5 mp0 -72.32 -31.59 65.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.617 -0.791 . . . . 0.0 109.757 178.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.408 ' O ' HG22 ' A' ' 21' ' ' THR . 11.4 t80 -67.37 -50.43 59.79 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 123.542 0.737 . . . . 0.0 110.533 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 m -63.65 -36.83 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 123.555 0.535 . . . . 0.0 109.964 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.46 -34.41 61.44 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.12 0.968 . . . . 0.0 110.742 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.535 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 58.0 mm-40 -84.11 -37.41 22.05 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.042 0.537 . . . . 0.0 111.112 -175.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.459 HG23 HD13 ' A' ' 75' ' ' ILE . 11.7 t -102.48 3.74 37.93 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.539 0.736 . . . . 0.0 112.414 -172.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.429 ' HA ' ' SD ' ' A' ' 26' ' ' MET . 8.8 mt -75.15 108.16 7.72 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.948 0.499 . . . . 0.0 109.672 174.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.586 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 39.7 mt-30 -85.8 130.72 49.62 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 123.657 0.783 . . . . 0.0 108.914 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.83 82.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 123.333 2.689 . . . . 0.0 113.52 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.36 17.73 1.55 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.721 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.586 ' HB3' ' HB2' ' A' ' 23' ' ' GLN . 14.2 ptm -91.35 173.78 7.73 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.677 0.751 . . . . 0.0 111.267 -175.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.8 tpt85 -96.25 131.42 42.75 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.109 -169.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.54 154.36 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 124.375 1.07 . . . . 0.0 111.396 -167.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -129.7 147.05 51.45 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.71 1.604 . . . . 0.0 108.092 169.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.426 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 32.9 tpp -98.41 129.45 45.05 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.011 0.924 . . . . 0.0 108.724 170.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.636 HD23 ' HB2' ' A' ' 74' ' ' GLU . 3.8 pp -106.88 2.38 25.34 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -176.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -140.6 172.37 12.81 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.543 0.337 . . . . 0.0 110.152 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -83.46 140.74 32.16 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 122.001 -0.437 . . . . 0.0 110.798 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.41 173.2 11.54 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.377 1.071 . . . . 0.0 110.427 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -50.57 -44.5 56.76 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.392 1.477 . . . . 0.0 112.674 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -138.23 4.19 2.44 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.455 0.702 . . . . 0.0 111.776 -175.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.2 mp -119.57 145.12 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.5 m -112.33 162.95 14.97 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 123.312 0.645 . . . . 0.0 109.887 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.3 118.69 9.03 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.193 0.597 . . . . 0.0 109.815 173.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.87 0.74 28.77 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 116.435 -0.348 . . . . 0.0 113.221 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -88.95 156.4 18.91 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.043 0.449 . . . . 0.0 110.647 173.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -123.97 148.56 46.84 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.392 -169.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -145.42 -170.06 14.08 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.091 -175.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -135.57 137.0 41.56 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.606 ' HZ ' ' HB3' ' A' ' 48' ' ' SER . 87.6 t80 -76.55 118.85 19.63 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.413 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 21.4 mmm-85 -105.3 -47.08 4.05 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -175.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 46' ' ' ARG . 0.4 OUTLIER -152.86 158.66 42.5 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.959 -176.175 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.606 ' HB3' ' HZ ' ' A' ' 45' ' ' PHE . 77.4 p -116.46 175.69 5.45 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.846 0.858 . . . . 0.0 110.699 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.479 HD21 HE22 ' A' ' 56' ' ' GLN . 83.0 m-20 . . . . . 0 C--O 1.237 0.42 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.859 179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.403 ' HA ' ' HE1' ' A' ' 70' ' ' TRP . 12.7 Cg_endo . . . . . 0 CA--C 1.577 2.67 0 N-CA-C 116.565 1.717 . . . . 0.0 116.565 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.736 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 71.8 Cg_endo -73.84 98.68 1.09 Allowed 'Trans proline' 0 C--N 1.384 2.399 0 CA-C-N 122.598 1.963 . . . . 0.0 112.097 169.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.546 HG23 ' HA ' ' A' ' 48' ' ' SER . 7.6 p -83.37 150.46 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 125.126 1.37 . . . . 0.0 111.588 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.479 HE22 HD21 ' A' ' 49' ' ' ASN . 1.7 mp0 -90.86 127.79 36.5 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.197 0.599 . . . . 0.0 110.362 -175.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.19 134.2 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.315 1.446 . . . . 0.0 107.722 178.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 69.3 t80 -81.28 107.81 14.37 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.531 ' HB2' HG22 ' A' ' 62' ' ' THR . 83.5 m95 -92.76 123.4 36.01 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.888 0.875 . . . . 0.0 109.408 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -63.85 -29.04 70.27 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.777 0.673 . . . . 0.0 111.128 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.8 t -61.93 -46.71 88.12 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.166 0.986 . . . . 0.0 112.018 -175.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.531 HG22 ' HB2' ' A' ' 59' ' ' TRP . 9.8 t -98.6 -14.06 20.09 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.658 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.78 16.61 74.82 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 116.126 -0.488 . . . . 0.0 114.165 176.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -152.14 165.85 33.5 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.409 0.623 . . . . 0.0 111.547 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -87.01 114.44 23.63 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.368 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -124.83 153.82 41.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.671 0.748 . . . . 0.0 110.391 -173.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.736 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 7.8 m0 -83.87 116.82 22.94 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.102 -172.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.9 m -131.21 149.35 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -76.22 147.64 38.23 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.403 ' HE1' ' HA ' ' A' ' 53' ' ' PRO . 59.1 m95 -53.11 -38.93 63.04 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 124.118 0.967 . . . . 0.0 111.453 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -67.59 -28.41 67.74 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -175.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.411 ' HA ' HD11 ' A' ' 31' ' ' LEU . 4.9 mpp? -96.15 -5.56 40.37 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.497 0.319 . . . . 0.0 111.494 176.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.3 tt -90.1 122.23 32.88 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 174.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.636 ' HB2' HD23 ' A' ' 31' ' ' LEU . 35.1 tt0 -110.73 149.14 30.93 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.507 1.123 . . . . 0.0 108.698 174.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.459 HD13 HG23 ' A' ' 21' ' ' THR . 34.7 pt . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 170.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.7 t80 . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.3 -37.86 80.84 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.059 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -70.38 -34.21 72.32 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.438 0.695 . . . . 0.0 110.068 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -69.92 -49.68 49.56 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.201 0.6 . . . . 0.0 111.511 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.0 m -59.11 -37.91 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 123.515 0.51 . . . . 0.0 110.772 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -54.48 -34.97 62.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.065 0.946 . . . . 0.0 111.835 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 42.1 mm-40 -81.63 -42.36 20.13 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.907 -175.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.6 t -92.14 3.34 55.51 Favored 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 123.416 0.687 . . . . 0.0 112.175 -174.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -74.67 122.18 22.81 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 122.99 0.516 . . . . 0.0 110.2 177.522 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -104.2 132.43 20.99 Favored Pre-proline 0 N--CA 1.488 1.456 0 C-N-CA 123.832 0.853 . . . . 0.0 110.573 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.78 89.97 0.29 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.98 2.453 . . . . 0.0 111.245 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.8 -6.03 4.8 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.939 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 6.8 ptp -80.67 153.04 28.14 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 173.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -85.66 163.1 18.49 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.1 m -133.99 171.14 18.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -136.58 138.35 41.15 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.445 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 3.0 tpt -85.65 111.15 19.82 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.239 1.016 . . . . 0.0 108.974 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.485 HD11 ' HA ' ' A' ' 72' ' ' MET . 4.5 pp -91.04 -15.67 29.18 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 117.778 0.263 . . . . 0.0 111.248 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 30' ' ' MET . 21.3 t70 -125.75 151.91 46.05 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.753 0.821 . . . . 0.0 109.363 -176.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -80.45 119.34 23.01 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.663 0.385 . . . . 0.0 110.048 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -106.66 173.28 6.39 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.725 1.21 . . . . 0.0 111.645 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -48.09 -58.79 4.0 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.364 1.466 . . . . 0.0 112.484 -175.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -121.67 5.54 10.03 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.077 0.951 . . . . 0.0 111.39 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mp -120.0 133.29 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 173.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.6 m -99.92 155.44 17.68 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.992 0.517 . . . . 0.0 109.854 177.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.89 115.86 6.44 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.55 -29.23 3.31 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -172.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -74.51 157.36 35.65 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.51 0.724 . . . . 0.0 111.756 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 41.5 mt-10 -115.73 153.68 30.94 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.782 0.833 . . . . 0.0 111.057 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.83 -170.26 11.88 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.866 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -139.0 140.93 38.32 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 170.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.464 ' HA ' HG12 ' A' ' 57' ' ' VAL . 84.5 t80 -76.71 121.78 23.78 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.037 0.535 . . . . 0.0 110.645 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.528 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 19.9 mmm180 -108.51 -48.39 3.34 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.324 0.65 . . . . 0.0 110.141 -174.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.528 ' NE2' ' HB2' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -158.91 161.13 36.74 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.154 0.982 . . . . 0.0 109.636 -177.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.498 ' HA ' HG23 ' A' ' 55' ' ' VAL . 14.5 p -130.96 171.63 12.99 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.877 0.846 . . . . 0.0 111.896 -176.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 CA--C 1.543 0.688 0 CA-C-N 113.576 -1.647 . . . . 0.0 108.198 -178.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo . . . . . 0 CA--C 1.581 2.859 0 N-CA-C 118.088 2.303 . . . . 0.0 118.088 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.593 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 93.3 Cg_endo -80.36 108.61 2.19 Favored 'Trans proline' 0 C--N 1.379 2.15 0 CA-C-N 123.376 2.242 . . . . 0.0 112.084 168.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.498 HG23 ' HA ' ' A' ' 48' ' ' SER . 7.7 p -81.08 146.69 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.031 0.933 . . . . 0.0 110.71 172.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.559 ' HB3' HG22 ' A' ' 65' ' ' THR . 1.9 mp0 -93.74 127.91 39.69 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-O 121.191 0.519 . . . . 0.0 109.604 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.464 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -138.26 135.19 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 125.448 1.499 . . . . 0.0 108.052 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 47.6 t80 -80.92 106.76 13.18 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -177.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.489 ' HB2' HG22 ' A' ' 62' ' ' THR . 86.5 m95 -89.9 123.06 33.51 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.796 0.838 . . . . 0.0 109.811 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 16.9 pt20 -62.17 -28.11 69.43 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.19 0.996 . . . . 0.0 111.663 175.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.9 t -63.86 -44.49 92.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.853 0.861 . . . . 0.0 111.766 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.489 HG22 ' HB2' ' A' ' 59' ' ' TRP . 8.9 t -105.24 -6.01 20.12 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.494 0.718 . . . . 0.0 111.246 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.32 15.93 80.03 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 114.438 0.535 . . . . 0.0 114.438 175.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -152.83 165.94 33.81 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.323 0.582 . . . . 0.0 112.053 -172.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.559 HG22 ' HB3' ' A' ' 56' ' ' GLN . 2.0 m -87.26 117.99 26.39 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.141 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -125.86 156.82 39.01 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.461 0.648 . . . . 0.0 110.651 -171.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.593 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 11.9 m-90 -84.37 111.53 19.52 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.62 1.568 . . . . 0.0 109.488 -173.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.25 149.65 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.492 0.717 . . . . 0.0 110.092 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -78.5 146.61 34.28 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.766 0.426 . . . . 0.0 110.491 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -61.07 -46.17 91.73 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.57 0.748 . . . . 0.0 112.071 -176.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -67.95 -22.22 65.05 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.17 0.588 . . . . 0.0 111.266 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.485 ' HA ' HD11 ' A' ' 31' ' ' LEU . 38.5 mtp -101.85 13.28 35.27 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.764 1.226 . . . . 0.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -117.84 125.71 51.05 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -105.44 150.99 24.8 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 173.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.4 pt . . . . . 0 CA--C 1.54 0.574 0 C-N-CA 123.717 0.807 . . . . 0.0 110.11 176.212 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 62.4 t80 . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.82 -34.89 83.95 Favored Glycine 0 C--N 1.341 0.812 0 O-C-N 123.623 0.577 . . . . 0.0 112.797 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 44.6 mp0 -71.3 -41.4 69.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 123.945 0.898 . . . . 0.0 109.445 177.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.44 ' O ' HG22 ' A' ' 21' ' ' THR . 18.8 t80 -59.36 -51.17 71.07 Favored 'General case' 0 C--N 1.358 0.958 0 O-C-N 123.85 0.719 . . . . 0.0 110.964 178.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.7 m -63.17 -40.1 87.77 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -58.49 -47.48 83.96 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 124.003 0.815 . . . . 0.0 110.873 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 22.6 mm-40 -64.52 -46.37 83.2 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.714 0.293 . . . . 0.0 110.868 -175.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 17' ' ' TYR . 14.7 t -93.15 13.07 22.15 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.457 0.703 . . . . 0.0 111.93 -175.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.729 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.1 OUTLIER -70.94 114.96 9.53 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.91 0.484 . . . . 0.0 109.723 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.654 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 50.0 mt-30 -87.98 137.94 31.24 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.696 0.798 . . . . 0.0 110.777 -177.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.476 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 29.8 Cg_exo -62.74 88.16 0.12 Allowed 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.39 2.727 . . . . 0.0 113.118 177.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.72 40.96 1.79 Allowed Glycine 0 C--N 1.35 1.309 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.729 ' SD ' HD13 ' A' ' 22' ' ' LEU . 20.3 ptm -98.82 177.66 5.21 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.719 0.771 . . . . 0.0 110.814 -177.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -96.56 122.03 39.04 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.19 1.396 . . . . 0.0 108.942 -177.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.0 m -117.0 171.74 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.146 0.578 . . . . 0.0 109.607 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -143.01 143.26 31.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.103 1.361 . . . . 0.0 107.705 -176.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.7 tpt -88.3 125.53 34.72 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.465 HD11 ' HA ' ' A' ' 72' ' ' MET . 4.4 pp -105.38 -9.74 17.39 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.627 0.371 . . . . 0.0 111.085 178.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -125.16 156.14 38.86 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.336 0.655 . . . . 0.0 110.27 -175.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -87.23 121.01 29.1 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.217 0.607 . . . . 0.0 109.752 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.553 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 10.4 m-85 -110.68 173.39 6.35 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.512 1.125 . . . . 0.0 111.772 -175.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -50.41 -52.86 33.9 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.435 1.494 . . . . 0.0 111.401 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.526 ' HG3' HG13 ' A' ' 37' ' ' ILE . 10.0 pt-20 -117.3 -19.2 9.69 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.815 -174.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 34' ' ' TYR . 4.6 mt -104.89 145.75 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.45 1.1 . . . . 0.0 108.995 -176.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 m -110.72 152.29 26.74 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.48 113.66 4.88 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 138.17 -29.1 2.65 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 119.569 -0.573 . . . . 0.0 113.711 -178.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -90.42 160.68 15.93 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 118.06 0.93 . . . . 0.0 111.927 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -109.26 159.99 16.5 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.922 0.889 . . . . 0.0 111.641 -164.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -141.64 -176.14 15.69 Favored Glycine 0 C--O 1.241 0.58 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.481 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -133.97 140.52 46.79 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 174.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.539 ' HA ' HG12 ' A' ' 57' ' ' VAL . 78.1 t80 -72.37 121.96 20.38 Favored 'General case' 0 C--N 1.342 0.261 0 O-C-N 123.494 0.496 . . . . 0.0 110.244 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.518 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 7.5 mmm180 -108.35 -47.76 3.46 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -177.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.537 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -166.31 151.24 8.07 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.05 0.94 . . . . 0.0 109.561 179.061 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.42 ' HA ' HG23 ' A' ' 55' ' ' VAL . 30.8 p -118.02 178.23 4.5 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.234 1.014 . . . . 0.0 111.004 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 . . . . . 0 CA--C 1.538 0.496 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 168.466 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo . . . . . 0 CA--C 1.577 2.664 0 N-CA-C 118.901 2.616 . . . . 0.0 118.901 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.32 105.3 1.39 Allowed 'Trans proline' 0 C--N 1.381 2.269 0 CA-C-N 123.112 2.147 . . . . 0.0 112.092 172.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.42 HG23 ' HA ' ' A' ' 48' ' ' SER . 3.2 p -89.53 138.77 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.238 1.015 . . . . 0.0 109.923 169.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.537 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.1 mp0 -92.73 124.1 36.49 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -134.65 142.37 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.913 1.285 . . . . 0.0 108.631 -179.19 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -84.84 107.66 17.12 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.564 ' HB2' HG22 ' A' ' 62' ' ' THR . 83.2 m95 -91.06 127.46 36.49 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.751 0.821 . . . . 0.0 110.133 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -21.37 63.63 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.762 0.664 . . . . 0.0 112.01 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.9 t -65.99 -46.28 78.59 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.08 0.552 . . . . 0.0 112.132 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.564 HG22 ' HB2' ' A' ' 59' ' ' TRP . 9.9 t -97.41 -16.14 20.34 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.816 0.846 . . . . 0.0 110.351 -177.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.18 15.68 80.72 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.494 -0.615 . . . . 0.0 114.037 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -151.4 176.99 10.73 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 117.632 0.716 . . . . 0.0 111.252 -174.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.08 138.52 31.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.38 1.072 . . . . 0.0 109.268 178.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -141.8 156.48 45.56 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.06 0.457 . . . . 0.0 110.966 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 -83.07 106.72 15.12 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.777 1.231 . . . . 0.0 109.98 -177.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.6 m -121.19 156.77 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.226 0.61 . . . . 0.0 110.129 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -89.44 146.48 24.62 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.697 0.799 . . . . 0.0 109.675 -176.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -56.17 -49.3 74.41 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.866 0.866 . . . . 0.0 112.607 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -70.06 -19.97 63.26 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.428 0.691 . . . . 0.0 111.582 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.465 ' HA ' HD11 ' A' ' 31' ' ' LEU . 31.2 mtp -100.26 1.55 41.88 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.708 0.803 . . . . 0.0 111.23 176.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.0 tt -104.48 130.71 52.38 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.617 1.167 . . . . 0.0 108.235 170.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.42 ' HB2' HD23 ' A' ' 31' ' ' LEU . 41.3 tt0 -107.45 146.89 31.16 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.103 0.961 . . . . 0.0 108.746 173.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.1 pt . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 120.831 0.348 . . . . 0.0 110.116 170.951 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.1 t80 . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.5 -44.93 39.28 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-O 121.785 0.658 . . . . 0.0 113.357 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -70.92 -26.19 63.09 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.191 0.596 . . . . 0.0 109.682 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -71.28 -49.22 45.15 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.456 1.102 . . . . 0.0 111.585 174.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 m -62.71 -33.99 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 122.563 0.345 . . . . 0.0 110.426 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.85 -33.35 49.18 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.22 1.008 . . . . 0.0 110.545 177.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -80.66 -53.42 6.54 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.208 0.603 . . . . 0.0 110.577 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.5 t -90.94 17.07 8.32 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.649 0.78 . . . . 0.0 112.463 -167.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.66 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.2 OUTLIER -76.24 149.76 37.13 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 173.25 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.534 ' N ' HE21 ' A' ' 23' ' ' GLN . 0.0 OUTLIER -117.69 140.24 27.34 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.252 1.021 . . . . 0.0 109.612 177.045 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.509 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 72.8 Cg_endo -72.68 78.98 1.98 Allowed 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.34 2.693 . . . . 0.0 113.429 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.67 28.31 0.82 Allowed Glycine 0 C--N 1.352 1.422 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.66 ' SD ' HD13 ' A' ' 22' ' ' LEU . 27.8 ptm -98.95 170.84 8.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.241 0.616 . . . . 0.0 111.29 -176.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -82.76 124.3 30.13 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.179 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.0 m -116.45 170.47 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.472 ' HE ' ' HG2' ' A' ' 42' ' ' GLU . 21.4 tpp85 -138.41 153.57 48.89 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -175.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' MET . . . . . 0.436 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 11.4 tpt -97.26 124.57 41.41 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.2 tp -96.23 -9.69 29.8 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.456 0.702 . . . . 0.0 111.258 -173.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 30' ' ' MET . 12.2 t70 -151.22 157.03 42.1 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.282 0.633 . . . . 0.0 109.325 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -73.43 142.16 46.9 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -132.44 172.19 12.8 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.979 0.511 . . . . 0.0 110.434 -177.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -40.74 -55.53 2.39 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 126.178 1.791 . . . . 0.0 113.05 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -124.19 0.4 8.41 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.552 -172.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.6 mt -118.71 138.72 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 124.142 0.977 . . . . 0.0 108.508 -175.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.2 m -87.9 150.94 23.19 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 122.915 0.486 . . . . 0.0 110.426 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.17 119.71 11.94 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 171.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.71 11.91 54.31 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.969 -177.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -79.56 153.49 29.45 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.91 0.484 . . . . 0.0 110.079 175.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.472 ' HG2' ' HE ' ' A' ' 29' ' ' ARG . 48.5 mt-10 -112.62 120.44 41.57 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.929 0.492 . . . . 0.0 110.601 -176.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.94 -172.6 21.87 Favored Glycine 0 C--O 1.243 0.683 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.569 173.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -134.04 138.21 45.2 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 171.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.509 ' HD2' ' HA ' ' A' ' 24' ' ' PRO . 64.1 t80 -70.47 123.27 21.37 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.54 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 21.7 mmm180 -106.36 -49.41 3.35 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -177.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.567 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -167.71 167.29 13.34 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.929 -179.406 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 72.3 p -141.51 -179.93 6.44 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.825 0.85 . . . . 0.0 110.922 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 . . . . . 0 CA--C 1.539 0.543 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 168.988 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo . . . . . 0 CA--C 1.577 2.667 0 N-CA-C 118.831 2.589 . . . . 0.0 118.831 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.14 110.22 1.93 Allowed 'Trans proline' 0 C--N 1.385 2.492 0 CA-C-N 123.597 2.32 . . . . 0.0 111.594 169.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.78 141.67 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.134 0.974 . . . . 0.0 110.152 170.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.567 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 1.6 mp0 -93.32 121.34 34.6 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.472 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -135.87 137.2 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.977 1.311 . . . . 0.0 108.403 -177.136 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -83.59 106.08 15.03 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.494 ' HB2' HG22 ' A' ' 62' ' ' THR . 87.5 m95 -95.6 131.62 41.62 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.367 1.067 . . . . 0.0 110.326 -176.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -69.36 -25.05 63.99 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 123.847 0.717 . . . . 0.0 112.268 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.8 t -59.65 -44.17 93.64 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.348 0.594 . . . . 0.0 110.881 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.494 HG22 ' HB2' ' A' ' 59' ' ' TRP . 10.1 t -105.16 -14.49 15.37 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.957 -1.019 . . . . 0.0 111.826 -174.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.13 15.83 81.13 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.111 -0.495 . . . . 0.0 114.097 178.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -152.94 173.46 15.36 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.317 0.579 . . . . 0.0 111.578 -172.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.1 132.67 34.22 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.14 1.376 . . . . 0.0 109.576 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -141.5 158.11 44.27 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.265 0.555 . . . . 0.0 111.695 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -88.2 115.75 25.92 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.497 1.519 . . . . 0.0 109.776 -174.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.81 147.53 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.861 0.865 . . . . 0.0 109.251 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.605 ' HD2' ' H ' ' A' ' 71' ' ' HIS . 15.5 t60 -73.3 146.88 45.0 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -54.1 -31.26 51.51 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.57 1.548 . . . . 0.0 113.863 -177.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . 0.605 ' H ' ' HD2' ' A' ' 69' ' ' HIS . 59.1 t-80 -79.39 -18.11 52.99 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.731 0.812 . . . . 0.0 111.191 -173.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.5 mtm -100.31 4.84 44.35 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.484 0.714 . . . . 0.0 110.655 171.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 tt -103.68 120.32 40.69 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 170.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -105.19 129.09 53.65 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.314 1.046 . . . . 0.0 108.235 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.9 pt . . . . . 0 CA--C 1.54 0.592 0 CA-C-O 121.543 0.687 . . . . 0.0 109.896 175.613 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 79.8 t80 . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 120.858 0.361 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.48 -32.76 84.22 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.034 -0.984 . . . . 0.0 112.931 177.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.524 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 41.2 tt0 -62.86 -48.94 76.84 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.098 0.559 . . . . 0.0 110.274 173.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.412 ' O ' HG22 ' A' ' 21' ' ' THR . 10.3 t80 -57.51 -50.42 73.14 Favored 'General case' 0 C--N 1.358 0.971 0 O-C-N 124.017 0.823 . . . . 0.0 110.838 -176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.466 ' HB ' HD23 ' A' ' 22' ' ' LEU . 29.5 m -67.74 -39.01 81.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 O-C-N 123.535 0.522 . . . . 0.0 110.645 -177.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -56.91 -31.25 64.72 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.153 0.581 . . . . 0.0 111.723 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 26.4 mm-40 -81.94 -40.57 22.07 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.191 -177.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 17' ' ' TYR . 12.5 t -100.46 -6.06 26.13 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -168.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.482 HD13 ' SD ' ' A' ' 26' ' ' MET . 1.1 mm? -69.7 107.79 3.61 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 118.164 0.438 . . . . 0.0 110.612 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -87.46 142.45 33.1 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.08 0.952 . . . . 0.0 110.498 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.5 ' HA ' ' HD1' ' A' ' 45' ' ' PHE . 34.7 Cg_exo -59.59 79.18 0.06 OUTLIER 'Trans proline' 0 C--N 1.377 2.06 0 C-N-CA 123.531 2.821 . . . . 0.0 114.061 176.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.33 19.32 1.22 Allowed Glycine 0 C--N 1.353 1.525 0 CA-C-O 119.534 -0.592 . . . . 0.0 113.015 173.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.482 ' SD ' HD13 ' A' ' 22' ' ' LEU . 4.7 ptp -93.91 174.68 7.04 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 117.704 0.752 . . . . 0.0 110.876 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.618 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 21.4 tpt180 -97.02 126.97 42.54 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.747 1.219 . . . . 0.0 109.055 -171.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.441 HG12 HD11 ' A' ' 22' ' ' LEU . 5.7 m -116.03 172.34 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.676 0.791 . . . . 0.0 109.999 -174.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -144.58 140.95 29.1 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.173 1.389 . . . . 0.0 108.329 -172.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.4 tpt -98.95 112.15 24.34 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 74' ' ' GLU . 4.7 pp -89.48 -3.7 58.26 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -140.7 154.01 46.18 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -75.63 127.04 32.2 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.221 0.534 . . . . 0.0 110.144 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.471 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 0.6 OUTLIER -107.06 172.68 6.69 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.734 0.813 . . . . 0.0 110.989 -178.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -50.11 -35.78 26.99 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.818 1.647 . . . . 0.0 113.237 -172.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -138.58 3.6 2.31 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.859 0.864 . . . . 0.0 111.182 -179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.471 ' HB ' ' HB2' ' A' ' 34' ' ' TYR . 7.2 mt -118.78 144.19 27.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.438 1.095 . . . . 0.0 108.503 -172.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.9 m -91.77 153.69 19.44 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.85 0.46 . . . . 0.0 110.909 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.11 116.14 12.18 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 166.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.7 -5.71 29.48 Favored Glycine 0 CA--C 1.525 0.701 0 CA-C-N 115.756 -0.656 . . . . 0.0 112.346 -172.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -79.17 156.23 28.31 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 122.748 0.419 . . . . 0.0 110.108 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -129.88 158.21 40.12 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.252 0.621 . . . . 0.0 111.136 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -149.26 -166.88 13.5 Favored Glycine 0 C--N 1.34 0.777 0 CA-C-N 114.86 -1.064 . . . . 0.0 112.501 -172.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -135.47 139.26 43.93 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 174.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.5 ' HD1' ' HA ' ' A' ' 24' ' ' PRO . 38.7 t80 -69.13 119.52 13.55 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 175.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.511 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 14.5 mmm180 -103.65 -46.96 4.38 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -177.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.628 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -172.21 156.92 4.05 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.734 1.214 . . . . 0.0 108.885 176.421 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 71.7 p -127.39 178.2 6.22 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.473 0.709 . . . . 0.0 110.335 176.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 31.6 m-80 -118.31 136.27 53.8 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 170.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -67.93 -52.71 32.98 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.226 0.61 . . . . 0.0 110.898 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.29 -23.31 32.18 Favored Glycine 0 C--N 1.341 0.828 0 CA-C-N 115.18 -0.918 . . . . 0.0 113.282 -177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.549 HG22 ' HD2' ' A' ' 54' ' ' PRO . 5.9 mm -101.68 114.06 65.7 Favored Pre-proline 0 N--CA 1.479 0.988 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 -177.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_endo -59.51 -33.55 97.11 Favored 'Trans proline' 0 CA--C 1.577 2.656 0 N-CA-C 118.361 2.408 . . . . 0.0 118.361 -174.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.549 ' HD2' HG22 ' A' ' 52' ' ' ILE . 28.9 Cg_endo -61.68 107.75 0.55 Allowed 'Trans proline' 0 C--N 1.384 2.415 0 CA-C-N 123.101 2.143 . . . . 0.0 112.51 175.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 p -89.04 136.46 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.28 1.032 . . . . 0.0 109.502 169.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.628 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 1.8 mp0 -90.4 123.35 34.05 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 177.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -137.03 136.75 47.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 C-N-CA 125.0 1.32 . . . . 0.0 108.546 -174.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 54.2 t80 -82.53 105.58 13.69 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 -175.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.486 ' HB2' HG22 ' A' ' 62' ' ' THR . 95.6 m95 -90.14 130.61 36.27 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.064 0.946 . . . . 0.0 110.432 -176.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -70.31 -31.33 68.61 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 123.863 0.727 . . . . 0.0 112.727 -174.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 36.6 t -70.08 -46.08 65.68 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 117.951 0.341 . . . . 0.0 111.536 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.486 HG22 ' HB2' ' A' ' 59' ' ' TRP . 9.8 t -86.45 -18.13 32.5 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 122.736 0.414 . . . . 0.0 110.676 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.8 19.71 78.69 Favored Glycine 0 C--N 1.351 1.397 0 CA-C-O 119.727 -0.485 . . . . 0.0 114.277 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -153.04 165.0 36.95 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 121.317 0.579 . . . . 0.0 112.244 -173.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.546 HG22 ' HB3' ' A' ' 56' ' ' GLN . 2.1 m -87.05 121.63 29.78 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.933 -177.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -130.64 157.15 43.53 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.964 0.411 . . . . 0.0 111.283 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 12.3 m-90 -79.02 114.34 17.88 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.714 1.205 . . . . 0.0 110.191 -178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.461 HG21 HD23 ' A' ' 73' ' ' LEU . 11.6 m -129.05 155.34 41.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 122.838 0.455 . . . . 0.0 110.652 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -89.47 147.06 24.21 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.736 0.814 . . . . 0.0 110.169 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -59.82 -42.36 93.33 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.428 0.691 . . . . 0.0 112.59 -176.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -66.99 -24.94 66.09 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 117.661 0.21 . . . . 0.0 111.336 -176.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 71.4 mtm -99.88 -1.82 36.43 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 122.732 0.413 . . . . 0.0 111.62 175.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.461 HD23 HG21 ' A' ' 68' ' ' VAL . 2.5 tm? -92.66 121.23 33.87 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 172.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.522 ' HB2' HD23 ' A' ' 31' ' ' LEU . 39.6 tt0 -115.69 151.59 34.78 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.882 1.273 . . . . 0.0 108.458 176.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.435 HG21 ' SD ' ' A' ' 26' ' ' MET . 10.7 pt -114.18 123.2 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 118.433 0.56 . . . . 0.0 110.723 169.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 84.0 mt -121.7 3.73 10.08 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.971 0.908 . . . . 0.0 109.838 173.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.618 ' HA3' ' HB3' ' A' ' 27' ' ' ARG . . . . . . . . 0 C--N 1.352 1.466 0 O-C-N 123.659 0.599 . . . . 0.0 113.197 176.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 53.4 t80 . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.02 -31.77 81.99 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.893 176.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 12.1 tp10 -69.14 -48.05 63.42 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 177.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.41 ' O ' HG22 ' A' ' 21' ' ' THR . 42.0 t80 -59.06 -49.92 76.05 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-N 114.986 -1.007 . . . . 0.0 111.396 -177.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.8 -40.67 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 O-C-N 123.677 0.611 . . . . 0.0 110.721 -178.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -57.64 -36.31 71.67 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.507 0.723 . . . . 0.0 111.932 179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 23.5 mm-40 -80.21 -35.79 35.77 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.009 0.524 . . . . 0.0 111.171 -177.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 17' ' ' TYR . 14.8 t -101.04 7.82 43.24 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 122.806 0.443 . . . . 0.0 112.117 -176.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -73.97 113.98 11.76 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.489 ' HB3' ' HB3' ' A' ' 26' ' ' MET . 34.3 tt0 -87.44 134.71 35.57 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.06 0.944 . . . . 0.0 109.673 -176.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.51 ' HA ' ' CD1' ' A' ' 45' ' ' PHE . 52.7 Cg_endo -64.81 80.3 0.18 Allowed 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 123.151 2.567 . . . . 0.0 113.457 -178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.99 26.44 1.54 Allowed Glycine 0 C--N 1.351 1.401 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.057 175.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.489 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 24.6 ptm -96.53 168.97 10.22 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 121.608 0.718 . . . . 0.0 110.54 -178.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.56 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 18.6 tpp180 -90.01 126.31 35.71 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.463 -1.244 . . . . 0.0 108.851 -177.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.476 HG12 HG22 ' A' ' 75' ' ' ILE . 8.0 m -116.44 171.02 5.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.754 0 C-N-CA 124.209 1.003 . . . . 0.0 108.833 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.451 ' HD2' ' N ' ' A' ' 30' ' ' MET . 2.6 tmm_? -137.29 143.93 42.41 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.451 ' N ' ' HD2' ' A' ' 29' ' ' ARG . 1.9 tpt -92.77 112.68 24.72 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.642 0.777 . . . . 0.0 109.133 -177.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 74' ' ' GLU . 4.4 pp -89.19 -9.58 50.29 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 122.571 0.348 . . . . 0.0 111.547 -178.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -127.02 162.62 25.6 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.944 0.898 . . . . 0.0 109.344 -174.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -87.43 146.19 25.96 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 177.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.553 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 13.8 m-85 -133.53 173.07 11.9 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.645 0.778 . . . . 0.0 111.117 -176.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -50.93 -47.4 61.03 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.15 1.38 . . . . 0.0 112.043 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -131.09 -1.35 4.08 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.696 -175.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 34' ' ' TYR . 3.9 mp -112.64 143.02 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 24.2 t -103.32 154.5 19.31 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.263 0.625 . . . . 0.0 109.751 177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.83 114.18 6.93 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.406 ' HA2' HH11 ' A' ' 29' ' ' ARG . . . 124.58 -17.54 7.33 Favored Glycine 0 CA--C 1.526 0.771 0 CA-C-N 115.629 -0.714 . . . . 0.0 112.314 -176.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.62 154.71 41.59 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.209 0.603 . . . . 0.0 111.259 -177.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.437 ' HB3' ' HD2' ' A' ' 27' ' ' ARG . 45.0 mt-10 -112.79 138.61 49.37 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.601 0.761 . . . . 0.0 110.813 -175.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.56 -176.74 14.59 Favored Glycine 0 C--N 1.338 0.647 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.99 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -135.36 137.18 42.1 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.515 ' HA ' HG12 ' A' ' 57' ' ' VAL . 60.4 t80 -69.65 120.35 15.29 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.496 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 9.9 mmm-85 -107.42 -47.52 3.63 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.619 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -169.06 166.38 10.99 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 124.252 1.021 . . . . 0.0 109.398 178.624 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 92.3 p -152.93 -179.18 7.43 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.689 0.757 . . . . 0.0 111.509 -176.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 18.8 m-80 -121.71 122.59 39.9 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 168.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -84.02 1.41 43.93 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -175.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -123.72 -29.56 1.15 Allowed Glycine 0 C--N 1.339 0.727 0 N-CA-C 111.537 -0.625 . . . . 0.0 111.537 175.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.578 HG22 ' HD2' ' A' ' 54' ' ' PRO . 5.1 mm -105.22 127.0 29.51 Favored Pre-proline 0 N--CA 1.482 1.164 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -62.9 -29.04 75.81 Favored 'Trans proline' 0 CA--C 1.584 2.982 0 N-CA-C 119.221 2.739 . . . . 0.0 119.221 -171.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.578 ' HD2' HG22 ' A' ' 52' ' ' ILE . 37.6 Cg_endo -63.95 106.24 0.63 Allowed 'Trans proline' 0 C--N 1.389 2.692 0 CA-C-N 123.558 2.306 . . . . 0.0 113.054 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 p -95.44 132.3 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.318 167.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.619 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.1 mp0 -92.12 124.62 36.34 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 177.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -134.71 139.05 48.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 125.09 1.356 . . . . 0.0 108.636 -174.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -81.52 107.13 14.03 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.562 0.745 . . . . 0.0 109.731 -176.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.424 ' NE1' HG23 ' A' ' 57' ' ' VAL . 93.0 m95 -93.83 130.1 39.99 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.944 0.898 . . . . 0.0 110.618 -178.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -71.17 -26.25 62.89 Favored 'General case' 0 CA--C 1.545 0.778 0 O-C-N 123.965 0.791 . . . . 0.0 112.508 -178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.3 t -62.62 -45.85 90.96 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 121.047 0.451 . . . . 0.0 111.401 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.9 t -99.16 -12.19 20.69 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.913 0.885 . . . . 0.0 110.36 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.18 22.31 74.34 Favored Glycine 0 C--N 1.352 1.458 0 CA-C-N 115.966 -0.561 . . . . 0.0 114.17 178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -151.35 172.45 15.89 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 117.324 0.562 . . . . 0.0 111.202 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.11 139.64 31.57 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.268 1.027 . . . . 0.0 109.102 -175.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -144.71 155.41 43.55 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 121.056 0.455 . . . . 0.0 111.139 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -79.75 120.73 24.44 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 125.033 1.333 . . . . 0.0 109.351 -177.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 73' ' ' LEU . 6.7 m -131.44 160.91 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 123.206 0.602 . . . . 0.0 109.665 176.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 72' ' ' MET . 46.7 t60 -93.86 145.83 24.33 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.734 0.813 . . . . 0.0 108.826 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 96.0 m95 -60.15 -46.88 88.18 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 123.396 0.678 . . . . 0.0 112.501 -176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -73.15 -19.4 61.13 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.16 0.584 . . . . 0.0 111.003 -177.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.471 ' HA ' HD11 ' A' ' 31' ' ' LEU . 46.5 mtp -98.32 2.64 48.3 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.252 1.021 . . . . 0.0 110.668 176.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.457 HD13 HG21 ' A' ' 68' ' ' VAL . 58.5 tp -111.03 133.78 53.15 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 124.518 1.127 . . . . 0.0 109.142 176.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.488 ' HB2' HD23 ' A' ' 31' ' ' LEU . 35.5 tt0 -107.25 152.56 23.94 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 172.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.476 HG22 HG12 ' A' ' 28' ' ' VAL . 21.7 pt -111.99 137.64 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 122.905 0.482 . . . . 0.0 109.801 166.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.1 tt -159.98 96.71 1.24 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.56 ' HA3' ' HB3' ' A' ' 27' ' ' ARG . . . . . . . . 0 CA--C 1.528 0.849 0 CA-C-O 118.823 -0.987 . . . . 0.0 112.127 -177.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 55.4 t80 . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 110.907 -0.034 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.91 -40.71 95.54 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.363 0.414 . . . . 0.0 113.247 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 25.7 tt0 -71.36 -36.09 71.35 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 122.925 0.49 . . . . 0.0 110.348 177.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.9 t80 -64.47 -49.49 71.22 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.096 0.958 . . . . 0.0 111.255 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.8 m -63.45 -39.63 86.03 Favored 'Isoleucine or valine' 0 C--N 1.354 0.77 0 O-C-N 123.65 0.593 . . . . 0.0 110.316 -176.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -55.81 -38.77 70.43 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.196 0.599 . . . . 0.0 111.202 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 23.9 mm-40 -78.66 -38.94 38.27 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.408 -178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.6 t -94.11 2.06 56.04 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -173.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.49 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.2 OUTLIER -71.11 127.99 34.42 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 118.114 0.415 . . . . 0.0 109.944 176.448 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 50.9 mt-30 -116.41 133.67 22.95 Favored Pre-proline 0 N--CA 1.488 1.443 0 C-N-CA 124.26 1.024 . . . . 0.0 109.775 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 23' ' ' GLN . 24.1 Cg_exo -63.03 90.55 0.13 Allowed 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 123.227 2.618 . . . . 0.0 112.805 -175.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.61 8.06 3.26 Favored Glycine 0 C--N 1.345 1.033 0 CA-C-N 116.147 -0.478 . . . . 0.0 112.782 176.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.49 ' SD ' HD13 ' A' ' 22' ' ' LEU . 9.8 ptp -87.33 157.48 19.27 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 173.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -87.27 157.19 19.36 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.748 0.785 . . . . 0.0 109.342 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.546 HG12 HG22 ' A' ' 75' ' ' ILE . 9.5 m -133.88 173.63 14.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.423 ' HB3' HD13 ' A' ' 76' ' ' LEU . 3.6 tmt_? -151.21 145.84 25.67 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.458 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 31.9 tpp -98.43 126.95 44.15 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.009 0.924 . . . . 0.0 110.297 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.598 HD23 ' HB2' ' A' ' 74' ' ' GLU . 3.9 pp -95.47 -7.63 37.62 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.221 0.608 . . . . 0.0 111.857 -176.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 30' ' ' MET . 21.7 t70 -132.64 168.47 18.22 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.449 0.7 . . . . 0.0 110.411 -174.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -80.19 130.69 35.4 Favored 'General case' 0 N--CA 1.477 0.901 0 O-C-N 122.137 -0.352 . . . . 0.0 110.248 175.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.464 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 1.2 m-85 -120.07 171.79 8.21 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.045 0.938 . . . . 0.0 110.433 176.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 55.6 mm-40 -50.44 -49.51 54.77 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.497 1.519 . . . . 0.0 113.009 -176.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -126.17 0.38 7.13 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.645 0.778 . . . . 0.0 111.318 -177.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.477 HD11 ' HB3' ' A' ' 66' ' ' TYR . 4.9 mt -116.56 126.37 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -176.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.1 m -89.43 155.17 19.49 Favored 'General case' 0 C--O 1.244 0.773 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.26 113.36 3.54 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.405 ' HA2' ' NE ' ' A' ' 29' ' ' ARG . . . 124.37 -21.92 6.72 Favored Glycine 0 C--N 1.338 0.653 0 CA-C-N 115.907 -0.588 . . . . 0.0 113.22 -177.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.415 ' OD2' ' HB3' ' A' ' 59' ' ' TRP . 28.4 t0 -62.19 142.45 57.65 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.301 0.64 . . . . 0.0 112.07 -176.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -104.1 148.29 26.43 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.256 1.022 . . . . 0.0 110.761 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.63 -173.85 13.09 Favored Glycine 0 C--N 1.332 0.329 0 CA-C-N 114.671 -1.15 . . . . 0.0 111.434 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -134.91 140.69 45.96 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.487 ' HA ' HG12 ' A' ' 57' ' ' VAL . 59.3 t80 -71.63 119.75 16.24 Favored 'General case' 0 C--O 1.239 0.509 0 O-C-N 123.864 0.727 . . . . 0.0 110.08 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.5 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 11.4 mmm180 -107.58 -47.68 3.57 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -174.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.544 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -164.42 157.18 17.1 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.338 1.055 . . . . 0.0 109.412 177.179 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.469 ' HA ' HG23 ' A' ' 55' ' ' VAL . 29.8 p -117.4 178.31 4.42 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.914 0.886 . . . . 0.0 111.169 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 27.9 m-80 -132.14 120.98 23.02 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -72.27 -33.38 67.43 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.212 0.605 . . . . 0.0 111.22 -174.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -105.71 -8.28 35.05 Favored Glycine 0 C--N 1.346 1.124 0 O-C-N 123.773 0.67 . . . . 0.0 113.537 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.586 HG22 ' HD2' ' A' ' 54' ' ' PRO . 13.1 mm -118.94 112.57 36.38 Favored Pre-proline 0 N--CA 1.486 1.366 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -60.88 -29.89 89.0 Favored 'Trans proline' 0 CA--C 1.581 2.832 0 N-CA-C 118.074 2.298 . . . . 0.0 118.074 -175.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.586 ' HD2' HG22 ' A' ' 52' ' ' ILE . 43.1 Cg_endo -68.51 109.09 1.97 Allowed 'Trans proline' 0 C--N 1.384 2.401 0 CA-C-N 123.325 2.223 . . . . 0.0 111.827 169.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 48' ' ' SER . 3.2 p -90.34 141.62 14.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.621 1.168 . . . . 0.0 110.478 171.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.544 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.0 mp0 -93.33 125.17 37.8 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.549 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.487 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -138.89 138.45 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.167 1.387 . . . . 0.0 108.538 -176.581 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.0 t80 -81.96 106.67 14.06 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.46 ' HB2' HG22 ' A' ' 62' ' ' THR . 97.6 m95 -91.73 130.49 37.51 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.579 1.152 . . . . 0.0 110.647 -176.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -74.23 -26.93 60.53 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -174.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.3 t -72.6 -41.49 65.56 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 118.025 0.375 . . . . 0.0 111.378 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.48 HG23 ' H ' ' A' ' 64' ' ' ARG . 10.5 t -87.76 -30.78 20.03 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 122.783 0.433 . . . . 0.0 109.843 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.58 16.76 58.07 Favored Glycine 0 C--N 1.35 1.316 0 CA-C-N 115.911 -0.586 . . . . 0.0 114.096 177.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.48 ' H ' HG23 ' A' ' 62' ' ' THR . 0.0 OUTLIER -151.75 175.37 12.47 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.593 0.757 . . . . 0.0 112.032 -177.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.47 132.96 33.8 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.882 1.273 . . . . 0.0 109.716 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.477 ' HB3' HD11 ' A' ' 37' ' ' ILE . 12.7 t80 -138.82 156.99 46.88 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.09 0.472 . . . . 0.0 111.028 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 12.9 m-90 -83.51 113.74 21.0 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 125.128 1.371 . . . . 0.0 109.744 -177.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.421 HG21 HD13 ' A' ' 73' ' ' LEU . 17.0 m -130.15 154.55 40.6 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 123.326 0.651 . . . . 0.0 110.546 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 72.2 t60 -80.62 145.5 31.66 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 122.994 0.518 . . . . 0.0 110.352 -177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -59.51 -45.59 91.29 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.526 0.731 . . . . 0.0 112.042 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 15.9 t-160 -70.56 -25.36 63.05 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.528 -176.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 74.7 mtm -93.2 1.27 57.17 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.745 0.418 . . . . 0.0 111.13 174.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.421 HD13 HG21 ' A' ' 68' ' ' VAL . 26.5 tp -97.11 118.82 34.39 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 174.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.598 ' HB2' HD23 ' A' ' 31' ' ' LEU . 42.9 tt0 -108.2 108.4 19.42 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.975 0.91 . . . . 0.0 108.924 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.546 HG22 HG12 ' A' ' 28' ' ' VAL . 17.9 pt -89.62 115.59 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-O 121.737 0.779 . . . . 0.0 111.415 -174.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.423 HD13 ' HB3' ' A' ' 29' ' ' ARG . 10.9 mp -98.84 3.24 47.3 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.228 1.011 . . . . 0.0 110.247 173.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.532 0 C-N-CA 123.292 0.472 . . . . 0.0 112.785 174.613 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 86.1 t80 . . . . . 0 N--CA 1.481 1.118 0 CA-C-O 120.823 0.344 . . . . 0.0 110.118 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.62 -42.99 87.01 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.147 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 3.8 mp0 -71.05 -22.49 62.12 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.769 0.827 . . . . 0.0 111.735 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -70.95 -50.99 28.54 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.27 0.228 . . . . 0.0 110.792 170.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.8 m -66.63 -41.55 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -169.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -55.78 -30.29 61.05 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.336 0.654 . . . . 0.0 112.706 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 56.5 mm-40 -78.32 -36.93 45.7 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.056 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.2 t -94.36 -0.36 54.96 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.45 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.6 OUTLIER -72.1 117.61 13.93 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 122.039 -0.413 . . . . 0.0 110.738 177.074 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -96.86 135.66 22.01 Favored Pre-proline 0 N--CA 1.485 1.323 0 C-N-CA 124.112 0.965 . . . . 0.0 110.253 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 27.9 Cg_exo -62.97 82.19 0.11 Allowed 'Trans proline' 0 C--N 1.382 2.311 0 C-N-CA 123.657 2.905 . . . . 0.0 113.188 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.03 15.92 1.64 Allowed Glycine 0 C--N 1.345 1.056 0 CA-C-N 116.4 -0.363 . . . . 0.0 112.467 177.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.45 ' SD ' HD13 ' A' ' 22' ' ' LEU . 5.3 ptp -90.7 163.75 14.39 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.539 0.685 . . . . 0.0 110.298 176.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.569 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 25.2 tpt180 -83.73 129.02 34.95 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.192 -177.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 m -115.62 172.03 4.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -141.63 141.94 33.42 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 125.228 1.411 . . . . 0.0 108.272 -172.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.3 tpt -86.43 110.53 19.79 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 30.3 tp -81.13 -29.44 34.77 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.061 0.544 . . . . 0.0 110.599 -175.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -143.1 151.75 41.08 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -66.33 151.0 48.01 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.062 0.545 . . . . 0.0 111.51 -168.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -133.15 172.16 13.03 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.636 0.774 . . . . 0.0 111.436 -174.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -49.23 -47.8 46.08 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 126.037 1.735 . . . . 0.0 112.483 -175.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -129.99 2.88 4.82 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.995 0.918 . . . . 0.0 111.32 -177.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -118.56 143.87 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.4 m -98.98 148.76 23.67 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.907 0.483 . . . . 0.0 110.208 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.1 117.48 5.59 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 122.998 0.519 . . . . 0.0 110.076 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.28 -15.93 20.17 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.994 -0.548 . . . . 0.0 112.487 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.98 151.06 43.51 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-N 117.265 0.533 . . . . 0.0 109.856 174.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -118.34 146.37 44.42 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-O 121.403 0.62 . . . . 0.0 110.939 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.445 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . -127.9 -165.36 11.83 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 114.487 -1.233 . . . . 0.0 111.252 179.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -136.27 142.64 43.97 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 170.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.449 ' HA ' HG12 ' A' ' 57' ' ' VAL . 75.4 t80 -75.57 119.58 19.81 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.416 0.686 . . . . 0.0 110.276 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.546 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 11.9 mmm180 -108.06 -49.6 3.18 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -175.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.546 ' NE2' ' HB2' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -164.82 163.67 21.17 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.44 1.096 . . . . 0.0 109.271 -179.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.418 ' HB3' HG23 ' A' ' 55' ' ' VAL . 87.8 p -161.95 179.74 7.79 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 122.088 0.947 . . . . 0.0 112.517 -176.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.445 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 3.2 m-80 -133.49 128.95 36.47 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 167.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -78.3 -33.7 49.2 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.642 0.377 . . . . 0.0 110.798 -177.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -86.5 -32.7 15.3 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 116.283 -0.417 . . . . 0.0 112.721 178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.445 ' HB ' ' HB2' ' A' ' 49' ' ' ASN . 35.3 mm -100.15 100.62 12.09 Favored Pre-proline 0 N--CA 1.471 0.612 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 175.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -62.47 -22.14 73.66 Favored 'Trans proline' 0 CA--C 1.578 2.678 0 N-CA-C 118.848 2.595 . . . . 0.0 118.848 -165.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.66 101.75 0.27 Allowed 'Trans proline' 0 C--N 1.389 2.662 0 CA-C-N 123.256 2.199 . . . . 0.0 112.199 171.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.418 HG23 ' HB3' ' A' ' 48' ' ' SER . 2.1 p -89.11 135.3 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.722 168.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.53 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.0 mp0 -91.01 121.89 33.21 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.449 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -135.27 136.6 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 124.91 1.284 . . . . 0.0 108.411 -176.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.8 t80 -82.38 106.18 14.04 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 122.849 0.46 . . . . 0.0 109.917 -176.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.408 ' HB2' HG22 ' A' ' 62' ' ' THR . 84.6 m95 -94.11 131.0 40.08 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.053 0.941 . . . . 0.0 110.535 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -71.04 -24.8 62.42 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 46.5 p -62.03 -45.75 92.22 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.414 0.626 . . . . 0.0 111.53 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.408 HG22 ' HB2' ' A' ' 59' ' ' TRP . 9.8 t -99.51 -17.87 17.69 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.367 -176.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.59 19.21 74.12 Favored Glycine 0 C--N 1.346 1.083 0 CA-C-O 119.789 -0.45 . . . . 0.0 113.961 177.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -152.27 170.12 20.83 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.499 0.666 . . . . 0.0 111.216 -175.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.474 HG22 ' HB3' ' A' ' 56' ' ' GLN . 1.3 m -86.52 129.14 34.97 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 114.358 -1.292 . . . . 0.0 108.773 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.9 t80 -131.99 154.71 49.05 Favored 'General case' 0 N--CA 1.477 0.912 0 CA-C-O 121.268 0.556 . . . . 0.0 111.612 -174.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 7.9 m-90 -85.18 100.48 11.78 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.396 1.478 . . . . 0.0 109.427 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.8 m -116.94 162.02 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 122.744 0.418 . . . . 0.0 110.348 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.615 ' HD2' ' H ' ' A' ' 71' ' ' HIS . 8.8 t60 -91.59 147.79 22.75 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.301 0.641 . . . . 0.0 109.846 -179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -58.84 -45.66 89.54 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.363 1.065 . . . . 0.0 113.291 -177.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.615 ' H ' ' HD2' ' A' ' 69' ' ' HIS . 57.5 t-80 -66.44 -21.59 66.2 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.431 0.693 . . . . 0.0 111.797 -178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 76.3 mtm -101.94 9.66 40.37 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.2 0.6 . . . . 0.0 111.248 174.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.7 tt -109.64 120.62 43.05 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 172.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -106.86 150.22 26.61 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.903 1.281 . . . . 0.0 107.774 171.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.2 pt -113.96 116.65 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.295 0 CA-C-N 119.123 0.874 . . . . 0.0 111.818 174.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 66.0 mt -102.49 11.56 37.74 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.743 0.817 . . . . 0.0 110.182 170.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.569 ' HA2' ' HB3' ' A' ' 27' ' ' ARG . . . . . . . . 0 C--N 1.352 1.425 0 CA-C-O 119.147 -0.807 . . . . 0.0 113.308 174.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 75.1 t80 . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 120.539 0.209 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -62.56 -28.81 71.95 Favored Glycine 0 C--N 1.354 1.563 0 CA-C-N 115.731 -0.668 . . . . 0.0 113.6 176.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -70.27 -47.73 59.98 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.963 0.505 . . . . 0.0 110.406 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.2 t80 -58.08 -50.21 74.25 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.055 0.847 . . . . 0.0 110.925 -176.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.5 m -66.23 -37.3 79.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.608 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.311 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.83 -31.36 59.19 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 123.72 0.808 . . . . 0.0 110.687 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -91.96 -47.98 7.01 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.573 0.749 . . . . 0.0 111.2 -174.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.9 t -79.13 -11.99 59.99 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -173.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.415 HD12 ' CG ' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -68.71 112.17 5.28 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 117.917 0.326 . . . . 0.0 110.575 177.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -97.53 132.81 24.52 Favored Pre-proline 0 N--CA 1.48 1.056 0 C-N-CA 123.875 0.87 . . . . 0.0 109.771 178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.01 84.45 0.25 Allowed 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 123.021 2.48 . . . . 0.0 112.666 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 143.68 -0.68 1.25 Allowed Glycine 0 C--N 1.345 1.082 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.826 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.8 ptp -88.73 154.56 20.19 Favored 'General case' 0 N--CA 1.477 0.875 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 173.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -85.28 157.91 20.45 Favored 'General case' 0 C--O 1.245 0.866 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 m -128.69 173.3 13.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 114.728 -1.123 . . . . 0.0 108.316 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.537 ' HD3' ' HA2' ' A' ' 40' ' ' GLY . 3.6 tmm_? -141.54 136.6 31.29 Favored 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.2 tpt -76.82 111.45 12.36 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.511 1.124 . . . . 0.0 109.279 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 41.2 tp -69.88 -36.53 75.52 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.137 0.575 . . . . 0.0 111.0 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -141.34 150.92 43.09 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.668 0.787 . . . . 0.0 109.18 -178.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -65.58 129.88 41.33 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.831 0.707 . . . . 0.0 111.234 -170.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -106.97 173.58 6.26 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.128 0.971 . . . . 0.0 110.749 -177.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -47.41 -44.95 24.98 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.813 1.645 . . . . 0.0 113.386 -175.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -131.36 7.33 4.55 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.885 0.874 . . . . 0.0 111.058 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.23 144.79 26.59 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 123.825 0.85 . . . . 0.0 109.391 179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.4 m -93.44 147.33 23.05 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.076 0.55 . . . . 0.0 110.543 176.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.48 117.86 8.6 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 169.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.537 ' HA2' ' HD3' ' A' ' 29' ' ' ARG . . . 115.16 -18.95 15.56 Favored Glycine 0 N--CA 1.469 0.862 0 N-CA-C 111.937 -0.465 . . . . 0.0 111.937 -175.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -66.64 144.45 56.39 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.606 0.762 . . . . 0.0 110.648 178.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -109.1 144.14 37.52 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.407 0.623 . . . . 0.0 110.659 -177.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -129.65 -168.43 12.32 Favored Glycine 0 C--N 1.337 0.598 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.639 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -137.18 142.49 42.15 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 169.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 48' ' ' SER . 85.4 t80 -88.31 118.23 27.78 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 123.924 0.889 . . . . 0.0 109.451 177.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.431 ' HG2' ' NE2' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -115.94 -47.17 2.79 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 122.317 0.247 . . . . 0.0 111.286 175.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.431 ' NE2' ' HG2' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -136.86 150.66 48.4 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.606 0.362 . . . . 0.0 110.407 -177.095 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.447 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 64.4 p -145.12 165.28 28.74 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.638 0.775 . . . . 0.0 111.745 -177.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 8.2 m-80 -124.42 121.47 35.0 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 173.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.02 -30.58 44.29 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.015 0.526 . . . . 0.0 110.382 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -88.27 -34.63 9.41 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.78 177.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.487 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 13.8 mm -100.64 106.58 44.16 Favored Pre-proline 0 N--CA 1.479 1.004 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -61.59 -25.34 79.17 Favored 'Trans proline' 0 CA--C 1.579 2.747 0 N-CA-C 118.292 2.382 . . . . 0.0 118.292 -171.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.648 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 57.4 Cg_endo -71.36 109.09 2.52 Favored 'Trans proline' 0 C--N 1.383 2.393 0 CA-C-N 123.523 2.294 . . . . 0.0 112.241 169.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' A' ' 48' ' ' SER . 6.4 p -86.93 144.45 9.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.061 0.944 . . . . 0.0 110.774 173.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -89.64 122.63 32.95 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.14 136.16 55.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -80.93 104.12 11.22 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -176.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.507 ' HB2' HG22 ' A' ' 62' ' ' THR . 88.6 m95 -92.01 130.03 37.84 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.434 1.094 . . . . 0.0 109.745 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -70.01 -34.87 73.86 Favored 'General case' 0 CA--C 1.546 0.803 0 O-C-N 123.61 0.569 . . . . 0.0 111.775 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.1 t -60.65 -45.18 95.07 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.666 0.386 . . . . 0.0 111.371 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.507 HG22 ' HB2' ' A' ' 59' ' ' TRP . 8.9 t -90.88 -16.68 27.76 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.762 0.425 . . . . 0.0 110.984 177.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.78 14.56 80.82 Favored Glycine 0 C--N 1.351 1.401 0 CA-C-O 119.612 -0.549 . . . . 0.0 114.206 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -152.77 176.83 11.36 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 117.439 0.619 . . . . 0.0 110.9 -172.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 2.6 p -84.91 136.84 33.46 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.006 0.522 . . . . 0.0 109.727 173.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -134.89 156.02 49.68 Favored 'General case' 0 C--O 1.24 0.58 0 O-C-N 123.886 0.742 . . . . 0.0 110.041 176.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.648 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 14.9 m-90 -87.6 101.37 13.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.34 1.456 . . . . 0.0 109.498 -173.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.3 m -117.09 153.27 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.147 0.579 . . . . 0.0 109.7 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -85.19 146.71 26.96 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -177.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -58.91 -40.13 83.61 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.886 0.875 . . . . 0.0 112.764 -174.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 60.9 t-80 -69.69 -20.76 63.55 Favored 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 123.316 0.646 . . . . 0.0 112.164 -176.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 69.4 mtm -106.1 14.29 27.94 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 122.973 0.509 . . . . 0.0 111.424 174.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.414 HD22 HD21 ' A' ' 22' ' ' LEU . 8.3 tt -104.53 121.69 44.01 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 172.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -106.6 152.7 23.38 Favored 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 171.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.7 pt -113.71 126.17 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 C-N-CA 122.864 0.465 . . . . 0.0 111.71 174.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 69.3 mt -104.44 6.74 35.17 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.457 0.703 . . . . 0.0 110.017 167.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.584 0 O-C-N 123.773 0.67 . . . . 0.0 112.448 174.626 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 47.2 t80 . . . . . 0 N--CA 1.486 1.361 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.89 -30.4 77.9 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 114.443 -1.253 . . . . 0.0 113.71 175.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 26.5 tt0 -70.34 -41.79 72.73 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 175.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -60.37 -49.57 77.07 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.243 0.617 . . . . 0.0 111.148 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.417 ' HA ' HG22 ' A' ' 21' ' ' THR . 34.2 m -64.94 -36.45 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 O-C-N 123.397 0.435 . . . . 0.0 110.493 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.1 -30.97 60.83 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.676 0.79 . . . . 0.0 111.27 177.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.407 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 43.8 mm-40 -80.32 -52.8 7.27 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 122.774 0.429 . . . . 0.0 110.771 177.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.417 HG22 ' HA ' ' A' ' 18' ' ' VAL . 10.8 t -82.8 -7.42 59.66 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -167.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.559 HD12 ' HB2' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -69.43 107.13 3.21 Favored 'General case' 0 CA--C 1.558 1.251 0 CA-C-N 118.519 0.599 . . . . 0.0 110.801 176.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -88.37 134.26 34.88 Favored Pre-proline 0 N--CA 1.481 1.122 0 C-N-CA 124.143 0.977 . . . . 0.0 110.226 176.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -57.91 90.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 123.117 2.545 . . . . 0.0 112.227 171.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.14 -2.38 3.92 Favored Glycine 0 C--N 1.345 1.066 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.996 175.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 8.1 ptp -87.79 164.81 15.74 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 117.353 0.577 . . . . 0.0 110.57 177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.62 140.01 31.06 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 124.699 1.199 . . . . 0.0 109.821 -173.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.441 HG12 HD11 ' A' ' 22' ' ' LEU . 4.4 m -117.19 172.83 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 123.816 0.846 . . . . 0.0 109.187 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.6 tpp180 -145.07 143.92 30.69 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.558 1.143 . . . . 0.0 108.651 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 26.1 tpp -97.62 139.1 34.03 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 122.779 0.431 . . . . 0.0 110.696 176.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 74' ' ' GLU . 3.3 pp -112.87 -7.42 13.76 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.235 1.014 . . . . 0.0 111.676 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -127.13 172.2 10.74 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 124.244 1.018 . . . . 0.0 109.58 -174.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -91.11 143.09 27.05 Favored 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.797 -0.565 . . . . 0.0 110.629 175.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.412 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 8.7 m-85 -133.28 171.77 13.59 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.984 1.313 . . . . 0.0 110.231 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -45.93 -46.98 16.4 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 125.367 1.467 . . . . 0.0 112.266 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -139.08 1.84 2.06 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.85 0.86 . . . . 0.0 111.398 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.412 ' HB ' ' HB2' ' A' ' 34' ' ' TYR . 5.0 mp -115.1 146.45 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 174.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.0 m -130.74 164.25 25.51 Favored 'General case' 0 C--O 1.245 0.819 0 O-C-N 121.988 -0.445 . . . . 0.0 110.051 172.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.29 114.63 2.5 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 123.788 0.68 . . . . 0.0 110.286 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.28 -34.35 2.95 Favored Glycine 0 C--N 1.344 0.977 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.399 -174.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.405 ' HB3' HG23 ' A' ' 37' ' ' ILE . 50.5 t0 -65.09 145.84 55.77 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.033 0.533 . . . . 0.0 110.192 177.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -120.4 146.29 46.34 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.998 0.919 . . . . 0.0 110.357 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.7 -167.52 12.4 Favored Glycine 0 C--N 1.334 0.462 0 CA-C-N 115.371 -0.831 . . . . 0.0 112.126 -178.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -136.89 141.38 42.73 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 171.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.559 ' HB2' HD12 ' A' ' 22' ' ' LEU . 76.8 t80 -74.97 119.66 19.45 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.877 0.471 . . . . 0.0 109.988 178.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.506 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 19.5 mmm180 -108.99 -49.22 3.16 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.679 0.791 . . . . 0.0 109.592 -173.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.52 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -161.7 164.04 29.35 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.48 1.112 . . . . 0.0 109.056 177.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . 16.3 p -132.07 168.56 17.75 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.622 0.769 . . . . 0.0 112.01 -175.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.432 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 14.6 m-80 -137.14 121.47 18.13 Favored 'General case' 0 C--O 1.238 0.495 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 164.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -75.12 -38.75 60.99 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -177.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -91.52 -18.35 45.53 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-N 115.347 -0.842 . . . . 0.0 113.418 -176.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.472 HG22 ' HD2' ' A' ' 54' ' ' PRO . 20.5 mm -104.27 102.49 33.24 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 173.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -60.55 -22.41 72.12 Favored 'Trans proline' 0 CA--C 1.576 2.605 0 N-CA-C 117.775 2.183 . . . . 0.0 117.775 -171.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.55 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 66.5 Cg_endo -76.35 111.42 3.26 Favored 'Trans proline' 0 C--N 1.377 2.062 0 CA-C-N 122.851 2.054 . . . . 0.0 112.295 165.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.7 p -84.38 142.95 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 124.598 1.159 . . . . 0.0 110.076 169.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.52 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.0 mp0 -92.32 122.69 35.02 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 177.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -136.3 138.11 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 124.892 1.277 . . . . 0.0 108.566 -178.222 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -82.88 104.68 13.29 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 -177.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.503 ' HB2' HG22 ' A' ' 62' ' ' THR . 89.2 m95 -86.29 128.17 34.88 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.977 0.911 . . . . 0.0 109.684 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -71.71 -23.62 61.67 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -173.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.0 t -78.08 -44.68 25.56 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 118.48 0.582 . . . . 0.0 111.326 -178.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 59' ' ' TRP . 11.0 t -85.3 -18.94 32.39 Favored 'General case' 0 CA--C 1.55 0.975 0 CA-C-O 121.006 0.432 . . . . 0.0 110.453 176.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.38 22.07 73.97 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-N 115.867 -0.606 . . . . 0.0 114.465 174.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -153.18 168.41 26.03 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 117.459 0.63 . . . . 0.0 111.999 -174.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.456 HG22 ' HB3' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -86.8 126.18 34.45 Favored 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.554 1.142 . . . . 0.0 109.215 -176.243 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -135.56 157.43 46.9 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.286 0.565 . . . . 0.0 111.42 -173.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.55 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 12.4 m-90 -86.28 111.22 20.23 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.389 1.476 . . . . 0.0 109.58 -174.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 54' ' ' PRO . 13.4 m -131.67 150.67 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 123.126 0.57 . . . . 0.0 110.013 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 12.5 t-160 -78.51 146.6 34.25 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 122.677 0.391 . . . . 0.0 110.964 -175.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -59.54 -48.77 80.36 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.332 1.053 . . . . 0.0 112.013 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -68.04 -27.91 66.94 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.283 0.563 . . . . 0.0 110.438 -177.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.507 ' HA ' HD11 ' A' ' 31' ' ' LEU . 38.8 mtp -93.69 9.09 38.39 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.068 179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 31.7 tp -112.22 120.05 40.45 Favored 'General case' 0 C--N 1.346 0.434 0 C-N-CA 123.728 0.811 . . . . 0.0 108.842 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.531 ' HB2' HD23 ' A' ' 31' ' ' LEU . 39.0 tt0 -107.56 135.89 48.26 Favored 'General case' 0 C--O 1.207 -1.14 0 C-N-CA 124.733 1.213 . . . . 0.0 107.789 175.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.401 HD13 HD22 ' A' ' 22' ' ' LEU . 20.4 pt -111.73 119.01 58.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 119.73 1.15 . . . . 0.0 111.914 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 9.3 mp -96.38 -0.94 48.64 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.469 1.108 . . . . 0.0 110.629 173.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.298 0 CA-C-O 119.726 -0.486 . . . . 0.0 112.732 174.641 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.411 ' HB3' ' CD2' ' A' ' 71' ' ' HIS . 41.1 t80 . . . . . 0 N--CA 1.477 0.897 0 CA-C-O 120.904 0.383 . . . . 0.0 110.064 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.15 -29.86 75.74 Favored Glycine 0 C--N 1.339 0.748 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.83 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 44.0 tt0 -72.92 -38.48 66.84 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.4 t80 -62.38 -48.32 80.25 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.165 0.586 . . . . 0.0 111.222 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.47 ' HB ' HD23 ' A' ' 22' ' ' LEU . 33.0 m -62.1 -37.25 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 177.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -29.99 62.97 Favored 'General case' 0 CA--C 1.562 1.419 0 C-N-CA 123.984 0.914 . . . . 0.0 110.454 178.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 54.5 mm-40 -78.88 -47.33 16.73 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 122.988 0.515 . . . . 0.0 110.101 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.0 t -96.96 4.52 51.51 Favored 'General case' 0 CA--C 1.558 1.251 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 -166.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.485 HD13 ' SD ' ' A' ' 26' ' ' MET . 2.0 mm? -87.59 115.28 24.91 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.818 -0.551 . . . . 0.0 111.574 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.429 ' O ' ' HG2' ' A' ' 26' ' ' MET . 1.4 mp0 -92.94 137.24 23.94 Favored Pre-proline 0 N--CA 1.481 1.121 0 C-N-CA 124.003 0.921 . . . . 0.0 109.688 171.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -65.56 86.68 0.21 Allowed 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.472 2.115 . . . . 0.0 111.371 172.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 144.71 4.55 0.62 Allowed Glycine 0 C--N 1.347 1.171 0 CA-C-N 115.737 -0.665 . . . . 0.0 113.065 177.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.67 ' SD ' HG21 ' A' ' 75' ' ' ILE . 6.2 ptp -95.01 175.52 6.6 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 117.345 0.573 . . . . 0.0 110.827 178.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.1 tpt180 -99.52 128.4 45.63 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.058 1.343 . . . . 0.0 109.815 -170.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 m -115.58 171.36 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 123.589 0.756 . . . . 0.0 109.655 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.516 ' HA ' ' HG2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -144.0 126.95 16.37 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 -174.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -78.89 121.91 25.45 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 176.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.515 HD23 ' HB2' ' A' ' 74' ' ' GLU . 4.2 pp -105.6 14.09 28.98 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 117.945 0.339 . . . . 0.0 111.34 176.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -137.04 172.37 13.11 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 124.144 0.978 . . . . 0.0 111.327 177.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -97.35 140.53 31.67 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.889 0.876 . . . . 0.0 110.107 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -134.41 173.66 11.39 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.677 1.191 . . . . 0.0 111.421 -176.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -46.34 -45.03 17.35 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.585 1.554 . . . . 0.0 111.955 175.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -140.84 -1.95 1.37 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.183 -171.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.402 HG23 ' OD2' ' A' ' 41' ' ' ASP . 3.8 mp -116.22 147.58 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 124.251 1.021 . . . . 0.0 108.344 175.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.1 m -127.49 160.96 29.89 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.958 0.503 . . . . 0.0 109.674 176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.1 113.89 4.83 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 140.17 -61.04 0.56 Allowed Glycine 0 C--N 1.343 0.947 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -172.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.402 ' OD2' HG23 ' A' ' 37' ' ' ILE . 4.9 p-10 -77.33 148.72 35.48 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.4 0.619 . . . . 0.0 110.632 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.516 ' HG2' ' HA ' ' A' ' 29' ' ' ARG . 42.4 mt-10 -125.62 161.34 27.45 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.014 -161.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -134.75 -171.97 12.64 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.887 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -133.07 135.87 45.58 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.506 ' HA ' HG12 ' A' ' 57' ' ' VAL . 16.3 t80 -72.66 121.37 19.68 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.531 0.732 . . . . 0.0 109.258 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.519 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 7.9 mmm180 -107.32 -46.37 3.89 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -175.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.519 ' NE2' ' HB2' ' A' ' 46' ' ' ARG . 0.3 OUTLIER -152.86 159.56 43.03 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.851 0.861 . . . . 0.0 110.071 -179.127 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 64.7 p -119.58 173.39 7.03 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 123.72 0.808 . . . . 0.0 111.205 -176.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -126.88 138.88 53.38 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.429 -178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -62.11 -38.81 90.31 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.925 0.89 . . . . 0.0 112.223 -176.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -162.26 26.58 0.24 Allowed Glycine 0 C--N 1.345 1.044 0 CA-C-N 116.013 -0.539 . . . . 0.0 112.711 179.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.7 mm -101.19 108.52 55.19 Favored Pre-proline 0 N--CA 1.477 0.886 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.16 -39.31 91.61 Favored 'Trans proline' 0 CA--C 1.576 2.61 0 C-N-CA 122.638 2.225 . . . . 0.0 116.71 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.69 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 96.1 Cg_endo -75.68 97.5 1.11 Allowed 'Trans proline' 0 C--N 1.384 2.444 0 CA-C-N 122.411 1.897 . . . . 0.0 112.397 169.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 13.8 p -90.64 153.27 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.004 0.922 . . . . 0.0 111.297 176.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -96.76 129.9 44.1 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.237 0.615 . . . . 0.0 111.665 -172.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.506 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -139.85 141.79 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 125.743 1.617 . . . . 0.0 108.788 178.313 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -81.2 107.25 13.84 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.913 0.885 . . . . 0.0 109.143 179.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.526 ' HB2' HG22 ' A' ' 62' ' ' THR . 99.0 m95 -90.9 133.82 34.95 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.147 0.979 . . . . 0.0 111.097 -177.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -59.57 -35.19 73.78 Favored 'General case' 0 CA--C 1.552 1.024 0 O-C-N 124.04 0.837 . . . . 0.0 111.535 176.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 54.9 p -66.8 -45.31 78.81 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.653 0.781 . . . . 0.0 112.221 -173.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.526 HG22 ' HB2' ' A' ' 59' ' ' TRP . 10.6 t -104.84 -9.4 18.06 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.175 0.59 . . . . 0.0 111.695 -174.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 67.52 21.6 72.69 Favored Glycine 0 C--N 1.351 1.401 0 N-CA-C 114.291 0.476 . . . . 0.0 114.291 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 24.3 ptt180 -151.8 176.08 11.78 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.277 0.631 . . . . 0.0 110.665 -176.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.421 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 2.1 p -85.23 129.62 34.77 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.066 0.547 . . . . 0.0 109.969 175.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -130.13 158.54 39.41 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.314 0.578 . . . . 0.0 110.196 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.69 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 18.7 m-90 -81.59 104.82 12.28 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.796 1.239 . . . . 0.0 110.782 -176.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.5 m -126.21 156.84 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 123.063 0.545 . . . . 0.0 110.33 176.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.479 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 9.1 t-160 -84.44 147.51 27.06 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 122.939 0.496 . . . . 0.0 110.944 -174.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 77.0 m95 -59.94 -47.01 87.55 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.898 0.879 . . . . 0.0 111.253 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.411 ' CD2' ' HB3' ' A' ' 14' ' ' TYR . 58.1 t-80 -66.32 -25.85 67.03 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.56 0.744 . . . . 0.0 111.471 -178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.479 ' SD ' ' HB3' ' A' ' 69' ' ' HIS . 59.5 mtp -95.14 -2.42 49.91 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.954 0.902 . . . . 0.0 111.676 -171.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 4.5 pp -110.07 157.73 19.03 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.192 -0.669 . . . . 0.0 109.192 167.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.515 ' HB2' HD23 ' A' ' 31' ' ' LEU . 30.7 tt0 -138.13 137.13 37.38 Favored 'General case' 0 C--O 1.213 -0.837 0 C-N-CA 125.074 1.35 . . . . 0.0 108.231 178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.67 HG21 ' SD ' ' A' ' 26' ' ' MET . 7.2 pt -85.72 112.19 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 169.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 31.4 tp -119.09 6.71 11.29 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.416 -177.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.458 0 CA-C-O 119.447 -0.64 . . . . 0.0 113.021 179.769 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 40.8 t80 . . . . . 0 N--CA 1.481 1.108 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.61 -26.63 71.05 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 114.59 -1.186 . . . . 0.0 113.401 174.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 15.1 tp10 -71.45 -47.34 56.4 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 178.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -58.38 -50.01 75.18 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.955 0.784 . . . . 0.0 111.052 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 32.2 m -67.59 -36.35 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.833 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -54.96 -34.59 63.42 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.405 0.682 . . . . 0.0 111.333 177.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 48.5 mm-40 -85.06 -48.69 8.95 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.074 -176.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 t -85.98 -9.98 55.9 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -168.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.496 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.2 OUTLIER -66.89 107.21 2.13 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 118.589 0.631 . . . . 0.0 110.176 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -94.75 132.72 27.9 Favored Pre-proline 0 N--CA 1.485 1.286 0 C-N-CA 124.016 0.926 . . . . 0.0 110.424 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.2 84.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 123.388 2.725 . . . . 0.0 113.868 178.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 141.05 4.8 1.07 Allowed Glycine 0 C--N 1.343 0.944 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.759 175.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.496 ' SD ' HD13 ' A' ' 22' ' ' LEU . 5.4 ptp -91.89 166.82 12.53 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 117.479 0.64 . . . . 0.0 110.717 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -88.76 134.84 33.79 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.595 1.158 . . . . 0.0 109.375 -174.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.0 m -117.15 172.31 5.05 Favored 'Isoleucine or valine' 0 C--O 1.241 0.658 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 174.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -151.01 140.01 21.03 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 17.7 tpp -85.94 128.94 34.95 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.142 0.496 . . . . 0.0 110.863 -175.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 23.2 tp -106.03 -5.79 19.24 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 123.868 0.867 . . . . 0.0 111.365 -173.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -138.27 160.66 38.9 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.537 0.735 . . . . 0.0 111.136 -174.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -82.74 127.39 33.38 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 177.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -122.49 171.36 9.15 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.07 0.948 . . . . 0.0 111.409 -174.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.5 mm-40 -49.66 -45.4 48.58 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.542 1.537 . . . . 0.0 111.847 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -132.16 -5.4 3.45 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 114.767 -1.106 . . . . 0.0 111.684 -170.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.0 mt -118.74 140.74 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.7 t -100.85 153.53 19.4 Favored 'General case' 0 C--O 1.246 0.921 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 172.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.4 115.26 4.93 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 174.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.78 -36.1 2.22 Favored Glycine 0 C--N 1.338 0.694 0 O-C-N 123.665 0.603 . . . . 0.0 112.089 -175.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -63.24 141.62 58.7 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.23 0.612 . . . . 0.0 111.608 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -102.45 161.62 13.57 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.672 0.789 . . . . 0.0 111.13 -175.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -153.83 -170.2 19.59 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 115.005 -0.998 . . . . 0.0 111.466 -177.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -135.3 137.81 42.84 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 48' ' ' SER . 57.4 t80 -85.23 119.6 25.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.484 -0.78 . . . . 0.0 108.927 173.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.414 ' HG2' ' NE2' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -115.79 -45.95 2.86 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 122.236 0.214 . . . . 0.0 111.198 172.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.485 ' NE2' ' H ' ' A' ' 47' ' ' GLN . 0.5 OUTLIER -126.85 163.54 23.39 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 122.917 0.487 . . . . 0.0 110.056 -177.394 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 37.8 t -148.86 168.52 22.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.596 0.758 . . . . 0.0 112.265 -167.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -137.36 118.52 14.48 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 164.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 21.9 m-80 -89.91 -3.81 57.86 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 123.024 0.53 . . . . 0.0 111.761 -175.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -117.77 -25.4 3.1 Favored Glycine 0 C--N 1.344 0.981 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.023 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.641 HG22 ' HD2' ' A' ' 54' ' ' PRO . 7.2 mm -104.7 118.54 56.16 Favored Pre-proline 0 CA--C 1.557 1.212 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -61.39 -29.02 84.84 Favored 'Trans proline' 0 CA--C 1.581 2.828 0 N-CA-C 118.111 2.312 . . . . 0.0 118.111 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.641 ' HD2' HG22 ' A' ' 52' ' ' ILE . 58.6 Cg_endo -72.57 106.5 2.11 Favored 'Trans proline' 0 C--N 1.383 2.354 0 CA-C-N 123.084 2.137 . . . . 0.0 112.521 170.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.544 HG23 ' HA ' ' A' ' 48' ' ' SER . 8.9 p -86.49 146.12 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.642 168.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -91.94 128.14 37.67 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.91 136.47 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 C-N-CA 124.269 1.028 . . . . 0.0 108.485 178.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.1 t80 -81.88 108.68 15.6 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.507 ' HB2' HG22 ' A' ' 62' ' ' THR . 95.3 m95 -93.15 131.0 38.61 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.941 0.896 . . . . 0.0 110.864 -177.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -63.81 -27.28 69.07 Favored 'General case' 0 CA--C 1.548 0.89 0 O-C-N 124.133 0.896 . . . . 0.0 110.66 172.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.8 t -65.49 -47.04 77.41 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 124.369 1.068 . . . . 0.0 112.055 -173.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.507 HG22 ' HB2' ' A' ' 59' ' ' TRP . 6.6 t -103.28 -14.48 16.3 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.002 0.921 . . . . 0.0 110.458 -177.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.84 14.14 82.35 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-N 115.86 -0.609 . . . . 0.0 113.688 178.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -150.26 172.01 16.05 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.266 0.555 . . . . 0.0 110.979 -174.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.43 124.52 33.51 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.629 1.172 . . . . 0.0 108.917 -177.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -128.27 154.51 45.81 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.184 0.516 . . . . 0.0 110.763 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 14.4 m-90 -81.04 111.27 17.36 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 114.358 -1.292 . . . . 0.0 109.736 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.9 m -126.81 159.15 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 C-N-CA 123.026 0.53 . . . . 0.0 109.838 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.4 t60 -86.81 147.11 25.96 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.386 0.674 . . . . 0.0 110.124 -174.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -61.41 -48.5 80.9 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.084 0.554 . . . . 0.0 111.691 -178.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -69.3 -11.43 60.8 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.447 0.699 . . . . 0.0 111.734 -177.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 34.8 mtp -113.62 10.03 17.97 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.233 1.013 . . . . 0.0 110.787 -178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 44.9 tp -113.82 121.42 43.97 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 124.211 1.004 . . . . 0.0 108.708 176.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -107.84 132.44 53.42 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.911 0.885 . . . . 0.0 110.028 178.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.401 HD13 HD22 ' A' ' 22' ' ' LEU . 28.8 pt -113.03 134.69 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 O-C-N 121.824 -0.548 . . . . 0.0 111.012 172.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -98.32 7.73 45.82 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.65 0.78 . . . . 0.0 109.514 168.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.935 0 C-N-CA 124.308 0.956 . . . . 0.0 113.764 179.675 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 70.1 t80 . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -68.49 -36.83 84.58 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-O 121.409 0.449 . . . . 0.0 112.963 -177.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.469 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 8.3 mp0 -71.26 -42.56 68.63 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.805 0.842 . . . . 0.0 109.132 176.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -60.28 -48.91 79.73 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 124.183 0.927 . . . . 0.0 111.798 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 30.8 m -64.06 -38.31 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.799 0 O-C-N 123.264 0.353 . . . . 0.0 110.572 -178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -56.13 -32.44 64.23 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.266 0.626 . . . . 0.0 111.103 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 41.8 mm-40 -77.16 -51.78 10.4 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.575 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.2 t -87.69 5.54 39.26 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.618 0.767 . . . . 0.0 112.383 -170.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.435 HD13 ' HA ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -72.17 108.83 5.55 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 177.311 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.461 ' HB3' ' HB3' ' A' ' 26' ' ' MET . 35.1 tt0 -87.31 131.86 43.0 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 123.686 0.794 . . . . 0.0 110.179 -177.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.441 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 72.4 Cg_exo -53.12 88.37 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.32 0 C-N-CA 123.682 2.921 . . . . 0.0 113.031 170.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 113.73 22.86 5.23 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.714 -0.676 . . . . 0.0 112.155 170.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.461 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 3.8 ptp -89.39 168.73 11.99 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 121.256 0.551 . . . . 0.0 110.387 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.436 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 1.4 ttt180 -86.95 147.08 25.91 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 124.838 1.255 . . . . 0.0 108.967 -176.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.522 HG22 HG22 ' A' ' 75' ' ' ILE . 55.9 t -130.71 164.08 34.73 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 C-N-CA 124.444 1.098 . . . . 0.0 109.469 -172.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.418 ' HD2' ' N ' ' A' ' 30' ' ' MET . 3.5 tmm_? -142.7 145.65 33.59 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.376 1.47 . . . . 0.0 107.607 172.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.418 ' N ' ' HD2' ' A' ' 29' ' ' ARG . 4.4 tpt -85.18 112.26 20.55 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.137 0.575 . . . . 0.0 109.734 -175.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 39.0 tp -86.46 -20.02 28.74 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.339 0.656 . . . . 0.0 111.682 -174.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -136.67 155.12 50.31 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.741 0.416 . . . . 0.0 110.29 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -76.51 138.98 40.58 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.933 0.493 . . . . 0.0 110.339 -176.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -131.21 171.42 13.32 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.306 1.042 . . . . 0.0 110.822 -172.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -48.58 -58.76 4.22 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.126 1.37 . . . . 0.0 112.032 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -117.96 -1.0 11.55 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.11 0.964 . . . . 0.0 111.402 -175.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mp -118.18 139.86 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 176.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.6 m -104.79 152.48 22.52 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.72 114.24 3.88 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 176.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 134.99 -36.12 2.1 Favored Glycine 0 C--N 1.346 1.131 0 O-C-N 123.488 0.493 . . . . 0.0 112.36 -173.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -61.61 147.82 44.44 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 123.198 0.599 . . . . 0.0 111.753 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -102.23 155.46 18.2 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.337 0.655 . . . . 0.0 111.009 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -140.32 -175.73 14.67 Favored Glycine 0 C--N 1.338 0.658 0 CA-C-N 114.792 -1.094 . . . . 0.0 111.835 -175.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -139.33 138.54 36.74 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 168.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.562 ' HA ' HG12 ' A' ' 57' ' ' VAL . 87.1 t80 -71.07 122.4 20.01 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 122.685 0.394 . . . . 0.0 110.015 176.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.531 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 22.8 mmm180 -108.75 -48.57 3.28 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -176.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.531 ' NE2' ' HB2' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -167.19 155.46 9.61 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.364 179.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.8 p -123.11 179.4 4.7 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.135 0.974 . . . . 0.0 109.955 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -107.84 140.07 41.49 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 172.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.445 HD22 ' N ' ' A' ' 51' ' ' GLY . 0.3 OUTLIER -51.43 -22.43 3.03 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 115.592 1.701 . . . . 0.0 115.592 -168.06 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.445 ' N ' HD22 ' A' ' 50' ' ' ASN . . . -173.65 30.67 0.1 OUTLIER Glycine 0 N--CA 1.467 0.761 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 176.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.627 HG22 ' HD2' ' A' ' 54' ' ' PRO . 4.9 mm -117.09 130.02 24.91 Favored Pre-proline 0 N--CA 1.477 0.904 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 -177.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.478 ' HA ' ' CD1' ' A' ' 70' ' ' TRP . 13.6 Cg_endo -55.43 -40.77 83.71 Favored 'Trans proline' 0 CA--C 1.584 2.982 0 C-N-CA 122.842 2.361 . . . . 0.0 118.172 -175.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.627 ' HD2' HG22 ' A' ' 52' ' ' ILE . 57.7 Cg_endo -68.84 101.45 0.79 Allowed 'Trans proline' 0 C--N 1.394 2.941 0 CA-C-N 122.736 2.013 . . . . 0.0 112.558 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 p -94.43 140.52 16.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.944 0.898 . . . . 0.0 109.918 171.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.49 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.1 mp0 -93.65 122.81 36.49 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.381 0.672 . . . . 0.0 109.72 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -132.78 140.63 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 125.262 1.425 . . . . 0.0 108.825 -178.522 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -79.38 108.1 12.64 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.506 ' HB2' HG22 ' A' ' 62' ' ' THR . 93.8 m95 -91.65 131.36 37.1 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 123.943 0.897 . . . . 0.0 110.066 177.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -59.41 -31.85 69.64 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.223 1.009 . . . . 0.0 111.688 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.7 t -67.55 -45.63 75.09 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.695 0.798 . . . . 0.0 112.07 -172.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.506 HG22 ' HB2' ' A' ' 59' ' ' TRP . 6.1 t -97.68 -21.24 17.12 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.32 0.648 . . . . 0.0 110.988 -177.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.8 18.66 69.7 Favored Glycine 0 C--N 1.349 1.282 0 CA-C-N 115.949 -0.569 . . . . 0.0 113.783 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 25.8 ptt85 -151.95 -176.93 5.85 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.138 0.575 . . . . 0.0 110.579 -176.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 56' ' ' GLN . 5.2 p -86.03 144.38 27.6 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.503 0.721 . . . . 0.0 110.753 173.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -140.0 154.47 47.15 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.198 0.599 . . . . 0.0 109.942 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 8.3 m-90 -81.4 111.99 18.26 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.555 1.142 . . . . 0.0 109.959 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.689 HG21 HD13 ' A' ' 73' ' ' LEU . 19.1 m -126.03 159.98 33.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.185 0.594 . . . . 0.0 110.772 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.513 ' HB3' ' HB2' ' A' ' 72' ' ' MET . 14.9 t-80 -91.14 147.04 23.34 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.283 1.033 . . . . 0.0 109.475 -177.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.478 ' CD1' ' HA ' ' A' ' 53' ' ' PRO . 97.2 m95 -64.99 -45.99 83.3 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.013 0.525 . . . . 0.0 111.917 -175.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -70.47 -17.26 62.97 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.077 0.465 . . . . 0.0 111.678 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.513 ' HB2' ' HB3' ' A' ' 69' ' ' HIS . 21.3 mtp -104.16 14.19 30.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.526 1.13 . . . . 0.0 110.502 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.689 HD13 HG21 ' A' ' 68' ' ' VAL . 29.1 tp -119.19 121.26 39.33 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.298 1.039 . . . . 0.0 108.578 178.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -112.68 119.81 39.37 Favored 'General case' 0 C--O 1.217 -0.655 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 175.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.522 HG22 HG22 ' A' ' 28' ' ' VAL . 14.0 pt -86.81 117.54 31.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.488 0.661 . . . . 0.0 110.533 175.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 16.8 tp -96.22 15.17 21.73 Favored 'General case' 0 CA--C 1.556 1.173 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.121 174.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 27' ' ' ARG . . . . . . . . 0 C--N 1.36 1.892 0 C-N-CA 123.741 0.686 . . . . 0.0 112.681 170.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.8 t80 . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -66.77 -36.43 91.18 Favored Glycine 0 C--N 1.339 0.723 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.497 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 33.6 tt0 -63.24 -47.45 82.42 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 171.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.8 t80 -57.83 -51.97 67.41 Favored 'General case' 0 N--CA 1.472 0.666 0 O-C-N 124.376 1.048 . . . . 0.0 111.854 -173.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.7 m -67.13 -37.88 80.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 O-C-N 123.789 0.681 . . . . 0.0 110.764 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.78 -34.17 67.37 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.575 0.75 . . . . 0.0 110.225 177.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 25.4 mm-40 -79.29 -50.01 11.57 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.815 0.446 . . . . 0.0 111.068 -179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.1 t -90.84 3.97 53.04 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 -169.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.83 125.09 25.87 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 26' ' ' MET . 21.3 tt0 -90.96 139.63 25.95 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 124.145 0.978 . . . . 0.0 109.384 177.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' HA ' ' CD1' ' A' ' 45' ' ' PHE . 25.9 Cg_exo -63.63 84.62 0.13 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.742 2.294 . . . . 0.0 112.922 172.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 116.59 31.51 1.79 Allowed Glycine 0 C--N 1.353 1.49 0 N-CA-C 112.022 -0.431 . . . . 0.0 112.022 171.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.501 ' HB3' ' HB3' ' A' ' 23' ' ' GLN . 25.9 ptm -100.59 174.61 6.0 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.268 0.556 . . . . 0.0 109.857 177.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.677 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 19.1 tpt180 -91.05 130.6 36.94 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 124.349 1.059 . . . . 0.0 108.995 -173.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.5 m -116.45 173.23 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.642 0 C-N-CA 123.439 0.696 . . . . 0.0 109.33 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.07 137.15 25.79 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -171.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.6 tpt -82.62 111.61 18.74 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 55.2 tp -80.39 -38.59 30.01 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.176 0.591 . . . . 0.0 110.698 -177.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -126.86 154.04 44.91 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.212 0.605 . . . . 0.0 110.553 -175.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -72.99 119.47 17.27 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.337 0.655 . . . . 0.0 110.605 -174.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -102.6 173.46 6.33 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.386 1.074 . . . . 0.0 111.502 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -45.61 -52.1 11.11 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 126.174 1.79 . . . . 0.0 112.2 -175.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -124.9 -11.41 7.15 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.462 -177.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.2 mp -102.21 132.19 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 69.7 m -94.48 148.66 22.02 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.496 0.318 . . . . 0.0 110.39 176.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.8 115.73 4.61 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.94 -18.93 8.43 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 123.479 0.487 . . . . 0.0 112.452 -172.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.1 t0 -75.24 155.21 37.02 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.156 0.582 . . . . 0.0 109.57 173.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -126.7 154.29 44.31 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.582 0.706 . . . . 0.0 111.165 -177.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.423 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . -137.42 -169.5 11.65 Favored Glycine 0 C--N 1.336 0.579 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.815 -176.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -137.22 144.34 42.76 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 173.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.542 ' CD1' ' HA ' ' A' ' 24' ' ' PRO . 51.1 t80 -69.62 121.86 17.96 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.443 0.697 . . . . 0.0 109.31 177.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.503 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 10.2 mmm180 -108.95 -43.75 4.14 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.629 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -170.78 172.68 5.59 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.354 1.461 . . . . 0.0 107.895 177.237 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 82.8 p -157.18 179.8 8.93 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.748 0.785 . . . . 0.0 112.317 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -126.46 126.55 43.95 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.076 -1.42 . . . . 0.0 107.633 171.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -73.51 -44.55 57.46 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.195 0.598 . . . . 0.0 110.72 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -87.98 -27.51 25.96 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.303 -0.862 . . . . 0.0 113.189 -179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.62 HG22 ' HD2' ' A' ' 54' ' ' PRO . 9.0 mm -100.55 118.72 60.42 Favored Pre-proline 0 CA--C 1.554 1.111 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -176.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -60.4 -31.01 92.13 Favored 'Trans proline' 0 CA--C 1.579 2.731 0 N-CA-C 118.961 2.639 . . . . 0.0 118.961 -172.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.62 ' HD2' HG22 ' A' ' 52' ' ' ILE . 56.8 Cg_endo -70.1 110.15 2.55 Favored 'Trans proline' 0 C--N 1.372 1.772 0 CA-C-N 122.925 2.08 . . . . 0.0 113.316 173.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.94 139.46 17.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 124.303 1.041 . . . . 0.0 109.82 167.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.629 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 1.7 mp0 -91.94 122.05 34.1 Favored 'General case' 0 CA--C 1.552 1.051 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 176.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -135.82 136.24 50.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.571 1.149 . . . . 0.0 108.819 -177.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 59.9 t80 -82.01 106.42 13.9 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 -176.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.45 ' HB2' HG22 ' A' ' 62' ' ' THR . 89.0 m95 -90.29 130.71 36.37 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.426 1.09 . . . . 0.0 110.125 -178.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -69.51 -37.93 77.36 Favored 'General case' 0 CA--C 1.554 1.099 0 O-C-N 123.842 0.714 . . . . 0.0 112.679 -173.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.1 t -69.59 -43.19 73.31 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.436 0.294 . . . . 0.0 111.677 -174.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 59' ' ' TRP . 11.4 t -86.18 -17.13 35.71 Favored 'General case' 0 CA--C 1.551 1.005 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.794 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.48 18.32 76.08 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 114.539 0.576 . . . . 0.0 114.539 172.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -152.8 166.55 31.91 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.229 0.538 . . . . 0.0 112.086 -172.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 1.4 m -85.67 130.79 34.47 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.841 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -137.16 148.91 46.92 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.885 0.374 . . . . 0.0 110.688 -173.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.461 ' CD1' ' HG3' ' A' ' 56' ' ' GLN . 11.1 m0 -76.76 114.15 15.21 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.462 1.105 . . . . 0.0 109.323 178.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.445 HG21 HD13 ' A' ' 73' ' ' LEU . 18.6 m -126.46 156.47 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 C-N-CA 123.112 0.565 . . . . 0.0 109.676 175.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -86.07 145.92 26.85 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -176.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.1 m95 -63.09 -42.7 99.67 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.219 0.608 . . . . 0.0 111.768 -175.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -68.11 -14.42 62.97 Favored 'General case' 0 CA--C 1.557 1.234 0 C-N-CA 123.538 0.735 . . . . 0.0 111.995 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 72.3 mtm -113.03 16.95 19.19 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.406 0.682 . . . . 0.0 110.958 174.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.445 HD13 HG21 ' A' ' 68' ' ' VAL . 40.6 tp -114.83 122.14 45.41 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.305 0.642 . . . . 0.0 109.295 176.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -105.23 147.29 28.2 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.409 1.084 . . . . 0.0 108.367 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.0 pt -112.43 115.95 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 121.378 0.609 . . . . 0.0 110.222 173.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 59.6 tp -136.62 101.66 4.69 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.677 ' HA3' ' HB3' ' A' ' 27' ' ' ARG . . . . . . . . 0 C--N 1.341 0.858 0 CA-C-O 119.432 -0.649 . . . . 0.0 112.465 -178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.404 ' OH ' ' HA ' ' A' ' 74' ' ' GLU . 64.5 t80 . . . . . 0 N--CA 1.479 1.016 0 CA-C-O 120.469 0.176 . . . . 0.0 111.167 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.0 -38.86 63.9 Favored Glycine 0 C--N 1.342 0.864 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.904 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.563 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 3.2 mp0 -70.91 -37.6 72.95 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 173.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 32.4 t80 -58.44 -49.12 78.45 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.913 0.758 . . . . 0.0 111.417 178.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 27.0 m -62.58 -38.96 82.82 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 18.0 tm0? -58.84 -40.64 84.8 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.141 0.576 . . . . 0.0 109.846 177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.563 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 25.1 mm-40 -66.76 -40.0 88.1 Favored 'General case' 0 N--CA 1.481 1.079 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.313 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 12.4 t -110.53 13.08 22.73 Favored 'General case' 0 CA--C 1.561 1.387 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -169.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.621 HD12 ' SD ' ' A' ' 26' ' ' MET . 18.1 tp -87.55 110.93 20.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.858 -0.527 . . . . 0.0 110.428 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.612 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 38.7 mt-30 -87.84 141.44 31.65 Favored Pre-proline 0 N--CA 1.474 0.759 0 C-N-CA 124.203 1.001 . . . . 0.0 109.892 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -61.89 85.48 0.1 OUTLIER 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.972 2.448 . . . . 0.0 111.728 173.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.64 73.71 1.19 Allowed Glycine 0 C--N 1.342 0.905 0 CA-C-N 114.457 -1.247 . . . . 0.0 111.797 -178.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.621 ' SD ' HD12 ' A' ' 22' ' ' LEU . 21.8 ptm -118.78 -58.32 1.97 Allowed 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 118.465 -0.779 . . . . 0.0 112.044 178.396 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.578 ' HB3' ' HA2' ' A' ' 77' ' ' GLY . 24.8 tpt180 146.08 122.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 128.088 2.555 . . . . 0.0 107.929 173.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.7 m -118.14 171.74 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.744 0 CA-C-O 121.326 0.584 . . . . 0.0 110.206 177.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.693 ' HB2' HD22 ' A' ' 76' ' ' LEU . 7.1 tpt180 -148.81 150.34 32.89 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.719 1.608 . . . . 0.0 107.529 -169.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.1 tpt -90.33 111.89 23.26 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 34.4 tp -77.41 -33.16 55.06 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.421 0.689 . . . . 0.0 110.912 -174.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -145.29 153.99 41.87 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.627 0.771 . . . . 0.0 109.072 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -62.46 142.03 58.09 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.52 0.728 . . . . 0.0 111.573 -172.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -126.33 171.76 10.69 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.818 0.847 . . . . 0.0 110.921 -175.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -47.37 -37.81 11.93 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 125.728 1.611 . . . . 0.0 113.233 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -139.94 -0.01 1.73 Allowed 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.494 -171.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 mt -119.83 141.01 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.224 1.01 . . . . 0.0 109.19 -175.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.4 p -91.41 142.35 27.77 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.059 0.544 . . . . 0.0 109.969 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.39 117.39 5.61 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 122.665 0.386 . . . . 0.0 110.069 171.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.92 -4.27 28.88 Favored Glycine 0 C--N 1.343 0.929 0 O-C-N 123.542 0.526 . . . . 0.0 112.537 -175.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -77.34 156.57 31.19 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.165 0.586 . . . . 0.0 109.658 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 51.0 mt-10 -113.15 157.26 21.88 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.752 0.787 . . . . 0.0 111.596 -178.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -146.25 -172.53 16.66 Favored Glycine 0 C--O 1.244 0.756 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.046 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -138.2 141.34 40.01 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 170.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.443 ' HE1' ' HB3' ' A' ' 48' ' ' SER . 32.8 t80 -70.58 120.45 16.23 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 123.639 0.776 . . . . 0.0 110.207 176.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.522 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 15.0 mmm180 -108.85 -47.63 3.42 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.804 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.575 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -163.78 155.86 17.23 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.537 1.135 . . . . 0.0 109.316 -177.12 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.443 ' HB3' ' HE1' ' A' ' 45' ' ' PHE . 41.4 p -132.09 179.03 6.34 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.715 0.806 . . . . 0.0 110.772 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 3.2 m-80 -139.51 132.7 29.78 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 169.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -86.49 -30.94 21.6 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.363 0.665 . . . . 0.0 110.054 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.62 -35.99 27.33 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.926 175.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 26.2 mm -106.74 100.97 34.13 Favored Pre-proline 0 N--CA 1.485 1.317 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -56.25 -30.65 81.13 Favored 'Trans proline' 0 CA--C 1.571 2.345 0 C-N-CA 122.746 2.297 . . . . 0.0 117.933 -173.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.638 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 55.9 Cg_endo -67.36 111.99 2.45 Favored 'Trans proline' 0 C--N 1.378 2.124 0 CA-C-N 123.297 2.213 . . . . 0.0 111.649 171.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 p -81.54 141.44 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.467 1.107 . . . . 0.0 110.689 171.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.575 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 1.7 mp0 -90.17 126.85 35.95 Favored 'General case' 0 CA--C 1.55 0.978 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 178.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.446 HG23 ' NE1' ' A' ' 59' ' ' TRP . 0.0 OUTLIER -138.26 137.34 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 C-N-CA 125.16 1.384 . . . . 0.0 108.817 -177.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -82.03 105.78 13.41 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.24 0.616 . . . . 0.0 109.818 -175.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.489 ' HB2' HG22 ' A' ' 62' ' ' THR . 91.7 m95 -92.58 132.62 36.7 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.34 1.056 . . . . 0.0 111.2 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 13.6 pt20 -69.2 -28.33 66.28 Favored 'General case' 0 CA--C 1.55 0.967 0 O-C-N 124.141 0.901 . . . . 0.0 112.078 179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 43.0 t -64.37 -46.46 83.27 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 118.05 0.387 . . . . 0.0 112.01 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.489 HG22 ' HB2' ' A' ' 59' ' ' TRP . 10.2 t -98.17 -12.08 22.08 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 123.543 0.737 . . . . 0.0 110.756 -176.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.3 16.09 79.94 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-N 115.986 -0.552 . . . . 0.0 113.898 176.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.8 ptt180 -151.9 170.69 19.22 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.345 0.593 . . . . 0.0 111.682 -174.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.569 HG22 ' HB3' ' A' ' 56' ' ' GLN . 1.7 m -87.0 120.06 27.86 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.271 -177.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -127.95 157.13 41.43 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.75 0.42 . . . . 0.0 111.152 -175.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.638 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 4.3 m-90 -75.65 120.67 21.37 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.456 1.102 . . . . 0.0 110.649 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.482 HG21 HD13 ' A' ' 73' ' ' LEU . 6.3 m -135.41 147.89 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 173.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -78.95 148.21 32.72 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.928 0.491 . . . . 0.0 110.496 -178.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -54.47 -49.66 69.56 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.282 1.033 . . . . 0.0 112.305 -178.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -74.83 -13.11 60.53 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-N 116.189 -0.459 . . . . 0.0 112.073 -175.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 29.1 mtp -106.76 13.88 27.44 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.857 0.863 . . . . 0.0 110.356 177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.482 HD13 HG21 ' A' ' 68' ' ' VAL . 53.6 tp -116.18 131.32 56.98 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.641 1.177 . . . . 0.0 108.799 176.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HA ' ' OH ' ' A' ' 14' ' ' TYR . 10.9 tp10 -106.12 140.89 38.38 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.753 1.221 . . . . 0.0 108.234 177.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 pt -115.4 148.43 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-N 118.435 0.562 . . . . 0.0 111.52 175.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.693 HD22 ' HB2' ' A' ' 29' ' ' ARG . 2.1 pt? -152.08 35.94 0.54 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.839 0.856 . . . . 0.0 109.559 178.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' A' ' 27' ' ' ARG . . . . . . . . 0 CA--C 1.537 1.459 0 CA-C-O 118.666 -1.074 . . . . 0.0 115.534 -173.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 80.1 t80 . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.49 -42.05 74.62 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-O 121.512 0.506 . . . . 0.0 112.601 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 8.4 mp0 -69.33 -34.33 74.48 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 176.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -65.22 -49.73 68.56 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 123.866 0.728 . . . . 0.0 111.891 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.4 m -59.62 -38.86 77.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 O-C-N 123.319 0.387 . . . . 0.0 110.435 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -54.71 -35.47 63.67 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.364 0.665 . . . . 0.0 111.493 178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.55 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 43.4 mm-40 -82.36 -36.25 27.02 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.716 -0.674 . . . . 0.0 112.463 -172.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.8 t -109.24 4.22 22.55 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 122.853 0.461 . . . . 0.0 112.142 -172.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.512 HD13 HG22 ' A' ' 75' ' ' ILE . 16.7 tp -86.08 116.73 24.47 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 122.007 -0.433 . . . . 0.0 109.994 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -92.01 137.47 25.15 Favored Pre-proline 0 N--CA 1.481 1.095 0 C-N-CA 124.207 1.003 . . . . 0.0 111.136 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.2 92.41 0.39 Allowed 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.017 2.478 . . . . 0.0 112.105 177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 136.0 -8.22 4.15 Favored Glycine 0 C--N 1.344 0.994 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.661 178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 5.5 ptp -92.46 166.5 12.51 Favored 'General case' 0 C--O 1.244 0.806 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 173.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.5 ptt180 -88.17 162.7 16.56 Favored 'General case' 0 C--O 1.245 0.838 0 CA-C-O 121.896 0.855 . . . . 0.0 110.305 -171.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.6 m -131.64 175.65 10.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.061 176.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -143.89 146.07 32.75 Favored 'General case' 0 CA--C 1.551 1.0 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -174.424 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.5 tpt -98.05 118.17 34.05 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.777 0.831 . . . . 0.0 110.043 178.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 64.8 mt -74.94 -43.39 54.4 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.417 0.687 . . . . 0.0 112.066 -177.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -129.5 163.99 24.71 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 109.468 -0.568 . . . . 0.0 109.468 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -67.09 120.53 13.85 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-O 121.292 0.568 . . . . 0.0 110.889 -176.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.03 173.12 6.98 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.988 0.915 . . . . 0.0 110.384 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -47.79 -48.07 30.52 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 125.348 1.459 . . . . 0.0 113.542 -176.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -128.31 8.5 6.03 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.306 0.642 . . . . 0.0 111.571 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.8 mp -120.07 143.56 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 40.3 m -99.46 154.02 18.55 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 118.561 0.619 . . . . 0.0 109.848 174.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.6 118.3 6.89 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.623 0.769 . . . . 0.0 110.068 174.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.53 -10.39 23.87 Favored Glycine 0 C--N 1.341 0.834 0 O-C-N 123.331 0.395 . . . . 0.0 113.237 -178.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -79.95 157.26 26.9 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 120.948 0.404 . . . . 0.0 110.725 174.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 45.0 mt-10 -120.55 159.95 24.19 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.038 -174.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -141.7 -167.76 11.35 Favored Glycine 0 C--N 1.336 0.532 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.647 -176.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -138.52 140.13 39.0 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 170.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.446 ' HA ' HG12 ' A' ' 57' ' ' VAL . 55.6 t80 -79.7 121.31 25.16 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.225 0.61 . . . . 0.0 110.102 176.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -108.26 -47.91 3.45 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.408 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -155.47 151.08 27.3 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.754 0.821 . . . . 0.0 110.109 -176.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.491 ' HA ' HG23 ' A' ' 55' ' ' VAL . 48.6 p -117.49 162.63 17.66 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 124.091 0.956 . . . . 0.0 111.123 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 52' ' ' ILE . 8.6 m-80 -124.46 121.47 34.96 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 105.708 -1.96 . . . . 0.0 105.708 160.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -89.87 -27.12 20.11 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.538 0.735 . . . . 0.0 109.943 -173.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.32 -28.08 34.48 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 115.477 -0.783 . . . . 0.0 112.125 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.456 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 3.1 mp -114.31 102.43 54.82 Favored Pre-proline 0 CA--C 1.55 0.966 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 -178.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.4 -26.12 81.98 Favored 'Trans proline' 0 CA--C 1.583 2.949 0 N-CA-C 118.268 2.372 . . . . 0.0 118.268 -170.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.523 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 39.4 Cg_endo -67.56 105.87 1.16 Allowed 'Trans proline' 0 C--N 1.389 2.67 0 CA-C-N 123.56 2.307 . . . . 0.0 111.793 169.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.491 HG23 ' HA ' ' A' ' 48' ' ' SER . 6.4 p -86.59 145.84 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.467 1.107 . . . . 0.0 110.709 176.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.408 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.0 mp0 -92.22 122.08 34.36 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.446 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -133.89 136.68 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 C-N-CA 124.857 1.263 . . . . 0.0 108.752 178.855 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -81.09 108.65 14.94 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 -178.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.514 ' HB2' HG22 ' A' ' 62' ' ' THR . 94.5 m95 -93.52 131.14 39.04 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.849 0.86 . . . . 0.0 110.898 -178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 18.4 pt20 -61.72 -27.21 68.55 Favored 'General case' 0 N--CA 1.479 0.997 0 O-C-N 124.114 0.883 . . . . 0.0 110.977 169.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.3 t -60.46 -45.16 94.71 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.609 1.164 . . . . 0.0 112.307 -176.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.514 HG22 ' HB2' ' A' ' 59' ' ' TRP . 8.6 t -113.09 -10.74 13.41 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.685 0.794 . . . . 0.0 111.265 -174.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.45 13.89 82.74 Favored Glycine 0 C--N 1.351 1.381 0 CA-C-N 116.359 -0.382 . . . . 0.0 113.91 178.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.0 ptm180 -152.47 173.65 14.86 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.274 0.559 . . . . 0.0 111.387 -173.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.05 126.78 34.98 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 114.655 -1.157 . . . . 0.0 109.557 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -128.67 155.35 45.17 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-O 120.984 0.421 . . . . 0.0 111.059 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.523 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 10.1 m-90 -82.09 108.66 15.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.991 1.316 . . . . 0.0 109.732 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.7 m -125.97 151.54 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 C-N-CA 123.128 0.571 . . . . 0.0 109.73 177.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -80.32 146.42 31.59 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 94.7 m95 -54.89 -45.37 74.65 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 124.833 1.253 . . . . 0.0 113.293 -177.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -72.54 -22.39 61.02 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -173.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 70.7 mtm -93.39 -6.28 47.53 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.205 0.602 . . . . 0.0 111.424 174.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 tt -90.93 123.56 34.53 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 171.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 29' ' ' ARG . 40.4 tt0 -104.04 143.58 32.7 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.512 HG22 HD13 ' A' ' 22' ' ' LEU . 37.5 pt -105.91 117.16 51.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 41.0 mt -112.97 5.28 17.19 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.214 0.605 . . . . 0.0 110.831 173.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.311 0 CA-C-O 118.922 -0.932 . . . . 0.0 112.132 -179.215 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 83.4 t80 . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.08 -30.18 75.49 Favored Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.802 -0.635 . . . . 0.0 113.028 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 8.3 tp10 -72.28 -47.47 49.81 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 171.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.422 ' O ' HG22 ' A' ' 21' ' ' THR . 38.5 t80 -57.45 -48.78 78.26 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.294 1.038 . . . . 0.0 111.256 -172.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.9 m -58.29 -43.31 85.82 Favored 'Isoleucine or valine' 0 C--N 1.35 0.612 0 O-C-N 123.729 0.643 . . . . 0.0 110.259 178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -62.12 -31.51 71.98 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.458 0.703 . . . . 0.0 111.189 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 79.5 mm-40 -82.22 -32.32 29.84 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.188 0.595 . . . . 0.0 111.519 -178.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.422 HG22 ' O ' ' A' ' 17' ' ' TYR . 14.2 t -107.79 8.35 28.73 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 122.944 0.498 . . . . 0.0 111.966 -175.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.608 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.1 OUTLIER -67.66 117.83 10.12 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.062 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.723 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 9.8 mm100 -86.23 133.4 40.77 Favored Pre-proline 0 CA--C 1.552 1.029 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -71.14 87.4 0.73 Allowed 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.875 2.383 . . . . 0.0 112.261 -177.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.24 23.99 2.8 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.723 ' HB3' ' HB2' ' A' ' 23' ' ' GLN . 16.8 ptm -91.69 168.48 11.45 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.194 0.597 . . . . 0.0 110.118 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.1 ppp_? -90.3 147.14 23.69 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.179 -0.919 . . . . 0.0 108.797 -179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 43.4 t -129.28 164.88 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 124.937 1.295 . . . . 0.0 107.648 -169.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -149.53 133.13 16.76 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 2.0 tpt -82.81 112.59 19.78 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.782 0.833 . . . . 0.0 109.869 -178.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.652 HD23 ' HB2' ' A' ' 74' ' ' GLU . 4.0 pp -85.9 -2.88 58.7 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 122.862 0.465 . . . . 0.0 111.19 176.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -124.79 162.87 23.37 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.198 0.999 . . . . 0.0 109.427 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -98.76 117.3 32.92 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -106.17 173.26 6.39 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.527 1.131 . . . . 0.0 112.175 -175.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -51.71 -44.95 63.37 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.818 1.647 . . . . 0.0 112.455 -175.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -133.63 3.95 3.59 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.969 0.908 . . . . 0.0 111.396 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 mp -118.41 137.39 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 175.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 45.3 m -99.32 155.07 17.71 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 118.24 0.473 . . . . 0.0 109.919 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.17 114.15 5.68 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.31 -26.54 3.91 Favored Glycine 0 C--N 1.346 1.094 0 O-C-N 123.572 0.545 . . . . 0.0 112.402 -174.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -69.94 158.22 36.0 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.234 0.613 . . . . 0.0 112.494 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -116.94 157.31 25.94 Favored 'General case' 0 C--O 1.243 0.741 0 C-N-CA 123.832 0.853 . . . . 0.0 111.552 -177.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.15 -173.75 14.97 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-N 114.615 -1.175 . . . . 0.0 111.731 -176.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -136.04 142.52 44.41 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 171.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.426 ' CE1' ' HB3' ' A' ' 48' ' ' SER . 91.4 t80 -87.28 118.29 26.6 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.004 0.922 . . . . 0.0 110.059 178.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.402 ' HG2' HE22 ' A' ' 47' ' ' GLN . 0.0 OUTLIER -112.32 -47.57 3.09 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-O 120.803 0.335 . . . . 0.0 110.653 178.475 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.402 HE22 ' HG2' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -145.77 161.93 38.81 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.61 0.764 . . . . 0.0 109.375 -175.66 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.426 ' HB3' ' CE1' ' A' ' 45' ' ' PHE . 53.4 p -158.64 169.28 24.76 Favored 'General case' 0 C--O 1.239 0.53 0 O-C-N 123.777 0.673 . . . . 0.0 111.988 -171.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.422 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 7.5 m-80 -139.13 139.66 37.7 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 171.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -93.62 -33.33 13.74 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.945 0.498 . . . . 0.0 110.319 179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.11 -31.01 40.07 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.943 174.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.422 ' HB ' ' HB2' ' A' ' 49' ' ' ASN . 3.6 mp -104.33 99.8 19.09 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 177.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -63.27 -24.68 72.04 Favored 'Trans proline' 0 CA--C 1.573 2.429 0 N-CA-C 117.767 2.18 . . . . 0.0 117.767 -171.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.605 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 49.2 Cg_endo -70.37 107.82 2.06 Favored 'Trans proline' 0 C--N 1.383 2.393 0 CA-C-N 123.145 2.159 . . . . 0.0 111.702 168.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.3 p -85.68 141.43 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.326 1.05 . . . . 0.0 110.311 171.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -87.99 122.67 31.86 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.39 136.15 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 124.43 1.092 . . . . 0.0 108.544 178.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 71.6 t80 -81.53 108.03 14.78 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -176.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -92.87 131.05 38.24 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.699 0.799 . . . . 0.0 111.115 -177.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -62.69 -31.3 72.17 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.928 0.891 . . . . 0.0 111.427 172.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.5 t -60.07 -43.74 95.26 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.82 1.248 . . . . 0.0 111.808 -172.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.1 t -113.07 -8.93 13.6 Favored 'General case' 0 CA--C 1.55 0.967 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.163 -174.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.02 15.39 81.19 Favored Glycine 0 C--N 1.351 1.369 0 CA-C-N 116.351 -0.386 . . . . 0.0 114.028 176.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -151.65 169.6 21.75 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.528 0.68 . . . . 0.0 111.598 -172.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.21 123.42 32.2 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.423 -1.262 . . . . 0.0 109.267 -176.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -126.74 155.67 42.38 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 121.523 0.678 . . . . 0.0 110.809 -176.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.605 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 9.3 m-90 -89.37 111.97 22.96 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.465 1.506 . . . . 0.0 109.288 -172.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.4 m -129.51 153.17 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 123.279 0.632 . . . . 0.0 110.51 -176.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 49.6 t60 -80.56 147.09 30.94 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 122.811 0.444 . . . . 0.0 110.734 -177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -59.42 -49.35 78.13 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 124.268 1.027 . . . . 0.0 112.929 -176.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -67.81 -23.18 65.16 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.164 0.585 . . . . 0.0 111.625 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.509 ' HA ' HD11 ' A' ' 31' ' ' LEU . 40.2 mtp -95.82 -4.13 44.36 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 124.573 1.149 . . . . 0.0 111.095 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.4 tt -93.95 141.07 28.94 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 172.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.652 ' HB2' HD23 ' A' ' 31' ' ' LEU . 39.4 tt0 -125.82 135.35 51.89 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.819 0.848 . . . . 0.0 108.902 177.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.1 pt -110.69 117.18 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 CA-C-O 121.235 0.54 . . . . 0.0 110.512 177.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 7.4 mp -92.14 -6.65 50.37 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 124.189 0.996 . . . . 0.0 110.309 175.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.348 1.249 0 CA-C-O 118.853 -0.971 . . . . 0.0 111.771 176.698 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 69.1 t80 . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.22 -34.65 86.47 Favored Glycine 0 C--N 1.344 1.007 0 O-C-N 123.279 0.362 . . . . 0.0 113.244 179.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 7.2 tp10 -73.74 -38.93 64.59 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 122.637 0.375 . . . . 0.0 110.411 174.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -57.99 -50.29 73.92 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.975 0.91 . . . . 0.0 111.417 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.533 ' HB ' HD23 ' A' ' 22' ' ' LEU . 28.1 m -62.52 -37.81 79.8 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.382 0 O-C-N 124.345 1.028 . . . . 0.0 110.657 -177.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.56 -42.11 70.6 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 123.136 0.574 . . . . 0.0 109.678 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.414 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 50.2 mm-40 -82.95 -29.52 29.04 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.461 -170.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.3 t -102.33 -2.43 28.98 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -176.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.533 HD23 ' HB ' ' A' ' 18' ' ' VAL . 0.9 OUTLIER -81.04 117.13 21.37 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 118.33 0.514 . . . . 0.0 110.946 179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -102.43 140.21 20.92 Favored Pre-proline 0 CA--C 1.544 0.716 0 C-N-CA 124.041 0.936 . . . . 0.0 109.508 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -67.48 87.85 0.34 Allowed 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.48 2.12 . . . . 0.0 111.232 174.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 148.2 2.19 0.44 Allowed Glycine 0 C--N 1.345 1.028 0 CA-C-N 115.222 -0.899 . . . . 0.0 113.153 176.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.437 ' SD ' HD13 ' A' ' 22' ' ' LEU . 12.3 ptp -96.63 165.45 12.14 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 117.706 0.753 . . . . 0.0 111.296 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.495 ' HD2' ' O ' ' A' ' 43' ' ' GLY . 20.6 tpt180 -91.51 128.46 37.34 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.828 1.251 . . . . 0.0 109.316 -171.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 m -116.28 170.96 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 123.631 0.773 . . . . 0.0 109.546 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.57 HH11 ' HA2' ' A' ' 40' ' ' GLY . 2.2 tmm_? -152.31 131.17 12.48 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.459 1.104 . . . . 0.0 108.083 -178.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.46 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 31.6 tpp -88.64 127.29 35.56 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.805 0.842 . . . . 0.0 111.195 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.495 HD23 ' HB2' ' A' ' 74' ' ' GLU . 3.3 pp -102.34 3.75 38.3 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.569 0.748 . . . . 0.0 112.153 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.438 ' O ' ' HG3' ' A' ' 30' ' ' MET . 29.6 t70 -126.76 164.13 22.01 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.779 0.832 . . . . 0.0 109.764 -178.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -95.96 117.09 29.96 Favored 'General case' 0 N--CA 1.476 0.83 0 O-C-N 121.886 -0.509 . . . . 0.0 110.015 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -111.16 170.52 8.05 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.0 1.32 . . . . 0.0 109.442 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -40.91 -55.33 2.52 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 125.919 1.688 . . . . 0.0 112.996 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -126.19 3.1 7.13 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.743 0.817 . . . . 0.0 111.47 -175.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.9 mp -119.64 101.61 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 C-N-CA 123.409 0.684 . . . . 0.0 109.167 177.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.8 t -78.82 150.58 32.28 Favored 'General case' 0 C--O 1.247 0.963 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.89 115.55 3.78 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.347 0.659 . . . . 0.0 110.757 -175.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.57 ' HA2' HH11 ' A' ' 29' ' ' ARG . . . 127.78 -14.45 6.36 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.86 -176.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -73.42 154.24 40.08 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.645 0.378 . . . . 0.0 111.58 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -114.88 159.26 20.89 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.726 0.811 . . . . 0.0 110.702 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.495 ' O ' ' HD2' ' A' ' 27' ' ' ARG . . . -151.94 -171.65 19.89 Favored Glycine 0 C--N 1.332 0.306 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.391 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -134.98 142.67 46.51 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 173.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.477 ' CG ' HD12 ' A' ' 22' ' ' LEU . 20.9 t80 -80.01 122.58 26.92 Favored 'General case' 0 C--O 1.222 -0.375 0 C-N-CA 123.499 0.719 . . . . 0.0 109.326 -176.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.558 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 12.2 mmm180 -108.4 -45.76 3.83 Favored 'General case' 0 N--CA 1.483 1.215 0 CA-C-O 121.315 0.578 . . . . 0.0 109.726 -171.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.558 ' NE2' ' HB2' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -151.71 157.22 41.75 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.85 -179.111 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.2 p -118.37 157.75 26.54 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 123.873 0.733 . . . . 0.0 110.642 178.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.658 HD21 ' HA ' ' A' ' 55' ' ' VAL . 0.3 OUTLIER -153.68 118.37 4.97 Favored 'General case' 0 CA--C 1.529 0.138 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 175.123 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 -100.19 -15.6 18.07 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.277 1.031 . . . . 0.0 110.319 -170.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -84.16 -20.14 59.6 Favored Glycine 0 C--N 1.349 1.275 0 N-CA-C 111.748 -0.541 . . . . 0.0 111.748 168.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 3.8 mp -114.73 98.94 50.96 Favored Pre-proline 0 CA--C 1.547 0.852 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.23 -31.09 92.75 Favored 'Trans proline' 0 CA--C 1.576 2.619 0 C-N-CA 122.106 1.871 . . . . 0.0 116.195 -177.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.734 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 92.3 Cg_endo -79.53 98.25 1.14 Allowed 'Trans proline' 0 C--N 1.382 2.296 0 CA-C-N 122.371 1.883 . . . . 0.0 111.861 166.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.658 ' HA ' HD21 ' A' ' 49' ' ' ASN . 14.5 p -82.55 154.51 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 124.333 1.053 . . . . 0.0 111.829 -178.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -94.86 128.81 41.89 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.151 0.58 . . . . 0.0 110.585 -172.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 65' ' ' THR . 0.0 OUTLIER -140.66 140.45 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 125.298 1.439 . . . . 0.0 108.627 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -81.8 106.84 14.05 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.46 ' CH2' ' HB2' ' A' ' 30' ' ' MET . 96.2 m95 -88.77 130.97 35.25 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.314 1.046 . . . . 0.0 110.374 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -69.52 -26.66 64.63 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 123.705 0.802 . . . . 0.0 112.171 -176.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 18.6 t -68.89 -44.22 73.67 Favored 'General case' 0 C--N 1.357 0.929 0 CA-C-O 120.69 0.281 . . . . 0.0 111.178 -177.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 8.2 t -94.88 -30.32 14.24 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.397 0.679 . . . . 0.0 111.681 -176.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 90.68 23.54 30.52 Favored Glycine 0 C--N 1.347 1.144 0 CA-C-O 119.733 -0.482 . . . . 0.0 114.271 177.085 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -154.19 176.87 11.75 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 117.439 0.62 . . . . 0.0 111.754 -175.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 2.0 p -83.59 142.35 30.9 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 172.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -144.98 154.76 42.89 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.35 0.595 . . . . 0.0 110.096 177.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.734 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 16.3 m-90 -81.98 115.68 21.25 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 114.094 -1.412 . . . . 0.0 109.01 -176.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.438 HG21 ' HZ2' ' A' ' 59' ' ' TRP . 19.9 m -137.68 145.11 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 123.365 0.666 . . . . 0.0 109.687 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.519 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 9.5 t-80 -69.44 147.06 51.46 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 122.607 0.363 . . . . 0.0 110.841 -177.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.452 ' O ' HG21 ' A' ' 18' ' ' VAL . 90.4 m95 -59.45 -45.78 90.62 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.546 0.738 . . . . 0.0 111.634 -176.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -65.18 -23.26 67.05 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.502 0.721 . . . . 0.0 111.918 -178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.519 ' SD ' ' HB3' ' A' ' 69' ' ' HIS . 33.8 mtp -90.04 -14.2 34.36 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.223 1.009 . . . . 0.0 111.077 179.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 8.4 tt -90.78 122.01 33.15 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 175.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.495 ' HB2' HD23 ' A' ' 31' ' ' LEU . 35.3 tt0 -123.12 125.23 44.78 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.296 1.039 . . . . 0.0 109.212 -176.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.463 HD13 HD22 ' A' ' 22' ' ' LEU . 12.2 pt -100.28 118.75 47.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 121.314 0.578 . . . . 0.0 111.609 -178.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.2 mp -106.56 9.23 31.51 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 165.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.434 0 CA-C-O 119.193 -0.782 . . . . 0.0 112.964 -175.201 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 55.3 t80 . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.59 -36.91 88.92 Favored Glycine 0 C--N 1.338 0.684 0 CA-C-O 122.029 0.794 . . . . 0.0 112.717 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.51 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 2.5 mp0 -73.78 -33.08 64.09 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.027 -1.086 . . . . 0.0 110.246 177.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -68.63 -49.41 59.39 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.825 0.85 . . . . 0.0 110.837 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.573 ' O ' ' HB2' ' A' ' 22' ' ' LEU . 20.9 m -59.11 -39.14 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 O-C-N 123.779 0.675 . . . . 0.0 110.135 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -57.57 -38.7 75.28 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 124.141 0.976 . . . . 0.0 111.55 179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.51 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 52.9 mm-40 -78.2 -43.03 29.64 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 122.412 0.285 . . . . 0.0 111.282 -176.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.1 t -88.66 2.0 54.03 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.109 0.563 . . . . 0.0 112.384 -174.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.573 ' HB2' ' O ' ' A' ' 18' ' ' VAL . 12.7 tp -76.72 124.99 28.49 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.455 0.702 . . . . 0.0 111.176 -173.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -113.6 124.89 30.38 Favored Pre-proline 0 N--CA 1.48 1.057 0 C-N-CA 123.736 0.815 . . . . 0.0 109.617 -175.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -50.47 85.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 124.24 3.293 . . . . 0.0 114.547 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.61 26.8 1.54 Allowed Glycine 0 C--N 1.346 1.087 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.837 174.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.508 ' SD ' HD12 ' A' ' 22' ' ' LEU . 4.5 ptp -91.73 175.63 6.83 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.436 0.636 . . . . 0.0 110.844 179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 25.0 tpt85 -94.61 126.55 39.98 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.735 -1.121 . . . . 0.0 109.931 -170.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.465 HG22 HG22 ' A' ' 75' ' ' ILE . 41.6 t -119.01 160.07 19.15 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.231 0 C-N-CA 124.572 1.149 . . . . 0.0 111.26 -167.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 7.5 tpp85 -140.71 151.87 44.85 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 126.673 1.989 . . . . 0.0 108.567 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 3.9 tpt -94.89 115.5 27.54 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.481 0.712 . . . . 0.0 109.524 177.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 74' ' ' GLU . 38.8 tp -83.68 -29.03 27.93 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 123.192 0.597 . . . . 0.0 111.149 -177.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -137.19 154.6 50.17 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 122.754 0.422 . . . . 0.0 110.777 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -65.29 144.44 57.14 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.677 0.791 . . . . 0.0 111.588 -176.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -133.12 175.34 9.47 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.964 1.306 . . . . 0.0 110.275 -175.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -57.57 -51.85 67.82 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 125.01 1.324 . . . . 0.0 111.706 -173.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -119.23 0.1 11.12 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.836 0.855 . . . . 0.0 111.741 -178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.1 mp -119.89 146.03 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.248 1.019 . . . . 0.0 108.487 175.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.7 m -112.01 160.2 17.71 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 119.242 0.928 . . . . 0.0 110.025 173.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.24 117.67 8.16 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 177.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.38 -30.67 4.89 Favored Glycine 0 C--N 1.343 0.926 0 O-C-N 123.551 0.532 . . . . 0.0 111.993 -174.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -67.73 153.4 43.79 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.482 0.713 . . . . 0.0 111.012 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -127.19 154.83 44.31 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.536 0.684 . . . . 0.0 112.178 -166.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -143.66 -169.77 12.92 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.458 -171.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -136.58 140.5 42.93 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 172.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.535 ' HA ' HG12 ' A' ' 57' ' ' VAL . 30.8 t80 -72.64 124.21 24.81 Favored 'General case' 0 CA--C 1.539 0.531 0 O-C-N 123.63 0.581 . . . . 0.0 110.579 178.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.494 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 11.1 mmm180 -109.14 -47.99 3.34 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.678 0.391 . . . . 0.0 111.216 -174.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.553 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.3 OUTLIER -167.43 147.67 5.32 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.725 0.81 . . . . 0.0 110.03 -179.318 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.449 ' HA ' HG23 ' A' ' 55' ' ' VAL . 38.9 p -117.76 173.22 6.87 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 123.665 0.786 . . . . 0.0 111.429 -175.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 34.3 m-80 -128.71 119.95 25.57 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.768 175.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.4 m-80 -88.37 71.17 9.08 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-O 121.409 0.623 . . . . 0.0 109.631 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 151.42 -27.68 0.97 Allowed Glycine 0 C--N 1.339 0.7 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.918 -179.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.594 HG22 ' HD2' ' A' ' 54' ' ' PRO . 6.7 mm -103.45 118.71 57.0 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 108.131 -1.062 . . . . 0.0 108.131 179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -61.57 -34.1 85.71 Favored 'Trans proline' 0 CA--C 1.575 2.564 0 N-CA-C 117.648 2.134 . . . . 0.0 117.648 -174.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.594 ' HD2' HG22 ' A' ' 52' ' ' ILE . 59.0 Cg_endo -70.79 111.04 2.92 Favored 'Trans proline' 0 C--N 1.386 2.501 0 CA-C-N 122.744 2.016 . . . . 0.0 112.351 171.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.53 HG11 HD22 ' A' ' 73' ' ' LEU . 3.0 p -91.33 137.22 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 124.281 1.032 . . . . 0.0 109.656 166.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.553 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 1.9 mp0 -90.14 126.79 35.92 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 122.983 0.513 . . . . 0.0 109.888 -178.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.535 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -135.52 137.22 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 124.923 1.289 . . . . 0.0 108.773 -177.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -81.47 108.45 15.07 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.503 ' HB2' HG22 ' A' ' 62' ' ' THR . 85.4 m95 -93.08 128.06 38.85 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.87 0.868 . . . . 0.0 110.049 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -67.49 -23.47 65.49 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 123.671 0.607 . . . . 0.0 110.887 173.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.7 t -60.63 -44.98 95.72 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 124.659 1.184 . . . . 0.0 111.764 -179.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 59' ' ' TRP . 8.7 t -108.02 -6.36 16.6 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.975 0.91 . . . . 0.0 110.777 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.25 13.67 76.74 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 116.134 -0.485 . . . . 0.0 113.869 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 15.9 ptt180 -151.4 173.97 13.9 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 117.321 0.56 . . . . 0.0 111.032 -175.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -86.11 136.3 33.27 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.132 -175.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -137.76 157.41 46.5 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 121.657 0.741 . . . . 0.0 111.036 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 15.8 m-90 -83.73 108.75 16.99 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.816 1.646 . . . . 0.0 110.089 -176.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 m -123.82 157.75 30.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 122.796 0.438 . . . . 0.0 110.93 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -87.43 148.94 24.76 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.576 0.75 . . . . 0.0 110.495 -175.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.411 ' HH2' ' HB2' ' A' ' 48' ' ' SER . 75.3 m95 -61.85 -43.8 98.11 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.671 0.788 . . . . 0.0 111.939 -176.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 11.7 t-80 -73.1 -11.66 60.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 122.689 0.396 . . . . 0.0 111.408 -176.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 70.5 mtm -114.33 6.35 16.05 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 124.058 0.943 . . . . 0.0 110.622 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.53 HD22 HG11 ' A' ' 55' ' ' VAL . 35.9 tp -92.01 119.49 31.77 Favored 'General case' 0 C--N 1.346 0.426 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 170.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.411 ' HB2' ' HB2' ' A' ' 31' ' ' LEU . 41.8 tt0 -121.48 128.02 51.66 Favored 'General case' 0 C--O 1.212 -0.92 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.465 HG22 HG22 ' A' ' 28' ' ' VAL . 15.3 pt -110.96 115.02 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 CA-C-O 121.417 0.627 . . . . 0.0 111.461 -176.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -106.81 80.69 1.47 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 170.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.339 0.723 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.827 -178.293 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 71.3 t80 . . . . . 0 N--CA 1.485 1.321 0 CA-C-O 120.61 0.243 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -71.79 -40.26 58.43 Favored Glycine 0 C--N 1.343 0.936 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.523 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.464 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 2.2 mp0 -69.97 -26.09 63.93 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.647 0.779 . . . . 0.0 110.788 177.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -75.11 -50.11 17.42 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.736 0.814 . . . . 0.0 110.671 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.2 m -63.97 -34.61 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 123.516 0.51 . . . . 0.0 110.265 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.431 HE21 ' NE2' ' A' ' 20' ' ' GLN . 0.7 OUTLIER -54.59 -31.28 56.63 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.442 1.097 . . . . 0.0 111.03 177.661 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 49.4 mm-40 -88.97 -44.67 10.25 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 122.982 0.513 . . . . 0.0 111.015 -176.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.8 t -83.8 -17.91 39.45 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -171.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.539 HD23 ' SD ' ' A' ' 26' ' ' MET . 10.9 mt -66.2 118.64 10.2 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 123.163 0.585 . . . . 0.0 111.341 -177.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -110.99 140.84 23.14 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 124.726 1.21 . . . . 0.0 110.157 -176.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -67.22 85.01 0.34 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.32 2.68 . . . . 0.0 112.41 -177.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.8 2.6 1.41 Allowed Glycine 0 C--N 1.342 0.907 0 CA-C-N 115.355 -0.839 . . . . 0.0 112.696 178.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.539 ' SD ' HD23 ' A' ' 22' ' ' LEU . 6.0 ptp -85.96 168.91 13.73 Favored 'General case' 0 C--N 1.357 0.919 0 CA-C-O 121.455 0.645 . . . . 0.0 111.224 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.413 ' NH1' ' HB3' ' A' ' 42' ' ' GLU . 15.7 tpt85 -99.84 123.21 43.85 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 124.772 1.229 . . . . 0.0 110.066 -168.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.412 HG21 HG11 ' A' ' 57' ' ' VAL . 3.7 m -118.77 174.21 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 C-N-CA 123.696 0.798 . . . . 0.0 110.832 -174.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.531 ' HG2' ' HG2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -149.11 140.4 23.18 Favored 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 125.165 1.386 . . . . 0.0 107.836 -172.726 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.4 tpt -94.81 113.69 25.47 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.931 0.892 . . . . 0.0 109.671 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.625 HD11 ' HA ' ' A' ' 72' ' ' MET . 3.6 pp -97.73 4.24 49.97 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 122.721 0.409 . . . . 0.0 111.678 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -133.07 162.43 31.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.156 0.583 . . . . 0.0 109.965 -170.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -89.04 122.6 32.54 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.259 0.624 . . . . 0.0 109.694 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -121.25 170.56 9.47 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.565 0.698 . . . . 0.0 112.292 -176.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -53.54 -49.03 68.51 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 113.781 -1.554 . . . . 0.0 112.178 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -128.67 1.45 5.5 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.404 0.682 . . . . 0.0 111.412 -177.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.2 mp -118.92 144.85 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 176.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.5 m -112.0 156.59 21.9 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 122.871 0.468 . . . . 0.0 109.758 176.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.3 116.7 6.91 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 172.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 126.06 -25.37 5.52 Favored Glycine 0 N--CA 1.469 0.883 0 N-CA-C 111.693 -0.563 . . . . 0.0 111.693 -173.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -76.85 155.21 33.14 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.144 0.578 . . . . 0.0 110.693 175.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.531 ' HG2' ' HG2' ' A' ' 29' ' ' ARG . 51.3 mt-10 -135.13 155.26 51.02 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.848 0.859 . . . . 0.0 110.225 -169.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -147.58 -166.0 12.27 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.836 -0.62 . . . . 0.0 113.049 -170.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -136.52 137.4 40.26 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.584 0.754 . . . . 0.0 109.374 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.498 ' HE1' HG21 ' A' ' 55' ' ' VAL . 71.5 t80 -71.38 124.99 25.81 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.265 0.626 . . . . 0.0 109.799 176.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.534 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 21.4 mmm180 -109.3 -49.65 3.09 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 122.804 0.441 . . . . 0.0 110.499 -173.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.619 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.2 OUTLIER -164.72 169.14 17.19 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.225 1.01 . . . . 0.0 109.237 -177.766 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.491 ' HA ' HG23 ' A' ' 55' ' ' VAL . 13.8 p -138.19 166.16 24.85 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.669 0.788 . . . . 0.0 112.04 -171.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -112.49 134.62 53.92 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 171.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -84.63 -5.75 59.33 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.962 0.905 . . . . 0.0 112.231 -172.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -141.27 -22.17 0.26 Allowed Glycine 0 C--N 1.347 1.149 0 CA-C-N 116.099 -0.5 . . . . 0.0 113.002 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.642 HG22 ' HD2' ' A' ' 54' ' ' PRO . 5.2 mm -98.66 118.34 63.24 Favored Pre-proline 0 CA--C 1.553 1.061 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 -173.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HA ' ' HE1' ' A' ' 70' ' ' TRP . 21.1 Cg_endo -59.75 -32.07 95.05 Favored 'Trans proline' 0 CA--C 1.583 2.972 0 N-CA-C 117.884 2.225 . . . . 0.0 117.884 -175.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.642 ' HD2' HG22 ' A' ' 52' ' ' ILE . 60.9 Cg_endo -71.06 107.76 2.17 Favored 'Trans proline' 0 C--N 1.387 2.567 0 CA-C-N 122.94 2.086 . . . . 0.0 112.297 171.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.498 HG21 ' HE1' ' A' ' 45' ' ' PHE . 5.5 p -90.9 143.33 11.44 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 124.841 1.256 . . . . 0.0 111.0 171.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.619 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 1.9 mp0 -93.79 131.83 38.77 Favored 'General case' 0 CA--C 1.553 1.095 0 CA-C-O 121.29 0.567 . . . . 0.0 110.225 -176.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.482 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -139.39 137.54 40.73 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 C-N-CA 125.639 1.576 . . . . 0.0 108.106 -178.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -81.36 109.06 15.5 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 -177.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.448 ' HB2' HG22 ' A' ' 62' ' ' THR . 85.8 m95 -93.51 117.81 30.56 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 123.72 0.808 . . . . 0.0 109.299 178.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -61.38 -25.88 67.47 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.05 0.94 . . . . 0.0 111.462 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 45.6 t -60.46 -45.13 94.82 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.436 1.094 . . . . 0.0 111.75 -178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.448 HG22 ' HB2' ' A' ' 59' ' ' TRP . 7.1 t -105.88 -9.81 16.97 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.912 0.885 . . . . 0.0 110.711 -177.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.79 16.5 79.96 Favored Glycine 0 C--N 1.35 1.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 114.24 176.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -152.77 165.12 36.33 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 121.412 0.625 . . . . 0.0 111.844 -173.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.616 HG22 ' HB3' ' A' ' 56' ' ' GLN . 2.7 m -88.45 120.37 29.77 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.309 -177.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -127.1 157.68 39.04 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.455 0.645 . . . . 0.0 110.661 -173.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.633 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 12.1 m-90 -83.94 116.61 22.88 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.505 1.522 . . . . 0.0 109.816 -173.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.462 HG21 HD13 ' A' ' 73' ' ' LEU . 7.1 m -130.12 158.36 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.897 0.879 . . . . 0.0 109.738 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.457 ' HB3' ' SD ' ' A' ' 72' ' ' MET . 11.4 t-80 -86.79 147.87 25.65 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 122.953 0.501 . . . . 0.0 110.287 -177.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.427 ' HE1' ' HA ' ' A' ' 53' ' ' PRO . 81.3 m95 -57.2 -50.41 72.96 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.002 0.921 . . . . 0.0 111.571 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -72.78 -1.45 16.6 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.607 0.763 . . . . 0.0 112.005 -176.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.625 ' HA ' HD11 ' A' ' 31' ' ' LEU . 43.0 mtp -120.58 14.39 11.84 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.173 0.989 . . . . 0.0 110.756 -178.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.462 HD13 HG21 ' A' ' 68' ' ' VAL . 33.8 tp -123.37 124.37 42.78 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.91 0.884 . . . . 0.0 109.415 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.557 ' HB2' HD23 ' A' ' 31' ' ' LEU . 10.8 tp10 -106.52 142.97 35.3 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.387 1.075 . . . . 0.0 109.56 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 26.8 pt -113.84 128.57 70.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 121.085 0.469 . . . . 0.0 112.009 178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.416 HD23 ' HB2' ' A' ' 29' ' ' ARG . 3.9 mm? -114.32 5.95 15.94 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.966 0.906 . . . . 0.0 110.215 172.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.338 0 CA-C-O 119.352 -0.693 . . . . 0.0 112.565 176.879 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.0 t80 . . . . . 0 N--CA 1.471 0.592 0 CA-C-O 120.652 0.263 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.44 -38.25 90.81 Favored Glycine 0 C--N 1.341 0.808 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.625 178.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.535 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 4.5 mp0 -72.32 -31.59 65.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.617 -0.791 . . . . 0.0 109.757 178.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.408 ' O ' HG22 ' A' ' 21' ' ' THR . 11.4 t80 -67.37 -50.43 59.79 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 123.542 0.737 . . . . 0.0 110.533 178.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 34.8 m -63.65 -36.83 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 O-C-N 123.555 0.535 . . . . 0.0 109.964 -178.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -54.46 -34.41 61.44 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.12 0.968 . . . . 0.0 110.742 178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.535 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 58.0 mm-40 -84.11 -37.41 22.05 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.042 0.537 . . . . 0.0 111.112 -175.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.459 HG23 HD13 ' A' ' 75' ' ' ILE . 11.7 t -102.48 3.74 37.93 Favored 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 123.539 0.736 . . . . 0.0 112.414 -172.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.429 ' HA ' ' SD ' ' A' ' 26' ' ' MET . 8.8 mt -75.15 108.16 7.72 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 122.948 0.499 . . . . 0.0 109.672 174.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.586 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 39.7 mt-30 -85.8 130.72 49.62 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 123.657 0.783 . . . . 0.0 108.914 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -60.83 82.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.081 0 C-N-CA 123.333 2.689 . . . . 0.0 113.52 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 130.36 17.73 1.55 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.721 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.586 ' HB3' ' HB2' ' A' ' 23' ' ' GLN . 14.2 ptm -91.35 173.78 7.73 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.677 0.751 . . . . 0.0 111.267 -175.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.604 ' HB3' ' HA3' ' A' ' 77' ' ' GLY . 14.8 tpt85 -96.25 131.42 42.75 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.109 -169.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 46.2 t -121.54 154.36 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 C-N-CA 124.375 1.07 . . . . 0.0 111.396 -167.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 18.1 tpp180 -129.7 147.05 51.45 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 125.71 1.604 . . . . 0.0 108.092 169.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.426 ' HB2' ' CH2' ' A' ' 59' ' ' TRP . 32.9 tpp -98.41 129.45 45.05 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.011 0.924 . . . . 0.0 108.724 170.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.636 HD23 ' HB2' ' A' ' 74' ' ' GLU . 3.8 pp -106.88 2.38 25.34 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -176.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -140.6 172.37 12.81 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.543 0.337 . . . . 0.0 110.152 -178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -83.46 140.74 32.16 Favored 'General case' 0 N--CA 1.477 0.884 0 O-C-N 122.001 -0.437 . . . . 0.0 110.798 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -132.41 173.2 11.54 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.377 1.071 . . . . 0.0 110.427 -179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -50.57 -44.5 56.76 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.392 1.477 . . . . 0.0 112.674 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -138.23 4.19 2.44 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.455 0.702 . . . . 0.0 111.776 -175.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.2 mp -119.57 145.12 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 174.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.5 m -112.33 162.95 14.97 Favored 'General case' 0 C--O 1.245 0.835 0 C-N-CA 123.312 0.645 . . . . 0.0 109.887 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.3 118.69 9.03 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.193 0.597 . . . . 0.0 109.815 173.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.87 0.74 28.77 Favored Glycine 0 CA--C 1.528 0.853 0 CA-C-N 116.435 -0.348 . . . . 0.0 113.221 -177.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -88.95 156.4 18.91 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.043 0.449 . . . . 0.0 110.647 173.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -123.97 148.56 46.84 Favored 'General case' 0 C--O 1.241 0.636 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.392 -169.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -145.42 -170.06 14.08 Favored Glycine 0 C--N 1.34 0.794 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.091 -175.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -135.57 137.0 41.56 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 172.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.606 ' HZ ' ' HB3' ' A' ' 48' ' ' SER . 87.6 t80 -76.55 118.85 19.63 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 173.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.413 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 21.4 mmm-85 -105.3 -47.08 4.05 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -175.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.413 ' NE2' ' HB2' ' A' ' 46' ' ' ARG . 0.4 OUTLIER -152.86 158.66 42.5 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.959 -176.175 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.606 ' HB3' ' HZ ' ' A' ' 45' ' ' PHE . 77.4 p -116.46 175.69 5.45 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.846 0.858 . . . . 0.0 110.699 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.479 HD21 HE22 ' A' ' 56' ' ' GLN . 83.0 m-20 -129.04 130.25 46.34 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.859 179.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -76.19 -28.62 57.34 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.473 0.709 . . . . 0.0 111.693 -177.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -136.09 1.24 3.4 Favored Glycine 0 C--N 1.348 1.248 0 O-C-N 123.665 0.603 . . . . 0.0 114.093 -175.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.2 mm -111.26 103.74 55.32 Favored Pre-proline 0 N--CA 1.483 1.179 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.403 ' HA ' ' HE1' ' A' ' 70' ' ' TRP . 12.7 Cg_endo -55.39 -37.52 94.64 Favored 'Trans proline' 0 CA--C 1.577 2.67 0 C-N-CA 122.374 2.05 . . . . 0.0 116.565 -179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.736 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 71.8 Cg_endo -73.84 98.68 1.09 Allowed 'Trans proline' 0 C--N 1.384 2.399 0 CA-C-N 122.598 1.963 . . . . 0.0 112.097 169.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.546 HG23 ' HA ' ' A' ' 48' ' ' SER . 7.6 p -83.37 150.46 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 125.126 1.37 . . . . 0.0 111.588 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.479 HE22 HD21 ' A' ' 49' ' ' ASN . 1.7 mp0 -90.86 127.79 36.5 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.197 0.599 . . . . 0.0 110.362 -175.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.19 134.2 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 125.315 1.446 . . . . 0.0 107.722 178.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 69.3 t80 -81.28 107.81 14.37 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.531 ' HB2' HG22 ' A' ' 62' ' ' THR . 83.5 m95 -92.76 123.4 36.01 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 123.888 0.875 . . . . 0.0 109.408 178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -63.85 -29.04 70.27 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 123.777 0.673 . . . . 0.0 111.128 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 35.8 t -61.93 -46.71 88.12 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.166 0.986 . . . . 0.0 112.018 -175.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.531 HG22 ' HB2' ' A' ' 59' ' ' TRP . 9.8 t -98.6 -14.06 20.09 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.658 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.78 16.61 74.82 Favored Glycine 0 C--N 1.351 1.407 0 CA-C-N 116.126 -0.488 . . . . 0.0 114.165 176.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -152.14 165.85 33.5 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.409 0.623 . . . . 0.0 111.547 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 58' ' ' PHE . 0.2 OUTLIER -87.01 114.44 23.63 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 114.57 -1.195 . . . . 0.0 108.368 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -124.83 153.82 41.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.671 0.748 . . . . 0.0 110.391 -173.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.736 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 7.8 m0 -83.87 116.82 22.94 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.102 -172.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.9 m -131.21 149.35 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -76.22 147.64 38.23 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.403 ' HE1' ' HA ' ' A' ' 53' ' ' PRO . 59.1 m95 -53.11 -38.93 63.04 Favored 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 124.118 0.967 . . . . 0.0 111.453 -178.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -67.59 -28.41 67.74 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -175.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.411 ' HA ' HD11 ' A' ' 31' ' ' LEU . 4.9 mpp? -96.15 -5.56 40.37 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.497 0.319 . . . . 0.0 111.494 176.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.3 tt -90.1 122.23 32.88 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 174.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.636 ' HB2' HD23 ' A' ' 31' ' ' LEU . 35.1 tt0 -110.73 149.14 30.93 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.507 1.123 . . . . 0.0 108.698 174.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.459 HD13 HG23 ' A' ' 21' ' ' THR . 34.7 pt -99.72 125.28 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 170.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.422 HD13 ' NH1' ' A' ' 27' ' ' ARG . 4.1 tt -97.56 -60.86 1.48 Allowed 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.604 ' HA3' ' HB3' ' A' ' 27' ' ' ARG . . . . . . . . 0 C--N 1.346 1.088 0 O-C-N 124.438 1.086 . . . . 0.0 113.778 -168.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 60.7 t80 . . . . . 0 N--CA 1.483 1.222 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.3 -37.86 80.84 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-N 115.985 -0.552 . . . . 0.0 113.059 177.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -70.38 -34.21 72.32 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 123.438 0.695 . . . . 0.0 110.068 175.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -69.92 -49.68 49.56 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.201 0.6 . . . . 0.0 111.511 -177.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.0 m -59.11 -37.91 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 O-C-N 123.515 0.51 . . . . 0.0 110.772 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -54.48 -34.97 62.56 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.065 0.946 . . . . 0.0 111.835 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 42.1 mm-40 -81.63 -42.36 20.13 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.907 -175.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 10.6 t -92.14 3.34 55.51 Favored 'General case' 0 CA--C 1.563 1.449 0 C-N-CA 123.416 0.687 . . . . 0.0 112.175 -174.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 22' ' ' LEU . 0.1 OUTLIER -74.67 122.18 22.81 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 122.99 0.516 . . . . 0.0 110.2 177.522 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -104.2 132.43 20.99 Favored Pre-proline 0 N--CA 1.488 1.456 0 C-N-CA 123.832 0.853 . . . . 0.0 110.573 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.78 89.97 0.29 Allowed 'Trans proline' 0 C--N 1.378 2.119 0 C-N-CA 122.98 2.453 . . . . 0.0 111.245 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.8 -6.03 4.8 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.703 -0.681 . . . . 0.0 112.939 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 6.8 ptp -80.67 153.04 28.14 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 173.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.5 ptp180 -85.66 163.1 18.49 Favored 'General case' 0 C--O 1.245 0.832 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 177.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 15.1 m -133.99 171.14 18.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.436 ' HB2' ' HB2' ' A' ' 76' ' ' LEU . 2.5 tmt_? -136.58 138.35 41.15 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.445 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 3.0 tpt -85.65 111.15 19.82 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.239 1.016 . . . . 0.0 108.974 -178.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.485 HD11 ' HA ' ' A' ' 72' ' ' MET . 4.5 pp -91.04 -15.67 29.18 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 117.778 0.263 . . . . 0.0 111.248 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.445 ' O ' ' HG3' ' A' ' 30' ' ' MET . 21.3 t70 -125.75 151.91 46.05 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.753 0.821 . . . . 0.0 109.363 -176.171 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -80.45 119.34 23.01 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 122.663 0.385 . . . . 0.0 110.048 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -106.66 173.28 6.39 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.725 1.21 . . . . 0.0 111.645 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 -48.09 -58.79 4.0 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.364 1.466 . . . . 0.0 112.484 -175.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -121.67 5.54 10.03 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.077 0.951 . . . . 0.0 111.39 -177.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.3 mp -120.0 133.29 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 173.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.6 m -99.92 155.44 17.68 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 122.992 0.517 . . . . 0.0 109.854 177.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.89 115.86 6.44 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 175.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 132.55 -29.23 3.31 Favored Glycine 0 C--N 1.345 1.062 0 N-CA-C 111.743 -0.543 . . . . 0.0 111.743 -172.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -74.51 157.36 35.65 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.51 0.724 . . . . 0.0 111.756 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' A' ' 60' ' ' GLN . 41.5 mt-10 -115.73 153.68 30.94 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.782 0.833 . . . . 0.0 111.057 -177.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -136.83 -170.26 11.88 Favored Glycine 0 C--N 1.34 0.785 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.866 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -139.0 140.93 38.32 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 170.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.464 ' HA ' HG12 ' A' ' 57' ' ' VAL . 84.5 t80 -76.71 121.78 23.78 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 123.037 0.535 . . . . 0.0 110.645 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.528 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 19.9 mmm180 -108.51 -48.39 3.34 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.324 0.65 . . . . 0.0 110.141 -174.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.528 ' NE2' ' HB2' ' A' ' 46' ' ' ARG . 0.2 OUTLIER -158.91 161.13 36.74 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.154 0.982 . . . . 0.0 109.636 -177.764 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.498 ' HA ' HG23 ' A' ' 55' ' ' VAL . 14.5 p -130.96 171.63 12.99 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-O 121.877 0.846 . . . . 0.0 111.896 -176.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.543 ' HB2' ' HB ' ' A' ' 52' ' ' ILE . 1.0 OUTLIER -147.93 119.23 7.82 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 113.576 -1.647 . . . . 0.0 108.198 -178.498 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -83.23 -30.31 27.78 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.453 0.701 . . . . 0.0 110.621 -173.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.8 -23.84 22.09 Favored Glycine 0 C--N 1.346 1.086 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.782 178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.544 HG22 ' HD2' ' A' ' 54' ' ' PRO . 42.8 mm -102.28 113.31 65.92 Favored Pre-proline 0 N--CA 1.482 1.159 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -64.76 -29.28 59.51 Favored 'Trans proline' 0 CA--C 1.581 2.859 0 N-CA-C 118.088 2.303 . . . . 0.0 118.088 -177.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.593 ' HB2' ' HB3' ' A' ' 67' ' ' TRP . 93.3 Cg_endo -80.36 108.61 2.19 Favored 'Trans proline' 0 C--N 1.379 2.15 0 CA-C-N 123.376 2.242 . . . . 0.0 112.084 168.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.498 HG23 ' HA ' ' A' ' 48' ' ' SER . 7.7 p -81.08 146.69 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 C-N-CA 124.031 0.933 . . . . 0.0 110.71 172.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.559 ' HB3' HG22 ' A' ' 65' ' ' THR . 1.9 mp0 -93.74 127.91 39.69 Favored 'General case' 0 CA--C 1.555 1.136 0 CA-C-O 121.191 0.519 . . . . 0.0 109.604 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.464 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -138.26 135.19 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 125.448 1.499 . . . . 0.0 108.052 -179.662 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 65' ' ' THR . 47.6 t80 -80.92 106.76 13.18 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 -177.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.489 ' HB2' HG22 ' A' ' 62' ' ' THR . 86.5 m95 -89.9 123.06 33.51 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.796 0.838 . . . . 0.0 109.811 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' A' ' 42' ' ' GLU . 16.9 pt20 -62.17 -28.11 69.43 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.19 0.996 . . . . 0.0 111.663 175.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 26.9 t -63.86 -44.49 92.96 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.853 0.861 . . . . 0.0 111.766 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.489 HG22 ' HB2' ' A' ' 59' ' ' TRP . 8.9 t -105.24 -6.01 20.12 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.494 0.718 . . . . 0.0 111.246 -178.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.32 15.93 80.03 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 114.438 0.535 . . . . 0.0 114.438 175.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -152.83 165.94 33.81 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.323 0.582 . . . . 0.0 112.053 -172.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.559 HG22 ' HB3' ' A' ' 56' ' ' GLN . 2.0 m -87.26 117.99 26.39 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.307 -1.315 . . . . 0.0 109.141 -177.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -125.86 156.82 39.01 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.461 0.648 . . . . 0.0 110.651 -171.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.593 ' HB3' ' HB2' ' A' ' 54' ' ' PRO . 11.9 m-90 -84.37 111.53 19.52 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 125.62 1.568 . . . . 0.0 109.488 -173.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.0 m -130.25 149.65 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.492 0.717 . . . . 0.0 110.092 178.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 -78.5 146.61 34.28 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 122.766 0.426 . . . . 0.0 110.491 -176.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -61.07 -46.17 91.73 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.57 0.748 . . . . 0.0 112.071 -176.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -67.95 -22.22 65.05 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.17 0.588 . . . . 0.0 111.266 -178.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.485 ' HA ' HD11 ' A' ' 31' ' ' LEU . 38.5 mtp -101.85 13.28 35.27 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.764 1.226 . . . . 0.0 110.694 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -117.84 125.71 51.05 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -105.44 150.99 24.8 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 173.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.4 pt -111.15 116.16 51.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 C-N-CA 123.717 0.807 . . . . 0.0 110.11 176.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.436 ' HB2' ' HB2' ' A' ' 29' ' ' ARG . 18.1 tp -100.65 -1.2 35.9 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 123.179 0.592 . . . . 0.0 109.918 178.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.789 0 CA-C-O 119.139 -0.811 . . . . 0.0 114.012 174.592 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 62.4 t80 . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.82 -34.89 83.95 Favored Glycine 0 C--N 1.341 0.812 0 O-C-N 123.623 0.577 . . . . 0.0 112.797 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 20' ' ' GLN . 44.6 mp0 -71.3 -41.4 69.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 123.945 0.898 . . . . 0.0 109.445 177.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.44 ' O ' HG22 ' A' ' 21' ' ' THR . 18.8 t80 -59.36 -51.17 71.07 Favored 'General case' 0 C--N 1.358 0.958 0 O-C-N 123.85 0.719 . . . . 0.0 110.964 178.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 29.7 m -63.17 -40.1 87.77 Favored 'Isoleucine or valine' 0 C--N 1.356 0.865 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -58.49 -47.48 83.96 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 124.003 0.815 . . . . 0.0 110.873 -179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 16' ' ' GLU . 22.6 mm-40 -64.52 -46.37 83.2 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 120.714 0.293 . . . . 0.0 110.868 -175.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 17' ' ' TYR . 14.7 t -93.15 13.07 22.15 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 123.457 0.703 . . . . 0.0 111.93 -175.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.729 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.1 OUTLIER -70.94 114.96 9.53 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.91 0.484 . . . . 0.0 109.723 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.654 ' HB2' ' HB3' ' A' ' 26' ' ' MET . 50.0 mt-30 -87.98 137.94 31.24 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.696 0.798 . . . . 0.0 110.777 -177.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.476 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 29.8 Cg_exo -62.74 88.16 0.12 Allowed 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.39 2.727 . . . . 0.0 113.118 177.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 106.72 40.96 1.79 Allowed Glycine 0 C--N 1.35 1.309 0 N-CA-C 110.238 -1.145 . . . . 0.0 110.238 173.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.729 ' SD ' HD13 ' A' ' 22' ' ' LEU . 20.3 ptm -98.82 177.66 5.21 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.719 0.771 . . . . 0.0 110.814 -177.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -96.56 122.03 39.04 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.19 1.396 . . . . 0.0 108.942 -177.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.0 m -117.0 171.74 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.146 0.578 . . . . 0.0 109.607 178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.2 tpp180 -143.01 143.26 31.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.103 1.361 . . . . 0.0 107.705 -176.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . . . . . . . . . 1.7 tpt -88.3 125.53 34.72 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.465 HD11 ' HA ' ' A' ' 72' ' ' MET . 4.4 pp -105.38 -9.74 17.39 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 122.627 0.371 . . . . 0.0 111.085 178.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -125.16 156.14 38.86 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.336 0.655 . . . . 0.0 110.27 -175.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -87.23 121.01 29.1 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.217 0.607 . . . . 0.0 109.752 -178.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.553 ' HB2' ' HB ' ' A' ' 37' ' ' ILE . 10.4 m-85 -110.68 173.39 6.35 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.512 1.125 . . . . 0.0 111.772 -175.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -50.41 -52.86 33.9 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.435 1.494 . . . . 0.0 111.401 178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.526 ' HG3' HG13 ' A' ' 37' ' ' ILE . 10.0 pt-20 -117.3 -19.2 9.69 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.815 -174.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 34' ' ' TYR . 4.6 mt -104.89 145.75 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.45 1.1 . . . . 0.0 108.995 -176.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.3 m -110.72 152.29 26.74 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 176.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.48 113.66 4.88 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 174.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 138.17 -29.1 2.65 Favored Glycine 0 C--N 1.346 1.109 0 CA-C-O 119.569 -0.573 . . . . 0.0 113.711 -178.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -90.42 160.68 15.93 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 118.06 0.93 . . . . 0.0 111.927 -178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -109.26 159.99 16.5 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.922 0.889 . . . . 0.0 111.641 -164.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -141.64 -176.14 15.69 Favored Glycine 0 C--O 1.241 0.58 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.481 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -133.97 140.52 46.79 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 174.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.539 ' HA ' HG12 ' A' ' 57' ' ' VAL . 78.1 t80 -72.37 121.96 20.38 Favored 'General case' 0 C--N 1.342 0.261 0 O-C-N 123.494 0.496 . . . . 0.0 110.244 178.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.518 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 7.5 mmm180 -108.35 -47.76 3.46 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 -177.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.537 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -166.31 151.24 8.07 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.05 0.94 . . . . 0.0 109.561 179.061 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.42 ' HA ' HG23 ' A' ' 55' ' ' VAL . 30.8 p -118.02 178.23 4.5 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.234 1.014 . . . . 0.0 111.004 -179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -130.14 121.62 26.66 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 168.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -64.29 -40.63 96.35 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.315 0.646 . . . . 0.0 112.096 -167.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -121.16 12.68 9.72 Favored Glycine 0 N--CA 1.471 1.031 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.91 -176.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.574 HG22 ' HD2' ' A' ' 54' ' ' PRO . 19.7 mm -121.51 110.47 33.87 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 176.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -59.94 -29.03 88.44 Favored 'Trans proline' 0 CA--C 1.577 2.664 0 N-CA-C 118.901 2.616 . . . . 0.0 118.901 -171.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.574 ' HD2' HG22 ' A' ' 52' ' ' ILE . 55.3 Cg_endo -69.32 105.3 1.39 Allowed 'Trans proline' 0 C--N 1.381 2.269 0 CA-C-N 123.112 2.147 . . . . 0.0 112.092 172.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.42 HG23 ' HA ' ' A' ' 48' ' ' SER . 3.2 p -89.53 138.77 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.238 1.015 . . . . 0.0 109.923 169.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.537 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 2.1 mp0 -92.73 124.1 36.49 Favored 'General case' 0 CA--C 1.549 0.936 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -134.65 142.37 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.913 1.285 . . . . 0.0 108.631 -179.19 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -84.84 107.66 17.12 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -178.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.564 ' HB2' HG22 ' A' ' 62' ' ' THR . 83.2 m95 -91.06 127.46 36.49 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.751 0.821 . . . . 0.0 110.133 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.55 -21.37 63.63 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.762 0.664 . . . . 0.0 112.01 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.9 t -65.99 -46.28 78.59 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.08 0.552 . . . . 0.0 112.132 177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.564 HG22 ' HB2' ' A' ' 59' ' ' TRP . 9.9 t -97.41 -16.14 20.34 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.816 0.846 . . . . 0.0 110.351 -177.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.18 15.68 80.72 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.494 -0.615 . . . . 0.0 114.037 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.1 ptt180 -151.4 176.99 10.73 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 117.632 0.716 . . . . 0.0 111.252 -174.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.08 138.52 31.43 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.38 1.072 . . . . 0.0 109.268 178.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.9 t80 -141.8 156.48 45.56 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-O 121.06 0.457 . . . . 0.0 110.966 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 14.4 m-90 -83.07 106.72 15.12 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.777 1.231 . . . . 0.0 109.98 -177.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.6 m -121.19 156.77 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.226 0.61 . . . . 0.0 110.129 177.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -89.44 146.48 24.62 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.697 0.799 . . . . 0.0 109.675 -176.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -56.17 -49.3 74.41 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 123.866 0.866 . . . . 0.0 112.607 -179.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -70.06 -19.97 63.26 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.428 0.691 . . . . 0.0 111.582 -177.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.465 ' HA ' HD11 ' A' ' 31' ' ' LEU . 31.2 mtp -100.26 1.55 41.88 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.708 0.803 . . . . 0.0 111.23 176.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.0 tt -104.48 130.71 52.38 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.617 1.167 . . . . 0.0 108.235 170.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.42 ' HB2' HD23 ' A' ' 31' ' ' LEU . 41.3 tt0 -107.45 146.89 31.16 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.103 0.961 . . . . 0.0 108.746 173.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.1 pt -111.56 121.09 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-O 120.831 0.348 . . . . 0.0 110.116 170.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 88.9 mt -121.0 14.57 11.51 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.845 0.858 . . . . 0.0 110.396 174.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.117 0 CA-C-N 115.507 -0.77 . . . . 0.0 113.375 172.958 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 73.1 t80 . . . . . 0 N--CA 1.487 1.411 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.5 -44.93 39.28 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-O 121.785 0.658 . . . . 0.0 113.357 -178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.3 mp0 -70.92 -26.19 63.09 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 123.191 0.596 . . . . 0.0 109.682 -178.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -71.28 -49.22 45.15 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.456 1.102 . . . . 0.0 111.585 174.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.2 m -62.71 -33.99 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 122.563 0.345 . . . . 0.0 110.426 -178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -52.85 -33.35 49.18 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.22 1.008 . . . . 0.0 110.545 177.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -80.66 -53.42 6.54 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.208 0.603 . . . . 0.0 110.577 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.5 t -90.94 17.07 8.32 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.649 0.78 . . . . 0.0 112.463 -167.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.66 HD13 ' SD ' ' A' ' 26' ' ' MET . 0.2 OUTLIER -76.24 149.76 37.13 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 173.25 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.534 ' N ' HE21 ' A' ' 23' ' ' GLN . 0.0 OUTLIER -117.69 140.24 27.34 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.252 1.021 . . . . 0.0 109.612 177.045 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.509 ' HA ' ' HD2' ' A' ' 45' ' ' PHE . 72.8 Cg_endo -72.68 78.98 1.98 Allowed 'Trans proline' 0 C--N 1.373 1.853 0 C-N-CA 123.34 2.693 . . . . 0.0 113.429 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.67 28.31 0.82 Allowed Glycine 0 C--N 1.352 1.422 0 N-CA-C 112.13 -0.388 . . . . 0.0 112.13 173.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.66 ' SD ' HD13 ' A' ' 22' ' ' LEU . 27.8 ptm -98.95 170.84 8.44 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.241 0.616 . . . . 0.0 111.29 -176.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 16.8 tpp180 -82.76 124.3 30.13 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.179 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.0 m -116.45 170.47 6.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 174.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.472 ' HE ' ' HG2' ' A' ' 42' ' ' GLU . 21.4 tpp85 -138.41 153.57 48.89 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -175.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' MET . . . . . 0.436 ' HG3' ' O ' ' A' ' 32' ' ' ASP . 11.4 tpt -97.26 124.57 41.41 Favored 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 26.2 tp -96.23 -9.69 29.8 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.456 0.702 . . . . 0.0 111.258 -173.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 30' ' ' MET . 12.2 t70 -151.22 157.03 42.1 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.282 0.633 . . . . 0.0 109.325 -178.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -73.43 142.16 46.9 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 -179.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -132.44 172.19 12.8 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 122.979 0.511 . . . . 0.0 110.434 -177.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -40.74 -55.53 2.39 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 126.178 1.791 . . . . 0.0 113.05 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -124.19 0.4 8.41 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.552 -172.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.6 mt -118.71 138.72 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 124.142 0.977 . . . . 0.0 108.508 -175.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 23.2 m -87.9 150.94 23.19 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 122.915 0.486 . . . . 0.0 110.426 177.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.17 119.71 11.94 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 171.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.71 11.91 54.31 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.969 -177.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -79.56 153.49 29.45 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 122.91 0.484 . . . . 0.0 110.079 175.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.472 ' HG2' ' HE ' ' A' ' 29' ' ' ARG . 48.5 mt-10 -112.62 120.44 41.57 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.929 0.492 . . . . 0.0 110.601 -176.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -107.94 -172.6 21.87 Favored Glycine 0 C--O 1.243 0.683 0 CA-C-N 115.047 -0.978 . . . . 0.0 111.569 173.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -134.04 138.21 45.2 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 171.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.509 ' HD2' ' HA ' ' A' ' 24' ' ' PRO . 64.1 t80 -70.47 123.27 21.37 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.54 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 21.7 mmm180 -106.36 -49.41 3.35 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -177.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.567 ' NE2' ' HB2' ' A' ' 56' ' ' GLN . 0.1 OUTLIER -167.71 167.29 13.34 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.929 -179.406 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 72.3 p -141.51 -179.93 6.44 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 123.825 0.85 . . . . 0.0 110.922 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -122.64 121.76 37.2 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 168.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -68.92 -28.0 66.26 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.279 1.032 . . . . 0.0 112.071 -172.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -102.15 -34.51 4.23 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.981 177.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.547 HG22 ' HD2' ' A' ' 54' ' ' PRO . 12.7 mm -98.44 113.72 64.47 Favored Pre-proline 0 N--CA 1.481 1.088 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 -171.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.78 -25.73 74.83 Favored 'Trans proline' 0 CA--C 1.577 2.667 0 N-CA-C 118.831 2.589 . . . . 0.0 118.831 -169.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.547 ' HD2' HG22 ' A' ' 52' ' ' ILE . 45.6 Cg_endo -67.14 110.22 1.93 Allowed 'Trans proline' 0 C--N 1.385 2.492 0 CA-C-N 123.597 2.32 . . . . 0.0 111.594 169.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.78 141.67 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.134 0.974 . . . . 0.0 110.152 170.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.567 ' HB2' ' NE2' ' A' ' 47' ' ' GLN . 1.6 mp0 -93.32 121.34 34.6 Favored 'General case' 0 CA--C 1.55 0.953 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.472 HG12 ' HA ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -135.87 137.2 49.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 124.977 1.311 . . . . 0.0 108.403 -177.136 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -83.59 106.08 15.03 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.494 ' HB2' HG22 ' A' ' 62' ' ' THR . 87.5 m95 -95.6 131.62 41.62 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.367 1.067 . . . . 0.0 110.326 -176.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -69.36 -25.05 63.99 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 123.847 0.717 . . . . 0.0 112.268 178.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 47.8 t -59.65 -44.17 93.64 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.348 0.594 . . . . 0.0 110.881 178.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.494 HG22 ' HB2' ' A' ' 59' ' ' TRP . 10.1 t -105.16 -14.49 15.37 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.957 -1.019 . . . . 0.0 111.826 -174.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.13 15.83 81.13 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.111 -0.495 . . . . 0.0 114.097 178.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -152.94 173.46 15.36 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.317 0.579 . . . . 0.0 111.578 -172.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.1 132.67 34.22 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.14 1.376 . . . . 0.0 109.576 -178.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -141.5 158.11 44.27 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.265 0.555 . . . . 0.0 111.695 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -88.2 115.75 25.92 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.497 1.519 . . . . 0.0 109.776 -174.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.81 147.53 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 123.861 0.865 . . . . 0.0 109.251 177.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.605 ' HD2' ' H ' ' A' ' 71' ' ' HIS . 15.5 t60 -73.3 146.88 45.0 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 175.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -54.1 -31.26 51.51 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.57 1.548 . . . . 0.0 113.863 -177.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . 0.605 ' H ' ' HD2' ' A' ' 69' ' ' HIS . 59.1 t-80 -79.39 -18.11 52.99 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.731 0.812 . . . . 0.0 111.191 -173.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 61.5 mtm -100.31 4.84 44.35 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.484 0.714 . . . . 0.0 110.655 171.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.8 tt -103.68 120.32 40.69 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 170.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -105.19 129.09 53.65 Favored 'General case' 0 C--O 1.22 -0.492 0 C-N-CA 124.314 1.046 . . . . 0.0 108.235 176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.9 pt -96.54 115.44 35.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-O 121.543 0.687 . . . . 0.0 109.896 175.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 18.1 tp -127.11 11.1 6.99 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 124.125 0.97 . . . . 0.0 109.181 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 1.663 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.949 171.252 . . . . . . . . 0 0 . 1 stop_ save_